ML20082S639
| ML20082S639 | |
| Person / Time | |
|---|---|
| Site: | Wolf Creek  |
| Issue date: | 12/31/1994 |
| From: | Hagan R WOLF CREEK NUCLEAR OPERATING CORP. |
| To: | NRC OFFICE OF INFORMATION RESOURCES MANAGEMENT (IRM) |
| References | |
| ET-95-0035, ET-95-35, NUDOCS 9505030148 | |
| Download: ML20082S639 (238) | |
Text
-
r i
I W@ NUCLEAR )LF CREEK OPERATING C i 1
l April 26, 1995 2T 95-0035 U. S. Nuclear Regulatory Commission ATTN: Document Control Desk Mail Stat 4.on P1-137 Washington, D. C. 20555 .i
Subject:
Docket No. 50-482: Annual Radioactive Effluent Release Report Gentlemen:
Enclosed is the Wolf Creek Generating Station (WCGS) Annual Radioactive Efflut.nt Release Report covering the period frotr January 1, 1994, through December 31, 1994. This report is being submitted pursuant to M:: tion 6.9.1.7 of the WCGS unit No. 1, Technical Specifications.
'If you should have any questions regarding this submittal, please contact me at (316) 364-8831, ext ension 4553, or Mr. Richard D.
Flanid/Jan at extension 4500.
Very truly yours, 7
.' (d obert C. Hagan RCH/jad Enclosure cc: L. J. Callan (NRC), w/e D. F. Kirsch GC) , w/e l J. F. Ringwald (NRC), w/e l J. C. Stone (NRC), w/e I 9505030148 941231 PDR ADDCK 05000482 X l R PDR /'
l 1 PO. Box 411/ Burlington. KS 66839 i Pnone. (316) 364-8831 An Equal C4iport;ruty Employer M F HC VET l
~ ~ ~ ~ ~~
- f. ,
Enclosure to ET 95-0035 Page of32 t
i i
i Wolf Creek Nuclear Operating Corporation Wolf Creek Generating Station j Docket No: 50-482 Facility Operating License No: NPF-42 ;
l Annual Radioactive EfGuent Release Report f
Report No.18 ;
i i
Reporting Period: January 1,1994 - December 31,1994 I
i r
f
]
Enclosure to ET 95-0035 Page 2 of 32 Table of Contents l Section I Liquid Radioactive Emuents 4 l Dose Summary 8 l Airborne Radioactive Effluents 10 i Dose Summary 13 l
Section 11 r Offsite Dose Calculation Manual Limits 15 !
Maximum Permissible Concentrations 15 I
Measurements and Approximations of Total Reactivity 16 Batch Releases 18 :
Cor;inuous Releases 18 l Doses to a Member of the Public from Activitics inside the Site Boundary 18 i Percentage Emuent Concentration Limit 19 (
Solid Waste Shipments 20 !
Irradiated Fuel Shipments 22 l Section III t
Meteorological Data 24 l Section IV Unplanned or Abnormal Releases 32 f Offsite Dose Calculation Manual 32 l Major Changes to Liquid, Gaseous or Solid Radwaste Systems 32 l
Land Use Census 32 i Radioactive Shipments 32 !
Inoperability of Airborne Effluent Monitoring Instrumentation 32 Storage Tanks 32 l Attachment 1
(
Offsite Dose Calculation Manual 1
I i
1 i
i i
I
Enclosure to ET 95-0035 Page 3 of 32 EXECUTIVE
SUMMARY
The p> rpose of the Annual Radioactive Effluent Release Report is to report on the quantities of liquid and gaseous effluents and solid waste released from Wolf Creek Generating Station (WCGS). This report covers the period beginning on January 1,1994, and ending on December 31,1994.
Section 1 provides a summary of the quantities of radioactive liquid and gaseous effluents for this reporting period. The format used is recommended in Regulatory Guide 1.21, Revision 1. An elevated release pathway does not exist at WCGS, therefore, all airborne releases are considered to be ground level releases.
The concurrent meteorological condition gaseous pathway dose determination is met by the WCGS Offsite Dose Calculation Manual (ODCM) methodology of assigning all gaseous pathways to a hypothetical individual residing at the highest annual X/Q and D/Q location. This results in a conservative estimate of dose to a member of the public rather than determining each pathway dose for each release condition. A conservative error of thirty percent has been estimated in the effluent data.
Sections 11,111 and IV provide additional information required by Regulatory Guide 1.21, Revision 1 and ODCM Section 7.2. Attachment I provides an updated Offsite Dose Calculation Manual.
l l
l l
Enclosure to ET 95-0035 Page 4 of 32 Section I Report of Radioactive Effluents (1994): Lionid Tvoe of Effluent )). nil Ouarter 1 Quarter 2 A. Fission and Activation Products
- 1. Total Release (not including tritium, gases, alpha) Ci 2.31E-02 1.60E-02
- 2. Average Diluted Concentration During Period uCi/ml 5.04 E-09 4.28E-09
- 3. Percent of Applicable Limit (1) % 4.63E-01 3.20E-01 B. Tritium
- 1. Total Release Ci 4.55E+02 1.62 E+02
- 2. Average Diluted Concentration During Period uCi/ml 9.90E-05 4.33 E-05
- 3. Percent of Applicable Limit (MPC) (2) % 3.30E+00 1.44 E+00 (ECL) % 9.90E+00 4.33 E+00 C. Dissolved and Entrained Gases
- 1. Total Release Ci 1.22E-01 1.53E-01
- 2. Average Diluted Concentration During Period uCi/ml 2.66E-08 4.09E-08
- 3. Percent of Applicable Limit (3) % 1.33E-02 2.05E-02 D. Gross Alpha Radioactivity
- 1. Total Release Ci 5.53E-05 5.03E-06 E. Volume of Waste Release (prior to dilution) Liters 1.08E+08 9.56E+07 F. Volume of Dilution Water Used Liters 4.49E+09 3.64E+09 (1) The applicable limit for the WCGS is 5 Curies per year. (Reference 10 CFR 50, Appendix 1, " Guides on Design Objective For Light-Water-Cooled Nuclear Power Reactors," paragraph A.2). The value printed here is derived by dividing the total released Curies by 5 Curies and then multiplying the result by 100.
(2) This salue is derised by the following formula:
?6 of Applicable Limit = ( Averace Diluted Concentration)(100)
(MPC/ECL, Appendix D. Table 11/210CFR20)
(3) This value is derised by the following formula:
46 of Applicable Limit = ( Averace Diluted Concentration) (100)
(2E-4 from ODCM Section 2.1) l l
l i
. . . _- __ _ __ _ . . _ ~. _ __ .__m_. . _. _.
l
!1 Enclosure to ET 95-0035 !
Page 5 of 32 l
Section I i i
Renort of Dadtaactive Emnents (1994h I.inuid j i
i Tvoc of Effluent Unil Ouarter 3 Ouarter 4 -l l
A. Fission and Activation Products !
1,. Total Release (not including tritium, gases, alpha) Ci 1.llE-01 1.97E-01 l
- 2. Average Diluted Concentration During Period uCi/ml 5.26E-09 6.41E-09 l
- 3. Percent of Applicable Limit (1) % 2.21E+00 3.94E+00 !
B. Tritium j
- 1. Total Release Ci 3.30E+02 2.71E+01 l
- 2. Average Diluted Concentration During Period uCi/mi 1.57E-05 8.80E-07 !
- 3. Percent of Applicable Limit (MPC) % 5.24E-01 2.93E-02 'i (ECL) (2) % 1.57E+00 8.80E-02 C. Dissolved and Entrained Gases .
- 1. Total Release Ci 2.72E+01 3.32E-02 i
- 2. Average Diluted Concentration During Period uCi/ml 1.29E-06 1.08E-09 !
- 3. Percent of Applicable Limit (3) % 6.47E-01 5.38E-04 D. Gross Alpha Radioactivity l l
- 1. Total Release Ci 2.98E-05 9.38E-06 !
E. Volume of Waste Release (prior to dilution) Liters 5.50E+06 8.54E+07 r 4 !
F. Volume of Dilution Water Used Liters 2.10E+10 3.07E+10 l V
(1) The applicable limit for the WCGS is 5 Curies per year. (Reference 10 CFR 50, Appendix 1, " Guides on Design Objective for Light-Water-Cooled Nuclear Power Reactors," paragraph A.2). The value printed here [
is derived by dividing the total released Curies by 5 Curies and then multiplying the result by 100.
(2) This value is derived by the following fonnula:
% of Applicable Lirnit = (Averace Diluted Concentration)(100)
(MPC/ECL, Appendix B, Table II/210CFR20)
(3) This value is derived by the following formula:
% of Applicable Limit = (Averane Diluted Concentration)(100)
(2E-4 from ODCM Section 2.1) i i
1 h
I i
i t
I i
j
Enclosure to IIT 95-0035 Page 6 of 32 LIOUID EFFLUENTS Continuous Mode Batch Mode Nudides Released I,Init Ouarter 1 Ouarter 2 Ouarter 1 Ouarter 2 H-3 Ci 4.55E-01 5.60E-01 4.54 E+02 1.61E+02 Cr-51 Ci 0.00E+00 0.00E+00 3.30E-05 0.00E+00 Mn-54 Ci <5.36E-02 <4.75E-02 2.34E-04 3.68E-04 Fe-55 Ci <l .07E-01 <9.50E-02 6.05E-03 4.87E-03 Fe-59 Ci <5.36E-02 <4.5 E-02 <5.13 E-04 <3.34 E-04 Co-57 Ci 0.00E+00 0.00E+00 1.33E-04 3.12E-05 Co-58 Ci 6.58E-07 <4.75E-02 5.02E-03 5.15E-04 Co-60 Ci 2.74 E-07 <4.75E-02 5.73E-03 7.81 E-03 Zn-65 Ci <5.36E-02 <4.75E-02 <5.13 E-04 <3.34E-04 Sr-89 Ci <5.36E-03 <4.75 E-03 <5.13E-05 <3.34E-05 Sr-90 Ci <5.36E-03 <4.75 E-03 <5.13 E-05 1.16E-05 Nb-95 Ci 0.00E+00 0.00E+00 7.76E-05 0.00E+00 Tc-99M Ci 0.00E+00 0.00E+00 0.00E+00 3.66E-05 Mo-99 Ci <5.36E-02 <4.75E-02 <5.13 E-04 <3.34 E-04 Ag-110M Ci 0.00E+00 0.00E+00 3.40E-06 5.49E-05 Sn-ll3 Ci 0.00E+00 0.00E+00 3.34E-06 0.00E+00 Sn-117M Ci 0.00E+00 0.00E+00 9.53 E-06 0.00E+00 Sb-125 Ci 7.33E-07 0.00E+00 4.86E-03 8.90E-04 I-131 Ci <l .07E-01 <9.50E-02 4.97E-05 2.66E-04 1-133 Ci 0.00E+00 0.00E+00 6.10E-06 1.30E-05 Cs-134 Ci <4.75 E-02 3.98E-04 4.21 E-04 Cs-137 Ci <5.36E-02 <4.75 E-02 5.23E-04 5.85E-04 La-140 Ci 0.00E400 0.00E+00 0.00E+00 6.40E-06 Ce-141 Ci <5.36E-02 <4.75E-02 <5.13 E-04 <3.34 E-04 Ce-144 Ci <5.36E-02 <4.75E-02 <5.13 E-04 1.03E-04 Ar-41 Ci <l .07E+00 <9.50E-01 <l .03 E-02 <6.68E-03 Kr-85M Ci < l .07E+00 <9.50E-01 1.05E-05 <6.68E-03 Kr-85 Ci <l .07E+00 <9.50E-01 <l .03 E-02 3.06E-03 Kr-87 Ci <l .07E+00 <9.50E-01 <l .C3 E-02 1.32E-04 Kr-88 Ci <l .07E+00 <9.50E-01 <l .03 E-02 <6.68E-03 Xe-131 M Ci <l .07E+00 <9.50E-01 1.15E-03 2.45E-03 Xe-133M Ci <l .07E+00 <9.50E-01 1.10E-03 7.02E-04 Xe-133 Ci <l .07E+00 <9.50E-01 1.18E-01 1.46E-01 Xe-135 Ci <l .07E+00 <9.50E-01 1.26E-03 8.02 F.0 %
Xe-138 Ci < l .07E+00 <9.50E-01 <l .03 E-02 (6 e41.-03 G-ALPilA Ci <l .07E-02 <9.50E-03 5.52E-05 5.03 E-06 PERIOD 10TAl- Ci 4.55E-01 5.60E-01 4.54 E+02 1.61E+02 NOTE: Less than values are calculated using the lower limit of detection (LLD) values listed in Table 2-1 of the ODCM muhiplied by the solume of waste discharged during the respective quarter. The less than values are not included in the summation for the total release values.
1
)
S, t Enclosure to ET 95-0035 l Page 7 of 32 -
t LIQUID EFFLUENTS Continuous Mode Batch Mode f Nucliden Released IJnig Ouarter 3 Ouarter 4 Ouarter 3 Ouaner 4 11-3 Ci 1.54 E-02 1.27E 3.30E+02 2.70E+01 Na-24 Ci 0.00E+00 0.00E+00 4.02E-06 3.34E-05 Cr-51 Ci 0.00E+00 0.00E+00 4.88E-03 3.02E-02 Mn-54 Ci <l .35E-03 <4.23 E-02 1.07E-03 1.82E-03 (
Fe-55 Ci <2.70E-03 <8.47E-02 1.61E-02 9.48E-03 l Fe-59 Ci <l .35E-03 <4.23 E-02 1.05E-03 3.19E-05 i Co-57 Ci 0.00E+00 0.00E+00 1.20E-04 2.50E-04 i Co-58 Ci <l .35E-03 <4.23E-02 4.58E-02 7.09E-02 l Co-60 Ci <l .35E-03 <4.23E-02 2.10E-02 1.39E-02 .
Zn-65 Ci <l .35E-03 <4.23 E-02 <l .15E-03 <6.33E-04 Rb-88 Ci 0.00E+00 0.00E+00 5.49E-04 0.00E+00 i Sr89 Ci <l .35 E-04 <4.23E-03 <l .15E-04 <6.33E-05 ,
Sr-90 Ci <l.35E-04 <4.23 E-03 <l .15E-04 <6.33E-05 Sr-92 Ci 0.00E+00 0.00E+00 2.90E-06 0.00E+00 ,
Zr-95 Ci 0.00E+00 0.00E+00 3.05E-04 3.96E-03 ;
Mo-99 Ci <l .35 E-03 <4.23 E-02 <l.15E-03 <6.33E-04 }
Nb-95 Ci 0.00E+00 0.00E+00 4.25E-04 6.81E-03 TC-99M Ci 0.00E+00 0.00E+00 7.56E-05 4.70E-05 Ru-103 Ci 0.00E+00 0.00E+00 1.00E-04 6.34E-04 l Ag-110M Ci 0.00E+00 0.00E+00 5.34E-05 0.00E+00 Sn-l l3 Ci 0.00E+00 0.00E+00 5.llE-05 6.08E-04 ,
Sn-ll7M Ci 0.00E+00 0.00E+00 1.01E-03 3.16E-05 [
Sb-124 Ci 0.00E+00 0.00E+00 1.49E-04 3.08E-03 ?
Sb-125 Ci 0.00E+00 0.00E+00 6.16E-03 4.32E-02 Sb-126 Ci 0.00E+00 0.00E+00 0.00E+00 8.93E-05 i l I-131 Ci <2.70E-03 <8.47E-02 6.85E-03 5.98E-03 l
l-132 Ci 0.00E+00 0.00E+00 0.00E+00 6.56E-05 I133 Ci 0.00E+00 0.00E+00 4.51E-05 4.25E-04 i 1-135 Ci 0.00E+00 0.00E+00 0.00E+00 3.16E-05 i Cs-134 Ci <l .35 E-03 <4.23E-02 1.84E-03 9.24E-04 ,
Cs-137 Ci <l .35E-03 <4.23E-02 2.47E-03 9.16E-04 La-140 Ci 0.00E+00 0.00E+00 1.58E-04 8.43E-05 '
Ce-141 Ci <l .35E-03 <4.23E-02 <l .15E-03 5.14E-05 i Ce-144 Ci <l .35E-03 <4.23 E-02 <l .15E-03 2.83E-04 i Ilf-181 Ci 0.00E+00 0.00E+00 0.00E+00 1.09E-04 l Ar-41 Ci <2.70E-02 <8.47E-01 <2.29E-02 <l .26E-02 l Kr-85M Ci <2.70E-02 <8.47E-01 1.25E-03 <l.26E .
Kr-85 Ci <2.70E-02 :8.47E-01 2.29E-01 2.50E-03 i Kr-87 Ci <2.70E-02 <8.47E-01 <2.29E-02 <l .26E-02 _
Kr-88 Ci <2.70E-02 <8.47E-01 2.31E-04 <l .26E-02 l Xe-131 Ci <2.70E-02 <8.47E-01 2.40E-01 4.17E-03 l Xe-133M Ci <2.70E-02 <8.47E-01 2.75E-01 <1.26E-02 !
Xe-133 Ci 5,03E-04 1.16E-03 2.67E+01 2.52E-02 !
Xe-135 Ci <2.70E-02 <8.47E-01 1.83E-01 1.07E-04 !
Xe-138 Ci <2.70E-02 <8.47E-01 <2.29E-02 <l.26E-02 ;
G-ALPilA Ci <2.70E-04 <8.47E-03 2.98E-05 9.37E-06 l PF.RIOD TOTAL Ci 1.59E-02 1.39E-02 3.57E+02 2.73E+01 >
NOTE: Less than values are calculated using the lower limit of detection (LLD) values listed in Table 2-1 of the l
OIX'M multiplied by the volume of wsste discharged during the respective quarter. The less than values are not i included in the summation for the total r lease values.
1
Enclosure to ET 95-0035 Page 8 of 32 LIOUID CUMULATIVE DOSE
SUMMARY
(1994)
Table 1 ODCM CALC. DOSE ODCM LIMIT (1) % OF LIMIT Quarter 1 of 1994 j TOTAL DOSE (mrem) FOR BONE 2.98E-03 5.00E+00 5.97E-02 1 TOTAL DOSE (mrem) FOR LIVER 5.81E-02 5.00E+00 1.16E+00
]
TOTAL DOSE (mrem)FOR TOTAL BODY 5.67E-02 1.50E+00 3.78E400 TOTAL DOSE (mrem) FOR TliYROID 5.30E-02 5.00E+00 1.06E+00 TOTAL DOSE (mrem) FOR KIDNEY 5.46E-02 5.00E+00 1.09E+00 TOTAL DOSE (mrem) FOR LUNG 5.35E-02 5.00E+00 1.07E+00 TOTAL DOSE (mrem) FOR GI-LLI 5.52E-02 5.00E+00 1.10E+00
)
Quarter 2 of 1994 TOTAL DOSE (mrem) FOR BONE 3.0$E-03 5.00E+00 6.1lE-02 TOTAL DOSE (mrem) FOR LIVER 3.63E-02 5.00E+00 7.27E-01 TOTAL DOSE (mrem) FOR TOTAL BODY 3.50E-02 1.50E+00 2.33 E+00 TOTAL DOSE (mrem) FOR TilYROID 3.18E-02 5.00E+00 6.35E-01 TOTAL DOSE (mrem) FOR KIDNEY 3.29E-02 5.00E+00 6.59E-01 TOTAL DOSE (mrem) FOR LUNG 3.18E-02 5.00E+00 6.36E-01 TOTAL DOSE (mrem) FOR GI LLI 3.19E-02 5.00E+00 6.39E-01 Quarter 3 of 1994 TOTAL DOSE (mrem) FOR BONE 1.37E-02 5.00E+00 2.75E-01 TOTAL DOSE (mrem) FOR LIVER 5.35E-02 5.00E+00 1.07E+00 TOTAL DOSE (mrem) FOR TOTAL BODY 4.74 E-02 1.50E+00 3.16E+00 TOTAL DOSE (mrem) FOR TilYROID 4.90E-02 5.00E+00 9.81 E-91 TOTAL DOSE (mrem) FOR KIDNEY 3.75E-02 5.00E+00 7.50E b TOTAL DOSE (mrem) FOR LUNG 3.22E-02 5.00E+00 6.44 E-v i TOTAL DOSE (mrem) FOR GI-LLI 4.15E-02 5.00E+00 8.29E-01 Quarter 4 of 1994 TOTAL DOSE (mrem) FOR BONE 6.62E-03 5.00E+00 1.32E-01 TOTAL DOSE (mrem) FOR LIVER 1.47E-02 5.00E+00 2.94E-01 TOTAL DOSE (mrem) FOR TOTAL BODY 1.18E-02 1.50E+00 7.91E-0:
TOTAL DOSE (mrem) FOR THYROID 1.85 E-02 5.00E+00 3.70F di TOTAL DOSE (mrem) FOR KIDNEY 6.58E-03 5.00E+00 1.3 IE-01 TOTAL DOSE (mrem) FOR LUNG 4.02E-03 5.00E+00 8/AE-02 TOTAL DOSE (mrem) FOR GI-LLI 1.28E-01 5.00E+00 2.56E+00 TOTALS FOR 1994 TOTAL DOSE (mrem) FOR BONE 2.64 E-02 1.00E+01 2.64E-01 TOTAL DOSE (mrem) FOR LIVER 1.62E-01 1.00E+01 1.62E+00 TOTAL DOSE (mrem) FOR TOTAL BODY 1.51E-01 3.00E+00 5.03 E+00 TOTAL DOSE (mrem) FOR TilYROID 1.52E-01 1.00E+01 1.52E+00 TOTAL DOSE (mrem) FOR KIDNEY 1,3 I E-01 1.00E+01 1.31 E+00 TOTAL DOSE (mrem) FOR LUNG 1.21 E-01 1.00E+01 1.2 ] E+00 TOTAL DOSE (mrem) FOR GI-LLI 2.56E-01 1.00E+01 2.56E+00
- 1. Ilased on ODCM Section 2.2 which restricts dose to the whole body to less than or equal to 1.5 mrem per quarter and 3.0 mrem per y car. Dose restriction to any organ is less than or equal to 5 mrem per quarter and 10 mrem per year.
Enclosure to ET 95-0035 Page 9 of 32 LIOUID CUMULATIVE DOSE
SUMMARY
(1994)
Table 2 Quarter 1 Ouarter 2 Ouarter 3 Ouarter 4 TOTAL A. Fission and Activation Products (not including H-3, gases, alpha)
- 1. Total Release -(Ci) 2.31 E-02 1.60E-02 1.llE-01 1.97E-01 3.47E-01
- 2. Maximum Organ Dose (mrem) 5.18E-03 5.10E-03 2.39E-02 1.25E-01 1.40E-01
- 3. Organ Dose Limit (mrem) 5.00E+00 5.00E400 5.00E+00 5.00E+00 1.00E+01
- 4. Percent of Limit 1.03E-01 1.02E-01 4.79E-01 2.5 l E+00 1.40E+00 B. Tritium
- 1. Total Release -(Ci) 4.55E+02 1.62E+02 3.30E+02 2.71E+01 9.74E+02
- 2. Maximum Organ Dose (mrem) 5.29E-02 3.12E-02 2.95E-02 2.63E-03 1.16E-01
- 3. Organ Dose Limit (mrem) 5.00E+00 5.00E+00 5.00E+00 5.00E+00 1.00E+01
- 4. Percent of Limit 1.05E+00 6.25E-01 5.91E-01 5.26E-02 1.16E+00 This table is included to show the correlation between Curies released and the associated calculated maximum organ dose. Wolf Creek OIX'M methodology is used to calculate the maximum organ dose which assumes that an individual drinks the water and cats the fish from the discharge point. ODCM Section 2.2 organ dose limits are used. The less than values are not included in the summation for the total release values.
l 1
Enclosure to ET 95-0035 i Page 10 of 32 REPORT OF RADIOACTIVE EFFLUENT (1994) AIRBORNE 1
Type of Effluent IJ.Dil Ouarter 1 Ouarter 2 Ouarter 3 Ouarter 4 i A. Fission and Activation Gases
- 1. Total Release Ci 1.33E+01 2.26E+01 4.95 E+02 4.06E+00
- 2. Average Release Rate for Period UCi/sec 1.71E+00 2.87E+00 6.23E+01 5.11E-01
- 3. Percent of ODCM Limit (1) % 2.47E-02 2.72E-02 3.83E-01 3.25E-03 ;
B. Iodines (Iodine-13 I)
- 1. Total Release Ci 0.00E400 0.00E+00 1.64 E-04 1.72E-04
- 2. Average Release Rate for Period UCi/sec 0.00E+00 0.00E+00 2.06E-05 2.17E-05
- 3. Percent of ODCM Limit (2) % 0.00E+00 0.00E+00 1.64 E-02 1.72E-02 C. Particulates (llalflives > 8 days)
- 1. Total Release Ci 0.00E+00 0.00E+00 0.00E+00 5.00E-06
- 2. Average Release Rate for Period uCi/sec 0.00E+00 0.00E+00 0.00E+00 6.30E-07
- 3. Percent of ODCM Limit (3) % 0.00E+00 0.00E+00 0.00E+00 3.55E-05
- 4. Gross Alpha Radioactivity Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 D. Tritium
- 1. Total Release Ci 5.10E+00 6.46E+00 6.42E+00 6.72E+00
- 2. Average Release Rate for Period uCi/sec 6.56E-01 8.22E-01 8.08E-01 8.45 E-01
- 3. Percent of ODCM Limit (4) % 5.02E-02 6.49E-02 6.12E-02 5.89E-02
- 1. The percent of ODCM limit for fission and activation gases is calculated using the following methodology:
% of ODCM Limit = (Otrly Total Heta AirdoseV10.0.) or (Otrly Total Gamma AirdoseV100) 10 mrad 5 mrad The largest value calculated between Gamma and Beta airdose is listed as the % of ODCM Limit.
% of 0DCM Limit =
(Total curies oflodine-131V1QQ) 1 Curie
- 3. The percent of ODCM limit for particulates is calculated using the fellowing methodology:
% of ODCM Limit = (Ilighest Organ Dose duc to ParticulresV100) 7.5 mrem
of ODCM Limit = 1Ilichest Orcan Dose Due to II-3V100) 7.5 mrem NOTE: This type of methodology is used since the Wolf Creek ODCM ties release limits to doses rather than Curie release rates. ,
l 1
i i
I I
l l
l
Enclosure to ET 95 0035 Page1Iof32 GASEOUS EFFLUENTS Continuous Mode Batch Mode Nus;lidss Released 1) nit Ouarter 1 Ouarter 2 Ouarter 1 Ouarter 2
- 1. fission Gases ar-41 Ci 0.00E+00 0.00E+00 3.75E-01 0.57E-02 Kr-85M Ci 9.20E-02 8.47E-02 0.00E+00 1.99E-05 Kr-85 Ci 0.00E+00 0.00E+00 1.50E+00 2.21E+00 Kr-87 Ci <l .48E+01 1.05E-01 <2.83 E-02 <l .75E-02 Kr-88 Ci <l .94E+01 2.10E-01 <3.70E-02 <2.30E-02 Xe-131M Ci 0.00E+00 0.00E+00 0.00E+00 1.48E-03 Xe-133M Ci <3.84E+01 <4.06E+01 2.43E-04 2.11 E-03 Xe-133 Ci 4.79E+00 1.47E+01 8.40E-02 1.88E-01 Xe-135 Ci 6.46E+00 4.88E+00 1.48E-03 3.41E-03 Xe-138 Ci <9.10E+01 <9.60E+01 <l .73 E-01 <l .08E-01 Total for Period Ci 1.13E+01 2.00E+0 i 1.96E+00 2.50E+00
- 2. Iodines 1-131 Ci <2.53 E-04 <2.67E-04 <4.81 E-07 <2.99E-07 1-133 Ci <2.53 E-02 <2.67E-03 <4.81 E-05 <2.99E-05 Total for Period Ci 0.00E+00 0.00E+00 0.00E+ 00 0.00E+00
- 3. Particulates
& Tritium 11-3 Ci 4.60E+ 00 6.26E+00 4.98E-01 2.01 E-01 Mn-54 Ci <2.53 E-03 <2.67E-03 <4.81 E-Of <2.99E-06 Fe-59 Ci <2.53 E-03 <2.67E-03 <4.81E '.s6 <2.99E-06 Co-58 Ci <2.53 E-03 <2.67E-03 <4.81'i-06 <2.99E-06 Co-60 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 Zn-65 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 Sr-89 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 Sr-90 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 Mo-99 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 Cs-134 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 Cs-137 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 Ce-141 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 Ce-144 Ci <2.53 E-03 <2.67E-03 <4.81 E-06 <2.99E-06 G-Alpha Ci <2.53 E-03 5.49E-08 <4.81 E-06 <2.99E-06 Total for Period Ci 4.60E+ 00 6.26E+00 4.98E-01 2.01 E-01 NOTE: Less than salues for Noble Gases are calculated using the lower limit of detection (LLD) values obtained at WCGS multiplied by the volume of air discharged during the respective quarter. For the llalogens and Particulates the ODCM LLD values are used. The less than values are not included in the summation for the total release values.
Enclosure to ET 95-0035 Page 12 of 32 GASEOUS EFFLUENTS Continuous Mode Batch Mode Nudides Released M Ouarter 3 Ouarter 4 Ouarter 3 Quai 1cLA
- 1. Fission Gases Ar-41 Ci 1.22E+00 0.00E+00 1.39E+00 5.90E-02 Kr-85M Ci 2.93E-01 0.00E+00 9.72E-04 0.00E+00 Kr-85 Ci 0.00E400 0.00E+00 1.07E+01 0.00E+00 Kr-87 Ci <l .51 E+01 <l .72E+01 <5.89E-01 <8.86E-01 Kr-88 Ci <l .97E+01 <2.25E+01 <7.71 E-01 <l .16E+00 Xe-131M Ci 0.00E+00 0.00E+00 8.16E+00 0.00E+00 Xc-133 Ci 2.45 E+02 3.09E+00 2.16E+02 7.04 E-01 Xe-133M Ci 6.71E-01 <4.46E+01 1.52E+00 <2.29E+00 Xe-135 Ci 8.58E+00 1.96E-01 1.15E-01 <2.37E-01 Xe-138 Ci <9.25E+01 <l .06E402 <3.61 E+00 <5.43 E+00 Total for Period Ci 2.56E+02 3.29E+00 2.38E+02 7.63E-01
- 2. lodines 1-131 Ci 1.63 E-04 1.72 E-04 <l .00E-05 <l .51 E-05 I-133 Ci <2.57E-02 <2.93 E-02 <l .00E-03 <l .5 i E-03 Total for Period Ci 1.63 E-04 1.72E-04 0.00E+00 0.00E+00
- 3. Particulates and Tritium 11-3 Ci 5.46E400 6.18E400 9.54E-01 3 30E-01 Mn-54 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l .51 E-04 Fe-59 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l .5 i E-04 Co-58 Ci <2.57E-03 5.00E-06 <l .00E-04 <l .5 I E-04 Co-60 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l .5 i E-04 Zn-65 Ci <2.57E-01 <2.93E-03 <l .00E-04 <l .5 i E-04 Sr-89 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l .51 E-04 Sr-90 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l .51 E-04 Mo-99 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l .51 E-04 Cs-134 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l.51E-04 Cs-137 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l .51 E-04 Ce-141 Ci <7.57E-03 <2.93 E-03 <l .00E-04 <l .51 E-04 Ce-144 Ci <2.57E-03 <2.93 E-03 <l .00E-04 <l .51 E-04 G-Alpha Ci <2.57E-03 <2.93 E-03 <1.00E-04 <l .51 E-04 Total for Period Ci 5.46E+00 6.18E+00 9.54E-01 5.30E-01 NOTE: Less than values for Noble Gases are calculated using the LLD values obtained at WCGS multiplied by the volume of air discharged during the respectise quarter. For the llalogens and Particulates the ODCM LLD values are used. The less than values are not included in the summation for the total release values.
l
Enclosure to ET 95-0035 Page 13 of 32 G ASEOUS CUMULATIVE DOSE
SUMMARY
(1994)
Table 1 ODCM CALC. DOSE ODCM LIMIT (1) % OF LIMIT Quarter I ofM TOTAL DOSE (mrem)FOR BONE 0.00E+00 7.50E+00 0.00E+00
- TOTAL DOSE (mrem) FOR LIVER 3.60E-03 7.50E+00 4.81E-02 TOTAL DOSE (mrem) FOR TOTAL BODY 3.60E-03 7.50E+00 4.81E-02 TOTAL DOSE (mrem) FOR TliYROID 3.60E-03 7.50E+00 4.81 E-02 ,
3.60E-03 7.50E+ 00 4.81 E-02 :
TOTAL DOSE (mrem) FOR KIDNEY TOTAL DOSE (mrem) FOR LUNG 3.60E-03 7.50E+00 4.81E-02 TOTAL DOSE (mrem) FOR GI-LLI 3.60E-03 7.50E+00 4.81 E-02 j Quarter 2 of M TO I AL DOSE (mrem) FOR BONE 0.00E+00 7.50E+00 0.00E+00 l TOTAL DOSE (mrem) FOR LIVER 4.57E-03 7.50E &00 6.09E-02 TOTAL DOSE (mrem) FOR TOTAL BODY 4.57E-03 7.50E+00 6.09E-02 TOTAL DOSE (mrem) FOR T11YROID 4.57E-03 7.50E+00 6.09E-02 TOTAL DOSE (mrem)FOR KIDNEY 4.57E-03 7.50E+00 6.09E-02 TOTAL DOSE (mrem) FOR LUNG 4.57E-03 7.50E+00 6.09E-02 TOTAL DOSE (mrem) FOR GI-LLI 4.57E-03 7.50E+00 6.09E-02 Quarter 3 of M 2.85E-04 7.50E+00 3.80E-03 i TOTAL DOSE (mrem) FOR BONE TOTAL DOSE (mrem)FOR L1VER 4.82E-03 7.50E+00 6.43E-02 TOTAL DOSE (mrem) FOR TOTAL BODY 4.70E-03 7.50E+00 6.26E-02 TOTAL DOSE (mrem) FOR T11YROID 9.88E-02 7.50E+00 1.31E+00 ;'
TOTAL DOSE (mrem) FOR KIDNEY 5.00E-03 7.50E+00 6.67E-02 TOTAL DOSE (mrem) FOR LUNG 4.54E-03 7.50E+00 6.05E-02 l TOTAL DOSE (mrem) FOR GI-LLI 4.56E-03 7.50E+00 6.08E-02 Quarter 4 ofM TOTAL DOSE (mrem) FOR BONE 3.00E-04 7.50E+00 4.01 E-03 TOTAL DOSE (mrem) FOR L1VER 5.05E-03 7.50E+00 6.73E-02 [
TOTAL DOSE (mrem) FOR TOTAL BODY 4.92E-03 7.50E+00 6.56E-02 TOTAL DOSE (mrem) FOR TilYROID 1.03E-01 7.50E+00 1.38E+00 i
TOTAL DOSE (mrem) FOR KIDNEY 5.24E-03 7.50E+00 6.99E-02 TOTAL DOSE (mrem) FOR LUNG 4.75E-03 7.50E+00 6.33E-02 TOTAL DOSE (mrem) FOR GI-LLI 4.78E-03 7.50E+00 6.37E-02 l TOTALS FOR M TOTAL DOSE (mrem) FOR BONE 5.86E-04 1.50E+01 3.90E-03 TOTAL DOSE (mrem) FOR LIVER 1.80E-02 1.50E+01 1.20E-01 .
TOTAL DOSE (mrem) FOR TOTAL BODY 1.78E-02 1.50E+01 1.18E-01 !
TOTAL DOSE (mrem) FOR TilYROID 2.10E-01 1.50E+01 1.40E+00 ,
TOTAL DOSE (mrem) FOR KIDNEY 1.84E-02 1.50E+01 1.22E-01 TOTAL DOSE (mrem) FOR LUNG 1.74E-02 1.50E+0! 1.16E-01 ,
TOTAL DOSE (mrem) FOR GI-LLI 1.75E-02 1.50E+01 1.16E-01 l t
- 1. Itased on ODCM Section 3.2.2 which restricts dose during any calendar quarter to less than or equal to 7.5 mrem to any organ and during any calendar year to less than or equal to 15.0 mrem to any organ !
o Enclosure to ET 95-0035 -
Page 14 of 32 CASEOUS CUMULATIVE DOSE
SUMMARY
(1994)
Table 2 -
Nuclides Released Ouarter 1 QuMR12 ' Ouarter 3 Ouarter 4 1 9181 i A. Fission and Activation l
- 1. Total Release (Ci) 1.33E+01 2.26E+01 4.95E+02 4.06E+00 5.35E+02
- 2. Total Gamma Airdose(mrad) 1.24E-03 1.36E-03 1.44E-02 1.58E-04 1.71E-02
- 3. Gamma Airdose Limit (mrad) 5.00E+00 5.00E+00 5.00E+00 5.00E+00 1.00E+0!
- 4. Percent of Gamma Airdose Limit 2.47E-02 2.72E-02 2.88E-01 3.16E-03 1.71E-01
- 5. Total Beta Airdose(mrad)' l.77E-03 2.38E-03 3.83E-02 3.25E-04 4.28E-02
- 6. Beta Airdose Limit (mrad) 1.00E+01 1.00E+01 1.00E+01 1.00E+01 2.00E+01
- 7. Percent of Beta Airdose Limit (mrad) 1.77E-02 2.38E-02 3.83E-01 3.25E-03 2.14E-01. ,
B. Particulates -
- 1. Total Particulates (Ci) 0.00E+00 0.00E+00 0.00E+00 5.00E-06 5.00E-06
- 2. Maximum Organ Dose (mrem) 0.00E+00 0.00E+00 0.00E+00 2.66E-06 2.66E-06
- 3. Organ Dose Limit (mrem) 7.50E+00 7.50E+00 7.50E+00 7.50E+00 1.50E+01 ,
- 4. Percent of Limit 0.00E+00 0.00E+00 0.00E+00 3.55E-05 1.77E-05 C. Tritium
- 1. Total Particulates (Ci) 5.10E+00 6.46E+00 6.42E+00 6.72E+00 2.47E+01
- 2. Maximum Organ Dose (mrem) 3.76E-03 4.86E-03 4.59E-03 4.42E-03 1.76E-02
- 3. Organ Dose Limit (mrem) 7.50E+00 7.50E+00 7.50E+00 7.50E+00 1.50E+01
- 4. Percent of Limit 5.02E-02 6.49E-02 6.12E-02 5.89E-02 1.17E-01 D. Iodine
- l. Totall 131,1-133 (Ci) 0.00E+00 0.00E+00 1.64E-04 1.72E-04 3.36E-04 ,
- 2. Maximum Organ Dose (mrem) 0.00E+00 0.00E+00 1.67E-01 2.56E-02 1.93E-01
- 3. Organ Dose Limit (mrem) 7.50E+00 7.50E+00 7.50E+00 7.50E+00 1.50E+01 }
- 4. Percent of Limit 0.00E+00 0.00E+00 2.23E+00 3.41 E-01 1.28E+00 i
This table is included to show the correlation between Curies released and the associated calculated maximum organ i dose. The maxin'um organ dose is calculated using Wolf Creek ODCM methodology which assumes that an !
individual actually resides at the release point. ODCM Section 3.2.2 orgu dose limits are useo. l i
{
Enclosure to ET 95-0035 Page 15 of 32 ,
Section 11 SupplementalInformation +
Facility: Wolf Creek Generatine Stalian License Number: NPF-42
- 1. ODCM Limits A. For hquid waste effluents A.1 The concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS shall be limited to the concentrations specified in 10CFR20, Appendix B, Table 11, Column 2, for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to 2 x 10 -4 microcurie /ml total activity. ,
A.2 The dose or dose commitment to MEMBER OF THE PUBLIC from radioactive materials in liquid emuents released, from each unit, to UNRESTRICTED AREAS shall ba limited:
- a. During any calendar quarter to less than or equal to 1.5 mrems to the whole body and to less than or equal to 5 mrems to any organ and,
- b. During any calendar year to less than or equal to 3 mrems, to the whole body and to less than or equal to 10 mrems to any organ.
B. For gaseous waste emuents B.1 The dose rate due to radioactive material released in gaseous effluents from the site to ,
area at and beyond the SITE BOUNDARY shall be limited to the following:
- a. For noble gases: Less than or equal to 500 mrems/yr to the whole body and less i than or equal to 3000 mrems/yr to the skin, and ;
- b. For lodine-131, lodine-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days: Less than or equal to 1500 mrems/yr to any organ.
B.2 The air dose due to noble gases released in gaseous effluents, from each unit, to areas at ,
and beyond the SITE BOUNDARY shall be limited to the following: t
- a. During any calendar quarter: Less than or equal to 5 mrads for gamma radiation and less than or equal to 10 mrads for beta radiation, and
- b. During any calendar year: Less than or equal to 10 mrads for gamma radiation and less than or equal to 20 mrads for beta radiation.
B.3 The dose from Iodine-131, lodine-133, tritium, and a radionuclide in particulate form with half-lives greater than 8 days in gaseous effluents released to area at and beyond the SITE BOUNDARY shall be limited to the following:
- a. During any calendar quarter: Less than or equal to 7.5 mrems to any organ, and
- b. During any calendar year: Less than or equ-t to 15 mrems to any organ.
- 2. Maximum Permissible Concentrations (MPC's)
Water - covered in Section 1.A.
Air - covered in Section 1.B.
- 3. Average energy of fission and activation gaseous effluents is not applicable. See ODCM Section ;
3.1.2 for the methodology used in determining the release rate limits from noble gas releases. l l
Enclosure to ET 95-0035 Page 16 of 32
- 4. Measurements and Approximations of Total Radioactivity A. Liquid Effluents Liquid Release Sampling Method of Analysis Type of Activity ,
Type Frequency Analysis ;
- 1. Batch Waste P i Release Tank Each Batch P.H.A. Principal Gamma Emitters P
Each Batch P.H.A. 1-131
- a. Waste Monitor Tank P P.H.A. Dissolved and Entrained One Batch /M Gases (Gamma Emitters)
- b. Secondary Liquid P L.S. H-3 Waste Monitor Each Batch S.A.C. Gross Alpha ,
Tanks P O.S.L. Sr-89, Sr-90
- 2. Continuous Releases Daily P.H.A. PrincipalGamma Emitters Grab Sample P.H.A. 1-131 i
- a. Steam Generator M Dissolved and entrained Blowdown Grab Sample P.ll.A. Gases (Gamma Emitters) ;
- b. Turbine Building Daily L.S. H-3 l Sump Grab Sample ;
S.A.C. Gross Alpha
- c. Lime Sludge Pond Daily O.S.L. Sr-89, Sr-90 Grab Sarrple l
O.S.L. Fe-55 l
1 P = prior to each batch S.A.C. = scintillation alpha counter M = monthly O.S.L. = performed by an ofTsite laboratory L.S. = Liquid scintillation detector P.H.A. = gamma spectrum pulse height analysis using a Ifigh Purity Germanium detectar l
- _ - . - .- . - - -- . .. .. - - .. , ~
}
9 Enclosure to ET 95-0035 Page 17 of 32 B. Gaseous Waste Emuents Gaseous, Release . Sampling Frequency Method of Analysis Type of Activity Type ' Analysis ,
P P.ll.A. Principal Gamma Emitters Waste Gas Decay Tank Each Tank Grab Sample ,
Containment Purge or P P.H.A. Principal Gamma Emitters Vent Each Purge Grab Sample Gas Bubbler and L.S. 11-3 (oxide)
Unite Vent M P.H.A. Principal Gamma Emitters Grab Sample Gas Bubbler and L.S. li-3 (oxide) -
L Radwaste Building M P.li.A Principal Gamma Emitters Vent Grab Sample ;
For Unit Vent and Continuous P.II.A. 1-131 Radwaste Building Vent release types I-133 listed above Continuous P.11.A. Principal Gamma Emitters .
Particulate l Sample l Continuous S.A.C. Gross Alpha Composite Particulate Sample l Continuous O.S.L. Sr-89, Sr-90 Composite Particulate Sample P = prior to each batch S.A.C. = scintillation alpha counter M = monthly O.S.L. = performed by an ofTsite laboratory 1 S. = 1.iquid scintillation detector P.II.A. = gamma spectrum pulse height analysis using a Ifigh Purity Germanium detector
Enclosure to ET 95-0035 Page 18 of 32
- 5. Batch Releases A batch release is the discontinuous release of gaseous or liquid effluent which takes place over a finite period of time usually hours or days.
There were 78 gaseous batch releases during the reponing period. He longest gaseous batch release lasted 9,892 minutes, while the shortest lasted 77 minutes. He average release lasted 1132 minutes with a total gaseous batch release time of 88,274 minutes.
There were 120 liquid batch releases during the reponing period. De longest liquid batch release lasted 666 minutes, while the shonest lasted 43 minutes. De average release lasted 115 minutes with a total liquid batch release time of 13,849 minutes.
- 6. Continuous Releases A continuous release is a release of gaseous or liquid effluent which is essentially uninterrupted for extended periods during normal operation of the facility.
There were three liquid release pathways designated as continuous releases during this reporting period: Steam Generator Blowdown, Turbine Building Sump, and Lime Sludge Pond. Here were two gas release pathways designated as continuous releases: Unit Vent and Radwaste Building Vent.
- 7. Doses to a Member of the Public from Activities Inside the Site Boundary Three activities by members of the public were considered in this evaluation: personnel making deliveries to the plant, workers at the Construction Administration Building located outside of the restricted area, and the access road south of the Radwaste building. The dose calculated for the maximum exposed individual for these three activities was as follows:
Plant Deliveries: 3.30E-02 mrem Construction Administration Workers 9.07E-03 mrem Access Road Users 5.59E-03 mrem The plant delivery calculations were based on deliveries 3 hours3.472222e-5 days <br />8.333333e-4 hours <br />4.960317e-6 weeks <br />1.1415e-6 months <br /> / week for 50 weeks / year. The Construction Administration Building occupancy was based on normal working hours of 2000/ year. The usage factor for the access road South of the Radwaste building was 25 hours2.893519e-4 days <br />0.00694 hours <br />4.133598e-5 weeks <br />9.5125e-6 months <br /> / year.
Pathways used in the calculation were gaseous inhalation, submersion, and ground plane. All ,
calculations were performed in accordance with the methodology and parameters in the ODCM. !
I l
1 l
l l
_y Enclosure to ET 95-0035 i Page 19 of 32 j
- 8. Percentage Effluent Concentration Limit [
Nudides Curies Averane Diluted 10 CFR20 % of ECL .!
Concentration ECL [
(pCi'ml) !
H-3 9.73E+02 1.62E-05 IE-03 1.62E+00 Na-24 3.74E-05 6.22E-13 5E-05 1.24E-06 +
Cr 51 3.51 E-02 5.84E-10 SE-04 1.17E-04 j Mn-54 3.49E-03 5.80D11 3E-05 1.93E-04 ;
}
Fe-55 6.21E-02 1.03E-09 1E-04 1.03E-03 ,
Fe-59 4.24E-03 7.05E-11 1E-05 7.05E-04 Co-57 5.34E-04 8.88E-12 6E-05 1.48E-05 !
Co-58 1.22E-01 2.03D09 2D05 1.02E-02 !
Co-60 4.84 E-02 8.05E-10 3E-M 2.68E-02 ;
Rb-88 5.49E-04 9.13E-12 4E-04 2.28E-06 ?
Sr-90 SE-07 Sr-92 2.90E-06 4.82E-14 4E-05 1.20E-07 i Zr-95 4.26E-03 7.08E-11 2E-05 3.54E-06 i
Nb-95 7.31E-03 1.22E-10 3E-05 4.07E-04 :
TC-99M 1.59E-04 2.64E-12 lE-03 2.64E-07 !
Ru-103 7.34E-04 1.22E-11 3E-05 4.07E-04 !
Ag-11OM 1.12E-04 1.86E-12 6E-06 3.1OE-05 j Sn-113 7.74E-04 1.29E-I l 3E-05 4.30E-05 ;
Sn-l 17M 1.05E-03 1.75E-11 3 DOS 5.83E-05 k Sb-124 3.23E-03 5.37D11 7E-06 7.67E-04 Sb-125 5.51E-02 9.16E-10 3E-05 3.05E-03 ,
Sb-126 8.93E-05 1.48E-12 7E-06 2.llE-05 ,
I 131 1.31E-02 2.18E-10 1E-06 2.1SE-02 l-132 6.56E-05 1.09D12 IE-04 1.09E-06 :
1-133 4.89E-04 8.13E-12 7E-06 1.16E-04 l l-135 3.16E-05 5.25D13 3E-05 1.75E-06 i' Cs-134 3.58E-03 5.95E-11 9E-07 6.61E-04 Cs-137 4.49E-03 7.47E-11 1E-06 7.47E-03 i La-140 2.42E-04 4.02E-12 9E-06 4.47E-05 !
Ce-141 5.14E-05 8.55D13 3E-05 2.85D06 Ce-144 6.08E-04 1.01Dil 3E-06 3.37E-04 lif-181 1.09E-04 1.81E-12 2E-05 9.05E-06 l Kr-85M 1.26E-03 2.10E-1I 2E-04 1.96E-03 Kr-85 2.35E-01 3.91E-09 2E-04 1.05E-05 !
Kr-88 2.31E-04 3.84E-12 2E-04 1.92E-06 ;
Xe-131M 2.4SE-01 4.12E-09 2E-04 2.06E-03 l Xe-133 2.65E+01 4.41E-07 2E-04 2.20E-01 Xe-133M 2.77E-01 4.61E-09 2E-04 2.30E-03 i Xe-135 4.61E-01 7.66D09 2D04 3.83E-05 {
I v
i
.-c --, ..m
Enclosure to ET 95-0035
- Page 20 of 32
, EFFLUENT AND WASTE DISPOSAL ANNUAL REPORT (1994)
SOLID WASTE SHIPMENTS A. SOLID WASTE SilIPPED OFFSITE FOR BURIAL OR DISPOSAL (Not irradiated fuel) f
- 1. Type of waste Unit I- Year Est. Total [
Period Error % l
. a. Spent resins, filter sludges, m3* 3.26E401 !
evaporator bottoms, etc. Ci 6.05E+02 2.50E+0! j
- b. Dry compressible waste, m3* 8.4E+00 ;
contaminated equip. etc. Ci 1.42E-01 2.50E+01
- c. Irradiated components, m3' O.00E+00 control rods, etc. Ci 0.00E+00 0.00E+00 f l !
- d. Other m3* 0.00E+00 Ci 0.00E+00 0.00E+00 [
m3* = cubic meters j
- 2. Estimate of major nuclide composition (by type of waste)
- a. Spent resin, filter sludges, evaporator bottoms, etc. !
Nu:lide Percent !
Name Abundance Cunes j Cs-134 40.137 2.43E+02 l Cs-137 34.332 2.08E+02 [
Fe-55 12.837 7.76E+01 !
Co-60 6.981 4.22E+01 ,
Ni-63 1.338 8.09E+01 Pu-241 ,147 8.89E-01 ,
Ni-59 .146 8.80E-01 !
Sr-90 .104 6.29E-01 C-14 .099 5.98E-01 11-3 .032 1.95E-01 Cm-242 .002 9.08E-03 Tc-99 .001 6.40E-03 I-129 <LLD 0.00E+00 u . _ ,.
l
<]
Enclosure to ET 95-0035 l Page 21 of 32 :
t j '
l
- b. Dry compressible waste, contaminated equipinent etc.
- Nuclide Percent Name Abundance Cunes Co-58 24.424 3.46E-02 -l Cs-134 24.079 3.41E-02 .!
Cs-137 18.849 2.67E-02 l Fe-55 15.816 2.24E-02 !
Ni-63 10.595 1.50E-02 !
Co-60 4.329 6.13E-03 11-3 '.670 9.49E C-14 .053 7.53E-05 ;
^
I-129 <LLD 0.00E+00 Tc-99 <LLD 0.00E+00 {
i
- c. Irradiated components, control rods etc. j I
r none
- d. Other J none i
- 3. Solid Waste Disposition l l
Number of Shinments Mode of Trancnortation Destination !
10 Truck Barnwell, SC - f r
i
- 4. Class of Solid Waste !
a Class A, Class B, Class C- Corresponding to 2a i
- b. Class A - corresponding to 2b
- c. Not applicable !
- d. Not applicable j r
i
(
- 5. Type of container ,
I
- a. LSA (Strong, tight), Type A, Type B - corresponding to 2a [
- b. LSA (Strong, tight) . conesponding to 2b ,
- c. Not applicable !
- d. Not applicable t
i i
Enclosure to ET 95-0035 Page 22 of 32
- 6. Solidification Agent
- a. Not applicable
- b. Not applicable
- c. Not applicable
- d. Not applicable B. IRRADIATED FUEL SillPMENTS (Disposition)
There were no irradiated fuel shipments during this period.
l r
Enclosure to ET 95-0035 Page 23 of 32 Section III HOURS AT EACH WIND SPEED AND DIRECTION All gaseous releases at the WCGS are ground level releases. The meteorological data supplied in these tables covers the period from January 1,1994 through December 31,1994 and indicates the number of hours at each wind speed and direction for each stability class.
i
)
Enclosure to ET 95-0035 Page 24 of 32 l
HOURS AT EACH WIND SPEED AND DIRECTION j I
PERIOD OF RECORD: January 1 through December 31,1994 STABILITY CLASS: A ELEVATION: 10 Meters ,
Wind Direction 1.to_3 4.lo_I 8 to 12 13-18 19-24 >24 IQIAL i N O 1 0 0 0 0 1 NNE O O O O O O O NE O O O O O 0 0 ENE O 1 0 0 0 0 1 r
E 1 1 0 0 0 0 2 ESE 1 2 0 1 0 0 4 SE O 1 1 1 0 0 3 SSE 0 4 1 1 1 0 7 S 0 2 0 3 0 0 5 SSW 0 1 0 0 0 0 1 SW 0 0 0 0 0 0 0 WSW 0 0 0 0 0 0 0 W 0 0 1 0 0 0 1 WNW 0 0 1 0 0 0 1 NW 0 0 1 0 0 0 1 NNW 0 0 0 2 0 0 2 Variable 0 0 0 0 0 0 0 TOTAL 2 13 5 8 1 0 29 Period of calm (hours): 3
Enclosure to ET 95-0035 Page 25 of 32 ,
HOURS AT EACH WIND SPEED AND DIRECTION PERIOD OF RECORD: January 1 through December 31,1994 STABILITY CLASS: B i
ELEVATION: 10 Meters Wind !
Dhecilon 112.3 d_to_I 8 to 12 13-11 18-24 >24 TOTAL N O 1 2 0 0 0 3 l NNE O O O O O O O NE O O O O O O O ENE O O O O O O O E O O 1 0 0 0 1 ESE O O O 0 0 0 0 SE O O 1 0 0 0 1 SSE O O 6 9 0 0 15 S 0 0 2 12 4 0 18 SSW 0 0 0 1 0 0 1 i SW 0 0 0 0 0 0 0 WSW 0 0 0 0 0 0 0 W 0 0 0 0 0 0 0 WNW 0 0 0 0 0 0 0 NW 0 0 0 0 0 0 0 i NNW 0 0 1 2 1 0 4 Variable 0 0 0 0 0 0 0 i
TOTAL 0 1 13 24 5 0 43 i Period of calm (hours): 0 :
i l
l
Enclosure to ET 95-0035 Page 26 of 32 HOURS AT EACH WIND SPEED AND DIRECTION PERIOD OF RECORD: January 1 through December 31,1994 STABILITY CLASS: C ELEVATION: 10 Meters Wind Direction 110_3 4.lo_Z 8 to 12 1h11 19-24 >2d
_ TOTAL N O 2 5 9 2 0 18 NNE O 1 3 0 0 0 4 NE O 1 4 0 0 0 5 ENE O O 4 0 0 0 4 E O 1 2 0 0 0 3 ESE O O 2 1 0 0 3 SE O 1 4 2 0 0 7 SSE 0 4 18 27 1 '!
50 S 0 3 13 29 6 0 51 SSW 0 1 3 8 3 0 15 SW 0 0 2 4 0 0 6 WSW 0 0 3 2 0 0 5 W 0 0 3 2 0 2 7 WNW 0 0 2 0 0 0 2 NW 0 0 0 0 0 0 0 NNVV 1 0 6 11 4 0 22 ,
l Variable 0 0 0 0 0 0 0 l TOTAL 1 14 74 95 16 2 202 Period of calm (hours): O l
i
Enclosure to ET 95 0035 Page 27 of 32 HOURS AT EACH WIND SPEED AND DIRECTION PERIOD OF RECORD: January 1 through December 31,1994 STABILITY CLASS: D l
ELEVATION: 10 Meters Wind Dkection f_to_3 4_to_I R_to.12 13-18 it-14 224 TOTAL N 9 76 166 130 28 2 411 l
NNE C 72 191 68 9 1 347 NE 10 132 112 4 0 0 258 I ENE 5 64 77 20 0 0 166 l
E 3 31 79 18 8 0 139 f ESE 6 40 100 34 3 0 183 1
SE 6 87 126 51 2 0 272 SSE 8 110 183 194 35 2 532 S 11 59 181 203 92 32 578 l l
SSW 13 45 67 85 29 10 249 1
SW 7 50 55 18 5 0 135 WSW 5 46 43 17 11 1 123 W 8 35 53 31 12 6 145 I I
WNW 5 34 58 42 13 2 154 NVV 2 41 94 109 39 1 286 NNW 6 71 180 159 45 6 467 Variable 0 0 0 0 0 0 0 TOTAL 110 993 1765 1183 331 63 4445 I
Period of calm thours): 13 l
Enclosure to ET 95-0035 Page 28 of 32 HOURS AT EACH WIND SPEED AND DIRECTION PERIOD OF RECORD: January 1 through December 31,1994 STABILITY CLASS: E i
ELEVATION: 10 Meters Wind }
Direction 11o_3 4101 8 to 12 13d8 1934 >24
_ TOTAL N 9 51 62 20 1 1 144 NNE 12 55 53 19 3 0 142 NE 31 S2 12 4 1 0 100 ENE 14 55 23 7 4 0 103 E 14 99 64 4 0 0 181 ESE 10 93 44 5 0 0 152 SE 9 111 105 15 1 0 241 i
SSE 9 101 216 91 13 5 435 S 8 58 181 166 58 12 483 SSW 9 53 44 42 3 0 151 SVV 7 48 20 4 1 0 80 i WSW 4 26 23 9 1 0 6?
W 5 33 19 3 0 0 60 WNW 9 25 18 4 0 0 56 NW 6 49 44 2 2 0 103 NNW 10 63 56 3 2 0 134 Variable 0 0 0 0 0 0 0 TOTAL 166 972 984 398 90 18 2628 Period of calm (hours): 8
Enclosure to ET 95-0035 Page 29 of 32 HOURS AT EACH WIND SPEED AND DIRECTION PERIOD OF RECORD: January 1 through December 31,1994 STABILITY CLASS: F ELEVATION: 10 Meters Wind Direction 11o_2 d_to_Z 8 to 12 12-18 19-24 W TOTAL N 4 34 8 0 0 0 46 NNE 6 62 12 4 0 0 84 NE 21 30 1 0 0 0 52 ENE 16 61 5 0 0 0 82 l
E 2 82 23 0 0 0 107 -
ESE 6 105 12 0 0 0 123 SE 9 104 6 0 0 0 119 SSE 1 27 17 4 0 0 49 r
S 11 19 24 4 1 0 59 ,
SSW 0 12 4 3 0 0 19 SW 2 18 1 0 0 0 21 l WSW 2 8 0 0 0 0 10 W 3 7 0 0 0 0 10 WNW 7 17 0 0 0 0 24 l NW 10 24 7 2 0 0 43 NNW 10 44 8 0 0 0 62 Variable 0 0 0 0 0 0 0 TOTAL 110 654 128 17 1 0 910 Period of calm (hours): 13
Enclosure to ET 95-0035 Page 30 of 32 HOURS AT EACH WIND SPEED AND DIRECTION PERIOD OF RECORD: January 1 through December 31,1994 STABILITY CLASS: G ELEVATION: 10 Meters .
Wind Direction 11ol Liol 8 to 12 1;E18 19-24 224 TOTAL N 2 14 3 0 0 0 19 NNE O 20 5 0 0 25 NE 4 8 0 1 0 0 13 ENE 1 5 2 0 0 0 8 E 2 17 5 0 0 0 24 .
ESE O 20 0 0 0 0 20 I SE O 6 0 0 0 0 6 SSR 1 2 4 0 0 0 7 ,
r S 0 1 0 0 0 0 1 l SSW 1 1 0 0 1 0 3 SW 0 1 0 0 0 0 1 WSW 0 3 1 0 2 0 6 W 0 0 0 0 3 0 3 WNW 0 0 0 2 0 0 2 I NW 0 7 0 1 0 0 8 NNW 2 12 0 0 0 0 14 Variable 0 0 0 0 0 0 0 TOTAL 13 117 20 4 6 0 160 l Period of calm (hours): 2
Enclosure to ET 95-0035 Page 31 of 32 HOURS AT EACH WIND SPEED AND DIRECTION PERIOD OF RECORD: January 1 through December 31,1994 STABILITY CLASS: ALL ELEVATION: 10 Meters Wind Dirgil0D 1 19_3 d_tol 8 to 12 13-18 19-24 224 TOTAL N 24 179 246 159 31 3 642 NNE 24 210 264 91 12 1 602 l NE 66 223 129 9 1 0 428 ENE 36 186 111 27 4 0 364 E 22 231 174 22 8 0 457 ESE 23 260 158 41 3 0 485 SE 24 310 243 69 3 0 649 SSE 19 248 445 326 50 7 1095 S 30 142 401 417 161 44 1195 SSW 23 113 118 139 36 10 439 ,
SVV 16 117 78 26 6 0 243 WSW 11 83 70 28 14 1 207 t
W 16 75 76 36 15 8 226 WNW 21 76 79 48 13 2 239 NW 18 121 146 114 41 1 441 ;
NNW 29 190 251 177 52 6 705 Variable 0 0 0 0 0 0 0 {
TOTAL 402 2764 2989 1729 450 83 8417 Period of calm (hours): 45 Hours of missing data: 298
Enclosure to ET 95-0035 l i
Page 32 of 32 i
Section IV l 1
AdditionalInformstion $
- l. Unplanned or Abnormal Releases nere was one abnormal release during this reporting period. On December 15,1994 Steam Generator Blowdown water was released for 11 hours1.273148e-4 days <br />0.00306 hours <br />1.818783e-5 weeks <br />4.1855e-6 months <br /> and 6 minutes directly to the Wolf Creek ,
Cooling Lake due to tube leaks in the Steam Generator Blowdown Non-Regenerative Heat j Exchanger.1.37 E-03 Curies of Tritium were released resulting in an organ dose of 1.49 E-07 mrem. 1
Administrative Procedure, "Offsite Dose Calculation Manual", Revision 5, was approved this
{
reporting period by the Plant Safety Review Committee and issued on November 25,1994. ~ A !
complete copy of the revised ODCM is attached. ;
}
- 3. Major Changes to Radwaste Treatment Systems j
Plant Modification Request (PMR) 03485 - Modified the Secondary Liquid Waste Evaporator to allow it to substitute for the Boron Recycle Evaporator in processing reactor coolant.
-f; i
Plant Modification Requests 03406 and 3761 - ne first PMR removed obsolete and unusable [i components from the Radwaste processing facility to make room for the changes and additions of the second PMR. The second PMR modified the facility to support the additional processing and !
storage requirements necessitated by the potential lack of a permanent off-site radwaste storage I facility. I l
Plant Modification Request 04474 - A spent Resin Storage Tank sampler was added to assure the l ability to maintain proper radioactive inventory control. This supports decisions pertaining to proper onsite storage / handling and shipping to off-site storage facilities.
l
- 4. Land Use Census ;
i nere were no new locations for dose calculation identified during this report period.
- 5. Radioactive Shipments Dere were ten shipments of radioactive radwaste during this report period. The shipments went j by Truck to Barnwell, South Carolina. i 4
- 6. Inoperability of Efiluent Monitoring Instrumentation j I
here were no events that involved inoperable liquid or gaseous effluent monitoring l instrumentation not being corrected within the time specified in Technical Specification .3.3.11. !
- 7. Storage Tanks nere were no events leading to liquid holdup tanks or gas storage tanks exceeding the limits of Technical Specification 3.11.1.4 or 3.11.2.6.
i i
i
W6' LF NUCLEAR CREEK OPERA l
1 l
i l
ADM 04-019 OFFSITE DOSE CALCULATION MAPGAL i i
Responsible Manager Superintendent Chemistry ;
5 l Revision Number Use Category Reference Yes Administrative Controls Procedure No Infrequently Performed Procedure 7B Program Number v '. 4 //hflqs,t-c . T!,,, i ? ',, '
.. ' # W i1 A'5'O l % f.W & c ;$ A a r p $ @ ] @ gi ggtj f,g g,(g g p4 g 4;g { ,:{77Jf p 5 ' ,
1.0 PURPOSE 1.1 This procedure contains the Offsite Dose Calculation Manual (ODCM) and the requirements for revision and submittal to the NRC.
2.0 PRECAUTIONS nwn LTMITATIONS 2.1 Technical Specification 6.14 shall be fully implemented by this procedure. i 3.0 RESPONSTRILITIES l 3.1 The Superintendent Chemistry is responsible for the ODCM.
i
4.0 REFERENCES
(
4.1 Technical Specification 6.14
, 4.2 AP 15C-001 Procedure Writers Guide i 4.3 AP 15C-004 Preparation, Review, and Approval of Documents 5.0 EECORDS REOUIRED 5.1 The following is a lifetime QA Record:
a) ADM 04-019, Offsite Dose Calculation Manual ,
L 6.0 PROCEDURE r
6.1 Revision Of The ODCM f 6.1.1 All revisions to the ODCM are to be submitted through the Superintendent Chemistry via a document revision request (DRR).
ADM 04-019 i Rev. 5 l Page 1 of 202 i
6e i t}d*: ~~_;,,",
-- &% '1 %K* ,,T.-. . . . JC.' J.k GM ?,K{T.TmKg,' 5{*g(Q k*!.QYYa5GGy,_'fl[] ] RQll
i 6.1.2 The Superintendent Chemistry shall ensure the Document Revision Request (DRR) package includes the following:
- 1) A copy of the revised pageo including revision bars and the date (e.g.,
month / year) in the right column.
- 2) sufficient information to support the change together with the appropriate analyses or evaluations justifying the change (s) and
- 3) A determination that the change will maintain'the level of Radioactive Effluent Control required by 10 CFR 20.106, 40 CFR Part 190, 10 CFR 50.36A, and Appendix I to 10 CFR Part 50 and not adversely impact the accuracy or reliability of effluent dose, or setpoint calculations.
6.1.3 The ODCM revision shall become effective after review and acceptance by the PSRC and the approval of the Vice President Plant Operations as documented on the Document Revision Request
- (DRR).
6.2 ODcM submittal To NRC 6.2.1 Changes to the ODCM shall be submitted to the Commission in the form of a complete, legible copy of the entire ODCM as a part of or concurrent with the Annual Radioactive Effluent Release Report for the period of the report in which any change to the ODCM was made. Each change shall be identified by markings in the margin of the affected pages, clearly indicating the area of the page that was changed, and shall indicate the date (e .g. , month / year) the change was implemented.
ADM 04-019 Rev. 5 Page 2 of 202 y .. m - m m m y g eggg; m g g3- .g. , ,g m .
I OFFSITE DOSE CALCULATION NANUAL l
TABLE OF CONTENTS ,
Page .
7 !
1.0 ' INTRODUCTION 8 j 2.0 LIQUID EFFLUENTS _
8 i 2.1 CONCENTRATION - COMPLIANCE WITH 10 CFR 20 13 l 2.2 DOSE - COMPLIANCE WITH 10 CFR 50 APPENDIX 1 15 i 2.3 PROJECTED DOSE 16 2.4 INSTRUMENTATION 32 ;
3.O GASEOUS EFFLUENTS 33 3.1 DOSE RATE - COMPLIANCE WITH 10 CFR 20 i 40 3.2 DOSE . COMPLIANCE WITH 10 CFR 50 APPENDIX I 50-3.3 PROJECTED DOSE 51 3.4 INSTRUMENTATION ,
66 ;
4.0 TOTAL DOSE
, 66 !
4.1 REMEDIAL FCTION 66 4.2 SURVEILLANCE REQUIREMENTS 67 j 5.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 67 .
5.1 MONITORING PROCRAM 67 !
5.2 LAND USS CENSUS !
68 5.3 INTERLABORATORY COMPARISON PROGRAM 68 5.4 REPORTING REQUIREMENTS ,
86 ,
s- 6.O BASES f 94 !
7.0 REPORTS 94 l 7.1 ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT '
95 7.2 ANNUAL RADIOACTIVE EFFLUENT RELEASE REPORT 99 APPENDIX Ar DOSE CONVERSION FACTOR TABT.ES 197 APPENDIX B: METEOROLOGICAL MODEL r
I f
l ADM 04-019 :
Rev. 5 :
1 Page 3 of 202
+
e gegg ;
7; ;,*,.,,,,,, , , , , .
7*'- MvetW;r;attupir,yg g y g gg g ;gyg.f , ,
l l
i LIST OF TABLES ;
Pace ;
Table 9
2-1 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM ,
18 2-2 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION 20 .
2-3 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS l 36 3-1 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM S3 4 3-2 RADIOACTIVS GASEOUS EFFLUENT MONITORING f INSTRUMENTATION 9 SS 3-3 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION SURVEILLANCE REQUIREMENTS j 70 S-1 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM +
76 5-2 SAMPLING, LOCATION NUMBERS, DISTANCES (MILES) AND DIRECTIONS l 77 5-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE '
ANALYSIS i 4 80 5-4 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAI. SAMPLES 100 A.1-1 BIOACCUMULATION FACTORS TO BE USED IN THE ADSENCE i OF SITE SPECIFIC DATA i 101 f A.1-2 DOSE FACTORS FOR NOBLE GASES AND DAUGHTERS 102 l A.2-1 INHALATION DOSE FACTORS FOR ADULTS 105 A.2-2 INHALATION DOSE FACTORS FOR TEENAGERS ?
108 l A.2-3 INHALATION DOSE FACTORS FOR CHILD 1 111 !
A.2-4 INHALATION DOSE FACTORS FOR INFANT i 114 ;
A.2-5 EXTERNAL DOSE FACTOR FOR STANDING ON CONTAMINATED ;
GROUND 116 A.3-1 INGESTION DOSE FACTOR FOR ADULTS -i i
119 A.3-2 INGESTION DOSE FACTOR FOR TEENAGERS l 122 i A.3-3 INGESTION DO"E FACTOR FOR CHILD i ADM 04-019 t
Rev. 5 Page 4 of 202 1
i
. % . 7 ' .
4 W .. ,T WTS, :~<%%5'MQMj$pffgyj.g{jg* * - .
LIST OF TABLES EA92 Inble 125 A.3-4 INGESTION DOSE FACTOR FOR INFANT 128 A.3-5 STABLE ELEMENT TRANSFER DATA 129 A.4-1 SITE RELATED INGESTION DOSE COMMITMENT FOR ADULT 132 A.4-2 SITE RELATED INGESTION DOSE COMMITMENT FACTOR FOR TEENAGER 135 A.4-3 SITE RELATED INGESTION DOSE COMMITMENT FACTOR FOR CHILD 138 A.4-4 SITE RELATED INGESTION DOSE COMMITMENT FACTOR FOR INFANT 141 A.5-1 INHALATION DOSE PARAMETER FOR THE CHILD 142 A.5-2 INHALATION PATHWAY FACTOR FOR ADULT (RI FACTOR) 145 A.5-3 INHALATION PATHWAY FACTOR FOR TEENAGER (RI FACTOR) 148 A.5-4 INHALATION PATHWAY FACTOR FOR CHILD (RI FACTOR) 151 A.5-5 INHALATION PATHWAY FACTOR FOR INFANT (RI FACTOR) 154 A.5-6 GRASS-COW-MILK PATHWAY FACTOR ADULT (RI FACTOR) OF SITE SPECIFIC DATA y
157 A.5-7 GRASS-COW-MILK PATHWAY FACTOR TEEN (RI FACTOR) 160 A.5-8 GRASS-COW-MILK PATHWAY FACTOR CHILD (RI FACTOT.)
163 A.5-9 GRASS-COW-MILK PATHWAY FACTOR INFANT (RI FAC"OR) 166 A.5-10 GRASS-COW-MEAT PATHWiY FACTOR ADULT (RI FACTOR) 169 A.5-11 GRASS-COW-MEAT PATHWAY FACTOR TEEN (RI FACTOR) 172 A.5-12 GRASS-COW-MEAT PATHWAY FACTOR INFANT (RI FACTOR) 175 A.5-13 VEGETATION PATHWAY FACTOR ADULT (RI FACTOR) 178 A.5-14 VEGETATION PATHWAY FACTOR TEEN (RI FACTOR) 181 A.5-15 VEGETATION PATHWAY FACTOR CHILD (RI FACTOR) 184 A.5-16 GROUND PLANE PATHWAY FACTOR (RI FACTOR) 185 A.5-17 GRASS-GOAT-MILK PATHWAY FACTOR ADULT (RI FACTOR) 188 A.5-18 GRASS-GOAT-MILK PATHWAY FACTOR-TEEN (RI FACTOR)
ADM 04-019 Rev. 5 Page 5 of 202 e 'Y 4 't.W%u".WM'"^ m;n ns;1.g tfg.Qr;ffijQ'17;Qqgg ;;fy-; .
** . t-
- '1
LIST OF TABLES EAER TAh1A . 191 ! A.5-19 GRASS-GOAT-MILK PATHWAY FACTOR CHILD (RI FACTOR) 194 A.5-20 GRASS-GOAT-MILK PATHWAY FACTOR INFANT (RI. FACTOR) i LIST OF FIGURES Paae Fiaure 31 l 2.1 BOUNDARY FOR LIQUID EFFLUENTS 65 3.1 BOUNDARY FOR GASEOUS EFFLUENTS 81 5,1 AIRBORNE PATHWAY SAMPLING LOCATIONS 82 5.2 DIRECT RADIATION PATHWAY SAMPLING LOCATIONS i 83 5.3 WATERBORNE PATHWAY SAMPLING LOCATIONS 84 5.4 INGESTION PATHWAY SAMPLING LOCATIONS B5 5.5 DISTANT SAMPLING LOCATIONS i 201 B-1 VERTICAL STANDARD DEVIATION OF MATERIAL IN A PLUME 201 B-2 PLUME TRAVEL DISTANCE VERSUS FRACTION REMAINING IN PLUME $ 202
~
B-3 PLUME TRAVEL DISTANCE VERSUS RELATIVE DEPOSITION RATE , t t i ADM 04-019 l Rev. 5 Page 6 of 202 ; O 1 ! 3x. <7r>?rt1r.r.iqiqLWE m g 3 g } g ,g M?a% gg g j4 .
?}
^ ~
l 1.O INTRODUCTIQN The Offsite Dose Calculation Manual describes the Radioactive Effluent Controls Program. The implementation of this program ensures compliance with the requirements of 10 CFR 50.36, 10 CFR 20.106, 10 CFR 50 Appendix I and 40 r CFR 190. On January 1, 1994, 10CFR20.1001-20.2402 shall be 12/93 ; implemented. Wolf Creek will continue to maintain the ! existing level of,,ef fluent control (10CFR20.106) to comply L with the new requirements. This method of compliance has been determined by the NRC to be ALARA. '
~
i The ODCM describes the methodology and parameters used in , the calculation of offsite doses due to radioactive liquid and gaseous effluents. The ODCM contents for calculation j of dose are based on " Preparation of Radiological Effluent , Technical Specifications for Nuclear Power Plants (NUREG- l 0133)," and Regulatory Guide 1.109, Revision 1. The ODCM provides the limitations on the operability of ! radioactive liquid and gaseous monitoring instrumentation , including surveillance tests and se'cpoint determination. ., Each Surveillance Requirement shall be performed within the j j specified surveillance interval with a maximum allowable 0 extension not to exceed 25% of the specified interval, , The ODCM provides the Padiological Environmental Monitoring h Program. The prcgram consists of monitoring stations and i sampling programs designed to confirm the dose estimates made under normal or accident conditions, and conform to l NRC requirements in 10 CFR Part 50. i The ODCM provides descriptions of the information that ! should be included in the Annual Radiological Environmental ! Operating and Annual Radioactive Effluent Release Reports. ; ADM 04-019 Rev. 5 Page 7 of 202 f
. N. '!* "'fCZ5?nlW W kW M 3.5%l M [g & R-&f Q Q y Q & & f-. jg Q ,ll Z, . -
l 1
C I 2.0 LIOUID EFFLUENTS 2.1 concentration - cn=nliance with 10 CFR 20 The concentration of radioactive material released in l liquid effluents to UNRESTRICTED AREAS (see Figure 2.1) I shall be limited to the concentration specified in 10 CFR ' Part 20, Appendix B, Table II, Column 2, for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall I be limited to 2x 10" microcurie /ml total activity. 2.1.1 R==mdial Action with the concentration of radioactive material released in , liquid effluents to UNRESTRICTED AREAS exceeding the above limits, immediately restore the concentration to within the above limits. i s 2.1.2 Surveillance Reauirements . equirement, concentrations of 3/91 To show compliance with this i actual liquid effluents will oe determined by performing Isotopic Analyses. Radioactive liquid wastes shall be sampled and analyzed according to the sampling and analysis l program of Table 2-1. 4
?
F t l i l t
- l s' ;
\ r i
. t F
k h ADM 04-019 l Rev. 5 Page a of 202 f r
*- 1 '
"i"Y ~ , , [
O 1 [~
*f W *"5' M E W J.c; p ; T h & j;.g g 4 . g { l g.] ,J 13{/,f *,'.]'; ,
TABLE 2-1 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM LOWER LIMIT MINIMUM OF DETECTION LIQUID RELEASE SAMPLING ANALYSIS TYPE OF ACTIVITY (1) (LLD) TYPE FREQUENCY FREQUENCY ANALYSIS (pCi/ml) Batch Waste P P Principal Gamma 1. pelease (2) Each Batch Each Batch (3) Emitters 5x10 Tanks I-131 1x10"
- a. Waste P M Dissolved and One Batch /M Entrained Gases 1x10" Monitor Tank '
(Gamma Emitters)
- b. Secondary P M ( '. ) H-3 Each Batch Composite 1x10" Liquid Waste Monitor Tank Gross Alpha 1x10
P Q (4) Each Batch Composite SR-89, Sr-90 5x10* Fe-55 1x10"
- 2. Continuous (6) W (4)
Daily Grab Composite Principal Gamma 5x10 (5) Releases Sample (3) Emitterc I-131 1x10" Steam Generator M M Dissolved and Grab Sample Entrained Gases 1x10 Blowdown (Gamma Emitters)
'(6) M (4)
Daily Grab Composite H-3 1x10* Sample I Gross Alpha 1x10" (6) Q (4) Daily Grab Composite SR-89, Sr-90 5x10 Sample Fe-55 1x10" 3/91 1 1 l ADM 04-019 Rev. 5 Page 9 of 202 e W 7.'w - M.TJEF'5'i'lTQ3x ""fiffM7ElMgg7g*_@,@gygpgg{'{QY{, gg.$ (( 'g ,i ,
E ._ 1 l TABLE 2-1 (Continued) TABLE NOTATIONS (1) The LLD is defined, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system, which may include radio-chemical separation: . 4.66 s* LLD = E x V x 2.22 x 10' x Y x Decay Where: LLD = the "a priori" lower limit of detection (microcuries per unit mass or volume), the standard deviation of the background counting rate or sb = of the counting rate of a blank sample as appropriate, (counts per minute), s.-/Itti Where: B = background sum (counts) LT = live time (minutes), E = the counting efficiency (counts per disintogration), i the sample size (units of mass or volume), V = 2.22 x 106= the number of disintegrations per minute per microcurie, Y - the fractional radiochemical yield, when applicable, i Decay = decay factor (s), There are three decay factors that may be appropriate for use depending on the nature of the sample and the half life of the nuclide. Any combination of the three may be used. The factors are as follows: A) This decay factor corrects for decay from the time of sampling to the start of the analysis, c'Mts, where: Ats = decay time = acquisition start time - sample time A = In2/ half-life 4/92 ADM 04-019 Rev. 5 Page 10 of 202 e ^ d ' /' *t
l l Taar2 2-1 (enntinued) h TABLE NOTATIONS (Continued) , i B) This decay factor corrects for decay during the analysis.
- g , ,.lar AxRT f
A= In2/ half-life RT = real time of counting C) This decay factor corrects for decay during sampling. t 1-e* AAtd A = In2/ half-life td - deposition time = sample time - deposition start time- ! NOTE: All times used in decay calculations should be in the same unite. Typical values of-E, V, Y, ts, td should be used in the calculation. ( It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a , particular measurement. i (2) A batch Eelease is the discharge of liquid wastes of a discrete i volume. Prior to sampling for analyses, each batch shall be { isolated, and then thoroughly mixed by a method described in j plant procedures to assure representative sampling. l l (3) The principal gamma emitters for which the LLD specification , applies include the following radionuclides: Mn-54, Fe-59, Co- l 58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144. This list does not mean that only these nuclides are to be considered. - other gamma peake that are identifiable, together with those of ; the above nuclides, shall also be analyzed and reported in the ! semiannual Radioactive Effluent Release Report in the format i outlined in Regulatory Guide 1.21, Appendix B, Revision 1, June l 1974. l 4/92 i i ADM 04-019 ! Rev. 5 f Page 11 of 202 ; I
$$ .?;1,y, t ,
- E!$;f[*} ' ;f.[l~~ ^ ?*L ' ,
u M& lN55.*IE.?5'.5 05&
i TABLE 2-1 (Continued) L (4) A composite sample is one in which the quantity of liquid . sampled is proportional to the quantity of liquid waste discharged and in which the method of sampling employed , results in a specimen that is representative of the liquids released. Prior to analysis, all samples taken for the > composite shall be thoroughly mixed in order for the composite samples to be representative of the effluent j release. ,. E (5) A continuous release is the discharge of liquid wastes of a nondiscrete volume, e.g., from a volume of a system that has an ; input flow during the continuous release. J (6) Samples shall be taken at the initiation of effluent flow and at : least once per 24 hours thereaf ter while the release is ; occurring. To be representative of the liquid effluent, the sample volume shall be proportioned to the effluent stream < discharge volume. The ratio of sample volume to effluent- , discharge volume shall be maintained constant for all samples ! taken for the composite sample. FREQUENCY NOTATION , 4 NOTATION FREOUENCY I S At lease once per 12 hours. l
,4 D At least once per 24 hours.
W At least once per 7 days M At least once per 31 days. O At least once per 92 days. SA At least once per 184 days, j At least once per 18 months. : R Prior to each reactor startup. ! S/U N.A. Not applicable. l p Completed prior to each release. 3/91 f i i
~
ADM 04-019 Rev. 5 , page 12 of 202 i -O P:. Of: M4@i?MY.W.?3itM44F4Mgl AM,g 5.hy Q : igg. 33 .g;j y g g y j g ((y~ u.ijp.g "*; g .g
i l 2.2 Dose - ca-nilance With 10 cFR 50 Appendix I i The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid efflue,nts released, from each unit, to UNRESTRICTED AREAS (see Figure 2.1) shall be ; limited: ; i
- a. During any calendar quarter to less than-or equal
- to 1.5 mrems to the whole body and to less than or equal to 5 mrems to any organ,. and
- b. During any calendar year to less than or equal to i 3 mre'ms to the whole body and to less than or i equal to 10 mrems to any organ.
1 << 2.2.1 gamedial Action , With the calculated dose from the release of radioactive 3/91 materials in liquid effluents exceeding any of the above limits, prepare and submit to the Commission within 30 ; days, pursuant to Technical Specification 6.9.2, a Special j Report that identifies the cause(s) for exceeding the limit (s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective ' actions to be taken to assure that subsequent releases will
! be in compliance with the above limits. This Special Report shall also include: (1) the results of radiological ,
analyses of the drinking water source, and (2) the l radiological impact on finished drinking water supplies i with regard to the requirements of 40 CFR Part 141, Clean Drinking Water Act. This requirement of (1) and (2) are applicable only if drinking water supply is taken from the i receiving body within 3 miles of the plant discharge. [ 2.2.2 Surveillance Remuirements Cumulative dose contributions from liquid effluents for the i current calendar quarter and the current calendar year shall be determined using the following methodology at l least once per 31 days. r . > F OT i A Ai1[ A t Ca t.: t o > l
- ADM 04-019 Rev. 5 page 13 of 202 ;
i O . * "": " .
- f- ha .- 9 UP^Q MM'"1NQ$}'Pfff MTgggtg1llYggg gjg ' ,]
I assim Where, DT= the cumulative dose commitment to the total body or any organ, T, from the liquid effluent for the total time period a t t,inmrem t=1 ot t = the length of the Lth time period over which Ctt and Ft are averaged for all liquid releases, in hours. Cit = the average concentration of radionuclide,
'i', in undiluted liquid effluent flow during time period Ato, in pCi/ml.
Fo = the near field average dilution factor for C 3 n during any liquid effluent release where: f
=
Ft (F)k, Where: f= Liquid Radioactive Waste Flow F= Discharge Structure Exit Flow, the sum of the release and dilution flow. K= Applicable factor; the site dependent value for the mixing effect of the discharge structure. This value is conservatively assumed to be 1 (one) for this section. A, = The site related ingestica dose commitment f actor to the total body or any organ,
'T', for each identified principal gamma and beta emitter, mrem /hr per pCi/ml. See Tables A.4-1 through A.4-4.
An = 1.14E5 (U, / Dw + U, x BF,)DF, i 1 l ADM 04-019 l Rev. 5 l Page 14 of 202 l e '
' *r$Vb '*7iS&il(W Ait Ur NBA, ."MsEM,=*
- ] p..',d f. ,;Q , ' ' ~ [~ ;
=.- _ . . _. .
2.2.2 surveillance Requir== ants - continued ! Where, , DW - Dilution factor from the near field area to j the potable water intake for water consumption, for Wolf Creek Generating Station this factor is 1 (one). .! l BFi= Bioaccumulation factor for radionuclide 'i', ! in fish, pCi/Kg per pCi/1, from Table A.1-1 from Regulatory Guide 1.109 (Rev. 1). j DFi= Dose Conversion factor for radionuclide, !
'i', in mrem /pCi, from Table A.3-1 through A.3-4, from Regulatory Guide 1.109 (Rev. 1). ,
Uw = Water consumption, in kg/yr. t Up = Fish consumption, in kg/yr. j i 5 10'pCi/ pCi x 10 ml/ Kg 1.14E5 = Units conversion factor = 8760 hr / yr j The dose calculations are based on the actual isotopic analysis of the radioactive liquid effluents, the radioactive liquid effluent flow, and the dilution flow.
]
> l 2.3 Projected Dose 'l l The Liquid Radwaste Treatment System shall be OPERABLE and 3/91 f appropriate portions of the system shall be used to reduce i releases of radioactivity when the projected doses due the liquid effluent, from each unit, to UNRESTRICTED AREAS (see i Figure 2.1) would exceed 0.06 mrem to the whole body or 0.2 i mrem to any organ in a 31 day period. l 2.3.1 Esmedi11 Action j i With radioactive liquid waste being discharged without 3/91 treatment and in excess of the above limits and any portion I of the Liquid Radwaste Treatment System not in operation, ; prepare and submit to the Commission within 30 days l pursuant to Technical Specification 6.9.2, a Special Report that includes the following information: k A. Explanation of why liquid radwaste was being 3/91 discharged without treatment, identification of any inoperable equipment,or subsystems, and the reason for the inoperability, , 1 ADM 04-019 { Rev. 5 page 15 of 202 j l l 6
. f r4 . . Sf;';n'77Ns 5!EE MEN 6gfjT?FfyUSNJM).YME.Q?*pyg@g.T?p. g ;
2.3.1 Remedial Action icontinued) B. Action (s) taken to restore the inoperable 3/91 equipment to OPERABLE status, and I C. Summary description of action (s) taken to prevent 3/91 a recurrence. 2.3.2 Surveillance Reauirements 2.3.2.1 Doses due to liquid releases from each unit to UNRESTRICTED 3/91 AREAS shall be projected at least once per 31 days in accordance with the following methodology when Liquid i Radwaste Treat' ment Systems are not being fully utilized. i D,, - x 31 _T, Where, D31 = Projected 31 day dose A - Cumulative dose for current quarter T - Current number of days in quarter 3/91 2.3.2.2 The installed Liquid Radwaste Treatment System shall be considered OPERABLE by meeting the requirements of Sections 2.1 and 2.2. 2.4 Instrumentation The radioactive liquid effluent monitoring instrumentation cnannels shown in Table 2-2 chall be OPERABLE with their Alarm / Trip Setpoints set to ensure that the limits of Section 2.1 are not exceeded. The Alarm / Trip Setpoints of these channels shall be determined and adjusted in accordance with the methodology and parameters described in Section 2.4.4. i ADM 04-019 Rev. 5 Page 16 of 202 e
.!! " M.* UX O 'T.E'lW UNMlFRi@@t2{'CRM M6'ND[.I9,N'YM)[h),(kg' (-j[g ,['$$;
. , ] ]',',
i 2.4.1 Ramadial Action 2.4.1.1 With a radioactive liquid effluent monitoring instrumentation channel Alarm / Trip Setpoint less ; conservative than required by the above, immediately j suspend the release of radioactive liquid effluents ! monitored by the affected channel, or declare the channel f inoperable. I 2.4.1.2 with less than the minimum number of radioactive liquid ; effluent monitoring instrumentation channels OPERABLE, take the ACTION shown in Table 2-2. Restore the inoperable j instrumentation to OPERABLE stc*tus within the time specified in the ACTION, or explain in the next Annual 9/93 Radioactive Effluent Release Report, why this inoperability was not corrected within the time specified. j 2.4.2 surveillance Rem 2irements Each radioactive liquid effluent monitoring instrumentatior channel shall be demonstrated OPERABLE by perfornance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL CALIBRATION and , ANALOG CHANNEL OPERATIONAL TEST at the frequencies shown-in Table 2-3. f i i 4 . i l l [
- I
- i. ,
1 b n Y l l ADM 04-019 i Rev. 5 Page 17 of 202 ; i l l
, e I
' t 1 t T* ',1 'SW.?l,C,FE%M HMfMM f.gR9 ll ; .
_3.] Q }y * .; .;'j. p.,
TABLE 2-2 k% b RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION IFSTRUMENT MINIMIM ACTION CHANNELS OPERABLE
- 1. Radioactivity Monitors Providing Alarm and Automatic Termination of Release
- a. Liquid Radwaste Discharge Monitor (HB-RE-18) 1 31
- b. Steam Generator Blowdown Discharge Monitor (BM- 1 32 RB-52)
- c. Turbine Building Drain Monitor (LE-RE-59) 1 32
- d. Secondary Liquid Waste System Monitor (HP-RE-45) 1 33
- e. Wastewater Treatment System Influent Monitor (HF- 1 32 l
RE- 95)
- 2. Flow Rate Measurement Devices
- a. Liquid Radwaste Discharge Line
.9', ' 1) Waste Monitor Tank A Discharge Line 1 34
- 2) Waste Monitor Tank B Discharge Line 1 34
- b. Steam Generator Blowdown Discharge Line 2 34 j 1
- c. Secondary Liquid Waste System Discharge Line 1 34 3/91 l 1
(h%
+N ADM 04-019 Rev. 5 Page 18 of 202 e
'
- M 'J?ATWTOTd tTifrEISUD11) M.27 Yppg . tM}l,$gy;;jggg;gy[Q: Fjp' gl.7, ' #
~ "I 4 , s}. ,@ ;;; p ~~g"] i
IABLE 2-2 (continued) ACTION STATEMENTS Action 31 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue for up to 14 days provided that prior to initiating a release:
- a. At least two independent samples are analyzed in accordance with Section 2.1.2, and
- b. At least two technically qualified members of the facility staff independently verify the release rate calculations and discharge line valving.
Otherwise, suspend release of radioactive effluents via this pathway. , Action 32 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue for up to 30 days provided grab samples are analyzed for principle gamma emitters and I-131 at a lower limit of detection as specified in Table 2-1,
- a. At least once per 12 hours when the specific activity of the secondary coolant is greater than 0.01 l microcurie / gram DOSE EQUIVALENT I-131, or
- b. At least once per 24 hours when the specific activity of the secondary coolant is less than or equal to 0.01
- , microcurie / gram DOSE EQUIVALENT I-131.
Action 33 - With the number of channels OPERABLE less than required by the Minimum Channels OPERABLE requirement, effluent releases via this pathway may continue for up to 30 days provided that prior to initiating a release:
- a. At least two independent samples are analyzed in ;l accordance with Section 2.1.2, and ,
I
- b. At least two technically qualified members of the !
facility staff independently verify the release rate calculations and discharge line valving. , Otherwise, suspend release of radioactive effluents via f this pathway. With the number of channels OPERABLE less than required Action 34 - by the Minimum Channels OPERABLE requirement, effluent . releases via this pathway may continue for up to 30 days provided the flow rate is estimated at least once per 4 hours during actual releases. Pump performance curves i generated in place may be used to estimate flow. 3/91 ADM 04-019 Rev. 5 Page 19 of 202 .e
- r J ; a < NFC6M[T?)%KKWysogy,ygfjf,yggiQ,'&fjy): , ,[*kY. } }q'.3 } K" fit; Q Q ,_ } jG
- _ ^ .)
TanLE 2-3 RADIOACTIVE LIOtJID EFFLTTENT MONTTORTNG TMfTRIMENTATION StJRVETLLANOE REOtfTREMENTS CHANNEL SOURCE CHANNEL ANALOC INSTRIMENT CHEFE CHECK CALIBRATION CHANNEL ' OPERATJ.Cti&L . TEST
- 1. Radioactivity Monitors providing alarm and automatic termination of release r
- a. Liquid Radwaste Discharge D P R(2) Q (1) g Monitor (HB-RE-18) <t j
- b. Steam Generator Blowdown D M R(2) Q (1)
Discharge Monitor (BM-RE-52) ; Turbine Building Drain D M R(2) Q(1) c. Monitor (LE-PE-.59) - Secondary Liquid Waste System D P R(2) Q(1) d. Monitor (HF-RE-45) , Wastewater Treatment System D M R(2) Q(1) e. Influent Monitor (HF-RE-95) i
- 2. Flow Rate Measurement Devices D(3) N.A. R N.A.
B a. Liquid Radwaste Discharge Line R N.A. j
- b. St'eam Generator Blowdown D(3) N.A.
i Discharge Line D(3) N.A. R N.A.
- c. Secondary Liquid Waste System Discharge Line 3/91 i
t ADM 04-019 . Rev. 5 Page 20 of 202 ,
.* 4 O 4 S4 4 1 m /
l 5
~
IABLE 2-3 (continued) TABLE NOTATIONS (1) The ANALOG CHANNEL OPERATIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation occur as appropriate if any of the following conditions exists:
- a. Instrument indicates measured levels above the Alarm / Trip setpoint (isolation and alarm), or
- b. Circuit failure (alarm only), or j
- c. Instrument indicates a downscale failure (alarm only), or l
- d. Instrument' controls not set in operate mode (alarm only) I (2) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference (gas or liquid and solid) standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST.
These standards shall permit calibrating the system over its intended range or energy, measurement range, and establish monitor response to a solid calibration source. For subsequent CHANNEL CALIBRATION, NIST traceable standard (gas, liquid, or solid) may be used; or a gas, liquid, or solid source that has been calibrated by relating it to equipment that was previously (within 30 days) calibrated by the same geometry and type of source standard traceable to NIST. (3) CHANNEL CHECK shall consist of verifying indication of flow Q' during periods of release. CHANNEL CHECK shall be made at least once per 24 hours on days on which continuous, periodic, or batch , releases are made. 3/91 ADM 04-019 Rev. 5 Page 21 of 202 e **'
~
9 ~:
- Ti lj[gy Q.3 F } g A'? M :rLLYGW%3ff'_O Y{9l'WQQf R$Qfy_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ - _ _
2.4.3 Llauld manitor calibration Methodology 1 The favo monitors associated with liquid releases are listed below- l 1 Monitor TD Description 0-BM-RE-52 Steam Generator Blowdown Discharge l Monitor 0-LE-RE-59 Turbine Building Drain Monitor 0-HF-RE-45 Secondary Liquid Waste System Monitor 0-HB-RE-18' Liquid Radwaste Discharge Monitor 0-HF-F.E-95 Wastewater Treatment System Influent l Monitor l Liquid effluent streams are monitored by an NaI(Tl) ' Detector. The detector operates in a gross counting mode and is gamma sensitive. Calibration of the liquid monitors shall be performed using , three standard colutions of Cs-137. The solutions shall cover the appropriate range of the detector and have i concentrations of approximately 5 x 10-7 pCi/cc, 1 x 10-5 pCi/cc, and 1 x 10-3 pCi/cc. The solutions shall be g presented to the detector and the meter reading in counts l per minute shall be recorded. A graph of counts per minute versus concentration shall be produced from the data. l Lianid Effluent Monitor setnoints i 2.4.4 : The Alarm / Trip Setpoints for the Liquid Effluent Radiation !
}
Monitors are based on instantaneous concentration limits of 10 CFR 20, Appendix B, Table II, Column 2 applied at the [ bom.dary of the restricted area. Specifically, the High l l Alarm Setpoint will correspond to the 10 CFR Part 20 limits at the Boundary of the restricted area; the Alert Alarm Setpoint is set one order of magnitude below the High Alarm / Trip Setpoint. Since the high alarm / trip initiates isolation of the particular system and termination of the ; release, this setpoint represents assurance that the i instantaneous liquid release limit of 10 CFR Part 20 is not j exceeded. Auditable records shall be maintained indicating j the actual setpoints used at all times. I l ADM 04-019 l Rev. 5 Page 22 of 202 e - t . Og +N Vs %QM9?'m**WfImp5K/VNMggggggFggy
_. __ .. _m . _ _ . . . - . . _ . . l < i The calculated Alarm and Trip Action Setpoints for the ! Liquid Effluent Line Monitors must satisfy the following ; equation: ; SC t F+f j Where: i C = The liquid effluent concentration limit (MPC)' ; implementing Section 2.1 in pCi/ml. { i c - The Satpoint, in pCa/ml, of the Radioactivity- [ Monitor measuring the radioactivity j concentration in the effluent line prior to , dilution and subsegur.nt releaser the Setpoint, which is inversely proportional to I ( the volumetric Flow of the effluent line and directly proportional to the Volumetric Flow f of the dilution stream plus the effluent stream, represents a value, which if exceeded l would result in concentrations exceeding the [ limits of 10 CFR 20 in the restricted area. ; f - The Pump Flow Rate as measured at the , Radiation Monitor Location, in Volume per y Unit Time, but in the same units as F, below. [ t F - The Dilution Water Flow Rate as measured prior to the release point, in Volume per [ j Unit Time. i Thus, the expression for determining the setpoint on the Liquid Radwaste Effluent Line Monitor becomes: , cs C(F + f) (pCi/ ml) 2.4.4.1 Continuous Liauid Effluent Monitors 1 The three monitors associated with continuous liquid [ releases are listed below: Monitor ID Description j 0-BM-RE-52 Stm Generator Blowdown Discharge Monitor 0-T.E-RE-59 Turbine Building Drain Monitor : 0-HF-RE-95 Waste Water Treatment System Influent Monitor ! ADM 04-019 l Rev. 5 ; Page 23 of 202 i -e J i Mf MWpMQQQgj.pg ][gy
~ 441 s'S"7 3IMillMR g'4 s
The Steam Generator Dlowdown Discharge Effluent Monitor continuously monitors the Blowdown Discharge Pump Outlet to detect excess radioactivity due to System Demineralizer breakthrough or abnormal Primary to Secondary leakage. The Blowdown Discharge Monitor's High Alarm Setpoint initiates CLOSURE of the Blowdown Isolation Valves and the Blowdown Discharge Valve. Similarly, the High Radiation Alarm on the Turbine Building Drain Monitor and Waste Water Treat-Monitor initiates CbOSURE of the Drain Line Isolation Valves to prevent the release of radioactive effluents. Monitor setpoints will be conservatively based on I-131, the most restrictive isotope expected to be present. This is particularfy appropriate for the Turbine Building Drain Line Monitor since the most probable source is the Secondary steam Systern which is expected to have negligible activity unless there is a significant Primary to Secondary leak. Due to changing activities, it will not be possible to select a radionuclide distribution on which to base the monitor setpoint. Additionally, maximum effluent flows and minimum dilution flows will normally be assumed. The High Alarm / Trip Setpoint will be set to correspond to the I-131 MPC limit at the boundary of the restricted area from 10 CFR Part 20, Appendix B, Table II, Column 2. The alert alarm is set one order of magnitude below the High Alarm / Trip Setpoint. This High Alarm / Trip Setpoint assures the limits of Section 2.1 are not exceeded at the boundary of the restricted area. In the event that an alarm in TRIPPED, an evaluation of the system will be made by taking an actual isotopic and flow analysis of the discharge. The above continuous liquid effluents are not radioactive effluents until activity has been detected by the Liquid Effluent Monitor, a Tritium analysis of the Secondary system, or a gross Beta analysis of the Secondary system. At that time an analysis of the effluent will be made to verify activity in the system effluent. During periods of time when the above liquid effluents are not radioactive the High Alarm / Trip Setpoint may be set to 1.5 times the background count rate. 2.4.4.1.1 Steam Generator Blowdown Discharoe Monitor SETPOINT(pCi/ ml) = MPCn3, x F + F" E,n ADM 04-039 Rev. 5 Page 24 of 202 e
.3.r.e,ea @ G Q*p:74 %=gg4 & w iiaf Z t* ] Q Q Q.y..,] { ' ))
" ~
g~
i l l I where, ; h MPCs.in = Maximum Permissible Concentration of - l of I-131, 3.0 E-7 pCi/ml. l l t Fm - Dilution flow rate. FB = Blowdown flow rate. The setpoint calculation is based on the minimum dilution , flow rate, the maximum possible blowdown flow rate, and, ' due to changing conditions, I-131_which is the most ; restrictive isotope expected to be present. 1 On the event that an alarm is reached, the setpoint will be ! re-evaluated using the actual dilution flow rate, the l actual blowdown flow rate, and the actual isotopic analysin j as outlined in Section 2 4.4.2. This evaluation will be ! used to ensure the limit of Section 2.1 was not exceeded. [ The setpoint will still be based on the MPC of I-131 due to the changing conditions of activity and I-131 being the r most restrictive isotope. f 2.4.4.1.2 Turbine Buildina Drain Manitor And Maste Water Trea&mant n System Influent Monitor B - F, + FT SETPOINT( Ci/ ml) = MPC,,3, x '! F7 r
?
l MPCs.gn = 3.0 E-7 pC1/ml. j t F. = ' Dilution flow rate b Ft = Effluent flow rate The setpoint is based on the minimum dilution flow rate, I the maximum possible effluent flow rate, and the most ! restrictive isotope expected to be present, I-131. f J c On the event that an alarm is reached, the release will be j evaluated to see if the limit of Section 2.1 was exceeded .l by using the actual Dilution Flow Rate, the actual Effluent { Flow Rate, and the actual isotopic analysis as outlined in ( section 2.4.4.2. The setpoint will still be based on the MPC of I-131 due to the changing conditions of activity and , I-131 being the most restrictive isotope. l l i ADM 04-019 ; L Rev. 5 i page 25 of 202 1
\
l
. l i GaAlwc %. i?x MMrl1gbW&MM,Q'~g'fMQQ$QQf[Rfg j.}
J
7
)
a l l l 2.4.4.2 Batch amAlsactive Liquid Effluent Manitor l The two monitors associated with liquid batch releases are l, listed below: ;
- Monitor ID Description j 0-HF-RE-45 Secondary Liquid Waste System Monitor :
0-HB-RE-18 Liquid Radwaste Discharge Monitor ! The setpoint is a function of dilution flow rate, tank flow ; rate, and isotopic composition. A laboratory isotopic analysis is made of each batch prior to discharge. Based ; on the isotopic analysis and existing flow condition, the setpoint will'be calculated and set on the appropriate i monitor to ensure the concentration limits of 10 CFR 20, Appendix B, Table II, Column 2 are not exceeded. The setpoints are determined using the following l methodology: i
- 1) Determine concentrations of radioactivity of the batch being considered for release. [
The isotopic concentration of the batch is the sum of the concentrations for the isotopes present as determined from the analysis required in Table 2-1. c Eci - Ec, + c, + c, + ci i c, i s e where: Ci - The concentration of nuclide i as ' determined by the analysis of the waste sample. , Cg = The sum of the concentrations Cg of each measured gamma emitting nuclide observed ' by gamma-ray spectroscopy of the waste sample. l
*Ca - The measured concentration Ca of alpha- '
emitting nuclideo observed by gross alpha analysis of the monthly composite sample. ,
*Cs = The measured concentrations of Sr-89 and' Sr-90 in liquid waste as determined by analysis of the quarterly composite sample. i i
t ADM 04-019 i Rev. 5 page 26 of 202 1 e _; "2 WtW/h Q pi,W O 3 Q[Qo: w..;g ,.p'gf f; i, ' ' '{ *~ *]~ '
~
=
+
2.4.4.2 Ratch mediametive Lienid affin==t uanitor ~(continued)
*Ct= wasteThe measured concentration of H-3 in liquid ,
as determined' by analysis ' of the j monthly composite. j
~
*cf - The measured concentration of Fe-55 in liquid waste as determined by analysis of 7 the querterly composite. l t
f
- Values for these concentrations will be based on l
previous composite sample analysis as required by Table 2-1. 'f
-i j
- 2) The measured radionuclide concentrations are used to calculate a dilution factor, Fd , which is the ratio of .
total dilution flow rate to tank flow rate required'to f assure that the limiting concentrations of Section 2.1 J are met at the point of discharge. This is referred to ! as the required dilution factor and is determined i according to: 1 C' j F, = s L MPCs xF' ; j i Where: Y Measured concentrations of Cg , Ca, Cs, Ct Ci = ( and cf, as defined in Step 1. Terms C a, C, ; Ce and C f , will be included in the l calculation as appropriate. MPCi. = MPCg , MPCa, MPCs, MPCt and MPCg, are ' limiting concentrations of the i appropriate radionuclide from 10 CFR 20, Appendix B. Table II, column 2. For dissolved or entrained noble gases, the , concentration shall be limited to 2.0E-04, I l pCi/ml total activity. Fg = The safety factor; a conservative factor used to compensate for statistical fluctuations and errors of measurement default value is 1.0. ADM 04-019 Rev. 5 Page 27 of 202 I 1 O ' ' * '~"
*.' . A 34%iiis'i[33MriV5%5}$rb5ITOR, &y5#f,gG')'e[QG,;*
l .,l.JG.}(( [ ,
~ ..
i f f 2.4.4.2 Batch nadiometive Liould Effluent unnitor (continundl i
- 3) For the case Fd<1, the waste tank effluent [
concentration meets the limits of 10 CFR 20 without dilution and the effluent may be released at any t desired flow rate. For the case Pd > 1, a modified ; dilution factor, F n,dmust be determined so that l available dilution flow may be apportioned among l simultaneous discharge pathways. E - F, / F, j Where Fa is the allocation factor which will modify the i required dilution factor so that simultaneous liquid [ releases may be made without exceeding 10 CFR 20 limits. r The most straight-forward determination of allocation , 1 factor is: l F, = 1/ n Where: e n = The number of liquid discharge pathways for ' which Fd>1 and wh'ch are planned for simultaneous release. 9 Iloweve r , this value for Fa may be unnecessarily restrictive , in that all release pathways are apportioned the same fraction of the available dilution stream, regardless of the relative concentrations of each of the sources. i I Since the'radionuclide concentration of the two continuous sources is expected to be less than that of the batch release source, it is acceptable to allocate smaller portions of the dilution stream to the continuous. releases and a larger portion to the batch releases. Therefore, Fa is defined as a flexible quantity with a
- default value of 1/n. Prior to initiating simultaneous release, a check will be made to assure that the sum of the allocation factors assigned to pathways for the simultaneous release is c 1. g .- J
- 4) The calculated maximum permissible waste tank effluent flow rate, Fmax, is based on the modified dilution factor, F dn, and the effective dilution flow rate, Fegg. .
ADM 04-019 Rev. 5 Page 28 of 202 e me n e, wwp:rFrtMTJa!$5iWA*W4HiGCQ-Z' l',$"'[l .* ,$,y"y {'" g '}', .g *'
2.4.4.2 match ==dioactive Lieuid affinant uanitor (continued) s The cooling lake into which the effluent is discharged is also the source of the dilution stream. It is therefore necessary to take into account the recirculation of pre- , viously emitted radionuclides should they be detected by sample analysis of the cooling lake water. This is accom-plished by defining an effective dilution flow rate as: , i tc f
- r. , . r. i. I nq.
g ;
't Where: ;
Fm
- The* expected minimum dilution water flow rate. ;
LC i = Measured concentration of nuclide i in the l cooling lake water sample. MPCi = Limiting concentration of radionuclide i from. ' 10 CFR 20, Appendix B, Table II, Column 2- . For the pur.ot 3 of setpoint calculations the expected mini- , mum d3F le flow rate is assigned a'value based upon the type ano e. e of pumps RUNNING into the circulating water , piping. ? Having established the values of Fdn and Feff, the calcu-lated maximum permissible waste tank flow rate is given by F + f, F'" f.,, s ,,F, for f,((Feff T. Where f p if the expected effluent flow rate; normally the > Thus the pump flow rated capacity of the effluent pump. rate is set at or below fmax. Even though the value of - fmax may be larger than the actual effluent pump capacity, f,p it does represent the upper limit to the effluent flow . rate, whereby the requirement of 10 CFR 20 may still be met. If Fd s 1, the effluent pump flow rate may be l
~
assigned any value since the waste tank effluent concentration meets the limits of 10 CFR 20 without : dilution and the release may be made without regard to the setpoints for other release pathways. For those discharge ; pathways selected to be secured during the release under ! consideration, the pump flow rate should be set at as low a value as practicable to detect any inadvertent release, r l ADM 04-019 t f Rev. 5 Page 29 of 202 i i I. , s sw.wy=rarmv99tgentgePJ5NEfGil?BP4flSMO.Cf.W;h75;!IGMI,1 U ' '4h(EM.h
m ---- -- - - -__-___-__ _ _ _ _ _ 2.4.4.2 Batch Radioactive Liquid Effluent Monitor (Continued) A setpoint for the dilution stream flow rate is not applicable since the minimum flow rate is administratively set.
- 5) The liquid radiation monitor setpoint may now be determined based on the values of I,C1, I and fmax-The monitor response is primarily to gamma radiation, therefore, the actual setpoint is based on E g, C g. The l
calculated monitor setpoint concentration is determined ! as follows: c=A C,(gCi / ml) Where: A= Adjustment factor which will allow the setpoint to be established in a practical manner for convenience and to prevent spurious alarms. I== A= f, If A > 1, calculated c and determine the maximum value for the actual monitor setpoint (pCi/ml). If A < 1, no release may be made.
.fFd<1, no further dilution is required and the release may be made without regard to available dilution or to other releases nede simultaneously. However, it is necessary to establish a monitor setpoint which will provide alarm should the release concentration inadvertently exceed 10 CFR 20 limits. This can be accomplished by establishing the adjustment factor as follows:
A - 1/ F, ADM 04 039 Rev. 5 Page 30 of 202 M .
' W # W Mi% S51;. t!N.Y * *
,,yf.',_
. , . . , . . .- ~ ~ . , -. - . - -
i
'1
' l i
)
t FIGURE 2.1 I
~
l BOUNDARY FOR LIQUID EFFLUFNTS 3/91 -i
./
h ' E. i i - __ o.a ' l 4L_. ..h - s ,
,==r# -.>,,. NA X ,- i i ,
_ . - ~
._ i p l*~ l !
a.. ,. k. . i 5 me - Q , . . . , s ... ,
)
^
m <. E j VY i s h. b A ;-} s-
-----c : / l
** 1 -.
- l. l Ml F ..
-g .f r-.- g wcs ottex ct.sc.urwe sn .:= 4 l
~w .) \\.
- u. r oa. . .
u,. r r ts s e., Z.1 s ,e s....a t,e sn
.- c. x (X >1 \ ~
v w l i i
) !
=.7.:.q- ga)nd l.L
- n. . ~m< l. . ~.. ..;,4 .
Jl
- .-l { --.-
. .. ..s. . _ .. a .
25 t
' fI i
ADM 04-01's t Rc't . 5 f Page 31 of 202 I i ie .g 37- 3,, .
"r"N* . - *f.TJ.4. SJ ;jgg;gg.,,yyggggry, twc. ,*
e ,nygg ymax w.sm:. ,%.<w w. .,...p
,,sma , _ ,;,,g.,.q;, g i
. .~ _
l l
)
3.O GAS 2OITE EFFLUENTS j Gaseous effluent releases from the Unit Vent and Radwaste Building Vent are monitored continuously. The Unit Vent is l the release point for the Fuel / Auxiliary Building, access ; control area, containment purge, and condenser air i discharge. The Radwaste Building Vent is the release point for Waste Gas Decay Tanks and the Radwaste Building Ventilation System. l Waste Gas Decay Tank releases and Containment Building releases are treated as batch releases. Waste Gas Decay , i Tank releases.are monitored by the Radwaste Building ! Exhaust Monitor. Containment Building releases (purges) l are monitored by the Containment Purge System monitors and the Plant Unit Vent Monitor. , I Monitor identificationa are as follows: ; i Monitor ID Release Point Descrintion
?
Unit Vent (Fuel / Auxiliary O-GT-RE-21 A and B ' Building, access control ares, containment purge, condenser air discharge) ; e
) Radwaste Building vent (Radwaste O-GH-RE-10 A and B Building, waste gas decay tank discharge. Acts to isolate Waste Gas Decay Tank discharge) ,
t 0-GT-RE-22 & 23 Containment Purge System Monitor (acts to isolate the purge; is not an effluent monitor) .
?
O-GT-RE-31 & 32 Containment Atmosphere Monitor (acts to isolate purge; not an l effluent monitor) r The setpoint for monitors may be determined either based on , total body dose or skin dose rate. The dose rate limitsThe , are for dose rates at the unrestricted area boundary. ' monitor setpoint is the lesser of the total body dose rate or skin dose rate. t ADM 04-019 l Rev. 5 Page 32 of 202 e ~ < .r ,~ ,o-
*: - ' ; ~ .;r Misis % .'K1Rr}!;f 5 % M ,M y th.3 M g g eg,' .
l i I 3.1 Dome Rate ea==11mnce with 10 CFR 20 i The dose rate due to radioactive materials released.in I gaseous effluents from the site to areas at and beyond the ! SITE BOUNDARY (see Figure 3.1) shall be limited to the following:
- a. For noble gases: Less than or equal to 500 mrems/yr to' l the whole body and less than or equal to 3000 mrems/yr l' to the skin, and
- b. For Iodine-131 and 133, for tritium, and for all [
radionuclides in particulate form with half-lives ; greater than 8 days: Less than or equal to 1500 ; mrems/yr to any organ. l l 4 3.1.1 R .=-dial Action ; I . With the dose rate (s) exceeding the above limits, ! f immediately restore the release to within the above limit (s). ! t 3.1.2 surveillance Reauirements !
)
The dose rate to radionuclides in gaseous effluents shall i be determined to be within the above limits'in accordance { j with the methodology described below by obtaining i representative samples and performing analyses in : accordance with the sampling and analysis program specified l in Table 3-1, 3/91 3 Based on the methodology of NUREG-0133; 1 1 l
- a. Release rate limit for nobles gases: l f
[K,(X / Q% < 500 mrem / yr for the total body, , I and I b ! i [(L, + 1.1 M )(X / Q) Q, < 3000 mrem / yr for the skin l l Where: , I Ki - Total body dose f actor due to gamma emi ssions l for each identified noble gas radionuclide, in l in mrem /yr per p.Ci/m3 , from Table A.1-2. l i f ADM 04-019
- Rev. 5 Page 33 of 202 l I
e ~
.-rT
W W,y5?X Q W M 'WE.T.,91C U W 1)}Ktj-w l';~c,l.f%d'1, ,
* } ,.
j
l l i 3.1.2 survai11==nm naquir---=tm (continued) 3!' (X / Q) = 2.2E-06 sec/m3, the highest calculated f annual average relative concentration at the restricted area boundary in the north sector. Release rate of radionuclide i from vent, i Qi = in pCi/sec. { I Li = Skin dose factor due to beta emissions for each identified noble gas radionuclide, in mrem /yr per pCi/m3, from Table A.1-2. Mi = Air dose factor due to gamma emissions Tv; . each identified noble gas radionuclide, in mrad /yr.per pCi/m 3 from Table A.1-2. 1.1 = Conversion constant of air dose to skin dose. , i
- b. Release rate limit for all radionuclides and radioactive materials in particulate form and j radionuclides other than noble gases:
)
[(P,)lN x (X / Q)x Q,)< 1500 mrem / yr to any organ. a
)
Where: The release rate of radionuclides, i, in Oi - gaseous effluent from all vent releases, in pCi/sec, P(i)IN = The dose parameter for radionuclides ' other than nobles gares for the inhalation pathway, in mrem /yr per pCi/m3 . See Table A.5-1. (X/Q) = 2.2E-06 sec/m3 (the highest annual average). The highest calculated annual average relative concentration for estimating the dose to any individual at the unrestricted , area boundary in the H cector. ADM 04-019 i Rev. 5 Page 34 of 202 e '
.m I
MQg,fQ,*,,tyQ* f;[sy:.y}},ty,g ', '((:;$jf f., '
~,:" DMSt.'*N iTh%) W K Q @, & ~f,q & ffbyg. _
r 3.1.2 surveillance Reauir---nts (continued) All radionuclides are assumed to be released in elemental ! form. The limit is applicable to the location (unrestricted area boundary or beyond), characterized by ;
.the value of X/O which results in the maximum total body or [
skin dose commitment. The factors K1, L i, and-Mi relate j the radionuclide airborne concentrations to various dose l rates assuming a semi-infinite cloud. These factors are ; taken from Table B-1 of the Regulatory Guide 1.109 and l multiplied by 10 6 to convert pCi-1 to pCi-1 and listed in f Table A.1-2. I The following, equation for P(i)IN was taken f rom NUREG j 0133: P(i)IN (Inhalation); , I P gp = K' (BR) DFA (mrem i / yr per pCi / m') l Where: ! K' = a constant of unit conversion, 106 pCi/pCi. BR = the breathing rate of the child age group in m3 /yr f t DFAi = the maximum organ inhalation dose factor for the child age group for'the i th l radionuclide, in mrem /pC1. The total body l is concidered as an organ in the selection of DFAi. l The age group considered is the child group. The child's breathing rate is taken as 3700 m3 /yr from Table E-5 of f Regulatory Guide 1.109. The inhalation dose factors for the child, DFAi are presented in Table E-9 of Regulatory ! Guide 1.109, in units of mrem /pC1. Resolutions of the units yields: Pi (Tnhalation) = 3.7 X 109 DFAi The Pi value for tritium is: Pi (Inhalation) = 3.7 x 109 DFAi ADM 04-019 Rev. 5 Page 35 of 202 e L: - ct .:.'*YK13NVtY5";. m tdA,. M W A g6.5 M ZQL%.[,Q}[ Q KRff{Q.g g ggg,gy-
IABI,E 3-1 RADIOACTIVE GASEOUS WASTE SAMPLING AND ANALYSIS PROGRAM MINIMUM TYPE OF ACTIVITY LOWER LIMIT GAS E:OUS , SAMPLING ANALYSIS ANALYSIS OF DETECTION RELEASE TYPE FREQUENCY FREQUENCY (LLD) (1) (pcI/ML) P P Principal Gamma Each Tank Emitters (2) 1x10"
- 1. Waste Gas Each Tank Decay Tank Grab Sample P P Principal Gamma Each Purge Each Purge Emitters (2) 1x10"
- 2. Containment Purge or vent (3) Grab (3)
Sample M H-3 (oxide) 1x10 M(3), (4) M(3) Principal Gamma Grab Sample Emitters (2) 1x10"
- 3. Unit Vent M(4)
H-3 (oxide) 1x10 M M Principal Gamma Grab Sample Emitters (2) 1x10"
- 5. Radwaste Building vent M
H-3 (oxide) 1x10 Continuous
- 1x10 **
(6) W(7) 1-131
- 6. Release i$ Typec as listed in 3. and 5.
above Charcoal 1x10 " Sample I-133 Continuous W (7) Principal Gamma Emitters (2) 1x10' * * (6) Particulate Sample Continuous M 1x10 ' * * (6) Particulate Gross Alpha Comrosite Sample Continuous Q Composite Particulate Sr-89, Sr-90 1x10"* (6) Sample 12/91 i 1 ADM 04-019 Rev. 5 l Page 36 of 202 f ~ a
l s [., .. L W I 5 [ f $~'h h , K } Q , f Q l G -Q* Q . ( ~{ ej ,>
J
. ~ ~ ,.- . .
i t Tanu 3 1 (Continued) TABLE NOTAT70NS (1) The LLD is defined, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only [ 5% probability of falsely concluding that a blank observation l r represents a "real" signal. For a particular measurement system, which may include ; r radiochemical separations r 4 4.66 s 6 ! LLD = E x V x (2.22E + 6)x Y x Decay . r where: LLD = the "a priori" lower limit of detection (microcuries per ? unit mass or volume) , sb = the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate, (counts per minute), sb = d i LT Where: B = background sum (counts) > LT = live time (minutes), V E = the counting efficiency (counts per disintegration), , V = the sample size (units of mass or volume), 2.22E+6 = the number of disintegrations per minute per ; microcurie, Y = the fractional radiochemical yield, when applicable, Decay - decay factor (s), There are three decay factors that may be . appropriate for use depending on the nature of the sample and the half life of the nuclide. Any combination of the j three may be used. The factors are as follows: A) This decay factor corrects for decay from the time of sampling to the start of the analysis, e uts, where: Ato - decay time = acquisition start time - sample time A = In2/ half-life 4/92 4 ADM 04-019 Rev. 5 Page 37 of 202 a0
= vi .
m smme:rmtomnyggy;;mgyy,y$rgu. xyygggg,7;p,py.pgi; , . ,
}
- )
i l I TABLE 3-1 (Continued) TABLE NOTATIONE (Continued) , B) This decay factor corrects for decay during the analysis. 1.e** AxRT j t A = In2/ half-life RT = real time of counting r C) This decay factor corrects for decay during sampling. ,
!-e* ;
t AAtd A = In2/ half-life Atd = deposition timo - sample time - deposition start time i NOTE: All times used in decay calculations should be in the same units. Typical values of E, V, Y, ts, td should be used in the calculation. l
? It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement.
+
(2) The principal gamma emitters for which the LLD specification ap-plies include the following radionuclides: Kr-87, Kr-88, Xe-133, l 133, Xe-133m, Xe-135, and Xe-138 in noble gas releases and Mn-54, , Fe-59, Co-58, Co-60, Zn-65, Mo-99, I-131, Cs-134, Cs-137, Ce-141 and Ce-144 in iodine and particulate releases. This list does not mean that only these nuclides are to be considered. Other gamma l peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the semi- i annual Radioactive Effluent Release Report in the format outlined , in Regulatory Guide 1.21, Appendix B, Revision 1, June 1974. (3) Sampling and analysis shall also be performed following shutdown, i startup, or a THERMAL POWER change exceeding 15% of RATED THERMAL POWER within 1 hour period. (4) Tritium grab samples shall be taken and analyzed at least once per 24 hours when the refueling canal is flooded. 4/92 ; ADM 04-019 , Rev. 5 Page 38 of 202 l I e v g wm Tn ?M.mww.9%* M gi; Q Q Q *if ,. i
r [
'raarm ' 3 1 ' f ranntinued)
.f TARLR NOTATIONS - (Contimind)
(6) The ratio of the sample flow rate to the sampled stream flow rate l shall be known for the time period covered by each dose 3.2 or dose and rate calculation made in accordance with Sections 3.1, [ i 3.3. (7) Samples shall be changed at'least. once per 7 days and analyses ! shall be completed within 48 hours after changing, or after l removal from sampler. For unit vent, sampling shall also be . l performed at least once per 24 hours for a least 7' days following l each shutdown, startup or THERMAL POWER change exceeding 15% of [ RATED THERMAL POWER within a 1-hour period, and analyses shall be completed within 48 hours of changing. When samples collected for- l$ 24 hours are analyzed, the corresponding LLD's may be increased by. (1) { a factor of 10. This requirement does not apply ifs l analysis shows that the DOSE EQUIVALENT I-131 concentration in the and (2) reactor coolant has not increased more than a factor of 3, , the noble gas monitor shows that effluent activity has not ; increased more than a factor of 3. v i I
?
N i i 4 i I ADM 04-019 l Rev. 5 . Page 39 of 202 1 lG -
, g-v -,is y . .qr- -r-- y .- , . y .g g -g .
. g ggpg.q t; . - - , f yl,y,g- ~ t,
)
E i i 3.2 ppme - c =pliance With 10 CPR 50 Annandix I ; 3.2.1 Nobles Qases The air dose due to nobles gases released in gaseous i effluents, from each unit, to areas at and beyond the SITE [ BOUNDARY (see Figure 3.1) shall be limited to the ; i following ( Less than or equal to 5 i
- a. During any calendar quarter: '
mrads for gamma radiation and less than or equal to 10 mrads for beta radiation, and ; i
- b. During any calendar year: Less than or equal to 10 l mrads for gamma radiation und less than or equal to 20 ;
f mrads for beta radiation. <
.f 3.2.1.1 Remedial Action r i
With the calculated air dose from radioactive noble gases I in gaseous effluents exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a special report . that identifies the cause(s) for exceeding the limit (s) and I defines the corrective actions that have been taken to
- reduce the releases and the proposed corrective actions to I
be taken to assure that subsequent releases will be in compliance with the above limits. 3.2.1.2 Surveillance Requirements , cumulative dose contributionn for the current calendar 3/91 j quarter and calendar year for noble gases shall be determined in accordance with the following methodelegy at least once per 31 days. The dose calculations for the ' actual releases of radioactive noble gases in gaseous effluent will be consistent with the methodology provided in Reg. Guide 1.109, Rev. 1. The following dose calculations will be performed:
- a. During any calendar quarter: ,
For gamma radiation; D = 3.17E-8 [M, [X / Q)x Q[ s 5 mrad. ADM 04-019 Rev. 5 Page 40 of 202 0
*w r w 9c p: s W S M :~;~i; M M l E y fe }; M Q Q -} 3 9 . , .
',}, ;
l i 3.2.1.2 surveillanee Reauir-- mts (Conti nued) 6 For beta radiation: ' D = 3.17E-8 [N, fX/ Q)x Q 10 mrad. 6-8
- b. During any calendar year For gamma radiation; ;
D = 3.17E-8 [M; 10 mrad. i-
)xQ ,
7 For beta radiation: l D = 3.17E-8 [N, (X / G)x Q,}$;20 mrad. . ( Where: , 4 3.17 E-B = The inverse of the number of seconds in 1 a year. Mi - The air dose factor due to gamma emissions for each identified noble gas radionuclide, in !
" in mrad /yr per pCi/m3 from Table A.1-2 (Reg.
Guide 1.109, Table B-1, Col. 4). f I f Ni = The air dose factor due to beta emissions for each identified noble gas radionuclide, in ! d mrad / year per pCi/m3 from Table A.1-2 (Reg. f Guide 1.109, Table B-1, Column 2). } i j (X / Q) = 2.2E-06 sec/m3, the highest calculated annual average relative concentration at the restricted area boundary in the north sector. t l Oi - The release of noble gas radionuclides, l
'i', in gaseous effluents, in pCi. ;
Releases shall be cumulative over the calendar quarter or year as appropriate. An average monthly air dose schedule should be setup to l The average monthly l ensure section 3.2.1 is not exceeded. air dose should be as follows: ADM 04-019 Rev. 5 Page 41 of 202
.e yt wvn:*6s;.<;s,;,%, m o;pg79qqegj M y q Qrg'f y.r.p g g i
a e < am i
i 3.2.1.2 surve111=nne n--uir- nes (continuedi
- a. For gamma radiation s 1.6 mrad /mo.
For beta radiation s 3.3 mrad /mo. ; If the monthly average air dose for (a) is exceeded, it : should be noted that if the release is continued at the i same (or higher) frequencies or activities the quarterly s limit of Section 3.2.1.A will be exceeded. i
- b. For gamma radiation s 0.8 mrad /mo.
For beta radiation s 1.6 mrad /mo. , r If the monthly average air dose fors (b) is exceeded, it should be noted that if the release is continued at the same (or higher) frequencies or activities the annual limit of section 3.2.1.B will be exceeded. . If any of the above monthly average air doses are exceeded, evaluation of the causes of the high air dose should be ! performed and steps should be taken to reduce the activity i or frequency (e.g. delay the release of a Waste Gas Decay Tank) of the release. ! i 3.2.2 Radiciodines. Particulates and Other Radionuclides The dose to a MEMBER OF THE PUBLIC from Iodine-131 and 133, - tritium, and all radionuclides in particulate form with { y half-lives greater than 8 days in gaseous effluents released, from each unit, to areas at and beyond the SITE i BOUNDARY (see Figure 3.1) shall be limited to the l following: l Less than or equal to 7.5 i
- a. During any calendar quarter:
mrems to any organ; and , i
- b. During any calendar years Less than or equal to 15 mrems to any organ. [
I i i t i i r ADM 04-019 Rev. 5 Page 42 of 202 l ee *
% 912fMLS/;+ M.E6 y*Mf$Q]Gggpg;](t('.[ ,;g,i ,[* .h: i ,,
r I
. i l
3.2.2.1 m---Maal Action With the calculated dose from the release of Iodine-131 and 133, tritium, and. radionuclides in particulate form with half-lives greater than 8 days, in gaseous effluents l exceeding any of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical ; Specification 6.9.2, a special report that identifies the ! cause (s) for exceeding the limits and defines the , j corrective actions that have been taken to reduce the > releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with l the above limits. 3.2.2.2 survalliance Rasuirements , Cumulative dose contributions for the current calendar quarter and current calendar year for Iodine-131 and 133, tritium, and radionuclides in particulate form with half- l lives greater than 8 days shall be determined in accordance , with the following methodology at least once per 31 days. , To show compliance, the dose calculations for the actual releases of the subject materials are consistent with the methodology provided in Regulation Guide 1.109, Revision 1. , The following dose calculations will be performed: w
- a. D (mrem) = 3.17E-8 [R,[(WQ,)]s 7.5 mrem
. i 3/82
- b. D (mrem) = 3.17E-8 [R [(WQ,)]s i 15 mrem '
Where: 3.17 E-8 = The inverse of the number of seconds in a 1 year. , t 01 = The release of radioiodines, radioactive l materials in particulate form and radionuclides l other than noble gases in gaseous effluents,
'i', in pCi. Releases shall be cumulative over ,
~
the calendar quarter or year as appropriate. The Q3 value shall be determined as the product of the flow rate through the release point and ; grab samples of the effluent analyzed in j accordance with Table 3-1. r i
?
ADM 04-019 i A Rev. 5 Page 43 of 202 i e 1-EC * '.UTi3M7"wsT%WRKM; .iEWMyyj;(-[K$,g((g][9))*[-}) ((} i .. , I
~
t 7-le---=tm 3.2.2.2 surveillane. = (cantinn=an i W = The annual average dispersion parameter for j i estimating the dose to an individual at the controlling location. ; w - (X/Q), 2.2 x 10-6 sec/m3 for the inhalation pathway. l W = (D/Q), 1.0 E-8 m-2, for the food and ground plane pathways. Ri - The dose factor for each identified radionuclide, 'i', in mrem /yr per pCi/m3 , see Table A.5-2 through Table A.5-20. ; Where: Inhalation Pathway Factor, RI i (X/Q) 3 R's [X /Q] = K' (BR),(DFAi ), (mem/ yr per pCi/ m ) l l Where: K' = a constant of unit conversion, 106 pCi/pCi. , I (BR)a = The breathing rate of the receptor of age. group (a), in m 3/yr. ; The breathing rates (BR)a for the various age groups are tabulated below, as given in Regulatory Guide 1.109, Table 3 E-5. AGE GROUP (a) BREATHING RATE 3/yr) Infant 1400 child 3700 : Teen 8000 ' Adult 8000 (DFA1 )a - The maximum organ inhalation dose factor for the receptor of age group (a) for the ; i th radionuclide, in mrem /pCi. The body is considered as an organ in tha selection of (DFA1 )a. See Tables A.2-1, A.2-2, A.2-3, & A.2-4. From Regulatory ; Guide 1.109, Tables E-7,E-8, E-9 and E-10. , t ADM 04-019 Rev. 5 Page 44 of 202 i
- 6I'rista1TW3.4CYM;CMZiggEM6TLy,qs-pgQ37Enggjj{pgM){(*.yspf ,]jj'Q;)ggTy.'g"g_Q,;ll/ . . p ] .'!
. , ,_ _ _ . _ _ . . . . ~ . .. . ._. _.m .. _ _ __m_ m ,
. .j 3.2.2.2 gurve111-= n== f r-- ,ts (continued).
Ground Plane Pathway Fact or, RGg [p/g) , I I
' 2 R 6 [D/Q]= K'K" (SF)DFO i fl.c^i )' A, m x mrem / yr per pCi/see) l Where:
K' = A constant of unit conversion, 106_peijpei, K" =- A constant of unit conversion, 8760 hr/ year. j I Ai = The decay constant for the i th radionuclide, sec-1 [ t = The exposure time, 4.73 E8 sec (15 years). j DFGi = The ground plane dose conversion factor for t the i th radionuclide (mrem /hr per pci/m') . l See Table A.2-5. (Regulatory Guide 1.109, Table E-6). , i t SF = The shielding factor (dimensionless), 0.7 (Reg. Guide 1.109) . l 1 C Grass-Cow-Milk Pathway Factor, R i(D/QJ .t 2 RC ,[D /Q] = K' F,(r)(DFL;),('/1;{e'*i'f{m mrem / yr per pCi/
*s ;
L l I Where: i K' = A constant of unit conversion, 106 pCi/pCi. I Op - The cow's consumption rate, in Kg/ day (wet weight), 50 kg/ day. (Reg. Guide 1.109, j Tablo E-3). l
. Uap = The receptor's milk consumption rate for age (a), in liters /yr. (Reg. Guide 1.109, Table l E-5). [
Infant = 330 1/yr ; Child = 330 1/yr { Teen = 400 1/yr l Adult = 310 1/yr ; ADM 04-019 Rev. 5 , Page 45 of 202 l t I O L.: G ~ iMT3MFC:VM;MfRM&MW,f%Q}'l[.{Rijp.[Qg)[:QQQ,'f}
I 3.2.2.2 surveill=nne naouir===nts (continued 1 Yp = The agricultural productivity by unit area of i pasture feed grass, in kg/m2 . 0.7 kg/m2, (Reg. Guide 1.109, Table E-15) i I Fm = The stable element transfer coefficients, in days / liter, see Table A.3-5. (Reg. Guide 1.109, Table E-1) r = Fraction of deposited activity retained on cow's feed grass, r=1 for radioiodine and r= 0.2 for particulates. (Reg. Guide 1.109, l T&ble E-15) l (DFLi)a - The maximum organ ingestion dose factor for the i th radionuclide for the receptor in age group 'a', in mrem /pci. See Tables A.3-1, A 3-2, A.3-3, and A.3-4. (Reg. Guide 1.109, Table E-11, E-12, E-13, and E-14) Ai = The decay constant for the i th radionuclide, in sec-1 E lj Aw - The decay constant for removal of activity on leaf and plant surfaces by weathering, 5.73 E-7 sec-1 (correcponding to a 14 day half-life), tg = The transport time from pasture to cow, to milk, to receptor, in sec, 1.73 E5 secs (2 days). (Reg. Guide 1.109, Table E-15). NOTE: The fraction of the year that the cow is on pasture and the fraction of the' cow feed that is pasture grass is assumed to be 1.0, which is the most restrictive case. Grass-Goat-Hilk Pathway Factor, R 3(D/Q) 2 C R i[D/Q] - K' F,(r)(DFL,),('Dde'*i'f[m mrem /yr per pCi/se I ADM 04-019 Rev. 5 Page 46 of 202 e ' ' *
' T d NE*{ N 4i.t ' .' :$ edi$ ,4,,* *f.1 ;. jI.N * *3/ / ',7 % [- ,, ,
3.2.2.2 surveillance peauirements (continued) 1 Where: Op = The goat's consumption rate, in Kg/ day (wet weight), 6 Kg/ day. (Reg.. Guide 1.109, Table E-3). tg - The transport time from pasture to goat, to milk, to receptor, in sec, 1.73 ES sec (2 days). (Reg. Guide 1.109, Table E-15). all other terms are defined under the Grass-Cow-Milk-Pathway Factor. NOTE: The fraction of the year that the goat is on pasture and the fraction of the goat feed that is pasture grass is assumed to be 1.0, which is the most restrictive case. The concentration of tritium in milk is based on the airborne concentration rather than the deposition. Therefore, the RC i is based on (X/g), RCi(X /Q) - K'K"
- F,,,QpU,,(DFL,),[0.75 (0.5/ H))(mrem /yr per Ci/ m')
1 Where K"' = a constant of unit conversion, 103 gm/Kg. 11 = Absolute humidity of the atmosphere, 8 gm/m' (Reg. Guide 1.109), , 0.75 = The fraction of total feed that is water. (NUREG 0133) 0.5 - The ratio of the specific activity of the feed grass water to the atmospheric water. (NUREG 0133) Grass-Cow-Meat Pathway Factor, RM g[p/g) R"'[D / Q) - K' F,(r) (DFL,),('/Y, {e-^i' f{m' mrem / yr per mci / s 8 w/ i ADM 04-019 Rev. 5 Page 47 of 202 O "*
.-M te.hN*.*FZIP'308MmWmM6M 9PP5E1WggMTL(712C*(ff ', "J.]MgEgigy.'{ .~.,.j]*;53 [ M W,
__ , _. . . _ _ . 1 l l 3.2.2.2 surve111=are neauir nts_ Mantinued) Where: Ff - The stable element transfer coefficients, in days /kg, Table A.3-5. (Reg. Guide 1.109, Table E-1). Uap = The receptor's meat consumption rate for age (a), in kg/yr. (Reg. Guide 1.109, Table E-5). Infant - 0 Child = 41 Teen = 65 Adult = 110 tf - The transport time from pasture to receptor, in sec., 1,73 E6 (20 days) (Reg. Guide 1,109, Table E-15). r The concentration of tritium in meat is based on its airborne concentration rather than the deposition. Therefore, the R Mi is based on . (X/Q) : 8 R";[X /Q) = K'K" ' FrQrU,(DFL;),[0.75 (0.5/ H))(mremlyr per Ci/m ) ! Where: j : All terms defined above. Vegetation Pathway Factor, RYi[D/Q) l Man is considered to consume two types of vegetation (fresh and stored) that differs only in the time period between harvest and consumption, therefore: 2 x mrem / yr per pCi / sec) Y R i [D / Q. K' (DFL;), t U'a)f. *i'tf aff f"l'h g Where: K' = A constant of unit conversion, 106 pCi/pC1. I U 'a = The consumption rate of fresh leafy vegetation by the receptor in age group (a), in kg/yr. (Reg. Guide 1.109, Table E-5). ADM 04-019 Rev. 5 Page 48 of 202 : I
- e ,'
W %..' ' ~ "**% y. Q M yE7*yg Q y g ) g go 3tg.qfgggyf'?) }} , - , ;;; .
y - l 3.2.2.2 : surveill=ne a macruir--nte (continued) Infant = -0 kg/yr Child = 26 kg/yr Teen = 42 kg/yr Adult = 64 kg/yr US a - The consumption rate of stored vegetation by the receptor in age group (a), Kg/yr. (Reg. Guide.l.109, Table E-5). Infant = 0 kg/yr Child = 520 kg/yr Teen = 630 kg/yr Adult - 520 kg/yr I fn - The fraction of the annual intake of fresh leafy vegetation grown locally. (default
= 1.0) (Reg. Guide 1.109).
fg - The fraction of the annual intake of stored vegetation grown locally (default = 0.76) (Reg. Guide 1.109). EL = The average time between harvcot of leafy veg'tation and its consumption, in seconds, 0.6 E4 secs (1 day) . (Reg. Guide 1.109). 'C) ~ th = The average time between harvest of stored vegetation and its consumption, in seconds, 5.18 E6 secs (60 days) (Reg. Guide 1.109, Table E-15). Yy = The vegetation area density, 2.0 kg/m2 , (Reg. Guide 1.109, Table E-15). All other factors previously defined. The concentration of tritium in vegetation is based on the airborne concentration rather than the deposition. Therefore, the RV1 is based on (X/Q): 3 RY e[X /Q) = K'K" ' [U'.ft + Us.f DFL;), p.75 (0.5 / H){ mrem / yr per pCi / m ) Where: All terTns defined previously. All values indicated are I default values from Reg. Guide 1.109 Rev. 1. ADM 04-019 Rev. 5 i Page 49 of 202 le
. 3 Wtd+; s u d 9sTri4T(M D M'w ,4Q.l:4,s'& d.y . .. , . ;/.' g, , , . ,
, 'J( ,
3.2.2.2 surveil 1=nce meanir- nts W tinu.dt An average monthlv Jose schedule should be setup to ensure Section 3.2.2 is not exceeded. The average monthly dose due to radiciodines, particulates, and other radionuclides which are included in this section should be as follows: l
- a. < 2.5 mrem /mo.
l If the monthly average dose for (a) is exceeded, it should l be noted that if the release is continued at the same (or I higher) frequencies or activities the quarterly limit of , Section 3.2.2.a will be exceeded.
- b. < 1.25 mrem /mo.
If the monthly average dose for (b) is exceeded, it should be noted that if the release is continued at the same (or higher) frequencies or activities the yearly limit of Section 3.2.2.b will be exceeded. If y of the above monthly doses are exceeded, evaluation of .2e causes should be performed and steps taken to reduce the activity or frequency of the release. 3.3 Proiected._ps33 U The VENTILATION EXHAUST TREATMENT SYSTEM and the WASTE GAS HOLDUP SYSTEM shall be OPERABLE and appropriate portions of these systems shall be used to reduce releases of radioactivity when the projected doses in 31 days due to gasects effluent releases, from each unit, to areas at and beyond the SITE BOUNDARY (see Figure 3-1) would exceeds
- a. 0.2 mrad to air from gamma radiation, or
- b. 0.4 mrad to air from beta radiation, or
- c. 0.3 mrem to any organ of a MEMBER OF THE PUBLTC.
3.3.1 Remedial Action with radioactive gaseous waste being discharged without treatment and in excess of the above limits, prepare and submit to the Commission within 30 days, pursuant to Technical Specification 6.9.2, a special report that includes the following information:
- a. Identification of any inoperable equipment or subsystems, and the reason for the inoperability, 3/91 ADM 04-019 Rev. 5 Page 50 of 202 e . . > p,, *
, , ye n-.
.' filW M M* twig 475 pef,3%!/f g g,Q g g g g gf.rqlg8gg,gg-'"'.g
- b. Action (s) taken to restore the inoperable equipment to OPERABLE status, and
- c. Summary description of action (s) taken to prevent 3/91 i
a recurrence. Survalliance namuir== ants 3.3.2 3.3.2.1 Doses due to gaseous releases from each unit to areas at and beyond the SITE BOUNDARY shall be projected at least ; once per 31 days in accordance with the following ; methodology when Gaseous Radwaste Treatment Systems are not being fully utilized. Du - x 31
.T.
Where: [ D31 = Projected 31 day dose A = Cumulative dose for current quarter ; T = current number of days into quarter g 3.3.2.2 The installed VENTILATION EXHAUST TREATMENT SYSTEM and < WASTE GAS HOLDUP SYSTEM shall be considered OPERABLE by t meeting Section 3.1 and 3.2 limits. i 3.4 Tnstru==ntation ( The radioactive gaseous effluent monitoring instrumentation ; channels shown in Table 3-2 shall be OPERABLE with their i Alarm / Trip Setpoints set to ensure that the limits of Section 3.1 are not exceeded. The Alarm / Trip Setpoints of f these channels meeting section 3.1 shall be determined and adjusted in accordance with the methodology and parameters ; of Section 3.4.4 below. , 3.4.1 Ramadial Action
- a. With a radioactive gaseous effluent monitoring l instrumentation channel flarm/ Trip Setpoint less ,'
conservative than required by the above specification, immediately suspend the release of radioactive gaseous , effluents monitored by the affected channel, or declare the channel inoperable. 1 1 ' ADM 04-019 1 1 Rev. 5 ! Page 51 of 202 e eiWWJU;,chMS'/MM*.h'p1Gi ffffi,E%gihQsygg j pggggy" gg ,{ ' {
I i
- b. With less than the minimum number of radioactive gaseous effluent monitoring instrumentation channels l OPERABLE take the ACTION shown in Table 3-2. Restore [
i the inoperable instrumentation to OPERABLE statuo within t.he time specified in the ACTION, or explain in f the next Annual Radioactive Effluent Release Repo" , l9/93 , why this inoperability was not corrected within t..* i
}
time specified. i 3.4.2 surveillance Requirassants ! Each radioactive gaseous effluent monitoring 3/91 ' instrumentation channel shall be demonstrated OPERABLE by performance of the CHANNEL CHECK, SOURCE CHECK, CHANNEL [ j CALIBRATION and ANALOG CHANNEL OPERATIONAL TEST at the frequencies shown in Table 3-3. ; i i e i i
?
E l 1 I { i I ADM 04-019 Rev. 5 Page 52 of 202 l l 1 r: : - W" L'31.TLTf3% W TNr) M . W gy,g[] Q 2
'g*Qf4y )ffg.[4 g .,
r
- __ _ - . . . . . _ i l
I
'ranLE 3-2 ;
t RADIDACTIVg CAMEOUS EFFLtJENT MONITnDTNG TN9TRIMENTATION i Y NETRtMENT MINIMUM APPLICAB7LITY ACTION l CHANNELS t OPERABLE i i
- 1. Unit Vent System !
1
- 40
- a. Noble Gas Activity l Monitor - Providing Alarm -
(GT-RE-21) , Iodine Sampler 1
- 43 b.
- 43-
- c. Particulate Sampler 1 N.A.
- 45 L
- d. Flow Rate ,
Sampler Flow Rate Monitor 1
- 39
- e. '
v J
- 2. Containment Purge System ,
i
- a. Noble Gas Activity
- 41 l l Monitor - Providing Alarm 1
[ and Automatic Termination ! of Release (GT-RE-22, GT-RE-33) ; @
- 43 l 1
- b. Iodine Sampler 1
- 43
- c. Particulate Sampler {
N.A.
- 45 f
- d. Flow Rate '
i Sampler Flow Rat'e Monitor 1
- 39 -
t
- e. 6 6
- 3. Radwaste Building Vent System ! !
i i
- a. Noble Gas Activity 1
- 38,40 l Monitor - Providing Alarm and Automatic Termination f of Release (GH-RE-10) I Iodine Sampler 1
- 43
- b. i I
1
- 43 t
- c. Particulate Sampler i N.A.
- 45 ,
- d. Flow Rate I i
- 39 j
- e. Sampler Flow Rate Monitor 1 3/91 {
ADM 04-019 7 Rev. 5 ! Page 53 of 202 i e
V *'
- f - ebel%r ,_ ;2W W T * % r"f*g Q ., g , g ,g*(,, g y p . .,3,. t
- g-Qj " ,'
TABLE 3-2 (Continued) TABLE NOTATIONS
- At all times.
ACTION STATEMENTS ACTION 38 - With the number of channels OPERABLE less than required by the minimum channels OPERABLE requirement, the contents of the tank (s) may be released to the environment for up to 14 days provided that prior to initiating the release:
- a. At least two independent samples of the tank's ;
l contents are analyzed, and i
- b. At leant two technically w alified members of the facility staff independently verify the release rate calculations and discharge valve lineup.
Otherwise, sucpend release of radioactive effluents via this pathway. ACTION 39 - With the number of channels OPERABLE less than required by the minimum channels OPERABLE requirement, effluent releases via this pathway may continue for up to 30 days provided the flow rate is estimated at least once per 4 hours. ACTION 40 - With the number of channels OPERABLE less than required by the minimum channels OPERABLE requirement, effluent releases via this pathway may continue for up to 30 days provided grab samples are taken at least once per 12 hours M and these samples are analyzed for radioactivity within 24 hourc. . ACTION 41 - With the number of channels OPERABLE less than required by the minimum channels OPERABLE requirement, immediately suspend PURGING of radioactive effluents via this pathway. ACTION 43 - With the number of channels OPERADLE less than required by the minimum channels OPERABLE requirement, effluent releases via the affected pathway may continue for up to 30 days provided samples are continuously collected with as required in Table 3-1. auxiliary sample equipment ACTION 45 - Flow rate for this system shall be based on fan status and operating curves or actual measurements. 3/91 l l l l l ADM 04-019 Rev. 5 l Page 54 of 202 e .- 5t ,
't W a A g?'i T.*5p#M K Q g g Q ,{, fr5 g {y -
-TABIE 3-3 RAnTOAtTiVE GJL9EOUS RFFt.tfENT MONITODYNC TnMTRUMEffrATION EURVE711ANCE REQUIREMENTS SOURCE CHANNEL &HM&G MODES FOR TMSTRUMENT. .CHANNE L CHECK CALIBRAT M CHANNEL WHICH CHECK OPERATIONAL SURVETLLANC'E ZES.T IS REOUIRED
- 1. Unit Vent System
- m. Noble Gas Activity D H R(3) Q(2)
Monitor-Providing Alam (GT-RE-21) W N.A. N.A. N.A.
- b. Iodine Sampler
~
- W N.A. N.A. N.A.
- c. Particulate Sampler
- d. Flew Rate N.A. N.A. R(4) N.A.
D N.A. R Q
- e. Sampler Flow Rate Monitor
- 2. Containment Purge System
- a. Noble Gas Activity D P R(3) Qtl)
- Monitor-Providing Alarm and Automatic Termination of Release (GT-RE-22, CT-RE-33)
N.A.
)
- b. Iodine Sampler W N.A. N.A.
Farticulate Sampler W N.A. N.A. N.A. c.
- d. Flow Rate N.A. N.A. R(4) N.A.
D N.A. R N.A.
- e. Sampler Flow Rate ,
Monitor
- 3. Radwaste Building Vent j
System
- a. Noble Gas Activity D,P M,P R(3) Q(1) l Monitor Providing Alarm and Automatic Termination of Release (GH-RE-10)
Iodine Sampler W N.A. N.A. N.A. b. Particulate Sampler W N.A. N.A. N.A. c.
- d. Flow Rate N.A. N.A. R(4) N.A.
l
- D N.A. R N.A.
- e. Sampler Flow Rate Monitor 3/91 ADM 04-019 Rev. 5 Page 55 of 202 e .>
f W*'*- ' r i v:*. t n M v3 sert;ur*/7.nM g(T "ggg.gfy,g .g;p
TABLE 3-3 (continuedi_ TABLE NOTATIONS
- At all times.
(1) The ANALOG CHANNEL OPERATIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation as appropriate occur if any of the following conditions exists:
- a. Instrument indicates measured levels above the Alarm / Trip Setpoint (isolation and alarm), or
- b. Circuit failure (alarm only), or l
- c. Instrument' indicates a downscale failure (alarm only) or
- d. Instrument controls not set in cperate mode (alarm only) .
(2) The ANALOG control roomCHANNEL OPERATIONAL alarm annunciation occursTESTifshall anyalso onedemonstrate that or combination of the following conditions exists:
- a. Instrument indicates measured levels above the alarm setpoint
- b. Circuit failure
- c. Instrument indicates a downscale failure
- d. Instrument controls not set in operate mode.
g_ (3) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference (gas or liquid and solid) standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activitiesover withits NIST. These standards shall permit calibrating the system intended range of energy, measurement range, and establish monitor response to a solid calibration sourec. For subsequent CHANNEL CALIBRATION, NIST traceable standard (gas, liquid or solid) may be used; or a gas, liquid, or solid source that has been calibrated by relating it to equipment that was previously (within 30 days) calibrated by the same geometry and type of source traceable to NIST. (4) fan status and fan If flow rate is determined by exhaustthe following surveillance operations shall performance curves, be performed at least once per 18 months:
- a. The specific vent flows by direct measurement, or
- b. The differential pressure across the exhaust fan and vent flow established by the fan's " flow- P" curve, or
- c. The fan motor horsepower measured and vent flow established by the fan's " flow-horsepower" <;urve. 3/91 ADM 04-019 Rev. 5 Page 56 of 202 l l
I e a
' ' a ' d LY.'.WiDWM7M($7 tgjVWg(g3][j){jp]g.gg ,
3,4,3 Airborne Radiation Monitor Calibration Methodolooy The following monitors are associated with gaseous releases , Monitor ID Monitor Description Monitor Type Plant Unit Vent Particulate, Iodine 0-GT-RE-21A Radwaste Building Particulate, Iodine I O-GH-RE-10A Effluent Plant Unit Vent. Wide Range Cac 0-GT-RE-21B Radwaste Building Wide Range Gas O-GH-RE-10B Effluent Containment Purge Particulate, Iodine, 0-GT-RE-22 & 33 Exhaust Gas Containment Particulate, Iodine, O-GT-RE-31 & $2 Atmosphere Gas 3.4.3.1 Particulate D_ntector Beta particulate is monitored by a 50 mm diameter by 0.25 mm thick plastic scintillator optically coupled to a 50 mm diameter photomultiplier tube. This detector shall be calibrated over its range of energy and rate capabilities. For energy range calibration four sources shall be used. Each source consists of a filter paper impregnated with a beta emitting radionuclide. The radionuclides used should g be Tc-99, Cs-137, Cl-36, and Rh-106. Each source shall be positioned in the filter paper retaining ring and counted separately. The count rates for each radionuclide source shall be recorded and the data plotted on a graph of cpm / Ci versus average he.ta energy. This curve represents the detectors response characteristics over the range of beta energies observed. The efficiency for setpoint calculations shall be based on the efficiency of the detector for Cs-137. The detector shall be calibrated for its rate capabilities using a filter paper impregnated with standard activities of Cs-137. Increasing amounts of a standard Cs-137 solution shall be impregnated on a filter paper. The counts per minute for each Cs-137 standard shall be
' recorded and the data plotted on a graph of counts per minute versus activity. At least three sources covering approximately 1/4, 1/2, and 3/4 of full scale shall be checked.
i ADM 04-019 Rev. 5 , Page 57 of 202 l I l e
** 'h e'tA W E M 1 M + Q* T , $ f, % Q T gt.=lp, % .. j g aQ g g g g p
l t 3.4.3.2 ToA4ne natector -; Iodine gas is monitored by absorbing the gas on a charcoal filter element. The charcoal filter is viewed by an NaI(Tl) integral line gamma scintillator assembly. Because of its short half-life and the difficulty in handling gaseous iodine, barium sources shall be used for calibration. The photo peaks of interest are as follows: A. Ba-133: 356 kev gamma is 0.69 efficient / l disintegration B. I-131: 364 kev gamma is 0.82 efficient / disintegration Therefore, each iodine disintegration will produce 0.82/O.69 x barium disintegrations. Assuming that the ' detector efficiency for 356 kev is the same as for the 364 kev, the sensitivity for I-131 equals 1.19 x Ba-133 (counts / min) pCi. The standard sources shall be constructed by impregnating a standard Ba-133 solution into the charcoal filter element. The geometry shall simulate , the iodine retention on the first surface of the charcoal. > Sources shall be prepared to cover approximately 1/4, 1/2 and 3/4 of full scale. The barium counts per minute for f each standard shall be adjusted to iodine counts per minute as described above. The adjusted counts per minute shall. D be plotted on a graph of counts per minute versus activity. . t 3.4.3.3 cas Detector t. The gas detectors associated with monitors O-GT-RE-22 & 33,
\
0-GT-RE-31 & 32 and the low-range detectors of monitors O-GT-RE-21B and 0-GH-RE-10B are a plastic scintillator identical to the particulate detector. The mid-range and { high-range detectors of monitors O-GT-RE-21B and 0-GH-RE-10B are cadmium telluride, solid state sensors. i F i ADM 04-019 f Rev. 5 Page 58 of 202 i r t
$ *\ " N go f
}
i i 1 3.4.3.3 Gas Detector (Continued) . Sources for all gas detectors shall be produced by evacuating the sample chamber with a vacuum pump. The sample chamber then shall be backfilled to the desired _ pressure with a source of standard Xe-133. The source is then counted and the counts per minute recorded. A graph i of counts per minute versus concentration shall be produced from the data. Sources shall be prepared to cover , approximately 1/4, 1/2 and 3/4 of full scale for the detectors associated with monitors O-GT-RE-22 and 33, 0-GT- ; RE-31 and 32 and the low-range detectors of monitors 0-GT- : RE-21B and 0-GH-RE-10B. Sources shall be prepared for the mid/high range detector to cover two points on' the mid- j range scale. For ALARA purposes, response for the high-
- range scale shall be extrapolated using the data from the j mid-range calibration. i 3.4.4 Airborne waaitor Attpoints t 3.4.4.1 Total Body Dome Rate Satooint Calculations The limit of the total body dose rate is 500 mrem /yr at the I un-restricted area boundary. The monitor alarm / trip setpoint based on total body dose will be calculated as follows:
Se s (SF x AF)x De x R, (1) j Where: , i The monitor alarm / trip setpoint based on Stb =
- the total body dose rate.
Dtb - Limit of 500 mrem /yr total body, conservatively interpreted as a continuous , release over a one year period. , SF = Normally will be set to 0.85. This number 1 is chosen since the gaseous monitors are set using Xe-133 energy level. Xe-133 comprises 85% of total noble gaseous activity expectod. (See USAR Table 11.1-If necessary the 0.85 can be further l
- 1) .
modified to compensate for statistical ! fluctuations and errors of measurement. , i ADM 04-019 Rev. 5 : Page 59 of 202
. ' -c
- mYr i
+-
i i l 3.4.4.1 Total n ody Dome mate setnoint calenlatinn= fcontinued)
]
AF = Allocation factor for each release so that ! simultaneous releases can be made without ! exceeding ~the limit. Normally AF is l calculated as follows: i i
, AF -
TF Where: ; RF = Release flow rate of the release point under consideration. f i TF - Total flow rate of all release points including release under consideration. , Rt- monitor response per mrem /yr to the total body, determined according to: f R = r 3 l Ki Qi .
<(X/Q > ; ; Where:
c= The monitor response to the gaseous effluent r noble gas (pci/cc) corresponding to grab sample ! radionuclide concentrations. ! (X/Q) = The highest calculated annual average ; atmospheric dispersion (sec/m3) at the [ t restricted area boundary. i The total body dose factor due to gamma j Ki - emissions from isotope i (mrem /yr per I pCi/m3 ) from Table A.1-2. Oi = Rate of release of noble gas radionuclide 1 (pci/sec) (concentration of radionuclide l i x release flow rate) . t k i ADM 04-019 I Rev. 5 , Page 60 of 202 i
! ANEN.%2?EeEM ihi2GC$h '$Si.0$Onllil t .h l :',,, I . ,5~
, ;. '..l l ~
(
U e 3.4.4.2 - skin M_-. mate calculation The limit of the skin dose rate is 3000 mrem /yr at the restricted area boundary. The monitor alarm / trip setpoint is calculated as follows: S, s (SF x AF)x D, x R, (2) Where Ss - The monitor alarm / trip setpoint based on the skin dose rate. Da= Limit of 3000 mrem /yr to the skin of the body, conservatively interpreted as a continuous release over a one year period. R, = Monitor response per mrem /yr to the skin of the body. R, = y X/Q (Li + 1.lM i )Qi Where: ? Li- Skin dose factor due to beta emissions from isotope 1 (mrem /yr per pCi/m3 ) from Table A.1-2. 1.1 = Conversion factor to mrem skin dose per mrad air dose. Mi = Air dose factor due to gamma emissions from isotope 1 (mrad /yr per pci/m3) from Table A.1-2. The factors SF, AF, c, (X/Q) and Qi are as defined 'in Section 3.4.4.1. The results of equations f rom Sections 3.4.4.1 and 3.4.4.2 are compared to determine the smaller setpoint. The actual monitor setpoint is the lower of the two values. ADM 04-019 Rev. 5 Page 61 of 202 .O mh*:.%9 AMP 33'*NtiGRiG7723l1315.K[?p {g7dWK?.{%K'*Qv :[tggg,.5;ggzggg ;_ _.y g .3, ,y;q
3.4.4.2 skin nome mate calculation (continuadt A pre-release isotopic analysis is performed for batch releases from Waste Gas Decay Tanks and Containment Building purges to determine the identity and quantity of the principal radionuclides. The appropriate alarm / trip setpoint(s) are adjusted accordingly to ensure that the limits of 3.1 are not exceeded. 3.4.4.3 Alare Alme= matpoint calculatinna L The Noble Gas Alert Alarm for the Plant Unit Vent (0-GT-RE-
- 21) and Radwaste Building Exhaust Monitor (0-GH-RE-10 ) .. is l
set to alert operators to that average concentration which l if maintained for a full year would result-in the 10 CFR 50, Appendix I Annual Dose Guidelines being reached. Section 3.2.1 limits the annual dose due to noble gases to s 10 mrads for gamma radiation and s 20 mrads for beta radiation. Section 3.2.2 limits the annual dose to a MEMBER OF THE PUBLIC from Iodine-131, Iodine-133, tritium and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents to s 15 mrem to any organ. These two sections contain the annual dose limits due to gaseous releases found in 10 CFR 50, Appendix I. 3.4.4.3.1 Noble Gas Alert Alarm Satpoint calculation I The alert alarm setpoint is the lesser of S, s (SF x AF) x Dy x Ry Sp s (SF x AF) x D x Rp Where: S7 - Monitor setpoint baced on gamma radiation. D, = Limit of 10 mrad /yr conservatively interpreted as a continuous release over a one year period. R, = Monitor response per mrad /yr determined according to: R, = , 3
<(xio)Db xoi s s ADM 04-019 f Rev. 5 Page 62 of 202 i
e Nh ,$M'6$%QMM[yg[((gjg'3,, ~ j,' ,p 'Q j}rs l
"l w.- 2 " J.rM W 5C9t*4F/.I 4
3.4.4.3.1 moble ama Alart Alarm setnaint emiculation ManH nned) Where:
- Gamma air dose factor (mrad /yr per Mi pCi/m 3). see Table A.1-2.
Sp - Monitor-setpoint based on beta radiation. Dp - Limit of 20 mrad /yr conservatively interpreted as a continuous release over a one year period. Rp = Monitor response per mrad /yr. determined according to: R,=, 3 (X / Q N; x Q, Where: Ni - Beta air dose factor (mrad /yr per pCi/m3). See Table A.1-2. A semi-fixed alert ai ann setpoint for the Plant Unit Vent Monitor (0-GT-RE-21) and Radwaste Building Vent Monitor (0-GH-RE-10) is calculated using the following: i f Setpoint(pCi/cc) = (5) i
,, u (X / Q)T,,P; x M x,, Q Where:
Pi = Fractional value of isotope expected, ci/CT ' t Where: Ci = Concentration in pCi/cc of isotope. Total Gaseous Activity from USAR Table 11.1-1
=
CT AF = Either unit vent flow or Radwaste Building vent flow divided by the combined flow of the unit vent and Radwaste Building vent. l- ADM 04-019 Rev. 5 Page 63 of 202 O ' ' - ' ;
, _.,g '
SMM?RtM1 CL'ikCh' %My2'G?lh9$, ._ . lf: y';.g:[ ; [
~
[ --- --_-_- ___ ..
g +- 9 I 3.4,4,3.1 Noble cas Alert Alarm Setnoint Calculation (Continued) Q = Vent flow rate in cc/sec. Isotopes used and Pi values are as follows: ISOTOPE E1 Kr-85M .018 Kr-87 .010 Kr-88 .033 Xe-133M 017 Xe-133 .851 Xe-135 .051 Should this semi-fixed alert alarm cause a continuous alarm condition, then actual setpoints will be calculated. 3.4.4.4 Particulate And Iodine Alarm Shtenints Setpoints for the gaseous effluent particulate and iodine channels are set using Cs-137 MPC for particulates and I-131 MPC for iodines. The following is the calculation used: l l 1 Setpoint(pCi/cc) = (MPC,)(AF)(SF) j (Q)(X/Q) Where: MPC3
= 5 x 10*" pCi/cc for Cs-137
= 1 x 10# pCi/cc for I-131 AF = as defined previously SF . .0625 for I-131
= .9375 for Cs-137 *
- derived from ratio of isotope activity (either I-131 orcs-137) to sum of activity of Cs-137 and I-131 found in USAR Table 11.1-1 for reactor coolant.
O = Vent flow in M 3/sec This will provide t..e hi alarm setpoint. The alert alarm setpoint is 10% of the hi alarm setpoint. ADM 04-019 Rev. 5 Page 64 of 202
-a.m.e:cusygeyqsaguppgg g g ggggg;g gw g g g. g g g.,-g .,
to--
FIGURE 3.1 > l BOUNDARY FOR GASEOUS EFFLUENTS ' 3/91
' I
- i
/
f - a [
- i 5 $ -
N) -
~
Q s.- -
-. ) ..
unis. m . i g ~ l* m 2 y.,' d,_
~ '
- t. 7 ,. .
- x.-% j' J '
~ ' " " '
{> kDM ! "" ~ .
, 7 J
. .L AS \ '
~~a ,
u,~,"*
> rh.
T 'Y ,
. .<-u ma .
y-- + : ? 4 . 1 17 -. g, .-
'I we.r extts ca.= tun : srirv2= i
.-~ w Unit ee0, t 1
c .i i* si 3.1 I we sa s.m ter:ms
-ese a m m .a
* .(\ ) T \ - .
v e
*mst oe
<*- <%yj' = ~** -
b *L ,
. ==l . . . ,
60 i ADM 04-019 Rev. 5 f Page 65 of 202 i i e
- p,.
g ; 4 * !*'m 5*T.T+/?.yrjuggi.M g g g g ;g g = g ,
s 4.O TOTAL DOSE The annual (Calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of. radioactivity and to radiation from uranium fuel cycle sources shall be ! limited to less than or equal to 25 mrems to the whole body l or any organ, except the thyroid, which shall be limited to 1ess than or equal to 75 mrems. l 4.1 Ran= dial Action ? l With the calculated doses from the release of radioactive materials in liquid or gaseous effluents exceeding twice the limits of Section 2.2a, 2.2b, 3.2.la, 3.2.lb, 3.2.2.a and 3.2.2b calculation should be made including direct radiation contributions from the units and from outside storage tanks to determine whether the above limits of If such is the case, Section 4.0 above have been exceeded. prepare and submit to the Commission within 30 days, , a special report pursuant to Technical Specification 6.9.2, that defines the corrective action to be taken to reduce subsequent releases to prevent recurrence of exceeding.the above limits. This special report, as defined in 10 CFR 20.405c, shall include an analysis'that' estimates the radiation exposure (dose) to a MEMBER OF.THE PUBLIC from N uranium fuel cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes ( the release (s) covered by this report. It shall also describe levels of radiation and concentrations of { radioactive material involved, and the cause of the i exposure levels or concentrations. If the estimated dose (s) exceeds the above limits, and if the release , condition resulting in violation of 40 CFR Part 190 has not j i already been corrected, the special report shall include a request for a variance in accordance with the provisions of l 40 CFR Part 190. Submittal of the report is considered a ( timely request, and a variance is granted until staff action on the request is complete. 4.2 Eurveillance Reauirements 4.2.1 Cumulative dose contributions from liquid and gaseous ! effluents shall be determined in accordance with the
- methodology of Sections 2.2 and 3.2 at least once per 31 days when the release of radioactive materials in liquid or gaseous effluents exceed twice the limits of Section 2.2a, 2.2b, 3.2.la, 3.2.lb, 3.2.2a and 3.2.2b. Otherwise, no further evaluation is required. 3/91 ADM 04-019 Rev. 5 Page 66 of 202 0
'm ccas.r>wrnemmygg ;.pgrgr;p;..gg.ggy 7.m pg- -
4.2.2 Cumulative dose contribution from direct radiation from the reactor unit and from Radwaste storage tanks shall be determined utilizing the results of routine pinne perimeter ourveys, TLD data or a combination of both, when necessary. This requirement is applicable only under conditions set forth in the remedial action above. 5.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM This section describes the Radiological Environmental Monitoring Program specified in Section 6.8.4 F of the Wolf Creek Technical Specifications. 5.1 Monitorino Prbaram Table 5-1 provides a schedule which describes the pathways, specific locations, sample collection frequencies, and analyses to be performed to implement the Radiological Environmental Monitoring Program. Figures 5.1 through 5.5 contain maps depicting sampling locations in relation to the WCGS site. Table 5-2 lists distances and directions to these locations from the WCGS site. Table 5-3 lists required detection capabilities for the ) analyses performed. 5.2 Land Use census A Land Use Census shall be conducted annually during the growing season to identify the nearest (1) milk animal, (2) residence ,' and (3) garden of greater than 500 square feet producing broadleaf vegetation
- in each of the 16 meteorological sections within five miles of the wcas site.
Methods shall be used in conducting the census that provide the best results, such as door-to-door surveys, telephone surveys, consulting the U.S.D.A office in Burlington, inspection of aerial photographs of the area, or reviewing 3/91 leasing records for area farms and residences.
- Broad leaf vegetation sampling of available vegetation may be performed at the site boundary in each of two different direction sectors with the highest predicted D/Qs in lieu of the garden census. Specifications for broad leaf vegetation sampling in Table 5-1, Part 4.c. shall be followed, including analysis of control samples.
ADM 04-019 Rev. 5 Page 67 of 202 <a P-9 e ~3 W y n.y sn#qqwggg .ygggwsyg gr qigitt , ,N 1" , ,
If a location (s) is identified which yields a. calculated dose or dose commitment (via the same exposure pathway) 20% greater than at a location from which samples are currently being obtained, the new location (s) shall be added to the Radiological Environmental Monitoring Program-within 30 days as described in Table 5-1, Note (1). The indicator sampling location (s) having the lowest calculated dose or dose commitment may then be deleted from the monitoring program. The revision to Table 5-1 and the corresponding Figure (s) as a result of such substitutions shall be documented in accordance with Section 6.14 of the Wolf Creek Technical Specifications. The results of the Land'Use census shall be included in the Annual Radiol 6gical Environmental Operating Report described in Section 7.1. 5.3 Inter 1=haratory C - =rison Proaram The analysis laboratory contracted to analyze samples from the Radiological Environmental Monitoring Program participates in the EPA Laboratory Intercomparison Program. Results of intercomparisons are provided to WCNOC semiannually. 11/94' A summary of intercomparison results shall be included in the Annual Radiological Environmental Operating Report d described in Section 7.1. 5.4 menorting neanir===nts 5.4.1 -manumi umAtoloalem1 unviran==ntal. Doeratina menort To meet the requirements of Wolt Creek Technical
- Specification 6.9.1.6, the Annual Radiological 11/94 Environmental Operating Report covering the previous year of operation shall be submitted to the NRC by May 1.of each year. The content of this report is described in Section 7.1.
ADM 04-019 Rev. 5 Page 68 of 202 2e tv -c * . inz:#3 rTY.!tc.hw y. dttfgtTGitWhi@Th yf*fM{@*f gQ 3 yga,;Qic,f((. - g',.. [
r 5.4.2 special Renorts A special report shall be prepared and submitted to the NRC within 30 dayo if levels of radioactivity as a result of plant effluents detected in an environmental medium at a specified location exceed the reporting levels of Table 5-4 The special when averaged over any calendar quarter. report shall identify the cause(s) for exceeding the limit (s) and define the corrective actions to be taken to reduce radioactive effluents so that the potential annual dose
- to a member of the public is less than the calendar year limits of Wolf Creek Technical Specification 6.8.4.e.
When one or more of the radionuclides in Table 5-4 are detected in the sampling medium, thic report shall be submitted if: concentration (1) + concentration (2) +. 21.0 Reporting Level (1) Reporting Level (2) When radionuclides other than those in Table 5-4 are detected and are the result of plant effluents, this report shall be submitted if the potential annual dose
- to a member of the public from all radionuclides is equal to or greater than the calendar year limits of Technical j Specification 6.8.4.e.
*The methodology and parameters used to estimate the O potential annual dose to a member of the public shall be ,
3/91 indicated in this report. ADM 04-019 l Rev. 5 Page 69 of 202 e -{. ?g.
- a .. .
of L "*.s'AM3'.W C GW&QM72Qyyyy.Qg*,*y.3 *; y { ,
i l TABIE 5-1 I manioLoarmt arvre.=---. At asostrTnarest2 parwmmu l Enemie N11er+ 4 nn Tvne and Freauency of j Pronsure Pathway / Number of c =el en anA Freauency Analyste comnic Tygg s --l e tocaelena til
- 1. AIRBORNE FIGURES 5.1 & 5.5 Samples from five Continuous sampler Analyze radiciodine Radiolodine and operation with sample canister weekly for l particulatec locations collection weekly, or I-131 more frequently if ,
e required by dust loading , Samples from locations near the, site boundary in three sectors having the highest calculated annual ; average D/O (locations 2,3
& 37 on Figure 5,1) ,
Sample from the vicinity Analyze particulate of a community having the filter weekly for l gross beta activity I highest calculated annual i average D/Q(Location 32 on (2); perform quarter-Fig-ure 5.1, New Strawn); ly gamma isotopic f analysis (3) composite (by location). I i Sample from a control lo- ! cation 10-20 miles distant $ in a low D/O sector (Loca-tion 40 on Figure 5.5). ! (11) ,
- 2. DIRECT RADIATION FIGURES 5.2 AND 5.5 (4) i f
40 routine monitoring sta- Quarterly Gamma dose quarterly tions with two or more dosimeters measuring dose continuously, placed as ; followss : An inner ring of stations, one in each meteorological sector 0-3 mile range from the site (Locations 1,7- 11/94 r 9.11-13, 18, 26, 27, 29- r 31, 37, T. 3B on Figure 5.2).
)
i ADM 04-019 f Rev. 5 Page 70 of 202 l e M f,Q.?
~ ,T, j" - W' *4' - ; W :
- o : j7 E ~~,* W 1,Trf,*!' q ] Q ,'T y ,'! ,g.gf.7"~.7
.. s l
TABLE E-1 (Continued) manioLoarm. anyinnennrrAL umrynnTMC PROGRAM Number of Mmer.nlem and Sm ele collection Tyne and Fggggent-v of Exposure Pathwav/ Frecuency Analvnis samnle Tyne Samnie Locatinna (11 DIRECT RADIATION An outer ring of stations, (4) (CONTINUED) one in each meteorological sector in the 3 to 5 mile range from the site (Loca-tions 4-6, 15-17, 19-25, 11/94 and 33-36 on Figure 5.2). Five sectors (A,B,D.G & L] contain an additional sta-tion (Locations 2,3,10, 14 and 28) . The balance of the sta-tions to be placed in special interest areas such as population centers (Locations 23 and 32), nearby residences (many locations are near a resi-dence), schools (Location 23), and in one or two areas to serve as control stations 10-20 miles dis-tant from the site (Loca-tivno 39 and 40 on Figure
- 5. 5) (11) h
- 3. WATERBORNE FIGURE 5.3 l Monthly gamma iso-Surface One sample upstream (5) Monthly grab sample (Location MUSH on Figure topic analysis (3) ,
5.31 and one sample down- and composite for tritium analysis ! stream (Location DC on Figure 5.3) quarterly. i Samples from one or two Quarterly Quarterly gamma iso-Ground topic analysis (3) sources only if likely to and tritium analysis. be affected Indicator samples at loca-tions hydrologically down- ! gradient of the site (Loe- , ations C.10, C-49 and D-65 on Figure 5.3); control sample at a location hydrologically upgradient of the site (Location B-12 on Figure 5.3)(6) ADM 04-019 Rev. 5 Page 71 of 202 'M. '
>RK%1WittMRL WWM $WN b b$ h kE{
TAnfE 5-1 (continued)_ manTouwmmu. ENVT* --- umL MONITnBrMC PROGRAM e mesure Pathwav/ Nn=har of Samnlem and Emmnle collection Tvne and Precuenev ef l e--le Locations (1) Framinnev Analvain gaggie Tvoe Sample of municipal water Monthly composite (7) Monthly gamma iso- :
- 3. WATERBORNE !
supply at an indicator topic analysis (3) (CONT.) and gross beta anal-Drinking location downstream of the site (Location LW-40 on ysis of composite Pig-ure 5.5); control sam- sample. Quarterly , pie from location upstream tritium analysis of of the site (Location BW- composites (R). 15 on Figure 5.3) One sample from the vie. Semiannually. Semiannual gamma Shoreline Sediment isotopic analysis (3) inity of Wolf Creek Cooling Lake discharge cove (Location DC on Figure 5.3); control sam- 11/94 ple from John Redmond Reservoir.
- 4. INGESTION FIGURES 5.4 AND 5.5 Samples f rom milking ani- Semimonthly while Gamma isotopic Milk mais at three indicator animals are on analysis (3) and I-locations within 5 miles posture (April to 131 analysis of each of the site having the November); monthly at sample.
highest dose potential other times (currently there are no (December-Ma rch) ( 9 ) locations producing milk , Q for human consumption , within 5 miles of the site);one sample from a control location greater than 10 miles from the l site (Location S-3 on Figure 5.5). (11) Indicator samples of 1 to Semiannually Gamma isotopic Fish 3 recreationally important analysis (3) on species from Wolf Creek edible portions cooling Lake (several sam- , pling areas indicated in Figure 5.4); control sam-ples of similar species ! f rom John Redmond Reser-voir Spillway (indicated i on Figure 5.4). l l ADM 04-019 Rev. 5 Page 72 of 202 0 s; g . ; W s ":8 myr eg.gMQ5 Eggy,ggggggg;ggpgg;ggg-{.;, e ,
T_intm 5-1 (continued) RADIOLOGIr at- ENVTRnWif MMITonruG PROGRAM Samnle Collection Tyne and Freunenmf of Frnosure Pathwavl Number of camnies and samole fm ations fil Frequency Analvsin samnie Tyne
- 4. INCESTION Samples of available Monthly when Gamma isotopic broadleaf vegetetion from available (9) analysis - (3) on (CONT.) edible portions.
Food Products two indicator locations with highest calculated r annual average D/o (Loca-tions R-1 and G-1 and al-ternate Location A-2 on 11/94 Figure 5.4); sample of l similar broadleaf vege- ! tation fr,om a control lo- , cation greater than 10 miles from the site in a low D/o section (Location S-4 on Figure 5.5) . (11) Food Products Sample of crops irri-gated At time of harvest Gamma isotopic with water from the Neosho (10) analysis (3) on River downstream of the edible portions Neosho River-Wolf Creek con-fluence (locations will vary f rom year to year, e.g., Location NR-D1 is NR-D2 on Figure 5.5). 3 ADM 04-019 Rev. 5 Page 73 of 202 .O y.
- en-X%n tuuraw,'Am%.M Lp7gpgJ;g.); yJyy:g<gp: v: M 3':y;[rryz~~~ q q- ,
TABLE 5-1 (Continuedl TABLE NOTATIONS (1) Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment, and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling period. All deviations from the sampling schedule shall be documented in the Annual Radiological Environmental Operating Report described in Section 7.1. It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desi-red location or time. In these instances, suitable specific alternative media and locations may be chosen for the particular pathway in question and appropriate substitutione made within 30 days. Revisions to this Table and to the corresponding Figure (s) as a result of such substitutions shall be documented in accordance with section 6.14 of Wolf Creek Technical Specifications. This documentation shall provide information identifying the cause of the unavailability of samples for that pathway and justifying the selection of the new location (s) for obtaining samples. (2) Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours or more after sampling to allow for RN-220 and Rn-222 daughter decay. If gross beta activity in air particulate samples is greater than 10 times the yearly mean of control samples, 4 gamma isotopic analysis shall be performed on the individual samples. (3) Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility. (4) One or more instruments, such as a pressurized ion chamber, for I I measuring and recording dose rate continuously may be used in place of, or in addition to, integrating dosimeters. For the purposes of f j this table, a thermoluminescent dosimeter (TLD) is considered to be j one phosphor two or more phosphors in a packet are considered as two or more dosimeters. Film badges shall not be used as dosimeters for j measuring direct radiation. The 40 stations is not an absolute number. l The number of direct radiation monitoring stations may be reduced ! according to geographical limitations, e.g., some sectors are over l water so that the number of dosimeters way be reduced accordingly. The f requency or analysis or readout for the TLD system depends upon the characteristics of the specific system used and is selected to obtain optimum dose information with minimal tading. (5) The " upstream" sample is taken at a distance beyond significant ' influence of the discharge. 3/91 TJX4 04 -019 Rev. 5 Page 74 of 202 e >fr<tttW;:vuTyn.7fmJgeeneyymg m y(5g(M @ yz W pyg g"y gegg y . ,( , , , y1n .-
i
*ramLE 5-1 (continued)
TABLE NOTATIONS ' (6) Ground water samples shall be taken when this source is tapped for l drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination. ; (7) A composite sample is one in which the quantity (aliquot) of liquid l sampled is consistent over the sampling period and in which the ~ is representative 1 method of sampling employed.results in a specimen that ! of the liquid concentrate. In this program, composite sample aliquots shall be collected at time intervals that are very short (e.g.,.every : [ two hours) relative to the compositing period (e.g. , monthly) in order, to assure obtaining a representative sample. ; r (8) If the dose calculated for consumption of water (using ODCM methodology and parameters) exceeds one millirem per year, composite samplirg at the indicator location shall be performed every two weeks and I-131 ; analysis shall be performed on the composite samples. (9) Milk and broadleaf vegetation samples are often temporarily, but not g permanently, unavailable at the scheduled sample collection times. Alternate sampling locations may therefore be listed in f the Table and used at these times to provide continued monitoring ; of these pathways. If samples are considered permanently unavailable as at a location, another location will-be selected (if available) described in Note (1) . (10) If harvest occurs more than once.a year, sampling shall.be performed ' h during each discrete harvest. If harvest occurs continuously, f sampling shall be monthly. Attention shall be paid to including l samples of tuberous and root food products. If (11) The purpose of this sample is to obtain background information. I it is not practical to establish control locations in accordance with ' Li the distance and wind direction criteria, other sites that provide valid background data may be substituted. 3/91 , J t i e l I t t ADM 04-019 ' Rev. 5 Page 75 of 202 l l O w;~ < -m;.mww..;;,;4 g w. gy,y3.-
~ ,
n.: . , ,
.. 3. . . - 3.,,
i TABLE 5-2 SAMPLING LOCATION NUMBERS, DISTANCES (miles) AND DIRECTIONS TLD AND MR DARTT f*f 7T ATE , Location Distance / Location Distance / Ineation Distance Direction
/ Location Number Distance Direction/ l Ninmher Direction Ny.t-2,e r Direction Number 1.6/E 21 3.8/S 31 3.0/WNW 1 1.4/N 11 32 3.2/WNW 2 2.7/N 12 1.8/ESE 22 4.1/SSW 13 1.5/SE 23 4.5/SW 33 3.7/WNW 3 3.0/NNE 34 4.0/NW 14 2.6/SE 24 4.1/WSW 4 4.0/NNE 35 4.6/NNW 5 4.0/NE 15 4.5/ESE 25 3.6/W 16 4.2/E 26 2.6/WSW 36 4.2/N 6 4.4/ENE 37 2.1/NNW 7 1.9/NE 17 -
3.6/SE 27 2.1/SW 18 3.2/SSE 28 2.8/SW 38 1.2/NW 8 1.6/NNE 39 13.0/N 9 2.0/ENE 19 4.0/SSE 29 2.6/SSW 20 3.3/S 30 2.2/W 40 >15.0/WNW 10 2.4/ENE Croundwater D_rinkincr Water Surface Water 2.2/NNE BW-15 3.9/SW MUSH 3.6/W B-12 LW-40 >10/SSE DC 0.6/WNW C-10 2.8/W C-49 2.9/SW D-65 3.9/S Milk L Fnnd Products A-2 2.9/N R-1 2.1/NNW f h >15.0/WNW G-1 1.6/SE S-3 S-4 >15.0/WNW , r Shoreline Irricated crocs Fish Sediments WCCL DC 0.6/WNW NR-D1 9.2/S JRR 4/W NR-D2 >10/S f JRR 4/W 11/94 l ADM 04-019 Rev. 5 Page 76 of 202 e . .j
> @taPQirf?%&iliQi?QMrJ;stg4:,(Tg"Q[y*,] ]; ' T
4 ,
?,L TinLE 5-3 m DETECTION CAPABILITIES FOR ENVIROtEGHTAL SAMPLE I' ' " ANALYSIS Lower Limit of Detection (LLD) AIRBORNE PARTICULATE EDOD j FISH MILK PRODUCTS SEDIMENT l WATER OR GAS (pCi/1) (pCi/m') (pCi/kg, wet) (pCi/1) (pCi/kg, wet) (pCi/kg, dry) ANALYSIS 1 Gross Beta 4 0.01 i 11 - 3 2000(4) 15 130 l Mn-54 30 260 Fe-59 Co-58,60 15 130 30 260 Zn-65 Zr-Nb-95 15 0.07 1 60 I-131 2 (5) 130 15 60 150 Cs.134 15 0.05 150 18 80 100 Cs-137 18 0.06 h 15 15 Ba-La-140 3/91 ADM 04-019 Rev. 5 Page 77 of 202 O ' 1PtVEsttp:LtQL557f LE gj'yy.jyj(";?[. ' qgi,y;q;ji,r,i ,'g;-Q: _;::g?Q['y,}g; .p [
~; .: :.
2+ t v . ', . '.. T ?: . ,
TABLE E-3 feaatinued) i TABLE NOTATIONS (1) This list does Other not raean oeaks thatthat onlyarethese nuclides are identifiabic, to bewith teether considered. those of the above cuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating Report described in Section 7.1. (2) Required detection capabilities for thermoluminescent dosimeters used for environmentalofmeasurements the recommendations Regulatory Guide shall4.13, be inRevision accordance with 2, 1977. (3) The LLD is defined, as the smallest concentration above of radioactive system material in a. sample that will yield a net count, background, that will be detected with 95% probability with only 5% probability'of falsely concluding that a blank observation represents a "real" signal. P For a particular measurement system, which may include radiochemical separation: 4.66 s* LLD = E V 2.22 Y exp(4 At) ( Where: LLD = the "a priori" lower limit of detection (picoCuries per h, unit mass or volume), Sb = the standard deviation of the background counting, rate or j of the counting rate of a blank sample as appropriate (counts per, minute), 1 E = the counting efficiency (counts per disintegration), ; V - the sample size (units of mass or volume), 2.22 = the number of disintegrations per minute per picocurie, Y - the fractional radiochemical yield, when applicable, A the radioactive ecay constant for the particular radionuclide (s p), and dt = the elapsed time between sawle collection, or end of the sample collectier. period, and time of counting (s) . Typical values of E, V, Y, and At should be used in the calculation. 3/91-ADM 04-019 Rev. 5 Page 78 of 202 l e ig{ Wi %WAMfi3di31RSMdSWe$pMgggige Qg Q{ ,.
TaafR E-3 Mantinued) TABLE NOTATIONS i It should be recognized that the LLD is defined as an a orlori (before the fact) limit representing the capability (afterofthe a fact) ; measurement system and not-as an a nosterioriAnalyses shall be performed limit for a particular measurement. l in such a manner thatOccasionally the stated LLDs will be achieved background under fluctuations, routine conditions. unavoidable small sample sizes, the presence of interfering i nuclides, or other uncontrollable circumstances In such cases, may render the contributing factorsthese shall ! LLDs unachievable. be identified and described in the Annual Radiological-l Environmental Operating Report described in Section 7.1. I (4) LLD for drinkJng water samples. If no drinking water pathway [, exists, a value of 3000 pCi/ liter may be used. (5) LLD for drinking water samples. If no drinking water pathway-exists, the LLD of gamma isotopic analysis may be used. 3/91 ~) ADM 04-019 Rev. 5 Page 79 of 202
-, n n.,n . , m.-wg ,
I l Tanum 5-4 l REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES i AIRBORNE FOOD PARTICULATE OR FISH MILK PRODUCTS WATEP-(pC1/li GAS (pCi/m') (pCi/kg, wet) (pCi/1) (pCi/kg, wet) , ANALYSIS H-3 20o000* 1,000 30,000 Mn-54 400 10,000 Fe-59 1,000 30,000 Co-58 300 10,000 , Co-60 l l 300 20,000 Zn-65 , e Zr-Nb-95 400 ! 0.9 3 100 I-131 2 i 1,000 60 1,000 l 30 10 Cs-134 > 2,000 ! 20 2,000 70 Cs-137 50 t i 200 300 Ba-La-140 , k If no drinking water ;
*For drinking water samples. This is 40 CFR Part 141 value.
pathway exists, a value of 30,000 pCi/l may be used.
; f 3/91 l
[ t l f I 1 1 i l ADM 04-019-Kev. 5 I Page 80 of 202 e p *j. ;- e . , .
'AW MWNW:6MM.$Q((ij.y2]{gg.g"?ir p.
FTGURV S.1 l l 1 -JA y \ f
\ ['_ .[
/
s j ._ _ l; ._ _ _ ; _ __ !~ 'I yl \(' [ 3??b .J j
-[
n ~ ~b ~
}- _ . . .
< m 4
,s < _ _ _ _ _ .
I i l Ns[a' Yo N
~~~ ~
N $ L ( I [ E
<- -- / -_.
i
,t t % 12 m
'~
,g_, - '
__ s
^
- ) A'? --
1.
' LN ('%
ib j
/,( ;, 1 A4 7
' xl \,
./gI-M- ' [
l / ,.
! i EL k l p
s l l
?
tj \' . _ f~ kh;,g fbg J .C_ -- ~~
\.) 'jf/ 3 Y
/ '
P! W J\ JTx"F T
?! f ) 1]
kn J _ _ WF i l'~ AIRBORNE PATHWAY SAMPLING LOC ATIONS
*- AIRBORNE PARTICULATE AND RADIOlODINE ADM 04-019 Rev. 5 Page 81 of 202 e .- . ~ . . ,,,, ,
"" W 4 G <.. . . err r g';gf jgyg .gg,argn e gg +- e g,- ,
EIcupt 5.2 EA r !
'- ,f
~~~~
i l #' l l
]~ j Bn i
- R A ...,.
; g '.
Nf lMf;c I
!'N _. _ _ _.
j
*W fQ* __
d:L !" _4 mrN{ )lv'vt
/7: .\L~~61
" '( -f . .
M. -- M.c.. ; /.,
/
i 4
"* ' \{, 7 -- ;*
.,,,=.
\
t ., s I,.
/ -
____ __:q_,- N f.pff. '(" N 2 :. .
>\ 's
. .. ! i t E
;sA .s___ i C- e
_ _L 8! f I Y N[-- A $< 45_g/ I"? 3 ,
/ /.( T > ._
,a .. g \g ;,,
/
/j_.-
!p iM # M4 ""
N/ I L. lw;i I
.gWJ;l,,,'.' , , . , '
L.,hlf '_ %lW-L* l-
- -il h/
\f-l'Jl' //E.'.'<,
l N'
?
l 4qbl
-T fIl h &.Mq* ..- g , gw ~ ~ ~ ~,,A Gi I.
Y v Lilli / el
~
% a ._ -
f y ~' s ,, I'# b i .- ! a_!<
!- l, /!
A
, m v ; , , .D c NNO Ig .:' '%l \, ;) lH jI 4 \T' J jg l l}'
l n DIRECT RADIATION PATHWAY SAMPLING LOCAT ! a- TLD LOCATIONS ADM 04-019 Rev. 5 Page 82 cf 202 e 2. .*;.' , ~....,. : ~.- EA??@M@*.:'fZif'.':.fi' .
FIGURE S.3 i l 1 fA j l B h #'
) ~~~~
l ! qR ,. , i I -
/ --
I ' ' I' j i, .., % e 9: , r
~-
g/ <. 3 {/
\
I,
--,lq__
l
'\
b - i E N =
^"
~( , <
;i _ _ ,
) !_ _ 'z
, K ^ $
sc_-- : ,, q
' b l g .
f
~ .
/E j - -~~ ~ ~ ~ ~
E L 4 / ^ -- ~ ! 6
.A ' NGlr ,.<' T
/- -
/
N.
'- 1"'8
?
/ 5\ ;, .
L] .b
], K [ P;
. J ! V~ \
WATERBORNE PATHWAY SAMPLING LOCATIONS
*-DRINKING WATER A-SURFACE WATER m-GROUND WATER v-SHORELINE SEDIMENT ADM 0 4 - O "_ ?
Rev. 5 Page ti3 cf 202 l e g,- f;. ,, ,. . . . . , .
'"'l.. ' ' li7ff , '.g',]f'g, a 3 g , . , , , ,,,. ,,
FTCupF S.4 l l t IA . h Y l ! s (",h5x"k [ ,
,c
'7 ___l L / _
f'4 Yl q;
'N-[ [\ yln/) ,
./(' /[
~ '
pd . ... [k--- /
- 7. "{, ,,/
\, D j 1, . . /. . . l ? I
[ 4' o....e. r.m.
. ~ : -
~
~~~ ~
l N c, [.
"a L i t
h
~~
T !E > 11/94 j , , 4p.;z 1 M' g\ l , , i -
./.. j ,s Is I
;N_- '
..\ \ : x
'l I i
, f a , lNl5..%,\\
W ^J, l F s[ #
'p. ,
_ f-v %.._g gg._
- :n, ,c . \
- \
fN y
/..L N i "
h. t Q GI!;
- i
! 't k'~t -
il /
,i .
I - J !M i Iri INGESTION PATHWAY SAMPLING LOCATIONS
*-FOOD PRODUCTS E-FISH (WCCL) A-FISH 'JRR) i l
ADM 04-019
.' .e v 5
Fage 84 of 202 e [, ,','([g [{h,h[f '[' ~-' ' * ! if I.9'h !.SY/$%I8@t%2k JJ@wg,Qff,'/3 [,37MM7,$f(( ((fT.[$[M ,[h[j, . [.
FVGURE 5.5 2 y - - y%- _ i
-j oecm c o
ot a v s. > = y , e - k 1 vsste : , ic ..t e
.s s
13 4r 8 A5 9:31 _ Mau.S suuusi s-.. 5 W8LE f 4ooli l r As in s s-3 k I l 2 6
-: 5: 3 , .
#WE b
9, e[ -\ om mmoe i T MEWUhCSE k 3
/ ~
j3 'W i m% sAs o ras se y evaum wn- ( Q** . y l 3 UT~[ /
] ^
j
\ !
i
! E5 b ~
un-os
* /
ossftEY
) .# l
. g - , ,
j
...,f~7*pc~
DISTANT SAMPLING LOC ATIONS
*-TLD a-DRINKING WATER f f
# .* * ' _ :-' --?RCADLEA ' ' E G E I AI' O'--
!RRIG ATED C .O'JS 7tDM 04 -019 Rev !i Page 85 :;f 202 e ,G ",:9Gy ye? ;'yyg.-*
'%( ! *!*7 ~T'"SCyWT"$4 "T3"'*Jf.Qf 'QQL%@g7}",*, 93;gy{, ' ,:l{-i7 .
g, s
6.0 BASES The bases contained on the succeeding pages summarizes the general requirements of Section 2.0, 3.0, 4.0 and 5.0 of the ODCM. Section 2.0 Lianid Effluents Sgg.ti,on 2.1 Concentration This section is provided to ensure that the concentration of radioactive materials released in liquid waste effluem.s to UNRESTRICTED AREAS will be less than the concentratie levels specified in 10 CFR Part 20, Appendix B, Table II, Column 2. This limitation provides additional assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within: (1) the Section II.A design objectives of Appendiv I, 10 CFR Part 50, to a MEMBER OF THE PUBLIC, and (2) the limits of 10 CFR Part 20.106(e) to the population. The concentration limit for dissolved or entrained nobles gaaec is based upon the assumption that Xe-135 is the controlling radioisotope and its MPC in air (submersion) was converted to an equivalent concentration in water using the methods described in International Commission on Radiological O Protection (ICRP) Publication 2. The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD,'and other detection limits can be found in HASL Procedures Manual, RASL-300 (revised annually), Currie, L.A., " Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry," Anal. chem. in, 586-93 (1968), and Hartwell, J.K., " Detection Limits for Radioanalytical Counting Techniques, " Atlantic Richfield Hanford Company Report ARM-SA-215 (June 1975) . 3/91 ADM 04-019 Rev. 5 Page 86 of 202 l $O .p . ... -J** y* ; a . ,y ,g , en g ; , .... ;3
, j
' 4 3$%?*I-y " M.%{"gQT y] "7,r-] 7 - .
{ V g.
1 1 l Section 2.2 Dome ; This section is provided to implement the requirements of ; i Section II.A, III.A and IV.A of Appendix I, 10 CFR Part 50. The remedial action implements the guides set forth in Sec- i tion II.A of Appendix I.and provides the required operating ( flexibility and at the same time implement the guides set I forth in Section IV.A of Appendix I to assure that the re-leases of radioactive material in liquid effluents to UN-RESTRICTED AREAS will be kept "as low as is reasonably ach-levable." Also, for fresh water sites with drinking water supplies that can be potentially affected by plant opera- 'f' tions ,there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations : in the finished drinking water that are in excess of the requirements of 40 CFR Part 141. The dose cal-culation methodology and parameters in the ODCM Amplement the re-quirements in Secticn III.A of Appendix ! ohich specify that conformance with the guides of Appendix I be shown by ! calculational procedures based on models and data, such , that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially under-estimated. The equations specified in the ODCM for calcu-lating the doses due to the actual release rates of. radio- l active materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, " Cal- ! culation of Annual Doses to Man from Routine Releases of ' Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I, " Revision 1, October 1977 and Regulatory Guide 1.113 " Estimating Aquatic Dispersion - of Effluents from Accidental and Routine Reactor Releases l for the Purpose of Implementing Appendix I," April 1977. l Section 2.3 Llauld Radwasta Tram &= ant System The OPERABILITY of the Liquid Radwaste Treatment Systems. ensures that this cystem will be available for use whenever , liquid effluents require treatment prior to release to the environment. The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of radioactive materials in liquid eff- t luents will be kept "as low as is reasonably achieveable." e This section implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and design objective given in Section II.D of , Appendix I to 10 CFR Part 50. The specified limits gov-erning the use of appropriate portions of the Liquid Rad-waste Treatment System were specified as a suitable frac-tion of the dose design objective. set forth in Section II.A of Appendix I, 10 CFR Part 50, for liquid effluents. 3/91 ADM 04-019 Rev. 5 Page 87 of 202 .e ,e <>W ,. w3f.CS?G w g3;;T.mym p ;spM m yggely ? Q \*Q ;:_ty'*y y.yyy ; y? . e .* g - r w'
ggetion 2.4 Radioactive Liould Effluent Monitorina f InstrumentatiSD The radioactive liquid effluent instrumentation is provided l to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The Alarm / Trip Setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in the ODCM to ensure that the alarm / trip will occur prior to exceeding the limits of 10 CFR Part 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50. Section 3.0 Gaseous Effluents Section 3.1 Dose Rate This section is provided to ensure that the dose at any time at and beyond the SITE BOUNDARY from gaseous effluents from all units on the site will be within the annual dose The annual limits of 10 CFR Part 20 to UNRESTRICTED AREAS. dose limits are the doses associated with the concentrations of 10 CFR Part 20, Appendix B, Table II, Column 1. These limits provide reasonable assurance that k radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, Table II of 10 CFR Part 20 (10 CFR 20.106(b)). For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy of that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for any increase in the atmospheric diffusion The specified factor above that for the SITE BOUNDARY. release rate limits restrict, at all times, the corresponding gamma and beta dose rates above background to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY to less than or equal to 500 mrems/ year to the whole body or to less than or equal to 3000 mrems/ year to the skin. These release rate limits also restrict, at all times the corresponding thyroid dose rate above background to a child via the inhalation pathway to less than or equal to 1500 3/91 . mrems/ year. ADM 04-019 Rev. 5 i Page 88 of 202 e y m. - .z . - , , . , . . .. ,
><MCM*'M:Q[Gri m.4}p QQ) g g q p5}Q g p g. ,
The required detection capabilities for radioactive materials in gaseous waste samples are tabulated in terms of the lower limits of detection (LLDs) . Detailed discussion of the LLD, and other detection limits can be found in HASL Procedures Manual, HARL-3 QA (revised annually), Currie, L.A., " Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry," Anal. chem 40, 586-93 (1968), and Hartwell, J.K., " Detection Limits for Radioanalytical Counting Techniques," Atlantic Richfield Hanford Company Report ARM-sA-215 (June 1975). Section 3.2.1 Dome - Noble Gases This section is provided to implement the requirements of Section II.B, III.A and IV.A of Appendix I, 10 CFR Part 50. The remedial action implements the guides set forth in Section II.B of Appendix I and provides the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The surveillance requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The dose calculation methodology and parameters established in the ODCM for calculating the doses due to the actual release rates of radioactive materials in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109,
" Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, " Methods for i Estiinating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled ;
Reactors," Revision 1, July 1977. The ODCM equations l provided for determining the air doses at and beyond the i SITE ROUNDARY are based upon either the historical average 3/91 ! or real time atmospheric conditions. f i I l 4 l ADM 04-019 Rev. 5 l Page 89 of 202 e - v % M H W i M P M jn f?? M iL'hk Q!?hKg ?TffgGQ, ..l,.{
- j .[~;, ' ((*
Section 3.2.2 Dome - Iodine-131 and 133. Tritium and Radioactive Material in Particulate Form This section is provided to implement the requirements of Sections II.C, III.A and IV.A of Appendix I, 10 CFR Part
- 50. The remedial actions are the guides set forth in Section II.C of Appendix I, and provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents to UNRESTRICTED AREAS will be kept "as low as is reasonably achievable." The ODCM calculational methods I
specified in the surveillance requirements implement the , requirements in Section III.A of Appendix I that l conformance with the guides of Appendix I be shown by ( calculational procedures based on models and data, such I that the actual exposure of a MEMBER OF THE PUBLIC through f appropriate pathways is unlikely to be substantially i underestimated. The ODCM calculational methodology and f parameters for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109,
" Calculational of Annual Doses to Man from Routine Releases 1 of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, " Methods for Estimating Atmospheric Transport and Dispersion of Gaseous
'I Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977. These, equations also provide for determining the actual doses based upon either the historical average or real time conditions. The release rate limits for Iodine-131 and 133, tritium, and radionuclides in particulate form with half lives greater that 8 days are dependent upon the existing radionuclide pathways to man, in the areas at and beyond the SITE BOUNDARY. The pathways that were examined in the development of these calculations were: (1) individual inhalation of airborne radionuclides, (2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, (3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption of the milk and meat by man, and (4) deposition 3/91 on the ground with subsequent exposure of man. ADM 04-019 Rev. 5 Page 90 of 202 e F n@mM
- FE&WTa'&1445WMM MW'ggg7g, ((ggg;{gg{ ,
Baction 3.3 82==mous n=Aa===ta Trea&= ant Bvatem The OPERABILITY of the WASTE GAS HOLDUP SYSTEM and the VENTILATION EXHAUST TREATMENT SYSTEM ensures that the systems will be available for use whenever gaseous effluents require treatment prior to release to the environment. The requirement that the appropriate portions of this system be used when specified provides reasonable assurance that the releases of "as radioactive low as ismaterials in reasonably gaseous effluents will be kept achievable." This section implements the requirements of 10 CFR 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objectives given in Section II.D of Appendix I to 10 CFR Part 50 The specified limits governing the.use of appropriate portions of the systems l were specified as a suitable fraction of the dose design objectives set forth in Section II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents. Section 3.4 nadiometive Gammous Efflumnt Manitorina Instra=antation The radioactive gaseous effluent instrumentation is the provided to monitor and control, as applicable, releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The Alarm / Trip Setpoints for these instruments shall be h' adjusted to values calculated in accordance with the methodology and parameters in the ODCM to ensure that the limits of 10 alarm / trip will occur prior to exceeding the CFR Part 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63 and 64 of Appendix A to 10' CFR Part 50. The sensitivity of any noble gas activity monitor used to show compliance with the gaseous effluent release requirements of Section 3.2 shall be such that 3/91 concentrations as low as 1 x 10-6 uCi/cc are measurable. ADM 04-019 Rev. 5 Page 91 of 202 e /, ; Lt7iCi~3 M 41GTn T % { Q.yg y,,<.g g g g g- }- . W
i ( l l Section 4.0 Total Dome This section is provided to meet the dose limitations of 40 CFR Part 190 that have been incorporated into 10 CFR Part 20 by 46 FR 18525. The section requires the preparation . and submittal of a special report whenever the calculated f doses due to releases of radioactivity and the radiation from uranium fuel cycle sources exceed 25 mrems to the whole body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrems. For sites containing up to four reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR Part 190 if the individual reactors remain within twice the dose design objectives of Appendix I, and if direct radiation doses from the reactor units and from outside storage tanks are kept small. The Special Report will describe a course of action that should f result in the limitation of the annual dose to a MEMBER OF I For the THE PUBLIC to within the 40 CFR Part 190 limits. purposes of the Special Report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible, with the exception that dose contributions from other nuclear fuel cycle facilities at the same site or within a radius of 8 km must be considered. If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40 CFR Part 190, the Special Report with a request for a variance C3 (provided the release conditions resulting in violation of 40 CFR Part 190 have not already been corrected), in accordance with the provisions ot 40 CFR 190.11 and 10 CFR 20.405c, is considered to be a timely request and fulfills l the requirements of 40 CFR Part 190 until NRC staff action is completed. The variance only relates to the limits of 40 CFR Part 190, and does not apply in any way to the other
- 20. An requirements for dose limitation of 10 CFR Part individual is not considered a MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any 3/91 operation that is part of the nuclear fuel cycle.
1 l l l t ADM 04-019 Rev. 5 Page 92 of 202 e ,ily.y g gt ;e - ;
* * * "Er ec 7 WAtgrs;ggg.ggg
l 1 l I section 5.0 mmdioloalcal Envirne==ntal Man 4toring Program ( Baction 5.1 unmitorina Proarna The Radiological' Environmental Monitoring Program provides representative measurements of radiation and of radioactive ! materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBERS OF THE PUBLIC resulting from the station operation. This monitoring program implenents Section IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the Radiological Effluent Monitoring Program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and the modeling of the environmental exposure pathways. Guidance for thiL monitoring program is provided by the Radiological Assessment Branch Technical Position on Environmental Monitoring, Revision 1, November _1979. The required detection capabilities for environmental ' sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs are considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as an a priori (before the fact) limit representing l the capability of a measurement system and not as an a Q. posteriori (after the fact) limit for a particular : measurement. I Detailed discussion of the LLD, and other detection limits, i can be found in HASL Procedures Manual, RAEL-300 (revised annually), Currie, L.A., " Limits for Qualitative Detection l and Quantitative Determination-Application to Radiochemistry," Anal. Chem. 40, 586-93 (1968), and Hartwell, J.K., " Detection Limits for Radioanalytical I Counting Techniques," Atlantic Richfield Hanford Company 3/91 Report ARM-sA-215 (June 1975). i i ADM 04-019 Rev. 5 Page 93 of 202 I e -} -rc.s vwo mm;py wvy,Emiv;-remmEQM8MM*5M$(7,Pj'{ g,Yggggg' .
-- - _ ~ _ _ . .
a. Sectian 5.2 fand Uma emnmum This section is provided to ensure that changes in the use r of areas at and beyond the SITE BOUNDARY are identified and that modifications to the Radiological' Environmental > Monitoring Program given in the ODCM are made if required by the results of this census. Information that will l l
. provide the best results, such as door-to-door survey, '
aerial survey, or consulting with local agricultural ' authorities,.shall be used. This census satisfies the j requirements of Section IV.B.3 of Appendix I to 10 CFR Part !
- 50. Restricting the census to gardens of greater than 50 '
m provides assurance that significant exposure pathways 2 l via leafy vegetables will be identified and monitored since- I a garden of this size is the minimum required to produce ' the quantity (26 kg/ year) of leafy vegetables assume in { Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following ,! assumptions were made: (1) 20% of the. garden was used for ! growing broad leaf vegetation (i.e., similar to2 lettuce and cabbage), and (2) a vegetation yield of 2 kg/m , sectinn 5.3 Interlaboratory Cannarison Proaram The requirement for participation in an approved Interlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of
! the measurements of radioactive material in environmental l
j sample matrices are performed as part of the quality ' assurance program for environmental monitoring in order to demonstrate that the results are valid for the purposes of Section IV.B.2 of Appendix I to 10 CFR Part 50, 3/91 7.0 REPORTS i 7.1 annumi Radioloaical Environaggial Operatina Renogt I c The Annual Radiological Environmental Operating Report ; shall include summaries, interpretations, and an analysis ; of trends of the results of the radiological environmental ; surveillance activities for the report period, including a l comparison with preoperational studies, with operational ; controls and with previous environmental surveillance reports, and an assessment of the observed impacts of the l plant operation on the environment. The reports shall also { include the results of the Land Uce Census described in Section 5.2. . ADM 04-019 Rev. 5 Page 94 of 202 ; i
, ,y-% ;r;g*.v.t;c- ~ ~
The Annual Radiological Environmental Operating Report shall include the results of analysis of all radiological environmental samples and of all environmental radiation measurements taken during the period pursuant to the locations specified in Table 5-1 as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Assessment Branch , Technical Position, Revision 1, November 1979. In'the i event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results. ' The missing data shall be submitted as soon as possible in a supplementary report. The reports shall also include the following: a summary ; description of the Radiological Environmental Monitoring < Program; legible maps covering all sampling locations keyed to a table giving distances and directions from the centerline of the reactor; the results of licensee , participation in the Interlaboratory Comparison Program and the corrective actions being taken if the specified program ! is not being performed as required by Section 5.3; reasons for not conducting the Radiological Environmental Program as required by Section 5.1 with plans for preventing a ; recurrence and discussion of all deviations from the sampling schedule of Table 5-1; discussion of environmental ' sample measurements that exceed the reporting levels of I Table 5-4 but are not the result of plant effluents, and discussions of all analyses in which the LLD required by ; Table S-3 was not achievable. l' 7.2 Annumi Radioactive Effluent Release Renort i The Annual Radioactive Rffluent Release Report shall '9/93 include a summary of the quantities of radioactive liquid ; i and gaseous effluents and solid waste released from the Unit as outlined in Regulatory Guide 1.21, " Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and < l Releases of Radioactive Materials in Liquid and Gaseous > Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof. For solid wastes, the format for Table 3 in Appendix B shall be supplemented with three additional categories: class of solid waste (as defined by 10 CFR Part 60), type of container (e.g., LSA, Type A, Type B, Large Quantity), and SOLIDIFICATION agent or absorbent (e.g., cement, urea l f or maldehyde) . l ADM 04-019 Rev. 5 Page 95 of 202 e
- WU.N Mf[W(,E M M M~~" $}}iff;7 j ,( yry y y - gg
~%; '
7.2 1"a"*1 *=dinactive Eff1"=at nelemme n nort (continued) [ The Annual Radioactive Effluent Release Report to be submitted before May 1 of each year shall also include an annual summary of hourly meteorological data collected over the previous. year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction, and atmospheric stability, and precipitation (if measured) , or in the form of joint frequency distributions of wind speed, wind direction, and 7 ! atmospheric stability.* This same report shall include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from the Unit or Station during the previous calendar year. This same report shall also include an assessment of the radiation doses from radioactive liquid and gaseous effluents to MEMBERS OF THE PUBLIC due to their activities inside the SITE BOUNDARY during the report period using historical average atmosphere conditions. All assumptions used in making these assessments, i.e., specific activity, exposure time and location, shall be included in these reports. The meteorological conditions concurrent with the time of release of radioactive materials in gaseous effluents, as determined by sampling frequency and measurement, shall be used for determining the gaseous pathway doses. The assessment of radiation doses shall be performed in accordance with the methodology and parameters in the ODCM. i, 1 The Annual Radioactive Effluent Release Report to be submitted before May 1 of each year shall also include an assessment of radiation doses to the likely most exposed MEMBER OF THE PUBLIC from reactor releases and other nearby uranium fuel cycle sources, including doses from primary effluent pathways and direct radiation, for the previous calendar year to show conformance with 40 CFR Part 190,
" Environmental Radiation Protection Standards for Nuclear Power Operation." Acceptable methods for calculating the dose contribution from liquid and gaseous effluents are given in Regulatory Guide 1.109, Rev. 1, October 1977.
The Annual Radioactive Effluent Release Report shall 9/93 include:
- a. A list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive materials in l
gaseous and liquid effluents made during the reporting l period. l ADM 04-019 Rev. 5 Page 96 of 202 e MU QVMWVMEM 5}MWhQQg&R '}}}'}
;?,' ' 'j
- i
)
i t
*In lieu of submission with the Annual Radioactive' Effluent 9/93 l
' Release Report, the licensee has the option of retaining l
l this summary of required meteorological. data on site in a j
' file that shall be provided to the NRC upon request, annual Radioactiva uffluent Relamma Renort (continued) f9/93 7.2 !
- b. Any changes made during the reporting period to the I ODCM, pursuant to Technical Specification 6.14. !
j
- c. Major changes to the Radwaste Treatment Systems for the ;
period in which the evaluation was reviewed and ' accepted by the PSRC. The discussion of each change j shall contain, i
- 1) A summary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR 50.59; i
- 2) Sufficient detailed information to totally j support the reason for the change without .
f benefit of additional and supplemental information; i
- 3) A detailed description of the equipment, components, and processes involved-and the interfaces with other plant systems. ;
I l
- 4) An evaluation of the change which shows the ;
predicted releases of radioactive materials in } liquid and gaseous effluents and/or quantity of j solid waste that differ from those previously l predicted in the license application and amendmen,ts thereto, t
- 5) An evaluation of the change, which shows the expected maximum exposures to a MEMBER OF THE f l
PUBLIC in the UNRESTRICTED AREA and to the ! general population that differ from those l previously estimated in the license application i and amendments thereto; i
- 6) A comparison of the predicted releases of radioactive materials. in liquid and gaseous effluents and in solid waste, to the actual l releases for the period prior to when the changes are to be made;
- 7) An estimate of the exposure to plant operating i personnel as a result of the change; and ADM 04-019 Rev. 5 Page 97 of 202 e ' >WhW }$3)(i Zw,jgM;ggpgg'QQg i 5; .
' 7:M :
E- , ! t L Annum 1 n=Alametive Effluent Ralaana menort (Continued) 9/93 f
- i. 7.2 I f i
8). Documentation of the fact that the change was l reviewed and found acceptable by the PSRC.
- d. A listing of new locations for dose calculations ;
identified by the Land Use Census, ,
- e. A description of the events leading to liquid holdup I i
tanks or gas storage tanks exceeding the limits of Technical Specification 3.11.1.4 or 3.11.2.6 respectively. ,
- f. An explanation as to why the inoperability of a liquid or gaseous effluent monitoring instrumentation was not !
corrected within the time specified. l,
- g. A description of the events leading to a missed sample required by Table 2-1 or 3-1.
t b . [ 5 l i i I ADM 04-019 i Rev. 5 Page 98 of 202 I
. 'y' '
i;r '
~
y-T W !. a% *R"3WQRRQJg ggfj QifzQ.",[Qf.; , Ti: >
- APPENDIY A Dose Conversion Factor Tables d
l i l A.1 1 I l i ADM 04-019 Rev. 5 Page 99 of 202 e I.
' fS '%i 3 % ".l M F. d 'I*f, M M M E b l b M fg ( d 4 h d $s(( fj~-;[.h?f g g,- g g';j a ~~
~ ,
1 Tant.m A.i.i. , BTQACCUMULATION FACTORE TO BE USED IN l THE ABSENCE OF SITE-CDECIFTED DATA (pci/kg per pCi/ liter) I ELEMENT FDFRHWATER FTRM [ H 9.0E-01 ' C 4.6E 03 Na 1.0E 02 ; l P 1.0E 05 Cr 2.0E 02 g Mn 4.0E 02 1 Fe l'.0E 02 Co 5.0E 01 Ni 1.OE 02 - Cu 5.0E 01 Zn 2.0E 03 Br 4.2E 02 , Rb 2.0E 03 Sr 3.0E 01 , Y 2.5E.01 Zr 3.3E 00 , Nb 3.0E 04 Mo 1.0E 01 , Tc 1.5E 01 Ru 1.0E 01 t Rh 1.0E 01 l Te 4.0E 02 I 1.5E 01 . Cs 2.0E 03 Ba 4.0E 00 La 2.5E 01 Ce 1.0E 00 2.5E 01 [ Pr ! Nd 2.5E 01 . I W 1.2E 03 Np 1.0E 01 , 2.3E 00 l
**Ag
**Sb 1.0E 00
- Taken from Regulatory Guide 1.109 (Rev.1) -
** Taken from Regulatory Guide 1.109 (Rev.0) i f
A-2 t i r ADM 04-019 Rev. 5 [ Page 100 of 202 , t k O,:' -
'MM&EtMWE?filFSMLIRMc614tdhiMEEfEh%f!3hii2WTustIsadii$$i. [. ' 95I-
~
S-[4 i
'rmar.m A 1-2 ,
DOSE FACTORS FOR NOBLE GASES AND DAUGHTERS * 'l t hin Dome C --- Air geta Air padlanucifde Total Body ; Factor Dame Factor Done Factor Dome Factor I bl 51 El El ferad/vr ner (mrad /vr ner , fmram/vr ner farem/vr ner pCi/mya l uci /m31 pc1/m 1 3 gCi/m lA 1.93E+01 2.88E+02 Kr-83M 7.56E-02** --- 1.46E+03 1.23E+03 1.97E+03 Kr-SSM 1.175+03 1.34E+03 1.72E+01 1.95E+03 Kr-85 1.615+01 i 9.73E+03 6.17E+03 1.03E+04 Kr-87 S.92E+03 4 i 2.37E+03 1.52E+04 2.93E+03 Kr 88 1.47E+04 l 1.01E+04 1.73E+04 1.06E+04 Ks-89 1.66E+04 7.29E+03 1.63E+04 7.83E+03 i h-90 1.56E+04 4.76E402 1.56E+02 1.11E+03 ; Xe-131M 9.15E+01 i 3.06E+02 3.53E+02 1.05E+03 Xe-133 2.94E+02 9.94E+02 3.27E+02 1.48E+03 Xe-133M 2.51E+02 'i 7.11E+02 3.36E+03 7.39E+02 Ke-135M 3.12E*03 1.86E+03 1.92E+03 2.46E+03 Xe-135 1.81E+03 1.22E 04 1.G1E403 1.27E+04 , Xe-137 1.42E+03 4.13E+03 9.21E+03 4.75E+03 : Xe-138 8.83E+03 i 3.29E+03 8.84E+03 2.69E+03 9.30E+03 Ar 41 r
- Based on Regulatory Guide 1.109 (Rev.1)
**7.56E-02 = 7.56 x 10 A-3 i
l 1 i l ADM 04-019 l Rev. 5 ; Page 101 of 202 e
- ' O.W W & ?b M & NkW W & hj & Q $'f5& & &j) & ?,j5 f *?{.ijify'. is'f;>lyg) [,T- .
^;f .
TABLE A.2-1* , INHALATION DOSE FACTORS FOR ADULTS (MREM PER PCI INHALED) KILWEY LUtG CI-LLI LIVER T EODY 'HIYROID tg LIDE tor!E 1.58E-07 1.58E-07 1.58E-07 1.58E-07 to DATA 1.58E-07 1.58E-07 4.26E-07 H 3 4.26E-07 4.26E-07 4.26E-07 4.26E-07 C 14 2.27E-06 4.26E-07 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06
. la 24 1.28E-06 1.28E-06 10 DATA 10 DATA 1.08E-05 9.64E-06 6. 26E-06 to DATA 4.15E-07 P 32 1.65E-04 7.44E-09 2.85E-09 1.80E-06 51 10 DATA 10 DAB 1.25E-08 9.67E-06 CR 10 DATA 1.23E-06 1.75E-04 54 10 DATA 4.95E-06 7.87E-07 MN to DATA 1.63E-10 1.18E-06 2.53E-06 56 PO DATA 3.55E-10 2.29E-11 7.54E-07 HN 4.93E-07 to DATA to DATA 9.01E-06 FE 55 3.07E-06 2.12E-06 1.27E-04 2.35E-05 3.47E-06 1. 32FA6 10 DAB 10 DAR FE 59 1.47E-06 20 DAM 10 DATA 1.16E-04 1.33E-05 58 10 DATA 1.98E-07 2.59E-07 3.56E-05 CD 10 DATA 10 DATA 7.46E-04 60 10 DATA 1.44E-06 1.85E-06 1.67E-06 CD 1.81E-06 to DATA 10 DAM 2.23FA5 10 63 5.40E-05 3.93E-06 10 Dhn 10 DATA 7.00E-07 1.54E-06 65 1.92E-10 2.62E-11 1.14E-11 6.12E-06 10 7.69E-11 10 DATA 5.78E-10 8.48E-07 CU 64 to DATA 1.83E-10 1.08E-04 6.68E-0G 5.82E-06 to DATA 8.62E-06 Zti 65 4.05E-06 1.29E-05 5.27E-12 1.15E-07 2.04E-09 4.23E-12 8.14E-12 5.65E-13 to DATA ZN 69 NO DATA 10 DATA 10 DATA 2.90E-08 BR 83 to DATA to DATA 3.01E-08 2.05E-13 to DATA 10 DATA 10 DATA BR 84 10 DATA 10 DATA 3.91E-08 g
to DATA 10 DATA IO DATA LT E-24 BR 85 to DATA 10 DATA 1.60E-09 2.08E-06 7.37E-06 10 DATA 20 DATA 10 DATA RB 86 10 DATA 1.69E-05 to DATA 4.18E-19 4.84E-08 2.41E-08 to DATA 10 DATA RB 88 to DATA 10 DATA 10 DATA 10 DATA 1.16E-21 RB 89 to DATA 3.20E-Od 2.12E-08 4.37E-05 1.09E-06 10 DATA 10 DATA 1.75E-04 SR 89 3.80E-05 to DATA 1.20E-03 9.02E-05 7.62C-04 NO DATA 10 DATA SR 90 1.24E-02 to DATA to DATA 10 DATA 4.56E-06 2.39E-05 91 7.74E-09 10 DATA 3.13E-10 SR to DAR 10 DATA 2.06E-06 5.38E-06 92 8.43E-10 10 DATA 3.64E-11 6.32E-05 SR 7.01E-09 10 DATA to dan 2.12E-05 Y 90 2.61E-07 to DATA 10 DATA 10 DATA 2.40E-07 1.66E-10 Y 91.M 3.26E-11 10 DATA 1.27E-12 4.81E-05 1.55E-06 10 DATA 10 DATA 2.13E-04 Y 91 5.78E-05 to DATA 1.96E-06 9.19E-06 to DATA 3.77E-11 PO DATA to DAB Y 92 1.29E-09
*Taken frcru Regulatory Guide 1.109 (Rev.1)
A-4 ADM '.4-01? Rev. r Page '_0 2 Of 202
-e c. ...
~~ 1 ***$ W T fj".y ? 7,. 7 48j {.{ ;g,e;' f
, .~ ~{ }
,. ~Q ,
~ .
TABLE A.2-1* (cont' d) INHALATION DOSE FACTORS FOR ADULTS (MREM PER PCI INHALED) KIDNEY IARG GI-ILI T BODY THYROID NUCLIDE BDNE LIVER 10 DATA 6.06E-06 5.27E-05 , to DMA 3.26E-10 10 DATA Y 93 1.18E-08 PO DATA 6.77E-06 2.21E-04 1.88E-05 1.34E-05 4.30E-06 2.91E-06 6.54E-05 ZR 95 to DATA 3.71E-09 9.84E-06 97 1.21E-08 2.45E-09 1.13E-09 ZR 9.67E-07 6.31E-05 1.30E-05 9.77E-07 5.26E-07 20 DATA NB 95 1.76E-06 10 DATA 3.64E-08 1.14E-05 3.10E-05 to DATA 1.51E-08 2.87E-09 9.55E-08 S.20E-07 10 99 4.63E-12 to DATA 5.52E-12
'IC 99M 1.29E-13 3.64E-13 1.35E-13 4.99E-08 1.36E-21 7.52E-15 7.38E-14 20 DATA 1.38E-05
'IC 101 5.22E-15 10 DATA 7.29E-07 6.31E-05 1.91E-07 NO DATA 8.23E-08 1.37E-06 6.02E-06 EU 103 3.89E-11 PO DATA 1.27E-10 RU 105 9 88E-11 NO DATA 1.67E-05 1.17E-03 1.14E-04 to DMA 1.09E-06 20 DATA RU 106 8.64E-06 2.46E-06 5.79E-04 3.73E-05 1.25E-06 7.43E-07 20 DATA AG 110M 1.35E-06 1.31E-07 1.55E-06 3.92E-05_ 0.83E-06 ,
4 27E-07 1.98E-07 5.d4E-08 TE 125M 4.11E-07 5.72E-06 1.20E-04 1.87E-05 1.58E-06 7.21E-07 1.96E-07 7.17E-06 TE 127M 1.32E-10 6.37E-10 8.14E-07 1.75E-10 8.03E-11 3.87E-11 1.45E-04 4.79E-05 TE 127 1.98E-07 4.30E-07 4.57E-06 l TE 129M 1,22E-06 5.84E-07 2.34E-11 2.42E-07 1.96E-08 2.99E-12 1.55E-12 4.87E-12 TE 129 6.22E-12 3.86E-08 1.82E-05 6.95E-05 5.45E-09 3.63E-09 6.88E-09 2.30E-09 TE 131M 8.74E-09 1.17E-12 5.46E-12 1.74E-07 1.39E-12 7.44E-13 4.49E-13 TE 131 2.37E-08 1.82E-07 3.60E-05 6.37I-05 3.25E-08 2.69E-08 2.02E-08 9.61P-07 TE 132 6.60E-07 1.42E-04 2.61E-06 to DATA 130 5.72E-07 1.68E-06 7.66E-06 to DATA 7.85E _0,7 I 4.47E-06 2.56E-06 1.49E-03 I 131 3.15E-06 6.48E-07 to DATA 5.08E-08 4.07E-07 1.45E-07 1.43E-05 1.11E-06 I 132 1.45E-07 2.69E-04 3.23E-06 10 DATA 133 1.08E-06 1.85E-06 5.65E-07 10 DATA 1.26E-10 I 7.69E-08 3.73E-06 3.44E-07 I 134 8.05E-08 2.16E-07 5.60E-05 1.39E-06 to DATA 6.56E-07 3.35E-07 8.73E-07 3.21E-07 1.22E-05 1.30E-06 I 135 to DATA 3.59E-05 4.66E-05 1.06E-04 9.10E-05 1.50E-06 1.46E-06 CS 134 1.38E-05 to DATA 1.07E-05 CS 136 4.88E-06 1.83E-05 ' 2.78E-05 9.40E-06 1.05E-06 7.76E-05 5.35E-05 10 DATA CS 137 5.98E-05 NO DATA 6.00E-08 6.07E-09 2.33E-13 4.14E-08 7.76E-08 4.05E-08 4.70E-07 1.12E-07 CS 138 3.42E-12 10 DATA 7.78E-14 BA 139 1.17E-10 8.32E-14 A-5 ADM 04-019 Rev. 5 Page 303 of 202 e ~ ~ ~ ~ 'n b*M y *QKQQ* y [ . r~ *. p ..p - .
. & 3"'
TABLE A.2-1* (cont' d) INHALATION DOSE FACTORS FOR ADULTS (MREM PER PCI INHALED) KIDNEY IJUtG CI-Ill LIVER T BODY 'IHYROID IONE FJCLIDE to DATA 2.09E-09 1.59E-04 2.73E-05 4.88E-06 6.13E-09 3.21E-07 1.45E-17 BA 140 4.20E-13 10 DATA 8.75E-15 2.42E-07 EA 141 1.25E-11 9.41F -15 2.86E-15 1.49E-07 1.96E-26 3.38E-15 2.07E-13 PO DATA 1% 142 3.29E-12 to DATA 1.70E-05 5.73E-05 4.30E-08 2.17E-08 5.73E-09 to IATA 2.64E-07 IA 140 FC DATA 10 DATA 7.91E-07 8.54E-11 3.88E-11 9.65E-12 1.50E-05 LA 142 1.91E-07 to DATA 7.83E-07 4.52E-05 CE 141 2.49E-06 1.69E-06 7.60E-09 9.97E-06 2.83E-05 1.72E-08 1.91E-09 70 DATA 1.02E-04 CE 143 2.33E-08 to DATA 1.06E-04 9.72E-04 4.29E-04 1.79E-04 2.30E-05 3.51E-05 2.50E-05 CE 144 5.80E-08 10 DATA 2.70E-07 PR 143 1.17E-06 4.69E-07 to DATA 8'.81E-13 1.27E-07 2.69E-18 3.76E-.12 1.56E-12 1.91E-13 2.76E-05 2.16E-05 PR 144 4.56E-08 10 DATA 4.45E-07 to 147 6.59E-07 7.62E-07 10 DATA 3.63E-06 1.94E-05 8.85E-10 3.10E-10 to DATA W 187 1.06E-09 8.75E-09 4.70E-06 1.49E-05 2.82E-09 1.SSE-09 to DATA NP 239 2.87E-08 gi l I l l A-6 ADM 04 - 019 Rei- 5 Pag 2 104 of 202 l e g7 7 'd W :.*' 6*N42G4EFEWLENWMT3l3EFf6#g*gQ$*
TABLE A.2-2* INHALATION DOSE FACTORS FOR TEENAGER (MREM PER PCI INHALED) BONE LIVER T BODY '1HYROID KIDNEY LUto GI-LLI tOCLIDE 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 H 3 10 DATA 1.59E-07 6.09E-07 6.09."-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 C 14 3.2SE-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 NA 24 1.72E-06 8.95E-06 10 DATA 10 EnTA 20 DATA 1.16E-05 P 32 2.36E-04 1.37E-05 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 CR 51 10 DATA 10 DATA 1.05E-06 to DATA 1.59E-06 2.48E-04 8.35E-06 HN 54 10 DATA 6.398-06 3.15E-11 10 DATA 2.24E-10 1.90E-06 7.18E-06 NN 56 10 DATA 2.12E-10 2.38E-06 ' 6.93E-07 to DATA 10 DATA 1.55E-05 7.99E-07 FE 55 4.38E-06 1.91E-04 2.23E-05 1.99E-06 4.62E-06 1.79E-06 to DATA to DATA l FE 59 2.59E-07 3.47E-07 10 DATA 10 DATA 1.68E-04 1.19E-05 CD 58 10 DATA 3.24E-05 1.89E-06 2.48E-06 10 DATA 10 DATA 1.09E-03 00 60 10 DATA 3.84E-05 1.77E-06 63 7.25E-05 5.43E-06 22 47E-06 NO DATA to DATA t(I 3.66E-11 1.59E-11 NO DATA to DATA 1.17E-06 4.59E-06 i NI 65 2.73E-10 7.68E-06 2.54E-10 1.05E-10 NO DATA 8.01E-10 1.39E-06 l CU 64 10 DATA 5.83E-06 1.67E-05 7.80E-06 to DATA 1.08E-05 1.55E-04 ZN 65 4.82E-06 1.15E-11 8.07E-13 NO DATA 7.53E-12 1.98E-07 3.56E-08 ZN 69 6.04E-12 LT E-24 to DATA 4.30E-08 10 DATA 10 DATA to DATA BR 83 to DATA LT E-24 to DATA 5.41E-08 to DATA 10 DATA PO DATA BR 84 to DATA 4 10 DATA 2.29E-09 to DATA to DATA 10 DATA LT E-24 BR 85 to DATA 2.38E-05 1.05E-05 10 DATA 10 DATA NO DATA 2.21E-06 RB 86 10 DATA 6.82E-08 3.40E-08 PO DATA PO DATA 10 DATA 3.65E-15 RB 88 to DATA 4.40E-08 2.91E-08 10 DATA 10 DATA 10 DATA 4.22E-17 RB 89 to DATA 4. 64 E-05 89 5.43E-05 10 DATA 1.56E-06 10 DATA 10 DATA 3.02E-04 SR 9.56E-05 90 1.35E-02 PO DATA 8.35E-04 to DATA to DATA 2.06E-03 SR 91 1.10E-08 to DATA 4.39E-10 10 DATA 10 DATA 7.59E-06 3.24 E-05 SR 1.19E-09 to DATA 5.08E-11 to DATA 10 DATA 3.43E-06 1.49E-05 SR 92 6.99E-05 3.73E-07 to DATA 1.00E-00 to DATA 10 DATA 3.66E-05 Y 90 1 10 DATA 10 DATA 4.00E-07 3.77E-09 I Y 91M 4.63E-11 to DATA 1.77E-12 10 DNIA 2.21E-06 10 DATA 10 DATA 3.67E-04 5.11E-05 Y 91 8.26E-05 2.06E-05 1.84E-09 to DATA 5.36E-11 10 DATA 10 DATA 3.35E-06 Y 92
*Taken frun Regulatory Guide 1.109 (Rev.1)
A-7 l ADM 04-019 Rev. 5 Page 3 05 of 202 O l( -J W3mdne.rgmeppgrPhr h yg E R ggg;4ggg , 7 3 .
TABLE A.2-2+ (cont'd) INHAIJLTION DOSE FACTORS FOR TEENAGER (MREM PER PCI INHALED) KIDNEY LUtG GI-LLI LIVER T BODY 'lifYROID NUCI.,T p_E BONE to DNIA 1.04E-05 7.24E-05 1 1.69E-08 to DJcA 4.65E-10 to IATA 1.86E-05 Y 93 to IATA 8.42E-06 3.36E-04 95 1.82E-05 5.738-06 3.94E-06 1.62E-05 7.88E-05 i ZR 1.57E-09 to IATA 5.155-09 ZR 97 1.72E-08 3.40E-09 to DNQ 1.25E-06 9.39E-05 1.21E-05 2.32E-06 1.29E-06 7.08E-07 3.36E-05 10 95 4.03E-09 10 IATA 5.14E-08 1.92E-05 10 99 10 IATA 2.11E -08 7.20E-12 1.44E-07 7.66E-07 1.73E-13 4.83E-13 6.24E-12 to IATA
'IC 99M to DNIA 1.90E-13 8.34E-08 1.09E-16 , 'IC 101 7.40E-15 1.05E-14 1.03E-13 1.36E-05 l 1.12E-07 to DNIA 9.29E-07 9.79E-05 RU 103 2.63E-07 to DNIA 1.76E-10 2.27E-06 1.13E-05 10 DNIA 5.42E-11 10_ DATA RU 105 1.40E-10 10 DNIA 2.38E-05 2.01E-03 1.20E-04 RU 106 1.23E-05 to DNIA 1.55E-06 3.41E-05 9.99E-07 10 DATA 3.13E-06 8.44E-04 AG 110M 1.73E-06 1.64E-06 6.70E-05 9.38E-06 2.80E-07 8.34E-08 1.75E-07 10 DNIA TE 125M 6.10E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 2.25E-06 1.02D-06 2.73E-07 1.01E-05 TE 127M 1.77E-10 9.10E-10 1.40E-06 TE 127 2.51E-10 1.14 E- 10 5.528-11 5.06E-05 5.72E-07 6.49E-06 2. 47E-04 1.74E-06 8.23E-07 2.81E-07
_TE 129M 6.48E-12 3.32E-11 4.12E-07 2. 02E-07 8.87E-12 4.22E-12 2.20E-12 7.76E-05 TE 129 9.06E-09 5.49E-08 2.97E-05 TE 131M 1.23E-08 7.51E-09 5.03E-09 1.89E-09
- 6. 30E-13 1.55E-12 7.72E-12 2.92E-07 TE 131 1.97E-12 1.04E-12 IP 3.07E-08 2.44E-07 5.61E-05 5.79E-05 TE 132 4.50E-08 3.63E-08 2.74E-08 1.14E-CE 8.96E-07 1.85E-04 3.44E-06 10 DATA 130 7.80E-07 2. 24 E-06 to DATA 8.11 E-07 I
6.14E-06 3.30E-06 1.83E-03 1.05E-05 I 131 4 . 4 3E-06 1.89E-05 8.65E-07 to DATA 1.59E-07 132 1.99E-07 5.47E-07 1.97E-07 1.29E-06 I 7.78E-07 3.65E-04 4.49E-06 10 DNIA 133 1.52E-06 2.56E-06 to DATA 2.55E-09 I 2.90E-07 1.05E-07 4.94E-06 4.58E-07 I 134 1.11E-07 7.76E-05 1.86E-06 10 DNTA 8.69E-07 135 4.62E-07 1.18E-06 4.36E-07 1.22E-06 I 6.86E-05 10 DATA 4.69E-05 1.83E-05 CS 134 6.28E-05 1.41E-04 2.22E-06 1.36E-05 2.42E-05 1.71E-05 10 DATA 1.38E-05 CS 136 6.44E-06 to DATA 3.80E-05 1.51E-05 1.06E-06 CS 137 8.38E-05 1.06E-04 3.89E-05 10 DATA 8.28E-08 9.84E-09 3.38E-11 CS 138 5.82E-08 1.07E-07 5.58E-06 4.87E-12 10 DATA 1.11E-13 8.08E 07 8.06E-07 m 139 1.67E-10 1.18E-13 1 I A-8
- ADM 04-019 Rev. 5 Page 106 of 202 I
e q-
' O N ?, ' ' ,?TVF~TY5]QfQ'C"f *}ig.t- 3; ,
' 'Gf;"
[ .r;-*[q 7 vsm
TABLE A.2-2* (Cont'd) INHALATION DOSE FACTORS FOR TEENAGER (MREM PER PCI INHALED)
'IWYROID KIDNEY LUfC GI-LLI 1 IONE LIVER T BODY tFILIDE to DATA 2.85E-09 2.54E-04 2.86E-05 6.84E-06 8.38E-09 4.40E-07 BA 140 5.93E-13 to dan 1.23E-14 4.11E-07 9.33E-14 BA 141 1.78E-11 1.32E-14 2.39E-07 5.99E-20 l 4.63E-15 2.84E-13 10 DATA 3.92E-15 BA 142 4.62E-12 )
10 DATA 10 DATA 2.68E-05 6.09E-05 l 5.99E-08 2.95E-08 7.82E-09 1.50E-06 i IA 140 1.32E-11 to DATA 10 DATA 1.27E-06 1A 142 1.20E-10 5.31E-11 7.67E-05 1.58E-05 2.37E-06 2.71r44 to DATA 1.11E-06 i CE 141 3.55E-06 to DATA 1.08E-08 1.63E-05 3.19E-05 CE 143 3.32E-08 2.42E-08. 2.70E-09 1.0BE-04 1.67E-03 2.53E-04 3.28E-05 to dan 1.51E-04 CE 144 6.11E-04 3.86E-07 6.04E -05 2.67E-05 ! 1.67E-06 6.64E-07 8.28E-08 10 IWA IR _ 143 2.19E-07 2.94E-14 [ 2.20E-12 2.72E-13 10 DATA 1.26E-12 PR 144 5.37E-12 6.28E-07 4.65E-05 2.28E-05 9.83E-07 1.07E-06 6.41E-08 10 dam ND 147 4.29E-10 to Dra'A_ 10 DATA 5.92E-06 2.21E-05 W 187 1.50E-09 1.22E-09 10 DATA 1.25E-08 8.11E-06 1.65E-05 1 4.23E-08 3.99E-09 2.21E-09 NP 239 l, Y : t i I I A-9 i l ADM 04-019 Rev. 5 ' Page 107 of 202 l l l P: .?259 " I C.WW nVG1 cpgm .apg .7
w TABLE A.2-3* I!JHALATION DOSE FACTORS FOR CHILD (MREM PER PCI IllHALED) TEKDY 'I1n*ROID KIDtJEY TIto GI-ILI NUCLIDE DJNE LIVER 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 H 3 10 DATA 3.04E-07 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 C 14 9.70E-06 4.35E-06 4.35E-06 4.35E-06 la 24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 2.67E-05 PO DATA 10 DATA 10 DATA 1.14E-05 l P 32 7.04E-04 3.09E-05 2.93E-07 70 DM 4.17E-08 2.31E-08 6.57E-09 4.59E-06 CR 51 20 DATA 4.26E-04 6.19E-06 54 10 DM 1.16E-05 2.57E-06 10 DATA 2.71E-06 MN 8.43E-11 10 DATA 4.52E-10 3.55E-06 3.33E-05 NN 56 10 DM 4.48E-10 6.80E-06' 2.10E-06 10 DATA 10 DATA 3.00E-05 7.75E-07 FE 55 1.28E-05 3.43E-04 1.91E-05 9.04E-06 4.51E-06 10 DATA 10 DATA FE 59 5.59E-06 4.79E-07 8.55E-07 10 D M 10 DATA 2.99E-04 9.29E-06 CD 58 FO D M 1.91E-03 2.50E-05 00 60 10 Dm 3.55E-06 6.12E-06 10 D M 10 DM
- 1. 25E.-05 7.56E-06 to DATA to DATA 7.43E-05 1.71E-06 III 63 2.22E-04 7.99E-11 4.44E-11 10 DATA 10 DATA 2.21E-06 2.27E-05 NI 65 8.08E-10 9.92E-06 to DATA 5.39E-10 2.90E-10 10 DATA 1.63E-09 2.59E-06 CU 64 4.41E-06 3.06E-05 1.90E-05 to DATA 1.93E-05 2.69E-04 ZN 65 1.15E-05 2.41E-12 10 DATA 1.58E-11 3.84E-07 2.75E-06 ZN 69 1.81E-11 2.61E-11 10 DATA 1.28E-07 10 DATA 10 DATA 10 DATA LT E-24 BR 83 10 DATA LT E-24 10 DATA 1.48E-07 to DATA 10 DATA 10 DATA BR 84 10 DATA 0 BR 85 10 DATA 10 DATA 6.84E-09 10 DATA 10 DATA 10 DATA LT E-24 3.09E-05 70 DATA 10 DATA 10 DATA 2.16E-06 RB 86 10 DATA 5.36E-05 4.66E-09 1.52E-07 9.90E-08 to DATA to DATA 70 DATA RB 88 10 DATA 9.33E-08 7.83E-08 to DATA 10 DATA 10 DATA 5.11E-10 RB 09 10 DATA 4.52E-05 89 1.62E-04 10 DATA 4.66E-06 10 DATA 20 DATA 5.f M G4 i SR 9.28E-05 SR 90 2.73E-02 to DATA 1.74E-03 to DATA 10 DATA 3.?fr J3 1.24E-09 to DATA 10 DATA 1.44E-05 4.70E-05 SR 91 3.28E-08 10 DATA 6.55E-05 3.54E-09 10 DATA 1.42E-10 to DATA 10 DATA 6.49E-06 SR 92 7.07E-05 7.24E-05 Y 90 1.11E-06 10 DATA 2.99E-08 10 DATA 10 DATA 10 DATA 4.98E-12 to DATA 10 DATA 7.60E-07 4.64E-07 Y 91M 1.37E-10 4.97E-05 2.47E-04 to DATA 6.59E-06 10 DATA NO DATA 7.10E-04 Y 91 6.46E-06 6.46E-05 5.50E-09 to DATA 1.57E-10 10 DATA 10 DATA Y 92
*Taken f tun Regulatory Guide 1.109 (Rev.1)
A-10 i ADM 04-01'r Rev. 5 l' age 108 of 202 j I
. ~ ~^
j(l ~ ~
.bl ah $ { $ $ ? $ 5 N 5 U f y <;p % g, { ^, h .& ,[. f *: h l , ;[ .
f i TABLE A.2-3* (cont'd) l I INHALATION DOSE FACTORS FOR CHILD (MREM PER PCI INHALED) LIVER T BODY 'UIYROID KIDNEY LUtG GI-LLI l s ta.CLIDE DONE ! 1.38E-09 NO DATA to DATA 2.01E-05 1.05E-04 l , Y 93 5.04E-08 to IRTA 6.03E-04 1.65E-05 ' 1.13E-05 1.00E-05 to IRTA 1.61E-05 ZR 95 5.13E-05 1.05E-08 3.06E-05 9.49E-05 5.07E-08 7.34E-09 4.32E-09 to DATA ZR 97 10 D M 2.33E-06 1.66E-04 1.00E-05 - NB 95 6.35E-06 2.48E-06 1.77E-06 3.42E-05 1.15E-08 to IATA 1.06E-07 3.66E-05 MD 99 10 DATA 4.66E-08 2.57E-07 1.30E-06 9.41E-13 1.56E-11 to DATA 1.37E-11 T 99M 4.81E-13 to DATA 3.92E-13 1.58E-07 4.41E-09 K 101 2.19E-14 2. 30E 2.91E-13 2.90E- 07 NO DATA 1.90E-06 1.79E-04 1.21E-05l RU 103 7.55E-07 PO DATA 4.30E-06 2.69E
- 10 DATA 1.50E-10 to DATA 3.63E-10 RU 105 4.135-10 .
20 DATA 4.97E-05 3.87E-03 1.16E-04 RU 106 3.68E-05 10 DATA 4.57E-06 2.71E-05 2.47E-06 NO DATA 5.74E-06 1.48E-03 IG 110M 4.56E-06 3.08E-06 1.29E-04 9.13E-06 2.47E-07 5.20E-07 NO DATA TE 125M 1.82E-06 6.29E-07 1.64E-06 1.72E-05 4.00E-04 1.93E-05 TE 127M 6.72E-06 2.31E-06 8.16E-07 5.30E-10 1.91E-09 2.71E-06 1.52E-05 - TE 127 7.49E-10 2.57E-10 1.65E-10 4.91E-05 8.22E-07 1.71E-06 1.36E-05 4.76E-04 l TE 129M 5.19E-06 1.85E 06 ! 1.93E-11 6.49E-11 7.93E-07 6.89E-06 r TE 129 2.64E-11 9.45E-12 6.44E-12 8.32E-05 1.37E-08 2.64E-08 1.08E-07 5.56E-05 TE 13 # 3.63E-08 1.60E-08 3.60E l 1.78E-12 4.59E-12 1.59E-11 5.55E-07 TE 1H 5.87E-12 2.28E-12 / 8.58E-08 4.79E-07 1.02.%04 3.72E-05 i TE 132 1.30E-07 7.36E-08 7.12E-08 4.99E-04 6.61E-06 to DNG 1.38E-06 l 130 2.21E-06 4.43E-06 2.28E-06 I 4.39E-03 2.13E-05 10 DATA 7.68E-07 l I 131 1.30E-05 1.30E-05 7.37E-06 5.23E-05 1.69E-06 10 DATA 8.65E-07 f I 132 5.72E-07 1.10E-06 5.07E-07 2.08E-06 1.04E-03 9.13E-06 10 DATA 1.48E-06 ; 133 4.48E-06 5.49E-06 No DATA 2.58E-07 I 5.84E-07 2.69E-07 1.37E-05 8.92E-07 I 134 3.17E-P7 2.14E-04 3.625-06 10 DATA 1.20E-06 135 1.33E-06 2. 36E-46 1.12E-06 I to DATA 8.93E-05 3.27E-05 1.04E-06 - CS 134 1.76E-04 2.74E-04 6.07E-05 to DATA 2.58E-05 3.93E-06 1.13E-06 CS 136 1.76E-05 4.62E-05 3.14E-05 7.63E-05 2.81E-05 9.78E-07 { 2.45E-04 2.23E-04 3.47E-05 to DATA CS 137 to DATA 1.68E-07 1.84E-08 7.29E-08 ; CS 138 1.71E-07 2.27E-07 1.50E-07 1.56E-05 1.45E-11 ?O DATA 2.33E-13 1.56E-06 l BA 139 4.98E-10 2.66E-13 v i A-11 ADM 04-019 Rev. 5 Page 109 of 202 e - .-
< NE ' EM5? tim 4Q[Mhyff;f.Q, f[*:r' Q Q,}tj. ,
;j. ,
.. . . .-. .-. - . -.~_ . - - -
L TABLE A.2-3* (cont'd) INHALATION DOSE FACTORS FOR CHILD (MREM PER PCT TNHALED) i T BODY 'INYROID KIDNEY UJtG GI-LLI i NLCLIDE IUTE LIVER NO DATA 5.71E-09 4.71E-04 2.75E-05 2.00E-05 1.75E-08 1.17E-06 7.44E-08 in 140 1.72E-12 70 DATA 2.56E-14 7.89E-07 ; BA 141 5.29E 2.95E-14 4.44E-07 7.41E-10 9.73E-15 7.54E-13 to DATA 7.87E-15 In 142 1.35E-11 NO DATA to DATA 4.94E-05 6.10E-05 ; IA 140 1.74E-07 6.08E-08 2.04E-08 2.05E-05 3.49E-11 FO DATA NO DATA 2.35E-06 : LA 142 3.50E-10' 1.11E-10 1.47E-04 1.53E-05 5.28E-06 7.83E-07 10 DATA 2.31E-06 CE 141 1.06E-05 f NO DATA 2.26E-08 3.12E-05 3.44&-05 9.89E-08 5.37E-08
- 7.77E.-09 CE 143 70 DATA 3.17E-04 3.23E-03 1.05E-04 -
CE 144 1.83E-03 5.72E-04, 9.77E-05 2.63E-05 2.47E-07 to DATA R.11E-07 1.17E-04 PR 143 4.99E-06 1.50E-06 i NO DATA 2.64E-12 4.23E-07 5.32E-08 PR 144 1.61E-11 4.99E-12 8.10E-13 2.22E-05 1.84E-07 10 DATA 1.30E-06 8.87E-05 10 147 2.92E-06 2.36E-06 1.11E-05 2.46E-05 2.61E-09 1.17E-09 to DATA to DATA W 187 4.41E-09 10 DATA 2.63E-08 1.57E-05 1.73E-05 NP 239 1.26E-07 9.04E-09 6.35E-09 I J I I f A-12 ADM 04-019 Rev. 5 Page 110 ut 202 e b1?W^f U*A.%WFWrSKMiMfi%'[ Q(;Q.~fffgfz-l,'gll;) ,- } zj; {; i :. ~ ,
TABLE A.2-4* INHALATION DOSE. FACTORS FOR INFANT (MREM PER PCI INHALED) BJNE LIVG,,_, T BODY 'I11YROID KIDNEY UJPG GI-T.LI IOCLIDE 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 4.62E-07 H 3 to dam 1.89E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 C 14 7.54E-06 7.54E-06 7. 54 E-06 7.54E-06 7.54E-06 7.54E-06 NA 24 7.54E-06 8.03E-05 5.53E-05 10 DATA 10 DAR 10 DATA 1.15E-05 P 32 1.45E-03 9.17E-06 2.55E-07 CR 51 PO DATA 10 DATA 6.39E-08 4.11E-08 9.45E-09 1.81E-05 3.56E-06 to DATA 3.56E-06 7.145-04 5.04E-06 MN 54 to DATA 1.10FA9 1.58E-10 10 DATA 7.86E-10 8.95E-06 5.12E-05 MN 56 10 dan 6.21E-05 7.82E-07 8.39E 2.38E-06 to DAR PC DATA FE 55 1.41E-05 1.77E-05 9.69E-06 1.68E-05 6.77E-06 to DATA 10 D M 7.25E-04 3 59 8.71E-07 1.30E-06 10 DATA 10 DATA 5.55E-04 7.95E-06 CD 58 10 DATA 8.41E-06 10 DATA 10 DATA 3.22E-03 2.28E-05 CD 60 to DATA 5.73E-06 1.46E-05 8.29E-06 10 DATA 10 DATA 1.49E-04 1.73E-06 NI 63 2.42E-04 2.03E-10 8.79E-11 10 DATA 10 DATA 5.80E-06 3.58E-05 NI 65 1.71E-09 1.07E-05 to DATA 1.34E-09 5.53E-10 10 DATA 2.84E-09 6.64E-06 CU 64 3.67E-05 1.38E-05 4.47E-05 2.22E-05 to dan 2.32E-05 4.62E-04 ZN 65 6.91E-11 5.12E-12 10 DATA 2.87E-11 1.05E-06 9.44E-06 ZN 69 3.85E-11 10 D m 2.72E-07 10 DATA 10 DATA FO DATA LT E-24 BR 83 to DATA LT E-24 10 DATA 10 DATA 2.86E-07 to DATA 10 DATA to DATA BR 84 i 10 DATA 1.46E-08 10 DATA to DATA 10 DATA LT E-24 DR 85 10 DATA 1.36E-04 6.30E.05 to DATA 10 DATA to DATA 2.17E-06 I RB 86 10 DATA 2.05E-07 to DATA 10 DATA 10 DATA 2.42E-0~ ( RB 88 tO DATA 3.98E-07 l 2.29E-07 1.47E-07 10 DATA 10 DATA 10 DATA 4.87E-08 RB 89 10 DATA 2.84E-04 10 DATA 8.15E-06 10 DATA 10 DATA 1.45E-03 4.575-05 SR 89 10 DATA 1.85E-03 to DATA to DATA 8.03E-03 9.36E-05 SR 90 2.92E-02 6.83E-08 10 DATA 2.47E-09 to DATA 10 DATA 3.76E-05 5.24E-05 SR 91 10 DATA 2.79E-10 10 DATA 10 DATA 1.70E-05 1.00E-04 SR 92 7.50E-09 2.35E-06 to DATA 6.30E-08 10 EATA to DATA 1.92E-04 7.43E-05 Y 90 2,91E-10 to DATA 9.90E-12 to Dm 10 DATA 1.99E-06 1.68E-06 Y 91M 4.20E-04 to DATA 1.12E-05 10 DATA 10 DATA 1.75E-03 5.02E-05 Y 91 1.17E-08 to DATA 3.29E-10 PO DATA 10 DATA 1.75E-05 9.04E-05 Y 92
*Taken frun Regulatory Guide 1.109 (Rev.1)
A-13 ADM 04-019
'le v . S Page 111 of 202 e ~~****
X?? M T.W'J?. W M T W FYlifi G ? ] ?l$ Q Q X Y O_
*a 41 %?ff '~ -
* ~ " ~ ,'
TABLE A.2-4* (cont'd) INHALATION DOSE FACTORS FOR INFANT i I (MREM PER PCI INHALED) l l T BJDY TITYHOID KIDNEY IDIO GI-LLI l ECLIDE BONE LIVER 20 DATA 2.91E-09 10 IATA 10 DATA 5.46E-05 1.19E-04 ; Y 93 1.07E-07 1.25E-03 1.55E-05 ZR 95 8.24E-05 1.99E-05 1.45E-05 10 DATA 2.22E-05 : 8.36E-09 to DAB 1.85E-08 7.88E-05 1.00E-04 l ZR 97 1.07E-07 1.83E-08
}
4.59E-06 2.70E-06 10 IATA 3.37E-06 3.42E-04 9.05E-06 NB 95 1.12E-05 9.63E-05 3.48E-05 20 99 to IRTA 1.18E-07 2.31E-08 FO DAB 1.89E-07 2.06E-12 2.66E-11 to dan 2.22E-11 5.79E-07 1.45E-06 j
'It 99M 9.98E-13 3 5.80E-13 to DAR 6.99E-13 4.17E-07 6.03E-07 ! 'IC 101 4.65E-14 5.88E-14 1.15E-05 1.44E-06 NO DAR 4.85E-07 20 DAR 3.03E-06 3.94E-04 RU 103 6.42E-10 1.12E-05 3.46E-05 RU 105 8.74E-10 to dan 2.93E-10 10 dan to DAR 7.77E-06 to dan 7.61E-05 8.26E-03 1.17E-04 RU 106 6.20E-05 2.36E-05 7.13E-06 5.16E-06 3.57E-06 10 dan 7.80E-06 2.62E-03 JG 110M 3.19E-04 9.22E-06 TE 125M 3.40E-06 1.42E-06 4.70E-07 1.16E-06 to DATA !
4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 TE 127M 1.19E-05 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-05 TE 127 1.59E-09 4.93E-05 4.35E-06 1.59E -06 3.91E-06 2.27E-05 1.20E-03 TE 129M 1.01E-05 2.48E-11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 TE 129 5.63E-11 1.42E-04 8.51E-05 TE 131M 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 5.87E-12 3.57E-12 1.13E-11 2.85E-II 1.47E-06 5.87E-06 TE 131 1. 24 E-11 I 1.99E-07 7.39E-07 2.4 3E-04 .3.15E-05 TE 132 2.66E-07 1.69E-07 1.26E-07 9.91E-06 3.98E-06 1.14E-03 1.09E-05 to DATA 1.42E-06 . I 130 4.54E-06 7.56E-07 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 to DATA l I 131 i 1.21E-06 2.53E-06 8.99E-07 1.21E-04 2.82E-06 to DATA 1.36E-06 ! I 132 1.37E-05 4.00E-06 2.54E-03 1.60E-05 10 DATA 1.54E-06 I 133 9.46E-06 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 to DATA 9.21E-07 I 134 , 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 10 DATA 1.31E-06 l I 135 2.83E-04 5.02E-04 5.32E-05 to DATA 1.36E-04 5.69E-05 9.53E-07 l CS 134 1.02E-06 CS 136 3.45E-05 9.61E-05 3.78E-05 to DATA 4.03E-05 8.40E-06 l 4.37E-04 3.25E-05 to DATA 1.23E-04 5.09E-05 9.53E-07 r CS 137 3.92E-04 5.58E-07 2.84E-07 to DATA 2.93E-07 4.67E-08 6.26E-07 l CS 138 3.61E-07 BA 139 1.06E-09 7.03E-13 3.07E-11 to DATA 4.23E-13 4.25E-96 3.64 E-05 i A-14 I l ADM 04-019 Rev. 5 Page 112 of 202 e ~~ -
. \ ', M* , ' QQ f}WQj ..Q,
. lQ;,%_ ,. . ( .
TABLE A.2-40 (cont'd) INHALATION DOSE FACTORS FOR INFANT (MREM PER PCI INHALED)
'11NROID KIDNEY LULU GI-LLI l BONE LIVER T BJOY NUCLIDE N3 DATA 9.59E-09 1.14E-03 2.74E-05 4.00E-05 4.00E-08 2.07E-06 BA 140 3.55E-12 NO DATA 4.64E-14 2.12E-06 3.39E-06 BA 141 1.12E-10 7.70E-14 1.36E-14 1.11E-06 4.95E-07 2.36E-14 1.40E-12 10 DATA BA 142 2.84E-11 10 DATA N3 DATA 1.20E-04 6.06E-05 3.61E-07 1.43E-07 3.68E-08 4.25E-05 LA 140 6.46E-11 10 DATA NO DATA 5.87E-06 IA 142 7.36E-10 2.69E-10 3.69E-04 1.54E-05 1.19E-05 1.42E-06 NO DATA 3.75E-06 CE 141 1.98E-05 to DAIA 4.03E-08 8.30E-05 3.55E-05 2.09E-07 1.38E-07 1.58E-08 1.06E-04 CE 143 1.26E-04 to DATA 3.84E-04 7.03E-03 CE 144 2.28E-03 8.65E-04 3.09E-04 2.66E-05 i 3.74E-06 4.99E-07 to DATA 1.41E-06 PR 143 1.00E-05 NO DATA 4.00E-12 1.15E-06 3.06E-06 '
3.42E-11 1.32E-11 1.72E-12 2.23E-05 8 PR 144 3.57E-07 10 DATA 2.2SE-06 2.30E-04 ND 147 5.67E-06 5.81E-06 to DATA 2.03E-05 2.54E-05 6.44E-09 2.23E-09 NO DATA W 187 9.26E-09 10 DAIA 4.73E-08 4.25E-05 1.78E-05 2.65E-07 2.37E-08 1.34E-08 rF 239 f A-15 ADM 04-019 Rev. 5 Page 113 of 202 e ;GJg13.q T W M *'El f % tt E?l?$ M 4y M M ........#. .,,
l TABLE A.2-5* , I I EXTERNAL DOSE FACTORS-FOR STANDING ON CONTAMINATED GROUND (mrem /hr per pCi/m*) i l TOTAL BODY ggIg ELEMENT J 0.0 0.0 H-3 ; 0.0 0.0 C-14 Na-24 2.50E-08 2.90E-08 f 0.0 0.0 ' P-32 I 2.20E-10 2.60E-10 Cr-51 Mn-54 5.80E-09 6.80E-09 ) Mn-56 1.10E-08 1.30E-08
- 0.0 0.0 Fe-55 l O.00E-09 9.40E-09 Fe-59 ;
7.00E-09 8.20E-09 Co-58 1,70E-08 2.00E-08 l Co-60 ; 0.0 0.0 Ni-63 3.70E-09 4.30E-09 Ni-65 1.50E-09 1.70E-09 l Cu-64 4.00E-09 4.60E-09 l Zn-65 l 0.0 0.0 2n-69 l 6.40E-11 9.30E-11 Ar-83 f 1.20E-08 1.40E-08 ' Br-84 Br-85 0.0 0.0 l 6.30E-10 7.20E-10 4 Rb-86 3.5CE-09 4.00E-09 j' Rb-88 1.50E-08 1.80E-08 , i Rb-89 I 5.60E-13 6.50E-13
# Sr-89 8.30E-09 Sr-91 7.10E-09 1.003-08 }
Sr-92 9.00E-09 Y-90 2.20E-12 2.60E-12 , l 3.80E-09 4.40E ' Y-91M 2.40E-11 2.70E-11 Y-91 l 1.60E-09 1.90E-09 Y-92 S.70E-10 7.80E-10 Y-93 Zr-95 5.00E-09 5.80E-09 5.50E-09 6.40E-09 ; Zr-97 5.10E-09 6.00E-09. Nb-35 . 1.90E-09 2.20E-09 Mo-99 f 9.60E-10 1.10E-09 Tc-99M j 2.70E-09 3.0vE-09 Tc-101 Ru-103 3.60E-09 4.20E-09 Ru-105 4.50E-09 5.10E-09 i 1.50E-09 1.90E-09 , Ru-106 1.80E-08 2.10E-08 Ag-110M i 3.50E-11 4.80E-11 Te-125M i 1.10E-12 1.30E-12 Te-127M 'l 1.00E-11 1.10E-11 Te-127 l 7.70E-10 9.00E-10 Te-129M
*Taken from Regulatory Guide 1.109 (Rev. 1)
A-16 ADM 04-019 Rev. 5 i Page 114 of 202 e ~.. -- ,- . Y>s: . A it % % % ly 9 3 g q 3 RJM X Gyy gr}Q*ggg .g
(- TABLE A.2-5 * - (cont' d) EXTERNAL DOSE FACT">RS FOR STANDING ON CONTAMINATED GROUND fmrem/hr per pCi/m*) ELEMENT TOTAL BODY M 7.10E-10 8.40E-10 Te-129 8.40E-09 9.90E-09 Te-131M 2.20E-09 2.60E-06 Te-131 1.70E-09 2.00E-09 Te-132 1.40E-08 1.70E-08 I-130 I-131 2.80E-09. 3.40E-09 1.7DE-08 2.00E-08 I-132 3.70E-09 4.50E-09 I-133 1.60E-08 1.90E-08 I-134 I-135
+
1.20E-08 1.40E-08 Cs-134 1.20E-06 1.40E-08 1.50E-08 1.70E-OS Cs-136 Cs-137 4.20E-09 4.90E-09 2.10E-08 2.40E-08 Cs-138 Ba-139 2.40E-09 2.70E-09 2.10E-09 2.40E-09' Ba-140 4.30E-09 4.90E-09 Ba-141 Ba-142 7.90E-09 9.00E-09 1.50E-08 1.70E-08 La-140 La-142 1.50E-08 1.80E-08 5.50E-10 6.20E-10 Ce-141 Ce-143 2.20E-09 2.50E-09 3.20E-10 3.70E-10 Ce-144 0.0 0.0 .d Pr-143 Pr-144 2.00E-10 2.30E-10 1.00E-09 1.20E-09 Nd-147 W-187 3.10E-09 3.60E-09 9.50E-10 1.10E-09 Np-239 4 i I l i A-17 ADM 04-019 f Rev. 5 ) Page 115 of 202 l i 1 TITT M ~24 T(?. W R G W U t;jg a fi3".','4p,%;pj,. ~ .'. 2, fg'tj+.
,, 7p- ,
~ - - ---- __---___ __ __ _ _ _ _ _ _ _ _ _ _ _
TABLE A.3-1* INGESTION DOSE FACTORS FOR ADULTS (MREM PER PCI INGESTED) LIVER T DODY 'IHYROID KIDNEY LUtG GI-LLJ tR.CLIDE 80tJE 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 tl 3 10 DATA 1.05E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 C 14 2.84E-06 1.70E-06 1.7QE-06 1.70E-06 1.70F-06 1.70E-06 1.70E-06 1.70E-06 IIA 24 7.46E-06 to DATA 10 DATA 10 DATA 2.17E-05 P 32 1.93E-04 1.20E-OS 6.69E-07 10 DAR 2.66E-09 1.59E-09 5.86E-10 3.53E-09 01 51 10 DATA 10 DATA 1.40E-05
- 4. 57E-06 8.72E-07 to DAR 1.36E-06 MN 54 10 DATA 2.04E-08 10 DAR 1.46E-07 10 DATA 3.67E-06 MN 56 10 DATA 1.15E-07 1.09E-06 4.43E-07 10 DATA 10 DATA 1.06E-06 FE- 55 2.75E-06 1.90E-06 2.85E-06 3.40E-05 1.02E-05 3.91E-06 to DATA 10 DATR FE 59 4.34E-06 1.67E-06 to DATA 10 DATA 10 DATA 1.51E-05 CD 58 10 DATA 7.45E-07 4.02E-05 2.14E-06 4.72E-06 10 DATA 10 DATA 10 DATA CO 60 10 DATA 10 DAR 1.88E-06 9.01E-06 4.36E-06 10 DATA 10 DATA III 63 1.30E-04 10 DATA 10 DATA 10 DATA 1.74E-06 FII 65 5.28E-07 6.86E-08 3.13E-08 7.10E-06 3.91E-08 10 DATA 2.10E-07 to DATA CU 64 ?O DATA 8.33E-08 to DATA 9.70E-06 65 4.84E-06 1.54E-05 6.96E-06 to DATA _1.03E-05 ZN 1.37E-09 10 DATA 1.28E-08 to DATA 2.96E-09 ZN 69 1.03E-08 1.97E-08 5.79E-08 10 DATA 4.02E-08 10 DATA to DATA 10 DAR DR 83 10 DATA to DATA 4.09E-13 10 DATA 10 DATA 5.21E-08 10 DATA to DATA Q BR 84 2.14 E-09 PO DATA 10 DATA 10 DATA LT E-24 BR 85 20 DATA 10 DATA 4.16E-06 2.11E-05 9.B3E-06 10 DATA to DATA to DATA RB 86 10 DATA 10 DATA B 36E-19 6.05E-08 3.21E-08 10 DATA 10 DATA RB 88 10 D?CA 2.82E-08 10 DATA 10 DATA 10 DATA 2.33E-21 RB 89 to DATA 4.01E-08 4.94E-05 to DATA 8.84E-06 10 DATA 10 DATA 10 DATA SR 89 3.08E-04 10 DATA 2 19E-04 to DATA 1.86E-03 10 DATA tO DATA SR 90 7.58E-03 2.29E-07 PO DAR 10 DATA 10 DATA 2.70E-05 SR 91 5.67E-06 to DATA 4.26E-05 10 DATA 9.30E-08 10 DATA 10 DATA 10 DAR SR 92 2.15E-06 10 DATA 1.02E-04 to DATA 2.58E-10 10 DATA 10 DATA Y 90 9.62E-09 3.52E-12 10 DATA 10 DATA 10 DATA 2.67E-10 Y 91M 9.09E-11 10 DATA 7.76E-05 10 DATA 3.77E-09 10 DAR 10 DATA 10 DATA Y 91 1.41E-07 10 DATA 1.48E-05 8.45E-10 to DATA 2.47E-11 10 DATA to DATA Y 92
*'Ibken frun Regulatory Guide 1.109 (Rev.1)
A-18 ADM 04-019 Rev. 5 Page 116 of 202 O _ $ _ _hT_-?k YE'Ni SMWY _ 'Y . ?.' f :7
TABLE A.3-1* (contSli INGESTION DOSE FACTORS FOR ADULTS (MREM PER PCI INGESTED) l KIDNEY LUtG GI-ILI f LIVER T EODY TiYROID ! NUCLIDE BONE l to DATA to DATA 10 DATA 8.50E-05 93 2.68E-09 70 DATA 7.40E-11 to DATA 3.09E-05 Y 6.60E-09 10 DATA 1.53E-08 ZR 95 3.04E-08 9.75E-09 5.12E-10 10 DATA 1.05E-04 i 3.39E-10 1.55E-10 to DATA ZR 97 1.68E-09 3.42E-09 to DATA 2.10E-05 3.46E-09 1.86E-09 to DATA 9.99E-06 NB 95 6.22E-09 10 DATA 9.76E-06 10 DATA 10 DATA 4.31E-06 8.20E-07 3.42E-10 4.13E-Ol
}O 99 8.89E-09 10 DATA 1.06E-08
'IC 99M 2.47E-10 6.98E-10 6.59E-09 1.87E-10 1.10E-21 l 3.66E-10 3.59E-09 to DATA 2.16E-05 7C 101 2.54E-10 10 DATA 7.06E-07 10 DATA l 1.85E-07 to DATA 7.97E-08 to DATA 9.42E-06 RU 103 6.08E-09 to DATA 1.99E-07 RU 105 1.54E-08 to DATA f 5.31E-06 10 DATA 1.78E-04 to DATA 3.48E-07 10 DATA RU 106 2.75E-06 2.91E-07 to DATA 6.04E-05 1.48E-07 8.79E-08 10 DATA 1.07E-05 AG 110M 1.60E-07 8.06E-07 1.09E-05 10 DATA 2.68E-06 9.71E-07 3.59E-07 TE 12SM 2.75E-05 10 DATA 2.27E-05 2.42E-06 8.25E-07 1.73E-06 8.68E-06 TE 127M 6.77E-06 8.15E-.08 4.48E-07 10 DATA 1.10E-07 3.95E-08 2.38E-08 10 DATA 5.79E-05 TE 127 1.82E-06 3.95E-06 4.80E-05 TE 129M 1.15E-05 4.29E 06 1.32E-07 NO DATA 2.37E-08 1.18E-08 7.65E-09 2.41E-08 TE 129 3.14E-08 1.34E-06 8.57E-06 to DATA 8.40E-05 8.46E-07 7.USE-07 2.79E-09 TE 131M 1.73E-06 1.62E-08 8.63E-08 10 DATA 1.97E-08 8.23E-09 6.22E-09 gpf TE 131 1.57E-05 to DATA 7.71E-05 1.63E-06 1.53E-06 1.80E-06 1.92E-06 TE 132 2.52E-06 1.89E-04 3.48E-06 to DA2A 7.56E-07 2.23E-06 8.80E-07 to DATA 1.57E-06 I 130 3.41E-06 1.95E-03 1.02E-05 I 131 4.16E-06 5.95E-06 8.65E-07 to DATA 1.02E-07 5.43E-07 1.90E-07 1.90E-05 2.22E-06 I 132 2.03E-07 3.63E-04 4.31E-06 10 DATA 1.42E-06 2.47E-06 '7.53E-07 10 DATA 2.51E-10 I 133 1.03E-07 4.99E-06 4.58E-07 I 134 1.06E-07 2.88E-07 1.86E-06 10 DATA 1.31E-06 1.16E-06 4.28E-07 7.65E-05 2.59E-06 135 4.43E-07 10 DhTA 4.79E-05 1.59E-05 I
6.22E-05 1.48E-04 1.21E-04 1.96E-06 2.92E-06 CS 134 1.85E-05 to DATA 1.43E-05 CS 136 6.51E-06 2.57E-05 3.70E-05 1.23E-05 2.11E-06 1.09E-04 7.14E-05 10 DATA 4.65E-13 CS 137 7.97E-05 10 DATA 8.01E-08 7.91E-09 5.52E-08 1.09E-07 5.40E-08 3.92E-11 1.72E-07 CS 138 2.84E-09 10 DATA 6.46E-11 BA 139 9.70E-08 6.91E-11 A-19 ADM 04-019 f Rev. 5 l Page 117 of 202 be m . r imamrw w;w r,mggg g M g g -; g g g g g ygg g -
i TABLE A.3-2* (cont'd) INGESTION DOSE FACTORS FOR ADULTS (MREM PER PCI INGESTED) e KIDNEY LUtG GI-LLI T DODY '1HYROID DONE LIVER ' M DE 8.67E-09 1.46E-08 4.18E-05 2.55E-08 1.33E-06 to DATA 2.02E-11 2.22E-17 BA 140 2.03E-05 N3 DATA 3.31E-11 3.56E-11 1.59E-09 1.85E-11 1.24E-11 3.00E-26 BA 141 4.71E-08 1.34E-09 to IRTA , 2.13E-08 2.19E-11 BA 142 to IATA 9.2SE-05 3.33E-10 to DATA to dam 4.25E-07 2.50E-09 1.26E-09 10 DATA 10 DATA IA 140 5.82E-11 1.45E-11 NO IRTA to DATA 2.42E-05 IA 142 1.28E-10 NO DATA 2.94E-09 9.36E-09 6.33E-09 " 7.18E-10 CE 141 20 DATA 4.56E-05 i 1.35E-10 to DATA 5.37E-10 1.65E-04 1.65E-09 1.22E-Od 1.21E-07 20 DATA CE 143 2.04E-07 2.62E-08 PO DATA 10 DATA 4.03E-05 CE 144 4.88E-07 to DATA 2.13E-09 3.69E-09 4.56E-10 ' PR 143 9.20E-09 4.33E-18 7.05E-12 10 DATA 1.25E-11 1.53E-12 to dam 10 DATA 3.49E-05 PR 144 3.01E-11 4.35E-10 10 DATA 4.25E-09 7.27E-09 to dan to DATA 2.82E-05 10 147 6.29E-09 3.01E-08 to DATA h 1.03E-07 8.61E-08 W 187 2.40E-05 3.65E-10 NODAn 6.45E-11 to DATA 7.95E-05 1.19E-09 1.17E-10 10 DATA 2.18E-06 NP 239 5.29E-08 1.11E-06 6.79E-09 1.3RE-06 1.97E-05 Sb 124** 2.00E-06 4.26E-07 1.82E-09 NO DATA 1.79E-06 2.00E-08 Sb 125** 9.40E-05 NO DATA 7.05E-07 4.15E-07 7.04E-09 4.44E-06 126** 1.15E-06 2.34E-08 10 DATA 10 DATA Sb 2.91E-07 10 DATA 57** to DATA 1.75E-07 Co
**Taken fmn Regulatory Guide 1.109 (Rev. 0) i i
A-20 l ADM 04-019 Rev. 5 Page 118 of 202 t O .i .
- Mf7/@O T@P T ,tQQt]fMf ]QQg]gg*p{j j{ < y :{ s ,
l,
~
l TABLE A-3.2 INHALATION DOSE FACTORS FOR TEENAGERS (MREM PER PCI INHALED) , i T DODY 'IWIPOID FJDNEY LUtG 91-LLI FOCLIDE BOffE LIVER 1.06E-07 1.06E-07 1.06E-07 1.06E-07 3 10 DATA 1.06E-07 1.06E-07 8.12E-07 H 8.12E-07 8.12E-07 8.12E-07 8.12E-07 C 14 4.06E-06 8.12E-07 2.30E-06 2.30E-06 2.30E-06 2.30E-06 7.30E-06 2.30E-06 FA 24 2.30E-06 10 DATA 10 DATA 20 DATA 2.32E-05 32 2.76E-04 1.71E-05 1.07E-05 5,14E-09 6.05E-07 P NO dan 3.60E-09 2.00E-09 7.89E-10 I CR 51 70 DATA 10 DA% 1.76E-06 20 dan 1.21E-05
-54 to dea 5.90E-06 1.17E-06 NN
}O DATA 2.00E-07 to DATA 1.04E-05 56 to DATA 1.58E-07 2.81E-08 1.16E-06 HN 6.25E-07 to DATA to dam 1.70E-06 FE 55 3.78E-06 2.68E-06 4.32E-06 3.24E-05 5.29E-06 to DATA 10 DATA FE 59 5.87E-06 1. 37E.-05 to DATA 10 DATA 20 dan 1.34E-05 58 to DATA 9.72E-07 2.24E-06 3.66E-05 CD 6.33E-06 10 DATA 10 DATA to DATA CD 60 10 DATA 2.81E-06 to DATA 1.99E-06 6.00E-06 to DATA 10 DATA NI 63 1.77E-04 1.25E-05 to DATA 10 dan 10 DATA 5.19E-06 65 7.49E-07 9.57E-08 4.36E-08 III to DATA 2.91E-07 to DATA .8.92E-06 ,
CU 64 10 DATA 1.15E-07 5.41E-08 8.47E-06 9.33E-06 10 DATA 1.28E-05 10 DATA ZN 65 5.76E-06 2.00E-05 10 DATA 1.83E-08 to DATA 5.16E-08 ZN 69 1.47E-08 2.80E-08 1.96E-09 LT E-24 5.74E-08 to dan 20 DATA 10 DATA BR 83 to DATA 10 DAB 10 DATA LT E-24 l to DATA 7.22E-08 70 DATA 10 DATA
% DR 04 to DATA i 10 DATA 10 DATA 10 DATA LT E-24 BR 85 to DATA 10 DATA 3.05E-09 4.41E-06 l 1.40E-05 10 DATA 10 DATA 10 DATA RB 86 to dan 2.98E-05 10 DATA 7.30E-15 8.52E-08 4.54E-08 10 DATA 10 DATA l RB 88 to DATA to DATA to DATA to dan 8.4 3E-17 10 DATA 5.50E-08 3.89E-08 RB 89 10 DATA 10 DATA 10 DATA 5.24E-05 l SR 89 4.40E-04 10 DATA 1.26E-05 2.33E-04 2.05E-03 to DATA 10 DATA 10 DATA SR 90 8.30E-03 10 DATA to DATA 10 DATA 10 DATA 3.66E-05 SR 91 8.07E-06 to dan 3.21E-07 7.77E-05 1.30E-07 10 DATA 10 DATA 10 DATA SR 92 3.05E-06 to DATA 10 DATA 1.13E-04 to DATA 3.69E-10 to DATA 10 DATA Y 90 1.37E-08 )
6.09E-09 j 4.93E-12 to DATA 10 dam to DATA Y 91M 1.29E-10 to DATA 10 DATA 8.24E-05 j to DATA 5.39E-09 10 DATA 10 DATA 91 2.01E-07 3.32E-05 Y 10 DATA 10 DA% 1.21E-09 to DATA 3.50E-11 to DATA Y 92
*Taken fron Regulatory Guide 1.109 (Rev.1)
A-21 ADM 04-019 Rev. 5 , I Page 119 of 202 i l 01WlJ MM7?"'Jg- g g:gyppggggygg.jggyg;gj.g:rgy y ggj , t 1
/
TABLE A-3.2 (cont'd) INHALATION DOSE FACTORS FOR TEENAGERS (MREM PER PCI ItGIALED)
'IlfYROID KIDtIEY LUto GI-LLI.
IWE LIVER T DODY tJUCLIDE 10 DATA 10 DATA 10 DATA 1.17E-04 93 3.83E-09 to IATA 1.05E-10 3.00E-05 Y 10 DATA 1.91E-08 10 DATA 95 4.12E-08 1.30E-08 8.94E-09 10 DATA 1.27E-04 ZR 4.69E-10 2.16E-10 to DATA 7.11E-10 3R 97 2.37E-09 10 DATA 4.42E-09 10 DATA 1.95E-05 95 8.22E-09 4.56E-09 2.51E-09 1.08E-05 NB 10 DATA 1.38E-05 10 DATA 10 DATA 6.03E-06 1.15E-06 6.08E-07 10 99 10 DATA 1.38E-08 5.14 E-10 3.32E-10 9.26E 10 1.20E-08
'IC 99M 10 DMA 9.26E-09 3.12E-10 8.75E-17
'IC 101 3.60E-10 5.12E-10 5.03E-09 10 DMA 2.13E-05 1.09E-07 10 DATA 8.99E-07 RU 103 2.55E-07 10 DATA ' 10 DATA 1.76E-05 8.46E-09 to DATA 2.75E-07 RU 105 2.18E-08 10 DATA 7.56E-06 to DATA 1.88E-04 to DATA 4.94E-07 10 DATA RU 106 3.92E-06 10 DMA 3.70E-07 to DMA 5.45E-05 2.05E-07 1.94E-07 1.18Fe07 l'.13E-05 IG 110M 5.12E-07 1.07E-06 10 DATA 10 IRTA TE 125M 3.83"-06 1.38E-06 2.30E-06 3.92E-05 10 DATA 2.41E-05 9.67E-06 3.43E-06 1.15E-06 1.22E-05 TE 127M 3.40E-08 1.09E-07 6.40E-07 10 DATA TE 127 1.58E-07 5.60E-08 6.82E-05 to DATA 6.12E-05 6.05E-06 2.58E-06 5.26E-06 TE 129M 1.63E-05 1.88E-07 10 DATA 2.45E-07 1.67E-08 1.09E-08 3.20E-08 TE 129 4.48E-08 1.22E-05 10 DATA 9.39E-05 1.17E-06 9.76E-07 1.76E-06 2.29R-09 TE 131M 2.44E-06 2.15E-08 1.22E-07 10 DATA 2.79E-08 1.15E-08 8.72E-09 TE 131 2.12E-05 to DATA 7.00E-05 D
2.21E-06 2.08E-06 2.33E-06 TE 132 3.49E-06 2.43E-04 4.59E-06 10 DATA 2.29E-06 1.03E-06 2.98E-06 1.19E-06 1.62E-06 I 130 2.39E-03 1.41E-05 to DATA 5.85E-06 8.19E-06 4. 40E-06 I 131 2.46E-05 1.15E-06 to DATA 3.18E-07 132 2.79E-07 7.30E-07 2.62E-07 to DMA 2.58E-06 I 3.41E-06 1.04E-06 4.76E-04 5.98E-06 I 133 2.01E-06 6.10E-07 10 DATA 5.10E-09 3.87E-07 1.39E-07 6.45E-06 I 134 1.46E-07 1.01E-04 2.48E-06 10 DATA 1.74E-06 6.10E-07 1.57E-06 5.82E-07 2.45E-06 I 135 10 DATA 6.26E-05 2.39E-05 CS 134 8.37E-05 1.97E-04 9.14E-05 2.90E-06 2.72E-06 2.27E-05 to DATA 1.84E-05 CS 136 8.59E-06 3.38E-05 10 DATA 5.07E-05 1.97E-05 2.12E-06 1.12E-04 1.49E-04 5.19E-05 6.76E-11 CS 137 7.45E-08 10 DATA 1.10E-07 1.28E-08 CS 138 7.76E-08 1.49E-07 6.74E-11 1.24E-06 4.05E-09 to DATA 9.22E-11 BA 139 1.39E-07 9.788-11 l I A-22 i l l i ADM 04-0]9 Rev 5 Page 120 cf 202 I l l e ;- -
- 9 ' .M Vth.$%iki,i..,'/fQMS $.g{ ggQ "a
- . . . - - -. ..~
i TABLE A-3.2 (cont *d) , INHALATION DOSE FACTORS FOR TEENAGERS (MREM PER PCI IN!!ALED)
'DiYROID KIDNEY IlRO GT-LLI LIVER T BODY tRXIIDE DONE to DATA 1.18E-08 2.34E-08 4.38E-05 2.84E-05 3.48E-08 1.83E-06 BA 140 2.24E-09 10 DATA 4.65E-11 3.43E-11 1.43E-13 BA 141 6.71E-08 5.01E-11 1.99E-11 9.18E-20 2.99E-11 1.84E-09 10 DATA 2.53E-11 BA 142 2.99E-08 20 DATA 10 DATA 10 DATA 9.82E-05 LA 140 3.48E-09 1.71E-09 4.55E-10 2.42E-06 10 DATA 10 DATA NO DATA 1.79E-10 7.95E-11 1.98E-11 2.54E-05 IA 142 1.02E-09 10 DATA 4.18E-09 10 DATA CE 141 1.33E-08 8.88E-09 '
to DATA 7.67E-10 to DATA 5.14E-05 CE 143 2.35E-09 1.71E-06 1.91E-10 1.75E-04 3.74E-08 to DATA 1.72E-07 20 DATA CE 144 6.96E-07 2.88E-07 10 DATA 4.31E-05 5.23E-09 6.52E-10 NO DATA 3.04E-09 PR 143 1.31E-08
}O DATA 1.01E-11 10 DATA 4.74E-14 4.30E-11 1.76E-11 2.18E-12 3.68E-05 PR 144 6.11E-10 to DATA 5.99E-09 10 DA'IA ND 147 9.38E-09 1.02E-08 NO DATA 3.22E-05 4.17E-08 10 DATA NO DATA W 187 1.46E-07 1.19E-07 to DN!:A 5.21E-10 10 DATA 2.67E-05 NP 239 1.76E-09 1.66E-10 9.22E-11 7.80E-05 1.51E-06 8.78E-09 10 DATA 3.38E-06 Sb 124** 3.87E-06 7.13E-08 2.18E-06 1.93E-05 5.80E-07 2.37E-09 10 DATA Sb 125** 2.48E-06 2.71E-08 8.99E-09 10 DATA ~ 1.14E-06 9.41E-05 Sb 126** 1.59E-06 3.25E-08 5.71E-07 4.44E-06 10 DATA to DATA 10 DATA Co 57++ 10 DATA 7.38E-07 3.99E-07 i
l.
**Taken frun Regulatory Guide 1.109 (Rev. 0)
A-23 ADM 04-019 Rev. 5 Page 121 of 202 e "{,
- * *
- I i 'T 4XM7UR*3QMgM.QQQ-Q., @[j"jg', *,yg ._ ; r ,
l l TABLE A.3-3 l INGESTION DOSE FACTORS FOR CHILD (MREM PER PCI INGESTED) ( IUFO GI-ILI
'nUROID KIDNEY LIVER T BODY t#XLIDE BONE 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.42E-06 H 3 to IRTA 2.03E-07 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 5.80E-06 5.80E-06 C 34 1.21E-05 5.80E-06 5.80E-06 5.80E-06 5.80E-06 in 24 5.80E-06 10 dam to IATA 2.28E-05 3.18E-05 to IATA 4.72E-07 P 32 8.25E-04 3.86E-05 4.94E-09 1.35E-09 9.02E-09 to dan 8.90E-09 10 DATA 8.98E-06 CR 51 to DATA 2.85E-06 to DATA 3.00E-06 54 10 DATA 1.07E-05 MN 4.84E-05 4.04E-07 10 DATA 7.54E-08 10 DATA 1.13E-06 MN 56 10 dan 3.34E-07 20 DATA 10 DATA 3.45E-06 6.10E-06 1.89E-06 7.74E-06 2.78E-05 FE 55 1.15E-05 1.33E-05 10 DAR 10 DATA 59 1.65E-05 2.67E-05 i FE 1.05E-05 10 dam ?O DATA 10 DATA 1.80E-06 5.51E-06 10 DATA 2.93E-05 CO 58 10 DATA 10 DATA 10 DATA 5.29E-06 1.56E-05 10 DATA 1.94E-06 CO 60 to DAIA 1.83E-05 to DATA to DATA NI 63 5.38E-04 2.88E-05_
10 DATA 10 DATA 2.56E-05 2.09E-07 1.22E-07 to DAR 1.15E-05 65 2.22E-06 5.92E-07 10 DATA NI 1.48E-07 to DATA 6. 41E-06 CU 64 to DATA 2.45E-07 to DATA 2.30E-05 to IATA 3.65E-05 2.27E-05 ZN 65 1.37E-05 3.84E-08 ?O DATA 3.99E-06 5.85E-09 to DATA LT E-24 69 4.38E-08 6.33E-08 10 DATA 10 DATA ZN 1.71E-07 to DATA LT E-24 83 10 DATA 10 DATA to DATA 10 DATA BR 1.98E-07 10 DATA 84 to DATA 10 DATA BR g 10 DATA 10 DATA LT E-24 9 12E-09 to DATA 4.31E-06 85 10 DATA 10 DAB 10 DATA 10 DATA BR 4.12E-05 to DATA 9.32E-09 86 to DATA 6.70E-05 10 DATA 10 DATA RB 1.32E-07 FO DATA 88 10 DATA 1.90E-07 RB
?O DATA 10 IRTA 1.02E-09 1.17E-07 1.04E-07 to DATA 5.11E-05 RB 89 10 DATA to DATA 10 DATA to DATA 10 DATA 3.77E-05 to DATA 2.29E-04 SR 89 1.32E-03 4.31E-03 to DATA to DATA 90 1.70E-02 10 DAB SR 10 DATA 10 DATA 5.30ES05 to inTA 9.06E-07 to DATA 1.71E-04 91 2.40E-05 10 DATA 10 DATA SR 10 DATA 3.62E-07 10 DATA 1.17E-04 SR 92 9.03E-06 10 DATA 10 DATA to dan 1.10E-09 10 DATA Y 90 4.11E-08 to DATA 10 DATA 7.48E-07 10 DATA 1.39E-11 10 DATA 8.02E-05 Y 91M 3.82E-10 to DATA 10 DATA 10 DATA 6.02E-07 to dan 1.61E-08 10 DATA 1.04E-04 Y 91 1.03E-10 10 DATA 10 DATA Y 92 3.60E-09 10 DATA
*Taken irtm Regulatory Guide 1.109 (Rev.1)
A-24 ADM 04-019 Rev. 5 Page 122 of 202 e i g,.,.__. ,
*~' ' 'id.T9 : QS ,,, ~. lj ' r g,,,.g., g{g. ;.
^ - - - - - - - - - - - - _ _ _ _ _ _ _ _ . _ _ _ _ _ _ _ __
l l l TABLE A.3-3 (cont'd) 1 INGESTION DOSE FACTORS FOR CHILD (MREM PER PCI INGESTED) i
'DIYROID KIDICI LUtO GI-ILJ BJNE LIVER T BCM FUCLIDE to DATA 10 DATA 10 DATA 1.70E-04l 93 1.14E-08 tO DATA 3.13E-10 10 DATA 2.66E-05 Y
2.55E-08 2.27E-08 to DATA 3.65E-08 ZR 95 1.16E-07 to DATA 1.45E-09 10 DATA 1.53E-04 97 6.99E-09 1.0]E-09 5.96E-10 J:R 8.23E-09 70 DATA 1.62E-05 8.76E-09 6.26E-09 to DATA NB 95 2.25E-08 2.84E-05 to DATA 1.10E-05 1.33E-05 3.29E-06 to DATA HD 99 to DATA to DATA 2.63E-08 9.19E-10 1.03E-06 9.23E-10 1.81E-09 3.00E-08 K 99M to DATA 1.91&O8 5.92E-10 3.56E-09 T 101 1.07E-09 1.12E-09 1.42E-08 to DATA 1.89E-05 2.81E-07 10 DATA 1.84E-06 RU 103 7.31E-07 to DATA 10 DATA 4.21E-05 i 2.34E-08 10 DATA 5.67E-07 RU 105 6.45E-08 to DATA 10 DATA 1.58E-05 to DATA 1.82E-04 1.17E-05 to DATA 1.46E-06 4.33E-05 RU 106 2.91E-07 to DATA 6.78E-07 to DATA
/G 110M 5.39E-07 3.64E-07 to DATA 10 DATA 1.10E-05 3.09E-06 1.52E-06 3.20E-06 TE 125M 1.14E-05 6.91E-06 8.24E-05 70 DATA 2.34E-05 2.89E-05 7.78E-06 3.43E-06 1.84E-05 TE 127M 1.01E-07 3.26E-07 1.34E-06 10 DATA TE 127 4.71E-07 1. 27E--07 to DATA 5.94E-05 7.56E-06 1.57E-05 1.43E-04 TE 129M 4.87E-05 1.36E-05 9.56E-08 3.92E-07 10 DATA 8.34E-06 1.34E-07 3.74E-08 3.18E-08 1.01E-04 TE 129 2.65E-06 5.12E-06 2.41E-05 to DATA TE 131M 7.20E-06 2.49E-06 2.51E-07 10 DATA 4.36E-07 2.53E-08 2.47E-08 6.35E-08 TE 131 8.30E-08 g 4.15E-05 to DATA 4.50E-05 4.47E-06 5.40E-06 6.51E-06 TE 132 1.01E-05 6.50E-04 8.82E-06 to DATA 2.76E-06 130 2.92E-06 5.90E-06 3.04E-06 1.54E-06 I 5.72E-03 2.84E-05 10 DATA I 131 1.72E-05 1.73E-05 9.83E-06 6.82E-05 2.25E-06 NO DATA 1.73E-06 132 8.00E-07 1.47E-06 6.76E-07 2.95E-06 1
2.77E-06 1.36E-03 1.22E-05 10 DATA 133 5.92E-06 7.32E-06 to DATA 5.16E-07 I 7.78E-07 3.58E-07 1.79E-05 1.19E-06 1 134 4.19E-07 ; 2.79E-04 4.83E-06 10 DATA 2.40E-06 1.75E-06 3.15E-06 1.49E-06 2.07E-06 I 135 10 DATA 1.19E-04 4.27E-05 , CS 134 2.34E-04 3.84E-04 8.10E-05 2.27E-06 4.18E-05 10 DATA 3.44E-05 5.13E-06 l CS 136 2.35W 05 6.46E-05 . to DATA 1.02E-04 3.67E-05 1.96E-06 3.27E-04 3.13E-04 4.62E-05 1.46E-07 CS 137 2.01E-07 10 DATA 2.23E-07 2.40E-08 CS 138 2.28E-07 3.17E-07 1.93E-10 1.30E-10 2.39E-05 4.14E-07 2.21E-10 1.20E-08 to DATA , BA 139 I A-25 ADM 04-019 Rev. 5 Page 123 of 202 I i e p /:' c' !M t ' 01tfMMEJJpy}yg
TABLE A.3-3 (cont'd) INGESTION DOSE FACTORS FOR CHILD (MREM PER PCI INGESTED)
'IWYROID KIDNEY IIRO GI-LLI DCNE LIVER T tJJtfi NLCLIDE 2.37E-08 4.34E-08 4.21E-05 7.28E-08 4.85E-06 to DA2A 1.14E-07 BA 140 0.31E-05 10 DA2A 9.69E-11 6.58E-10 2.00E-07 1.12E-10 6.51E-09 3.70E-11 1.14E-09 I BA 141 4.88E-09 to DATA 5.09E-11 1% 142 8.74E-08 6.29E-11
?O DATA 10 DATA 9.84E-05 3.53E-09 1.19E-09 10 DATA 3.31E-05 IA 140 1.01E-08 10 DATA 10 DATA NO DATA 5.24E-10 1.67E.10 5.23E-11 to DATA 2.47E-05 1A 142 1.98E-08 2.94E-09 10 D u 8.68E-09 CE 141 3.97E-08 to DATA 1.59E-09 10 DATA 5.55E-05 6.99E-09 3.79E-06' 5.49E-10 10 DATA 1.70E-04 CE 143 1.31E-07 10 DATA 3.61E-07 CE 144 2.08E-06 6.52E-07 6.39E-09 to DATA 4.24E-05 1.18E-08 1.95E-09 to DATA PR 143 3.93E-08 2.11E-11 10 DAHA 8.59E-08 3.99E-11 6.49E-12 10 DATA PR 144 1.29E-10 10 DA2A 1.24E-08 10 DATA 3.58E-05 2.79E-08 2.26E-08 1.75E-09 3.57E-05 10 147 1.14E-07 10 DA2A 10 DATA 10 DATA W 187 4.29E-07 2.54E-07 1.09E-09 10 DATA 2.79E-05 3.77E-10 2.65E-10 10 DATA NP 239 5.25E-09 2.45E-08 10 DATA 6.16E-06 6.94E-05 1.11E-05 1.44E-07 3.89E-06 1.71E-05 Sb 124** 6.63E-09 to DATA 3.99E-06 7.16E-06 5.52E-08 1.50E-06
_Sb 125** 10 DATA 2.10E-06 8.87E-05 6.73E-08 1.58E-06 2.58E-08 Sb 126** 4.40E-06 10 DATA 10 DATA 10 DATA 4.04E-06 to DATA 4.93E-07 9.98E-07 Co 57** 7'
**Taken frun Regulatory Guide 1.109 (Rev. 0) l A-26 ADM 04-019 Rev. 5 ,
Page 124 of 202 l
)
1 O . _ . . . ...
#" Nu:9 M QifmEQjk y;;.3gg g-.g ,
J
TABLE A.3-4* 1 INGESTION DOSE FACTORS FOR INFANT (MREM PER PCI INGESTED) T BJDY 'DIYROID KIENEY LtRC GI-ILI i l BONE LIVD1
.tRX'LIDE 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08F-07 i H 3 to DATA 5.06E-06 C 24 2.37E-05 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06l 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 i NA 24 1.01E-05 1.01E-05 6.59E-05 to DATA 10 DATA 70 DATA 2.30E-05 P 32 1.70E-03 1.00E-04 4.11E-07 10 DATA 1.41E-08 9.20E-09 2.01E-09 1.79E-08 ,
CR 51 to DATA 4.41E-06 10 DATA 7.31E-06 to DATA 1.99E-05 4.51E-06 10 DATA MN 54 1.41E-07 to DATA 7.03E-07 to DATA 7.43E-05 MN 56 to DATA 8.18E-07 1.14E-06 8.98E-06 2.40E-06 NO DATA 10 DATA 4.39E-06 < FE 55 1.39E-05 10 DRTA 1.59E-05 2.57E-05 l 59 3.00E-05 5.38E-05 2.12E-05 10 DATA FE 8.98E-06 to DATA 10 DATA to DATA 8.97E-06 CO 58 NO DATA 3.60E-06 2.57E-05 2.55E-05 10 DATA 10 DATA NO DATA CD 60 to DATA 1.08E-05 1.95E-06 2.20E-05 10 DATA 10 DATA NO DATA NI 63 6.34E-04 3.92E-05 2.42E-07 to DATA 10 DATA 10 DATA 4.05E-05 NI 65 4.70E-06 5.32E-07 1.25E-05 6.09E-07 2.82E-07 to DATA 1.03E-06 10 DATA CU 64 to DATA to DATA 5.33E-05 6.31E-05 2.91E-05 to DATA 3.06E-05 ZN 65 1.84E-05 1.25E-08 10 DATA 6.98E-08 to DATA 1.37E-05 ZN 69 9.33E-08 1.68E-07 LT E-24 3.63E-07 10 DATA 10 DATA 10 DATA BR 83 10 DATA 10 dan LT E-24 ' 3.82E-07 to DATA to DATA 10 DATA ' BR 84 to DATA to DATA ] NO DATA LT E-24 to DATA 1.94E-08 10 DATA 10 DATA BR 85 to DATA to DATA 4.35E-06 to DATA 1.70E-04 8.40E-05 N3 DATA to DATA RB 86 10 DATA 4.85E-07 4.98E-07 2.73E-07 PO DATA 10 DATA BB 88 to DATA 1.97E-07 10 DATA 10 DATA 10 DATA 9.74E-08 RB 89 10 DATA 2.86E-07 5.16E-05 7.20E-05 10 DATA to DATA 10 DATA SR 89 2.51E-03 NO DATA 10 DATA 2.31E-04 10 DAR 4.71E-03 to DATA 10 DATA SR 90 1.85E-02 l 10 DATA 1.81E-06 to DATA 10 DATA 10 DATA 5.92E-05 SR 91 5.00E-05 NO DATA 2.07E-04 1.92E-05 10 DATA 7.13E-07 10 DATA 10 DATA SR 92 10 DATA 10 DATA 1.20E-04 Y 90 8.69E-08 to DATA 2.33E-09 to DATA 2.76E-11 10 DATA 10 DATA 10 DATA 2.70E-06 Y 91M 8.10E-10 10 DATA 3.01E-08 to DATA 10 DATA 10 DATA 8.10E-05 Y 91 1.13E-06 10 DATA 2.15E-10 10 DATA 10 DATA 10 DATA 1.46E-04 Y 92 7.65E-09 NO DATA
*Taken frtrn Regulatory Guide 1.109 (Rev.10
)
A-27 ADM 04-019 Re I. 5 Page 125 of 202 e , .;. ,3 k& M F D $ 3 R N p M 7p p yp q Li g gg g s,,p g g g,<y,.gr y 4,
- a TABLE A.3-4* (cont' d)
INGESTION DOSE FACTORS FOR INFANT (MREM PER PCI INGESTED) l l LIVER T BODY 'DIYROID KIDNEY LUto GI-LLI IKCLIDE BONE 6.62E-10 10 DATA 10 [ATA 10 DATA 1.92E-04 ' f y 93 2.43E-08 10 DATA 3.56E-08 10 DATA 5.41E-08 10 [ATA 2.50E-05 i ZR 95 2.06E-07 5.02E-08 1.62E-04 2.54E-09 1.16E-09 10 DATA 2.56E-09 70 DATA l ZR 97 1.48E-08 1.00E-08 to DATA 1.24E-08 10 DATA 1.46E-05 NB 95 4.20E-08 1.73E-08 1.12E 05 3.40E-05 6.63E-06 20 DATA 5.08E-05 to DATA to 99 10 DATA 2.07E-09 1.15E-06 3.96E-09 5.10E-08 10 DATA 4.26E-08 SC 99M 1.92E-09 2.83E-08 10 DATA 3.40E-08 1.56E-09 4.86E-07 i 7C 101 2.27E-09 2.86E-09 ; 4.95E-07 20 DATA 3.08E-06 10 DATA 1.80E-05 RU 103 1.48E-06 PO DATA 10 DATA 5.41E-05 70 DATA 4.58E-08 to DATA 1.00E-06 RU 105 1.36E-07 10 DATA 3.01E-06 10 DATA 2.85E-05 to DATA 1.83E-04 : RU 106 2.41E-05 10 DATA 3.775-05 7.27E-07 4.81E-07 10 DATA 1.04E-06 AG 110M 9 96E-07 10 DATA 1.11E-05 2.33E-05 7.79E-06 3.15E-06 7.84E-06 10 DATA TE 125M 1.94E-05 7.08E-06 1.69E-05 1.44E-04 NO DATA 2.36E-05 TE 127H 5.85E-05 10 DATA 2.10E-05 ~ 3.35E-07 2.15E-07 8.14E-07 2.44E-06 TE 127 1.00E-06 3.84E-05 2.50E-04 to DATA 5.97E-05 TE 129M 1.00E-04 3.43E-05 1.54E-05 6.63E-08 2.38E-07 7.07E-07 20 DATA 2.27E-05 TE 129 2.84E-07 9.79E-08 1.03E-04 6.12E-06 5.05E-06 1.24E-05 4.21E-05 to DATA TE 13U1 1.52E-05 4.50E-07 10 DATA 7.11E-06 TE 131 1.76E-07 6.50E-08 4.94E-08 1.57E-07 1.03E-05 9.61E-06 1.52E-05 6.44E-05 to DATA 3.81E-05 TE 132 2.08E-05 1.48E-03 1.45E-05 10 DATA 2.83E-06 I 130 6.00E-06 1.32E-05 5.30E-06 1.86E-05 1.39E-02 4.94E-05 ?O DATA 1.51E-05 I 131 3.59E-05 4.23E-05 ! 3.37E-06 1.20E-06 1.58E-04 3.76E-06 10 DATA 2.73E-06 I 132 1.66E-06 3.08E-06 5.33E-06 3.31E-03 2.14E-05 10 DATA I 133 1.25E 1.82E-05 to DATA 1.84E-06 I 134 8.69E-07 1.79R-06 6.33E-07 4.15E-05 1.99E-06 1 7.24E-06 2.64E-06 6.49E-04 8.07E-06 10 DATA 2.62E-06 1 135 3.64E-06 7.42E-05 1.91E-06 7.03E-04 7.10E-05 10 DATA 1.81E-04 CS 134 3.77E-04 5.38E-05 1.10E-05 2.05E-06 CS 136 4.59E-05 1.35E-04 5.04E-05 to DATA 6.11E-04 4.33E-05 20 DATA 1.64E-04 6.64E-05 1.91E-06 CS 137 5.22E-04 3.905-07 6.09E-08 1.25E-06 CS 138 4.81E-07 7.82E-07 3.79E-07 10 DATA , 5.84E-10 2.55E-08 to DATA 3.51E-10 3. 54 E-10 5.58E-05 i BA 139 8.81E-07 l l A-28 ) ADM 04-019 Rev. 5 Page 126 of 202 e y ., MM*CM#>h*!.,i%%9tW3:pL%m.fiMWW@KfMyy*3gggy . .
~ , - .
TABLE A.3-4* (cont'd) INGESTION DOSE FACTORS FOR INFAfff (MREM PER PCI INGESTED) LIVER T BODY 'Ih7ROID Kil1NEY LUtG GI-LLI IELIDE BONE i 1.71E-04 1.71E-07 8.81E-06 10 [RTA 4.06E-08 1.05E-07 4.20E-05 l BA 140 1.75E-10 1.77E-10 5.19E-06 4 BA 141 4.25E-07 2.91E-10 1.34E-08 10 [RTA , 1.84E-07 1.53E-10 9.06E-09 10 [RTA 8.81E-11 9.26E-11 7.59E-07 2 i BA 142 8.32E-09 2.14E-09 10 IRTA 10 DATA NO DATA 9.77E-05 IA 140 2.11E-08 1.10E-09 4.04E-10 9.67E-11 10 DATA 10 DATA 10 DATA 6.86E-05 , IA 142 2.48E-05 CE 141 7.87E-08 4.80E-08 5.65E-09 to DATA 1.48E-08 NO DATA , i 1.48E-08 9.82E-06 1.12E-09 10 DPaA 2.86E-09 to DATA 5.73E-05 CE 143 4.93E-07 to DMA 1.71E-04 CE 144 2.98E-06 1.22E-06 1.67E-07 10 DMA 8.13E-08 3.04E-08 4.03E-09 NO [RTA 1.13E-08 10 DATA 4.29E-05 PR 143 2.74E-10 1.06E-10 1.30E-11 10 DATA 3.84E-11 NO DATA 4.93E-06 PR 144 3.60E-05 ND 147 5.53E-08 5.68E-08 3.48E-09 NODMA 2.19E-08 10 DATA 9.03E-07 6.28E-07 2.17E-07 NO DMA 10 IRTA NO DATA 3.69E-05 W 187 i 1.11E-08 9.93E-10 5.61E-10 10 DATA 1.98E-09 10 DATA 2.87E-05 NP 239 1.34E-05 6.60E-05 sb 124** 2.14E-05 3.15E-07 6.63E-06 5.68E-08 10 DPaA 1.23E-05 1.19E-07 2.53E-06 1.54E-08 10 DATA 7.72E-06 1.64E-05 Sb 125** , 1.58E-07 2.91E-06 6.19E-08 10 DATA 5.07E-06 8.35E-06 ! Sb 126** 8.06E-06 10 DATA 3.92E-06 l Co 57** 10 [RTA 1.15E-06 1.87E-06 NO DATA 10 DATA M * *Taken frcen Regulatory Guide 1.109 (Per. 0)
)
A-29 ADM 04-019 Rev. 5 Page 127 of 202 l gg.-
l TABLE A.3-5* ETant.r rt.rMENT TRANEFER DATA F_ fCow) Eg Element Ea Meat (d/kal vaa/ moil Milk (d/11 4.8E 00 1.0E-02 + 1.20E-02 H
- c. 5.5E 00 1.2E-02 + 3.1E-02 5.2E-02 4.0E-02 3.0E-02 Na 1.1E 00 2.EE-02 -4.6E-02 P
2.5E-04 2.2E-03 2.4E-03 Cr 2.9E-02 2.5E-04 8.0E-04 Mn 6.6E-04 1.2E-03 + 4.0E-02 Fe 9.4E-03 1.0E-03 1.3E-02 Co 1.9E-02 6.7E-03 5.3E-02 Ni 1.2E-01 1.4E-02 + e.os-03 Cu En 4.0E-01 3.9E-02 3.0E-02 1.3E-01 3.0E-02 3.1E-02 Rb 1.7E-02 8.0E-04 + 6.0E-04 Sr 2.6E-03 1.0E-05 4.6E-03 Y 1.7E-04 5.0E-06 3.4E-02 Zr 9.4E-03 2.5E-03 2.8E-01 Nb 1.2E-01 7.5E-03 8.0E-03 Mo 2.5E-01 2.5E-02 4.0E-01 Tc 5.0E-02 1.0E-06 4.0E-01 Ru 1.3E 01 1.0E-02 1.5E-03 Rh 1.5E-01 5.0E-02 1.7E-02 Ag 1.3E 00 1.0E-03 7.7E-02 Te 2.0E-02 6.0E-03 + 2.9E-03 g I 1.0E-02 1.2E-02 + 4.OE-03 Cs 5.0E-03 4.0E-04 3.2E-03 Ba La 2.5E-03 5.0E-06 2.0E-04 2.5E-03 1.0E-04 1.2E-03 Ce 2.5E-03 5.0E-06 4.7E-03 Pr 2.4E-03 5.0E-06 3.3E-03 Nd W 1.8E-02 5.0E-04 1.3E-03 2.5E-03 5.0E-06 2.0E-04 Np
+ r, (coat) values for milk (d/1)
Element Milk (d /11 H 1.7E-01 C 1.OE-01 P 2.5E-01 Fe 1.3E-04 Cu 1.3E-02 Sr 1.4E-02 1 6.0E-02 Cs 3 0E-01
*Taken from Regulatory Guide 1.109 (Rev. 1)
A-30 ADM 04-019 Rev. 5 Page 128 of 202 (. .O pg.<ggy;;
~l. . ,, py.m, e.;yg773,;,y-' gg;y,y.gg pg ---- .
.g
TABLE A.4-1 SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pCI/ML ADULT KINEY IIRG GI-LLI LIVER T BJDY 'mYROID j_1UCLIDE EO JE 8.96E 00 8.96E 00 8.96E 00 8.96E 00 8.96E 00 8.96E 00 6.30E 03 H 3 0.005-01 6.30E 03 6.308 03 6.30E 03 6.30E 03 6.30E 03 5.48E 02 5.48E 02 C 14 3.15E 04 5.48E 02 5.48E 02 5.48E 02 5.48E 02 5.48E 02 fa 24 0.00E-01 5.20E 06 j 1.79E 06 0.00E-01 0.00E-01 i 32 4.62E 07 2.87E 06 3.29E-01 1.98E 00 3.76E 02 , P 0.00E-01 1.49E 00 8.94E-01 1.46E Q4 I CR 51 0.00E-01 0.00E-01 1.42E 03 0.00&O1 0.00E-01 4.76E 03 9.08E 02 MN 54 1.52E 02 0.00E-01 3.82E 03 1.20E 02 2.12E 01 0.00E-01 3.52E 02 MN 56 0.00E-01 0.00E-01 0.00&01 3.42E 02 8.87E 02 6.13E 02 1.43E 02 9.19E 02 1.10E 04 f FE 55 1.26E 03 0.00E-01 0.00E-01 FE 59 1.40E 03 3.29E 03 0.005-01 0.00E-01 3.06E 03 3.39E 02 0.00E-01 00 58 0.00E-01 1.51E 02 0.00E-01 0.00E-01 8.16E 03 l 4.34E 02 9.58E 02 0.00E-01 6.07E 02 (D 60 0.00E-01 0.00E-01 0.00E-01 0.00E-01 l 2.94E 03 1.41E 03 NI 63 4.19E 04 0.00E-01 0.00E-01 5.61E 02 l 2.21E 01 1.01E 01 0.00E-01 1.44E 03 NI 65 1.70E 02 0.00E 01 4.26E-01 0.00E-01 0.00E-01 1.69E 01 7.93E 00 0.00E-01 4.73E 04 CU 64 3.39E 04 0.00 m01 5.02E 04 m 65 2.36E 04 7.50E 04 6.24E-01 0.00E-01 1.44E 01 9.60E 01 6.67E 00 0.00E-01 6.30E 01 EN 69 5.02E 01 0.00E-01 0.00h01 0.00E-01 0.00E-01 0.00E-01 4.38E 01 0.00E-01 4.45E-04 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00401 5.67E 01 I m 84 0.00E-01 0.00E-01 0.00E-01 1.09E-15l 0.00E-01 0.00E-01 2.33E 00 0.00E-01 2.03E 04 ER 85 0.00E-01 0.00E-01 0.00E-01 1.03E 05 4.79E 04 0.00E-01 4.07E-09 RB 86 1.56E 02 0.00&O1 0.00E-01 RB 88 0.00E-01 2.95E 02 0.00401 0.00E-01 1.13E-11 1.95E 02 1.37E 02 0.00E-01 7.66E 03 RB 89 0.00E-01 0.00LO1 0.00E-01 0.00E-01 89 4.70E 04 0.00L01 1.37E 03 0.00E-01 3.40E 04 SR 2.88E 05 0.00E-01 0.00E-01 SR 90 1.18E 06 0.00E-01 0.00E-01 0.00E-01 4.19E 03 0.00E-01 3.55E 01 0.00E-01 6.60E 03 SR 91 8.79E 02 0.00E-01 0.00E-01 0.00E-01 3.33E 02 0.00E-01 1.44E 01 0.00E-01 1.46E 04 SR 92 0.00E-01 0.00E-01 90 1.38E 00 0.00E-01 3.69E-02 Y 0.00E-01 0.00E-01 3.82E-02 0.00E-01 5.04E-04 0.00E-01 1.11E 04 Y 91M 1.30E-02 0.00E-01 0.00E-01 0.00E-01 2.02E 01 0.00E-01 5.39E-01 0.00E-01 2.12E 03 Y 91 0.00E-01 0.00E-01 1.21E-01 0.00E-01 3.53E-03 Y 92 A-31 9/93 ADM 04-019 f l Rav. S Page 129 of 202 l l
%,vnwwwww ggg.,.gg . .
l TABLE A.4-1 ( cont' d) ) 1 SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pCI/ML ADULT
'IHYROID KIDNEY UIC GI-ILI 90flE LIVER T DJDY NUCLIDE 0.00E-01 0.00E-01 1.22E 04 0.00E-01 1.06E-02 0.00E-01 2.82E 03 Y 93 3.83E-01 0.00E-01 1.39E 00 0.00E-01 2.77E 00 8.88E-01 6.01E-01 0.00E-01 9.57E 03 ZR 95 1.41E-02 0.00E-01 4.67E-02 ZR 97 1.53E-01 3.09E-02 0.00E-01 2.46E 02 0.00E-01 1.51E 06 95 4.47E 02 2.49E 02 1.34E 02 0.00E-01 1.07E 03 NB 8.79E 01 0.00E-01 1.05E 03 K) 99 0.00E-01 4.62E 02 1.26E 00 4.07E-02 4.92E 01 8.32E-02 1.06E 00 0.00E-01
'It 99M 2.94E-02 !
7.85E-01 2.23E-02 1.31E-13 ! 4.36E-02 4.28E-01 0.00E-01 2.31E 03
'IC 101 3.03E-02 0.00E-01 7.57E 01 0.00E-01 '
1.98E 01 0.00E-01 8.54E 00 0.00E-01 1.01E 03 RU 103 6.52E-01 0.00E-01 2.13E 01 RU 105 1.65E 00 0.00E-01 5.69E 02 0.00E-01 1.91E 04 0.00E-01 3.73E 01 0.00E-01 RU 106 2.95E 02 0.00E-01 2.58E 01 0.00E-01 5.36E 03 1.42E 01 1.31E 01 7.80E 00 0.00E-01 1.11E 04 ; AG 110M 3.74E 02 8.39E 02 1.13E 04 TE 125M 2.79E 03 1.01E 03 1.80E 03 2.86E 04 0.00E-01 2.36E 04 7.05E 03 2.52E 03 8.59E 02 0.00E-01 9.03E 03 TE 127M 2.48E 01 8.48E 01 4.66E 02 TE 127 1.14E 02 4.11E 01 5.00E 04 0.00E-01 6.03E 04 4.47E 03 1.89E 03 4.11E 03 TE 129M 1.20E 04 2.51E 01 1.37E 02 0.00E-01 2.47E 01 3.27E 01 1.23E 01 7.96E 00 8.74E 04 TE 129 7.34E 02 1.39E 03 8.92E 03 0.00E-01 TE 131M 1.80E 03 8.81E 02 8.98E 01 -0.00E-01 2.90E 00 8.57E 00 6.47E 00 1.69E 01 [ TE 131 2.05E 01 1.87E 03 1.63E 04 0.00E-01 8.02E 04 2.62E 03 1.70E 03 1.59E 03 2.29E 02 TE 132 1.05E 02 2.25E 04 4.15E 02 0.00E-01 1 130 9.01E 01 2.66E 02 1.22E 03 0.00E-01 1.87E 02 7.09E 02 4.06E 02 2.32E 05 I 131 4.96E 02 2.26E 03 1.03E 02 0.00E-01 1.22E 01 132 2.42E 01 6.47E 01 2.26E 01 0.00E-01 2.64E 02 I 8.97E 01 4.328 04 5.13E 02 133 1.69E 02 2.94E 02 0.00E-01 2.99E-02 1 1.23E 01 5.94E 02 5.46E 01 I 134 1.26E 01 3.43E 01 0.00E-01 1.56E 02 l 5.10E 01 9.11E 03 2.22E 02 ' 1 135 5.20E 01 1.38E 02 7.75E 04 1.26E 04 5.89E 05 0.00E-01 2.33E 05 ' CS 134 3.03E 05 7.21E 05 6.97E 04 9.55E 03 1.42E 04 1.25E 05 9.01E 04 0.00E-01 t CS 136 3.17E 04 0.00E-01 1.80E 05 5.99E 04 1.03E 04 CS 137 3.00E 05 5.31E 05 3.48E 05 2.27E-03 i 2.63E 02 0.00E-01 3.90E 02 3.85E 01 CS 138 2.69E 02 5.31E 02 5.99E-03 3.64E-03 1.60E 01 a 6.41E-03 2.64E-01 0.00E-01 1% 139 9.00E 00 A-32 i i ADM 04-019 Rev. 5 Page 130 of 202 ! i O
* ' ' **M M ' . M&855QZW$9 M'g' &&ggy,gQ}'f} ;,, &
TABLE A.4-1 (cont'd) SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pC1/ML ADUT,T KIDIEY LUTC GI-LLI T DCIE 'DIYROID l BOIE LIVER IRELIDE 1.35E 00 3.88E 03 : 0 00E-01 8.05E-01 2.37E 00 1.23E 02 3.07E-03 1.87E-03 2.06E-09 BA 140 1.88E 03 1.48E-01 0.00E-01 2.78E-18 4.37E 00 3.30D-03 1.72E-03 1.15E-03 DA 141 2.03E-03 1.24E-01 0.00E-01
,gA,_142 1.98E 00 1.32E 04 0.00E-01 0.00E-01 0.00E-01 1.80E-01 4.76E-02 0.00E-01 0.00E-01 6.08E-01 1A 140 3.58E-01 2.07E-03 0.00E-01 2.07E 03 1.83E-02 8.33E-03 0.00E-01 2.52E-01 0.00E-01 1A 142 5.42E-01 6.15E-02 CE 141 0.01E-01 3.90E 03 0.00E-01 4.60E-02 0.00E-01 1.41E-01 1.04E 02 1.16E-02 1.04E 01 0.00E-01 1.41E 04 4 CE *143 2.24E 00 0.00E-01 5.77E 03 4.18E 01 1.75E 01 3.05E-01 0.00E-01 CE 144 5.28E-01 6.52E-02 0.00E-01 PR 143 1.32E 00 1.01E-03 0.00E-01 6.19E-10 2.19E-04 0.00E-01 4.99E 03 4.31E-03 1.79E-03 0.00E-01 6.08E-01 0.00E-01 PR 144 1.04E 00 6.22E-02 0.00E-01 8.34E 04 ND 147 9.00E-01 0.00E-01 0.00E-01 2.55E 02 8.90E 01 W 187 3.04E 02 0.00E-01 2.57E 03 6.91E-03 0.00E- 01 3.91E-02 6.81E 03 1.28E-01 1.25E-02 0.00E-01 1.87E 02 te 239 4.53E 00 9.50E 01 5.81F -01 1.18E 02 1.69E 03 Sb 124 2.40E 02 1.56E -01 0.00E-01 1.71E 00 3.65E 01 Sb 125 1.53E 02 0.00E-01 6.04E 01 8.05E 03 3.55E 01 6.03E-01 9.01E 02 9.85E 01 2.00E 00 0.00E-01 0.00E-01 Sb 126 3.55E 01 5.90E 01 0.00E-C
$ Co 57 0.00E-01 l l l 1 l l l l A-33 ADM 04-019 Rev. 5 Pago 131 of 202 e '
~q !
* * -' ~ .".+f-95 N 3.2*$i N Y[4f'[,g";
! ;i"M, j
TABLE A.4-2 SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER UCI/ML TEEN
'1HYitOID KIDNEY IIRC GI-LLI BONE LIVER T BODY NtXIIDE i 6.34E 00 6.34E 00 6.34E 00 6.34E 00 i 0.00E-01 6.34E 00 6.34E 00 6.86E 03 [
H 3 6.86E 03 6.86E 03 6.86E 03 6.86E 03 C 14 3.43E 04 6.86E 03 5.53E 02 5.53E 02 5.53E 02 5.53E 02 5.53E 02 5.53E 02 NA 24 5.53E 02 0.00E-01 0.00E-01 0.00E-01 4.23E 06 32 5.04E 07 3.12E 06 1.95E 06 2.56E 02 P 1.52E 00 8.46E-01 3.34E-01 2.17E 00 CR 51 0.00E-01 0.00E-01 0.00E-01 9.53E 03 4.65E 03 9.22E 02 0.00E-01 1.39E 03 HN 54 0.00E-01 0.00E-01 1.58E 02 0.00E-01 8.19E 03 0.00E-01 1.24E 02 2.21E 01 2.79E 02 MN 56 1.50E 02 0.00E-01 0.00E-01 4.09E 02 FE 55 9.09E 02 6.45E 02 0.00E-01 1.04E 03 7.79E 03 3.30E 03 1.27E 03 0.00E-01 FE 59 1.41E 03 0.00E-01 0.00E-01 0.00E-01 2.00E 03 58 0.00E-01 1.45E 02 3.35E 02 5.47E 03 00 9.45E 02 0.00E-01 0.00E-01 0.00E-01 00 60 0.00E-01 4.20E 02 0.00E-01 4.798 02 1.44E 03 0.00E-01 0.00E-01 NI 63 4.26E 04 3.01E 03 0.00E-01 0.00E-01 0.00E-01 1.25E 03 65 1.80E 02 2.30E 01 1.05E 01 1.33E 03 NI 0.00E-01 4.35E 01 0.00E-01 0.00E-01 1.72E 01 8.08E 00 3.14E 04 CU 64 3.46E 04 0.00E-01 4.74E 04 0.00E-01 ZN 65 2.13E 04 7.41E 04 0.00E-01 6.78E 01 0.00E-01 1.91E 02 69 5.45E 01 1.04E 02 7.26E 00 8.24E-16 ZN 4.73E 01 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 8.24E-16 . 0.00E-01 5.95E 01 0.00E-01 0.00E-01 BR 84 0.00E-01 ( 8.24E-16 2.51E 00 0.00E-01 0.00E-01 0.00E-01 BR 05 0.00E-01 0.00E-01 0.00E-01 1.63E 04 1.10E 05 5.19E 04 0.00E-01 0.00E-01 RB 86 0.00E-01 0.00E-01 0.00E-01 2.71E-05 0.00E-01 3.16E 02 1.68E 02 0.00E-01 RB 88 0.00E-01 0.00E-01 '3.12E-07 f 0.00E-01 2.04E 02 1.44E 02 0.00E-01 ' RB 89 0.00E-01 0.00E-01 0.00E-01 5.91E 03 89 4.97E 04 0.00E-01 1.42E 03 2.63E 04 l SR 2.31E 05 0.00E-01 0.00E-01 0.00E-01 SR 90 9.37E 05 0.00E-01 0.00E-01 0.00E-01 0.00E-01 4.13E 03 91 9.11E 02 0.00E-01 3.62E 01 8.77E 03 SR 0.00E-01 1.47E 01 0.00E-01 0.00E-01 0.00E-01 SR 92 3.44E 02 0.00E-01 0.00E-01 1.17E 04 f 1.42E 00 0.00E-01 3.83E-02 0.00E-01 Y 90 0.00E-01 0.00E-01 0.00E-01 6.32E-01 91M 1.34E-02 0.00E-01 5.11E-04 8.55E 03 Y 5.59E-01 0.00E-01 0.00E-01 0.00E-01 l Y 91 2.09E 01 0.00E-01 0.00E-01 3.44E 03 0.00E-01 3.63E-03 0.00E-01 0.00E-01 Y 92 1.26E-01 A-34 ADM 04-019 Rev. 5 Page 132 of 202 l l
' NSWRWM6 -
pg 7 {g
TABLE A.4-2 (cont'd) SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pCI/NL TEEN TIGY 'IhTROID KIDNEY LUtG GI-ILI NLCLIDE BONE LIVER 0.00E-01 0.00E-01 0.00E-01 1.21E 04 93 3.97E-01 0.00E-01 1.09E-02 1.92E 03 Y 5.74E-01 0.00E-01 1.23E 00 0.00E-01 ZR 95 2.64E 00 8.34E-01 0.15E 03 3.01E-02 1.39E-02 0.00E-01 4.56E-02 0.09E-01
- , Zn 97 3.52E-01 0.00E-01 2.42E 02 0.00E-01 1.07E 06 95 4.50E 02 2.50E 02 1.37E 02 8.25E 02 NB 8.78E 01 0.00E-01 1.05E 03 0.00E-01 ND 99 0.00E-01 4.61E 02 4.39E-02 5.20E 01 7.92E-02 1.03E 00 0.00E-01 1.18E 00 TC 99M 2.84E-02 .
0.00E-01 7.92E-01 2.67E-02 7.48E-09,
'IC 101 3.08E-02 4.38E-02 4.30E-01 1.63E 03!
8.33E 00 0.00E-01 6.87E 01 0.00E-01 RU 103 1.95E 01 0.00E-01 0.00E-01 1.34E 03-0.00E-01 6.46E-01 0.00E-01 2.10E 01 RU 105 1.67E 00 0.00E-01 5.77E 02 0.00E-01 1.44E 04 RU 106 2.99E 02 0.00E-01 3.77E 01 7.36E 00 0.00E-01 2.31E 01 0.00E-01 3.40E 03! IG 110M 1.28E 01 1.21E 01 8.90E 03 : 4.03E 02 8.43E 02 0.00E-01 0.00E-01 TE 125M 3.02E 03 1.09E 03 1.81E 03 3.09E 04 0.00E-01 1.90E 04 TE 127M 7.62E 03 2.70E 03 9.06E 02 8.59E 01 5.04E 02 0.00E-01 9.61E 03 TE 127 1.24E 02 4.41E 01 2.68E 01 4.82E 04 2.03E 03 4.14E 03 5.37E 04 0.00E-01 TE 129M 1.28E 04 4.77E 03 2.52E 01 1.48E 02 0.00E-01 1.93E 02 TE 129 3.53E 01 1.32E 01 8.59E 00 7.40E 04 7.69E 02 1.39E 03 9.61E 03 0.00E-01 TE 131M 1.92E 03 9.22E 02 0.00E-01 1.80E 00 9.06E 00 6.87E 00 1.69E 01 9.61E 01 TE 131 2.20E 01 1.84E 03 1.67E 04 0.00E-01 5.51E 04 TE 132 2.75E 03 1.74E 03 1.64E 03 1.02E 02 2.08E 04 3.92E 02 0.00E-01 1.96E 02 130 8.81E 01 2.55E 02 0.00E-01 1.39E 02 I 7.00E 02 3.76E 02 2.04E 05 1.21E 03 I 131 5.00E 02 2.24E 01 2.10E 03 9.83E 01 0.00E-01 2.72E 01 132 2.39E 01 6.24E 01 2.21E 02 I 8.89E 0.1 4.07E 04 5.11E 02 0.00E-01 I 133 1.72E 02 2.92E 02 0.00E-01 4.36E-01 1.25E 01 3.31E 01 1.19E 01 5.51E 02 5.22E 01 I 134_ 4.98E 01 8.64E 03 2.12E 02 0.00E-01 1.49E 02 1 135 5.22E 01 1.342 02 9.08E 03 3.39E 05 0.00E-01 2.32E 05 8.86E 04 CS 134 3.10E 05 7.30E 05 1.07E 04 1.01E 04 1.25E 05 8.41E 04 0.00E-01 6.82E 04 CS 136 3.18E 04 1.92E 05 0.00E-01 1.88E 05 7.30E -04 7.86E 03 CS 137 4.15E 05 5.52E 05 2.51E-01 5.52E 02 2.76E 02 0.00E-01 4.08E 02 4.74E 01 CS 138 2.88E 02 6.03E-03 4.41E-03 8.11E 01 BA 139 9.10E 00 6.40E-03 2.65E-01 0.00E-01 A-35 ADM 04-01'r Rev, 5 Page 133 of 202
~
> h Y, W T T '4;GM%gyf{5fy;;gg[Q,fQQ:Q'Qf.fy[~Qf} -}<[ }~ ,
- . . - . _ - . - ~ . - - _ _ - - . ._ . . - - --- -- - - _-
TABLE A.4-2 (cont'd) SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pCI/ML TEEN KIONEY UEG GI-ILI LIVER T BODY 'nflROID _NLCLIDE BJNE 0.00E-01 7.72E-01 1.53E 00 2.87E 03 J BA 140 1.86E 03 2.28E 00 1.20E 02 2.24E-03 9.36E-06 1 1.47E-01 0.005-01 3.04E-03 BA 141 4.39E 00 3.28E-03 1.66E-03 1.30E-03 6.01E-12 l 1.96E-03 1.20E-01 0.00E-01 _IM 142 1.96E 00 0.00E-01 0.00E-01 0.00E-01 1.02E 04 IA 140 3.61E-01 1.77E-01 4.72E-02 0.00E-01 2.51E 02 2.05E-03 0.00E-01 0.00E-01 IA 142 1.86E-02 8.25E-03 2.51E-01 0.00E-01 1.52E 03 0.00E-01 CE 141 7.98E-01 5.32E-01 6.12E-02 ! l ' I 1.15E-02 0.006-01 4.60E-02 0.00E-01 3.08E03l 1.05E 04;i CE 143 1.41E-01 1.03E 02 1.03E 01 0.00E-01 j 1.73E 01 2.24E 00 0.00E-01 ' CE 144 4.17E 01 0.00E-01 3.15E-01 0.00E-01 4.47E 03 ! 1.36E 00 5.435-01 6.76E-02 PR 143 0.00E-01 2.05E-03 0.00E-01 4.92E-06 4.46E-03 1.83E-03 2.26E-04 3.82E 03 PR 144 6.34E-02 0.00E-01 6 21E-01 0.00E-01 i ND 147 9.73E-01 1.06E 00 0.00?-01 7.24E 04 2.67E 02 9.37E 01 0.00E-01 0.00"-01 W 187 3.28E 02 0.00E-01 3.98E-02 0.005-01 2.04E 03 1.7 ti>01 1.27E-02 7.04E-03 4.68E 03 NP 239 9.05E 01 5.26E-01 0.00E-01 2.03E 02 Sb 124 2.J2E 02 4.28E 00 1.31E 02_ 1.16E 03. 3.48E 01 1.42E-01 0.00E-01 Sb 125 1.49E 02 1.63E 00 5.39E-01 0.00E-01 6.84E 01 5.64E 03 l Sb 126 "i. m 01 1.95E 00 3.42E 01 0.00E-01 6.63E 02 i g 5.96E 01 0.00E-01 0.00E-01 Co 57 0 4.n-01 3.55E 01 i l l i l l j A-36 ! f I ADM 04-019 Rev. 5 Page 134 of 202 O m. .
~~. . M.csg.ymy;;gg g g g3 g;3 g.4 yg g
,;.,<g . --w a M:e, ,.s s.g, m
TABLE A.4-3 SITE RELATED DOSE COMMITMENT FACTOR AIT ! MREM /HR PER pcI/ML
' CHILD i
T BODY 'IWYROID KIDNEY IIRG GI-ILI [ BONE LIVER JRXLIDE 1.19E 01 1.19E 01 1.19E 01 1.19E 01 1.19E 01 H 3 0.00E-01 1.19E 01 8.90E 03 8.90E 03 8.90E 03 8.90E 03 8.90E 03 8.90E 03 i' C 14 4.45E 04 7.93E 02 7.93E 02 7.93E 02 24 7.93E 02 7.93E 02 7.93E 02 7.93E 02 NA ! 0.00E-01 0.00E-01 0.00E-01 1.79E 06 l I 6.49E 07 3.04E 06 2.50E 06 P 32 1.92E 00 1.06E 00 2.91E-01 1.94E 00 1.02E 02' l CR 51 0.00E-01 0.00E-01 0.00E-01 3.35E 03 i 0.00E-01 3.99E 03 1.06E 03 0.00E-01 1.12E 03 MN 54 ! 2.81E 01 0.00E-01 1.51E 02 0.00E-01 1.80E 04 , NN 56 0.00E-01 1.25E 02 4.72E 02 1.55E 02 8.34E 02 2.59E 02 0.00E-01 0.00E-01 i FE 55 1.57E 03 0.00E-01 1.06E 03 3.80E 03 ' 2.26E 03 3.65E 03 1.82E 03 0.00E-01 FE $9 i 5.37E 02 0.00E-01 0.00E-01 0.00E-01 1.02E 03-CO 58 0.00E-01 1.75E 02 2.86E 03 1.52E 03 0.00E-01 0.00E-01 0.00E-01 00 60 0.00E-01 5.16E 02 0.00E-01 2.65E 02 2.50E 03 0.00E-01 0.00E-01 N
.I 63 7.36E 04 3.94E 03 0.00E-01 0.00E-01 0.00E-01 3.50E 03 NI 65 3.04E 02 2.86E 01 1.67E 01 0.00E-01 5.77E 01 0.00E-01 1.12E 03 !
64 0.00E-01 2.39E 01 1.44E 01 1.05E 04 ! CU 3.70E 04 0.00E-01 3.75E 04 0.00E-01 ZN 65 2.23E 04 5.95E 04 0.00E-01 6.26E 01 0.00E-01 6.51E 03 , 69 7.15E 01 1.03E 02 9.54E 00 3.89E-16 i KN 6.64E 01 0.00E-01 0.00E-01 0.00E-01 f- BR 83 0.00E-01 0.00E-01 0.00E-01 3.89E-16 0.00E-01 7.69E 01 0.00E-01 0.00E-01 { DR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 3.89E-16 BR 85 0.00E-01 0.00E-01 3.54E 00 7.03E 03 l 6.72E 04 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 1.09E 05 0.00E-01 1.52E 01 j 3.10E 02 2.15E 02 0.00E-01 0.00E-01 RB 88 0.00E-01 j 1.70E 02 0.00E-01 0.00E-01 0.00E-01 1.66E 00 l RB 09 0.00E-01 1.91E 02 4.18E 03 4 3.08E 03 0.00E-01 0.00E-01 0.00E-01 l SR 89 1.08E 05 0.00E-01 0.00E-01 1.87E 01 0.00E-01 3.52E 05 0.00E-01 0.00E-01 l SR 90 1.39E 06 7.41E 01 0.00E-01 *0.00E-01 0.00E-01 4.33E 03 f SR 91 1.96E 03 0.00E-01 1.40E 04 2.96E 01 0.00E-01 0.00E-01 0.00E-01 SR 92 7.38E 02 0.00E-01 0.00E-01 9.10E 03 0.00E-01 8.56E-07 0.00E-01 0.00E-01 Y 90 3.20E 00 0.00E-01 0.00E-01 0.00E-Oi 5.82E 01 Y 91M 2.97E-02 0.00E-01 1.08E-03 1.25E-02 0.00E-01 0.00E-01 0.00Ed)1 6.24E 03 Y 91 4.68E 01 0.00E-01 8.09E 03 8.01E-03 0.00E-01 0.00E-01 0.00E-01 Y 92 2.80E-01 0.00E-01 A-37 ADM 04-019 Rev. 5 Page 135 of 202 e .'- 474!G.WQ21%3Fdjj.$;;ffg4{J3@hg[Mg] ;p ,j * - . -', ,- . if W.f
TABLE A.4-3 (cont'd) SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pcI/ML CHIT.D T BODY 'IHYROID KIDNEY URG GI-LLI fETLIDE DONE LIVER 0.00E-01 0.00E-01 0.00E-01 1.32E 04 Y 93 8.87E-01 0.00E-01 2.44E-02 1.62E 03 1.38E 00 0.00E-01 2.22E 00 0.00E-01 ZR 95 7.05E 00 1.55E 00 0.00E-01 9.29E 03 6.13E-02 3.62E-02 0.00E-01 8.81E-02 _ZR 97 4.25E-01 0.00E-01 1.95E 02 0.00E-01 3.83E 05 95 5.32E 02 2.07E 02 1.48E 02 7.26E 02 NB 2.178 02 0.00E-01 1.87E 03 0.00E-01 M) 99 0.00E-01 8.78E 02 1.84E 00 6.43E-02 7.20E 01
- 6.46E-02 1.27E-01 2.10E 00 0.00E-01
'JC 99M 2.49E-01 9.93E-01 0.00E-01 1.34E 00 4.14E-02
'IC 101 7.48E-02 7.83E-02 0.00E-01 1.25E 03 0.00E-01 1.85E 01 0.00E-01 1.21E 02 RU 103 4.83E 01 3.74E 01 0.00E-01 2.78E 03 4.26E 00 0.00E-01 1.54E 00 0.00E-01 RU 105 0.00E-01 1.04E 03 0.00E-01 1.20E 04 RU 106 7.72E 02 0.00E-01 9.64E 01 2.60E 03 '
1.74E 01 0.00E-01 4.068 01 0.00E-01 Y, 110M 3.23E 01 2.18E 01 0.00E-01 4.10E 03 4,25E 03 1.15E 03 5.67E 02 1.19E 03 0.00E-01 TE 12SM 1.28E 03 2.58E 03 3.07E 04 0.00E-01 8.72E 03 TE 127M 1.08E 04 2.90E 03 0.00E-01 6.86E 03 4.73E 01 3.77E 01 1.22E 02 5.00E 02 TE 127 1.76E 02 5.33E 04 0.00E-01 2.21E 04 l 1.82E 04 5.07E 03 1.70E 03 5.05E 03 TE 129M ! 1.19E 01 3.56E 01 1.46E 02 0.00E-01 3.11E 03 l TE 129 5.00E 01 1.39E 01 0.00E-01 3.77E 04 9.28E 02 9.88E 02 1.91E 03 8.98E 03 g TE 131M 2.68E 03 9.36E 01 0.00E-01 1.63E 02 3.09E 01 9 43E 00 9.21E 00 2.37E 01
. TE 131 2.01E 03 2.43E 03 1.55E 04 0.00E-01 1.68E 0' TE 132 3.77E 03 1.67E 03 1.93E 02 2.13E 02 4.55E 04 6.17E 02 0.00E-01 1 130 2.04E 02 4.13E 02 0.00E-01 1.00E 02 1.21E 03 6.88E 02 4.00E 05 1.99E 03 I 131 1.20E 03 !
4.73E 01 4.77E 03 1.57E 02 0.00E-01 1.21E 02 132 5.60E 01 1.03E 02 0.00E-01 '2.06E 02 I 4.14E 02 5.12E 02 1.'94E 02 9.51E 04 8.53E 02 I 133 8.32E 01 0.00E-01 3.61E 01 I 134 2.93E 01 5.44E 01 2.50E 01 1.25E 03 1.04E 02 1.95E 04 3.38E 02 0.00E-01 1.68E 02 I 135 1.22E 02 2.20E 02 6.97E 04 3.38E 03 6.26E 05 1.32E 05 0.00E-01 1.94E 05 CS 134 3.82E 05 5.61E 04 8.37E 03 3.70E 03 l 3.83E 04 1.05E 05 6.82E 04 0.00E-01 CS 136 7.54E 04 0.00E-01 1.66E 05 5.99E 04 3.20E 03 CS 137 5.33E 05 5.1]E 05 2.38E 02 5.17E 02 3.28E 02 0.00E-01 3.64E 02 3.92E 01 CS 138 3.72E 02 1.18E-02 7.97E-03 1.47E 03 2.54E 01 1.35E-02 7.35E-01 0.00E-01 BA 139 A-38 ADM 04-019 Rev. 5 Pago 136 of 202
. %%c,. h.MdN5N%55555$ ($5.N 5Dirh. > ~ u hts S% ENEi$$k. n *
. .~
TABLE A.4-3 (cont'd) SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pcI/ML' _ CHILD T tiAd 'IHYROID KIDNEY IRC GI-LLI 14XIIDE BONE LIVER 0.00E-01 1.45E 00 2.66E 00 2.58E 03' f BA 140 5.09E 03 4.46E 00 2.97E 02 6.99E 00 0.00E-01 5.94E-03 4.03E-02 BA 141 1.23E 01 6.86E-03 3.99E-01 2.27E-03 6.99E-02 2.99E-01 0.00E-01 3.12E-03 BA 142 5.36E 00 3.85E-03 0.00E-01 0.00E-01 0.00E-01 7.66E 03 LA 140 7.86E-01 2.75E-01 9.26E-02 2.58E 03 4.07E-03 0.00E-01 0.00E-01 0.00E-01 IA 142 4.08E-02 1.30E-02 5.11E-01 0.00E-01 1.46E 03 ) 1.17E 00 1.73E-01 0.00E-01 pf 141 2.34E 00 . 4 0.00E-01 9.37E-02 0.00E-01 3.27E 03 CE 143 4.12E-01 2.23E 02 3.24E-02 0.00E-01 1.00E 04 i 3.84E 01 6.54E 00 0.00E-01 2.13E 01 CE 144 1.23E 02 0.00E-01 4.97E-01 0.00E-01 3.30E 03 PR 143 3.06E 00 9.18E-01 1.52E-01 f 0.00E-01 1.64E-03 0.00E-01 6.68E 00 > PR 144 1.00E-02 3.10E-03 5.05E-04 2.79E 03 1.36E-01 0.00E-01 9.65E-01 0.00E-01 - ND 147 2.17E 00 1.76E 00 0.00E-01 3.58E 04 { 1.14E 02 0.00E-01 0.00E-01 W 187 4.30E 02 2.55E 02 0.00E-01 7.19E-02 0.00E-01 1.84E 03 NP 239 3.47E-01 2.49E-02 1.75E-02 4.09E 03 2.29E 02 1.44E 00 0.00E-01 3.63E 02 Sb 124 6.54E 02 8.49E 00 2.35E 02 1.01E 03 3.25E 00 8.84E 01 3.91E-01 0.00E-01 Sb 125 4.22E 02 i 1.52E 00 0.00E-01 1.24E 02 5.23E 03 Sb 126 2.59E 02 3.97E 00 9.31E 01 3.94E 02 9.73E 01 0.00E-01 0.00E-01 0.00E-01 Co 57 0.00E-01 4.81E 01 y : I
?
i I A-39 ADM 04-019 l l Rev. 5 l Page 137 of 202 I i O W$5WA&M [E[& MQ*g" y&MJK, 5 c .j ;- - . l
+. , .- - .. .- - - . - . .- . ..
TABLE A.4 4 SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pCI/ML INFANT l NtT3.,IDE IONE LIVER T 15Xff 'IHYROID KIDNEY LUfC GI-LLI 1.16E 01 f' i 1.16E 01 1.16E 01 1.16E 01 1.16E 01 H 3 0.00E-01 1.16E 01 1.90E 02 1.90E 02 1.90E 02 1.90E 02 1.90E 02 1.90E 02 C 14 8.92E 02 3.80E 02 3.80E 02 3.80E 02 l 3.80E 02 3.80E 02 3.80E 02 3.80E 02 NA 24 0.00E-01 0.00E-01 0.00E-01 8.65E 02 . 32 6.40E 04 3.76E 03 2.48E 03 1.55E 01
- P 3.46E-01 7.56E-02 6.73E-01 51 0.00E-01 0.00E-01 5.30E-01 0.00E-01 2.75E 02 CR 1.70E 02 0.00E-01 1.66E 02 MN 54 0.00E-01 7.49E 02 0.00E-01 2.64E 01 0.00E-01 2.80E 03 56 0.00E-01 3.08E 01 5.30E 00 4.29E 01 NN 9.03E 01 0.00E-01 0.00E-01 1.65E 02 FE 55 5.23E 02 3.38E 02 5.98E 02 9.67E 02 ;
7.98E 02 0.00E-01 0.00E-01 FE 59 1.16E 03 2.02E 03 0.00E-01 0.00E-01 0.00E-01 3.37E 02 ' CO 58 0.00E-01 1.35E 02 3.38E 02 0.00E-01 9.67E 02 9.59E 02 0.00E-01 0.00E-01 CD 60 0.00E-01 4.06E 02 0.00E-01 7.34E 01 1.47E 03 0.28E 02 G.00E-01 0.00E-01 NI 63 2.39E 04 0.00E-01 0.00E-01 0.00E-01 1.52E 03 l' NI 65 1.77E 02 2.00E 01 9.10E 00 4.70E 02 1.06E 01 0.00E-01 3.87E 01 0.00E-01 CU 64 0.00E-01 2.29E 01 0.00E-01 2.01E 03 f 2.37E 03 1.09E 03 0.00E-01 1.15E 03 ZN 65 6.92E 02 i 0.00E-01 2.63E 00 0.00E-01 5.15E 02 l 69 3.51E 00 6.32E 00 4.70E-01 ZN 0.00E-01 0.00E-01 0.00E-01 3.76E-17 , nR 83 0.00E-01 0.00E-01 1.37E 01 3.76E-17 f j 1.44E 01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 : 0.00E-01 0.00E-01 0.00E-01 3.76E-17 l 85 0.00E-01 0.00E-01 7.30E-01 1.64E 02 : BR 3.16E 03 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 6.40E 03 0.00E-01 1.82E 01 , 1.87E 01 1.03E 01 0.00E-01 0.00E-01 RB 88 0.00E-01 l 0.00E-01 0.00E-01 0.00E-01 3.66E 00 l RB 89 0.00E-01 1.08E 01 7.41E 00 1.94E 03 2.71E 03 0.00E-01 0.00E-01 0.00E-01 l SR 89 9.44E 04 0.00E-01 0.00E-01 8.69E 03 0.00E-01 1.77E 05 0.00E-01 0.00E-01 SR 90 6.96E 05 0.00E-01 0.00E-01 0.00E-01 2.23E 03 SR 91 1.88E 03 0.00E-01 6.81E 00 7.79E 03 l 2.68E 01 0.00E-01 0.00E-01 0.00E-01 SR 92 7.22E 02 0.00E-01 0.00E-01 4.51E 03 0.00E-01 8.77B-02 0.00E-01 0.00E-01 Y 90 3.27E 00 i 0.00E-01 0.00E-01 0.00E-01 1.02E 02 91M 3.05E-02 0.00E-01 1.04E-03 Y 0.00E-01 0.00E-01 0.00E-01 3.05E 03 91 4.25E 01 0.00E-01 1.13E 00 Y 0.00E-01 0._00E-01 0.00E-01 5.49E 03 Y 92 2.88E-01 0.00E-01 8.09E-03 I A-40 ADM 04-019 Rev. 5 Page 138 of 202 'O w: E '3*SifM ARfSGQg[si,(t[g.gggygg , :g,gg ; .
TABLE A.4-4 (cont'd) SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pCI/ML INFANT BCNE LIVER T BODY 'IHYROID KIDNEY LUtG GI-LLI NUCLIDE 0.00E-01 . 49E-02 0.00E-01 0.00E-01 0.00E-01 7.22E 03 Y 93 9.14E-01 7.75E 00 1.89E 00 1.34E 00 0.00E-01 2.04E 00 0.00E-01 9.41E 02 ZR 95 0.00E-01 6.09E 03 ER 97 5.57E-01 9.56E-02 4.36E-02 0.00E-01 9.63E-02 1.58E 00 6.51E-01 3.76E-01 0.00E-01 4.66E-01 0.00E-01 5.49E 02 NB 95 4.21E 02 0.00E-01 1.28E 03 2.49E 02 0.00E-01 1.91E 03 0.00E-01 PE) 99 4.33E 01 7.22E-02 1.49E-01 1.92E 00 0.00E-01 1.60E 00 7.79E-02
'IC 99M 1.08E-O'1 1.06E 00 0.00E-01 1.28E 00 5.87E-02 1.83E 01 TC 101 8.54E-02 0.00E-01 RU 103 5.57E 01 0.00E-01 1.86E 01 0.00D-01 1.16E 02 6.77E 02 l l 0.00E-01 1.72E 00 0.00E-01 3.76E 01 0.00E-01 2.04E 03 Ep 105 5.12E 00 l 9.07E 02 0.00E-01 1.13E 02 0.00E-01 1.07E 03 0.00E-01 6.88E 03 RU 106 0.00E-01 1.42E 03 AG 110M 3.75E 01 2.73E 01 1.81E 01 0.00E-01 3.91E 01 ;
8.77E 02 2.93E 02 1.19E 02 2.95E 02 0.00E-01 0.00E-01 4.18E 02 i IE 12SH 2.20E 03 7.30E 02 2.66E 02 6.36E 02 5.42E 03 0.00E-01 8.88E 02 TE 127M 7.90E 02 8.09E 00 3.06E 01 9.18E 01 0.00E-01 TE 127 3.76E 01 1*.26E 01 0.00E-01 2.25E 03 TE 129M 3.76E 03 1.29E 03 5.79E 02 1.44E 03 9.41E 03 1,07E 01 3.68E 00 2.49E 00 8.95E 00 2.66E 01 0.00E-01 8.54E 02 TE _129 0.00E-01 3.87E 03 TE 13D4 5.72E 02 2.30E 02 1.90E 02 4.66E 02 1.58E 03 6.62E 00 2.45E 00 1.86E 00 5.91E 00 1.69E 01 0.00E-01 2.67E 02 k TE 131 3.87E 02 3.62E 02 5.72E 02 2.42E 03 0.00E-01 1.43E 03 TE 132 7.82E 02 0.00E-01 1.06E 02 T 130 2.26E 02 4.97E 02 1.99E 02 5.57E 04 5.45E 02 131 1.35E 03 1.59E 03 7.00E 02 5.23E 05 1.86E 03 0.00E-01 5.68E 01 I I 132 6.24E 01 1.27E 02 4.51E 01 5.94E 03 1.41E 02 0.00E-01 1.03E 02
. I 133 4.70E 02 6.85E 02 2.01E 02 1.25E 05 0.05E 02 0.00E-01 1.16E 02 134 3.27E 01 6.70E 01 2.38E 01 1.56E 03 7.49E 01 0.00E-01 6.92E 01 I
7 135 1.37E 02 2.72E 02 9.93E 01 2.44E 04 3.04E 02 0.00E-01 9.86E 01 CS 134 1.42E 04 2.64E 04 2.67E 03 0.00E-01 6.81E 03 2.42E 03 7.19E 01 CS 136 1.73E 03 5.08E 03 1.90E 03 0.00E-01 2.02E 03 4.14E 02 7.71E 01 CS 137 1.96E 04 2.30E 04 1.63E 03 0.00E-01 6.17E 03 2.50E 03 7.19E 01 CS 138 1.81E 01 2.94E 01 1.43E 01 0.00E-01 1.47E 01 2.29E 00 4.70E 01 BA 139 3.31E 01 2.20E-02 9.59E-01 0.00E-01 1.32E-02 1.33E-02 2.10E 03 A-41 ADM 04-019 Th?v . 5 Page 139 Ot 202
- - ' ~.WE'WSIENMPMIR*J/AMy"BW5ll1L"4Eg3*gQ
,q g g g g gfj,gggqq, g
.. . _ _ _ _ . . .. _ . _ _ _m _ .. . _ . _ . _ _ _ _ _ _ _ _ m _
TABLE A.4-4 (cont'd) SITE RELATED DOSE COMMITMENT FACTOR AIT MREM /HR PER pCI/ML INFANT NUCLIDE BCNE LIVER T BODY 'DiYROID KIDNEY IDG GI-LLI l l l BA 140 6.43E 03 6.43E 00 3.31E 02 0.00E-01 1.53E 00 3.95E 00 1.58E 03 i BA 141 1.60E 01 1.09E-02 5.04E-01 0.00E-01 6.58E-03 6.66E-03 1.95E 02 1 BA 142 6.92E 00 5.76E-03 3. 41E-01 0.00E-01 3.31E-03 3.48E-03 2.86E 01 i IA 140 7.94E-01 3.13E-01 8.05E-02 0.00E-01 0.00E-01 0.00E-01 3.68E 03 IA 142 4.14E-02 1.52E-02 3.64E-03 0.00E-01 0.00E-01 0.00E-01 2.58E 03 l CE 141 2.96E 00 1.81E 00 2.13E-01 0.00E-01 5.57E-01 0.00E-01 9.33E 02 CE 143 5.57E-01 3.69E 02 4.21E-02 0.00E-01 1.08E-01 0.00E-01 2.16E 03 ' CE 144 1.12E 02 4.59E 01 6.28E 00 0.00E-01 1.85E 01 0.00E-01 6.43E 03 PR 143 3.06E 00 1.14E 00 1.52E-01 0.00E-01 4.2SE-01 0.00E-01 1.61E 03 PR 144 1.03E-02 3.99E-03 5.19E-04 0.00E-01 1.44E-03 0.00E-01 1.85E 02 ND 147 2.08E 00 2.14E 00 1.31E-01 0.00E-01 8.24E-01 0.00E-01 1.35E 03 i w 107 3.40E 01 2.36E 01 8.16E 00 0.00E-01 0.00E-01 0.00E-01 1.39E 03 NP 239 4.18E-01 3.74E-02 2.11E-02 0.00E-01 7.45E-02 0.00E-01 1.08E 03 Sb 124 8.05E 02 1.19E 01 2.49E 02 2.14E 00 0.00E-01 5.04E 02 2.48E 03 Sb 125 4.63E 02 4.48E 00 9.52E 01 5.79E-01 0.00E-01 2.90E 02 6.17E 02 f Sb 126 3.03E 02 5.94E 00 1.09E 02 2.33E 00 0.00E-01 1.91E 02 3.14E 03 ; Co 57 0.00E-01 4.33E 01 7.03E 01 0.00E-01 0.00E-01 0.00E-01 1.47E 02 ' [ I l
. I A-42 l
i ADM 04-019 Rev. 5 Page 140 of 202 l
- '~<-
's
.'55@M5LW/47hNjE MEMMW,Q7 p'$4]gtjy- ;
l
' ~ '
l TABLE A.5-1 -; i INHALATION DOSE PARAMETER FOR THE CHILD, PI NREM/YR per pCi/M' .f L ! H-3 1.12E 03 RU-103 6.62E 05 3.59E 04 RU-105 9.95E 04 f C-14 NA-24 1.61E 04 RU-106 1.43E 07 l P-32 2.60E 06 AG-110M 5.48E 06 l CR-51 1.70E 04 TE-125M 4.77E 05 l l MN-54 1.58E 06 TE-127M. 1.48E 06 ! MN-56 1.23E 05 TE-127 5.62E 04 ; TE-129M 1.76E 06 j FE-55 1.11E 05 2.55E 04 ! FE-59 1.27E 06 TE-129 TE-131M CO-58 1.11E 06 3.08E 05 CO-60 7.07E 06 TE-131 2.05E 03 l NI-63 8.21E 05- TE-132 3.77E 05 , NI-65 8.40E 04 I-130 1.85E 06 l CU-64 3.67E 04 I-131 1.62E 07 { ZN-65 9.955 05 I-132 1.94E 05 i ZN-69 1.02E 04 I-133 3.85E 06 l BR-83 4.74E 02 I-134 5.07E 04 .l 7.92E 05 ! BR-84 5.48E 02 I-135 BR-85 2.53E 01 CS-134 1.01E 06 1.98E 05 CS-136 1.71E 05 RB-86 RB-88 5.62E 02 CS-137 9.07E 05 . 3.45E 02 CS-138 8.40E 02 ! RB-89 SR-89 2.16E 06 BA-139 5.77E 04 : BA-140 1.74E 06 l SR-90 1.01E 08 2.92E 03 l SR-91 1.74E 05 BA-141 BA-142 1.64E 03 l SR-92 2.42E 05 2.26E 05 i Y-90 2.68E 05 LA-140 ' Y-91M 2.81E 03 LA-142 7.59 E 04 Y-92 2.39E 05 CE-141 5.44E 05 Y-93 3.89E 05 CE-143 1.27E b5 !
.51E O PR-144 1 57 03 97 NB-95 6.14E 05 ND-147 3.28E 05 ;
MO-99 1.355 05 W-187 9.10E 04 l TC-99M 4.81E 03 NP-239 6.40E 04 l TC-101 5.85E 02 l t i A-43 ~
)
ADM 04-019 , Rev. 5 ; I Page 141 of 202 1 I 1 l n "- y A(CMo.MHiytes!bWM6&g. gg5,ge,ggg,g{fgqggg+y "
, s(,e ,
;jy .
TABLE A.3-2 INHALATION PATHWAY FACTOR MREM /YR PER pCI/M ADULT (RI FACTORG) THYROID KIDNEY LUtG GI-ILI BONE LIVER T BODY tKCLIDE 1.26E 03 1.26E 03 1.26E 03 1.26E 03 0.00E 01 1.26E 03 1.26E 03 3.41E 03 H 3 3 41E 03 3.41E 03 3.41E 03 3.41E 03 C 14 1.82E 04 3.41E 03 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 tm 24 0.00E-01 0.00E-01 0.00E-01 8.64E 04 32 1.32E 06 7.71E 04 5.01E 04 1.44E 04 3.32E 03 P 0.00E 01 1.00E 02 5.95E 01 2.28E 01 CR 51 0.00E 01 0.00E-01 9.84E 03 1.40E 06 7.74E 04 MN 54 0.00E 01 3.96E 04 6.30E 03 8 0.00E-01 1.30E 00 9.44E 03 2.02E 04 MN 56 0.00E 01 1.24E 00 1.83E-01 7.21E 04 6.03E 03 3.94E 03 0.00E-01 0.00E-01 FE 55 2.46E 04 1.70E 04 1.02E 06 1.88E 05 1.06E 04 0.00E-01 0.00E-01 FE 59 1.18E 04 2.78E 04 0.00E-01 0.00E-01 9.28E 05 1.06E 05 58 0.00E 01 1.58E 03 2.07E 03 2.85E 05 ' CD 1.48E 04 0.00E-01 0.00E-01 5.97E 06 CO 60 0.00E 01 1.15E 04 1.78E 05 1.34E 04 1.45E 04 0.00E-01 0.00E-01 NI 63 4.32E 05 3.14E 04 0.00E-01 0.00E-01 5.60E 03 1.23E 04 NI 1.54E 00 2.10E-01 9.12E-02 4.90E 04 65 6.15E-01 0.00E-01 4.62E 00 6.78E 03 CU 64 0.00E 01 1.46E 00 8.64E 05 5.34E 04 4.66E 04 0.00E-01 6.90E 04 ZN 65 3.24E 04 1.03E 05 0.00E-01 4.22E-02 9.20E 02 1.63E 01 69 3.38E-02 6.51E-02 4.52E-03 2.32E 02 ZN 2.41E 02 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 1.64E-03 0.00E-01 3.13E 02 0.00E-01 0.00E-01 p BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 8.00E-15 85 0.00E-01 0.00E-01 1.28E 01 1.66E 04 BR 5.90E 04 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 1.35E 05 0.00E-01 3. 34 E-09 1.93E 02 0.00E-01 0.00E-01 RB 88 0.00E-01 3.87E 02 0.00E-01 0.00E-01 0.00E-01 9.28E-12 89 0.00E-01 2.56E 02 1.70E 02 3.50E 05 RB 8.72E 03 0.00E-01 0.00E-01 1.40E 06 SR 89 3.04E 05 0.00E-01 9.60E 06 7.22E 05 0.00E-01 6.10E 06 0.00E-01 0.00E 01 SR 90 9.92E 07 0.00E-01 0.00E-01 3.65E 04 1.91E 05 91 6.19E 01 0.00E-01 2.50E 00 4.30E 04 i SR 2.91E-01 0.00E-01 0.00E-01 1.65E 04 SR 92 6.74E 00 0.00E-01 1.70E 05 5.06E 05 5.61E 01 0.00E-01 0.00E-01 Y 90 2.09E 03 0.00E-01 0.00E-01 0.00E-01 1.92E 03 1.33E 00 Y 91M 2.61E-01 0.00E-01 1.02E-02 3.85E 05 1.24E 04 0.00E-01 0.00E-01 1.70E 06 Y 91 4.62E 05 0.00E-01 1.57E 04 7.35E 04 3.02E-01 0.00E-01 0.00E-01 Y 92 1.03E 01 0.00E-01 A-44 ADM 04-019 Rev. 5 Page 142 of 202 e n i
~ .s . .
"'<Nr- .. fan $?"$'j*y f }{ Q gff] M Q q f f g g
i TABLE A.5-2 (cont'd) INHALATION PATHWAY FACTOR l MREM /YR PER pCI/M' ADULT (RI FACTORS) T BODY 'IHYROID KIDNEY LUfG GI-LLI PAILIDE DONE LIVER 0.00E-01 0.00E-01 4.85E 04 4.22E 05 f 93 9.44E 01 0.00E-01 2.61E 00 1.50E 05 Y 2.33E 04 0.00E-01 5.42E 04 1.77E 06 ZR 95 1.07E 05 3.44E 04 2.97E 01 7.87E 04 5.23E 05 1.96E 01 9.04E 00 0.00E-01 ZR 97 9.68E 01 0.00E-01 7.74E 03 5.05E 05 1.04E 05 , 95 1.41E 04 7.82E 03 4.21E 03 2.48E 05 NB 2.30E 01 0.00E-01 2.91E 02 9.12E 04 to 99 0.00E-01 1.21E 02 4.42E-02 7.64E 02 4.16E 03 2.91E-03 3.70E-02 0.00E-01 K 99M 1.03E-03 0.00E-01 1.08E-03 3.99E 02 1.09E-11 i K 101 4.18E-05 6.02EN5 5.90E-04 1.10E 05 6.58E 02 0.00E-01 5.83E 03 5.05E 05 , RU 103 1.53E 03 0.00E-01 1.10E 04 4.82E 04 0.00E-01 3.11E-01 0.00E-01 1.02E 00 RU 105 7.90E-01 l 0.00E-01 1.34E 05 9.36E 06 9.12E 05 l 6.91E 04 0.00c-01 8.72E 03 3.02E 05 ! RU 106 5.94E 03 0.00E-01 1.97E 04 4.63E 06 AG 1101 1.08E 04 1.00E 04 3.14E 05 7.06E 04 1.58E 03 4.67E 02 1.05E 03 1.24E 04 TE 125M 3.42E 03 3.29E 03 4.58E 04 9.60E 05 1.50E 05 TE 127M 1.26E 04 5.77E 03 1.57E 03 5.74E 04 3.10E-01 1.06E 00 5.10E 00 6.51E 03 TE 127 1.40E 00 6.42E-01 1.16E 06 3.83E 05 4.67E 03 1.58E 03 3.44E 03 3.66E 04 TE 129M 9.76E 03 , 3.90E-02 1.87E-01 1.94E 03 1.57E 02 , TE 129 4.98E-02 2.39E-02 1.24E-02 5.56E 05 2.90E 01 5.50E 01 3.09E 02 1.46E 05 ' TE 131M 6.99E 01 4.36E 01 1.39E-03 1.84E01! 9.36E-02 4.37E-02 I TE 131 1.11E-02 5.95E-03 3.59E-03 * ; 1.90E 02 1.46E 03 2.88E 05 5.10E 05 ! 2.60E 02 2.15E 02 1.62E 02 7.69E 05 TE 132 5.28E 03 1.14E 06 2.09E 04 0.00E-01 130 4.5BE 03 1.34E 04 0.00E-01 6.28E 03 I 2.05E 04 1.19E 07 6.13E 04 I 131 2.52E 04 3.58E 04 1.14E 05 5.18E 03 0.00E-01 4.06E 02 - 132 1.16E 03 3.26E 03 1.16E 03 8.88E 03 I 4.52E 03 2.15E 06 2.58E 04 0.00E-01 133 8.64E 03 1.48E 04 0.00E-01 1.01E 00 I 6.15E 02 2.9BE 04 2.75E 03 I 134 6.44E 02 1.73E 03 l 4.48E 05 1.11E 04 0.00E-01 5.25E 03 135 2.68E 03 6.98E 03 2.57E 03 1.04E 04 I i I 7.28E 05 0.00E-01 2.87E 05 9.76E 04 CS 134 3.73E 05 8.48E 05 1.20E 04 1.17E 04 1.46E 05 1.10E 05 0.00E-01 8.56E 04 , CS 136 3.90E 04 i 0.00E-01 2.22E 05 7.52E 04 8.40E 03 CS 137 4.78E 05 6.21E 05 4.28E 05 1.86E-03 ! 3.24E 02 0.00E-01 4.80E 02 4.86E 01 I CS 138 3.31E 02 6.21E 02 3.76E 03 8.96E 02 6.66E-04 2.74E-02 0.00E-01 6.22E-04 BA 139 9.36E-01 i A-45 i ADM 04-019 ] R3V. 5 Page 143 of 202 ,
%&, ,' f.{dy; .g
TABLE A.5-2 (cont'd) INHALATION PATHWAY FACTOR MREM /YR PER pCI/M' ADULT (RI FACTORS) T DODY 'niYICID KIDNEY I12 0 GI-ILI
!JtX'LTDE IKNE LIVER 0.00E-01 1.67E 01 1.27E 06 2.18E 05 BA 140 3.90E 04 4.90E 01 2.57E 03 1.16E-07 7.53E-05 3.36E-03 0.00E-01 7.00E-05 1.94E 03 L% 141 1.00E-01 2.29E-05 1.19E 03 1.57E-16 2.63E-02 2.70E-05 1.66E-03 0.00E-01 1m 142 4.58E 01 0.00E-01 0.00E-01 1.36E 05 4.58E 05 IA 140 3.44E 02 1.74E 02 6.33E 03 2.11E 03 3.10E-01 7.72E-02 0.00E-01 0.00E-01 IA 142 6.83E-01 6.26E 03 3.62E 05 1.20E 05 1.99E 04 1.35E 04 1.53E 03 0.00E-01 CE 141 0.00E-01 6.08E 01. 7.98E 04 2.26E 05 CE 143 1.86E 02 1.38E 02 1.53E 01 8.16E 05 1.84E 05 0.00E-01 8.40E 05 7.78E 06 CE 144 3.43E 06 1.43E 06 2.81E 05 2.00E 05 3.75E 03 4.64E 02 0.00E-01 2.16E 03 PR 243 9.36E 03 1.53E-03 0.00E-01 7.05E-03 1.02E 03 2.15E-08 PR 144 3.10E-02 1.25E-02 2.21E 05 1.73E 05 6.10E 03 3.65E 02 0.00E-01 3.56E 03 to 147 5.27E 03 0.00E-01 2.90E 04 1.55E 05 8.48E 00 7.08E 00 2.48E 00 0.00E-01 W 187 1.24E 01 0.00E-01 7.00E 01 3.76E 04 1.19E 05 IP 239 2.30E 02 2.26E 01 I
A-46 ADM 04-019 Rev. 5 Page 144 of 202 e ' .12.~d2MN133EF3@[.;E'f[Y[M;f - D. N ? ' O f T" p tY8.9 ,
l TABLE A.5-3 I INHALATION PATHWAY FACTOR MREM /YR PER pCI/M' TEEN (RI FACTORS) T DODY 'nflROID KIDNEY IRG GI-IL1 g g;,IDE EOJE LIVER 1.27E 03 1,27E 03 1.27E 03 1.27E 03 ' 0.00E-01 1.27E 03 1.27E 03 4.87E 03 4.87E 03 ' H 3 4.87E 03 4.87E 03 4.87E 03 C 14 2.60E 04 4.87E 03 1.38E 04 1.38E 04 1.38E 04 1.30E 04 1.38E 04 1.38E 04 NA 24 1.38E 04 0.00E-01 0.00E-01 0.00E-01 9.28E 04 32 1.89E 06 1.10E 05 7.16E 04 2.10E 04 3.00E 03 P 1.35E 02 7.50E 01 3.07E 01 CR 51 0.00E-01 0.00E-01 1.27E 04 1.98E 06 6.6BE 04 5.11E 04 8.40E 03 0.00E-01 tel 54 0.00E-01 0.00E-01 1.79E 00 1.53E 04 5.74E 04 0.00E-01 1.70E 00 2.52E-01 1.24E 05 6.39E 03 MN 56 0.00E-01 0.00E-01 55 3.34E 04 2.38E 04 5.54E 03 1.53E 06 1.78B 05 FE 1.43E 04 0.00E-01 0.00E-01 FE 59 1.59E 04 3.70E 04 0.00E-01 0.005-01 1.34E 06 9.52E 04 0.00E-01 2.07E 03 2.78E 03 8.72E 06 2.59E 05 00 58 1.98E 04 0.00E-01 0.00E-01 00 60 0.00E-01 1.51E 04 0.00E-01 3.07E 05 1.42E 04 4.34E 04 1.98E 04 0.00E-01 NI 63 5.80E 05
.00E-01 9.36E 03 3.67E 04 2.93E-01 1.27E-01 0.00E-01 NI 65 2.38E 00 0.00E-01 6.41E 00 1.11E 04 6.14E 04 0.00E-01 2.03E 00 8.48E-01 4.66E 04 CU 64 0.00E-01 8.64E 04 1.24E 06 65 3.86E 04 1.34E 05 6.24E 04 ZN 6.02E-02 1.58E 03 2.85E 02 9.20E-02 6.46E-03 0.00E-01 ZN 69 4.83E-02 0.00E-01 0.00E-01 0.00E-01 8.00E-15 0.00E-01 0.00E-01 3.44E 02 8.00E-15
- BR 83 4.33E 02 0.00E-01 0.00E-01 0.00E-01 0 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 8.00E-15 0.00E-01 0.00E-01 1.83E 01 1.77E 04 BR 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1.90E 05 8.40E 04 2.92E-05 RB 86 2.72E 02 0.00E-01 0.00E-01 0.00E-01
,RB 88 0.00E-01 5.46E 02 0.00E-01 0.00E-01 0.00E-01 3.38E-07 89 0.00E-01' 3.52E 02 2.33E 02 2.42E 06 3.71E 05 RB 0.00E-01 1.25E 04 0.00E-01 0.00E-01 SR 89 4.34E 05 0.00E-01 0.00E-03 1.65E 07 7.65E 05 90 1.08E 08 0.00E-01 6.68E 06 ja 0.00E-01 0.00E-01 6.07E 04 2.59E 05 -
8.80E 01 0.00E-01 3.51E 00 1.19E 05 SR 91 4.0GE-01 0.00E-01 0.00E-01 2.74E 04 92 9.52E 00 0.00E-01 2.93E 05 5.59E 05 .t SR 8.00E 01 0.00E-01 0.00E-01 Y 90 2.98E 03 0.00E-01 0.00E-01 0.00E-01 3.20E 03 3.02E 01 3.70E-01 0.00E-01 1.42E-02 4.09E 05 Y 9EH 1.77E 04 0.00E-01 0.00E-01 2.94E 06 Y 91 6.61E 05 0.00E-01 0.00E-01 2.68E 04 1.65E 05 0.00E-01 4.29E-01 0.00E-01 JL 92 1.47E 01 A-47 s ADM 04-019
! Rev. 5 Page 145 of 202
# r;, .- .
'I WW75CfRT@QQr.EMy%%'IM(({'9]y y '!yr?",* .g ;
TABLE A.5-3 (cont' d) INH 7.LATION PATHWAY FACTOR 8 MREM /YR PER pC1/M TEEN (RI FACTORS) KIDNEY LUfG GI-LLI . T WDY TRYROID FATIIDE BONE LIVER 0.00E-01 0.00E-01 8.32E 04 5.79E 05 93 1.35E 02 0.00E-01 3.72E 00 2.69E 06 1.49E 05 Y 0.00E-01 6.74E 04 95 1.46E 05 4.58E 04 3.15E 04 1.30E 05 6.30E 05 ZR 2.72E 01 1.26E 01 0.00E-01 4.12E 01 ZR 97 1.38E 02 0.00E-01 1.00E 04 7.51E 05 9.68E 04 95 1.86E 04 1.03E 04 5.66E 03 1.54E 05 2.69E 05 ND 3.22E 01 0.00E-01 4.11E 02
}O 99 0.00E-01 169E 02 5.76E-02 1.15E 03 6.13E 03 3.86E-03 4.99E-02 0.00E-01 4C 99M 1.38E-03 0.00E-01 1.52E-03 6.67E 02 8.72E-07 5.92E-05 8.40E-05 8.24E-04 1.09E 05 TC 101 8.96E 02 0.00E-01 7.43E 03 7.83E 05 RU 103 2.10E 03 0.00E-411 1.82E 04 9.04E 04 4.34E-01 0.00E-01 1.41E 00 RU 105 1.12E 00 0.00E-01 0.00E-01 1.90E 05 1.61E 07 9.60E 05 9.84E 04 0.00E-01 1.24E 04 2.73E 05 RU 106 7.99E 03 0.00E-01 2.50E 04 6.75E 06 IG 110M 1.38E 04 1.31E 04 0.00E-01 5.36E 05 7.50E 04 2.24E 03 6.74E 02 1.40E 03 TE 125M 4.88E 03 4.38E 03 6.54E 04 1.66E 06 1.59E 05 1.80E 04 8.16E 03 2.18E 03 8.08E 01 TE 127M 4.42E-01 1.42E 00 7.28E 00 1.12E 04 TE 127 2.01E 00 9.12E-01 1.98E 06 4.05E 05 6.58E 03 2.25E 03 4.58E 03 5.19E 04 TE 129M 1.39E 04 5.18E-02 2.66E-01 3.30E 03 1.62E 03 7.10E-02 3.38E-02 1.76E-02 6.21E 05 TE 129 4.20E 01 7.25E 01 4.39E 02 2.38E 05 TE 131M 9.84E 01 6.01E 01 2.34E 03 1.51E 01 8.32E-03 5.04E-03 1.24E-02 6.18E-02 4 TE 131 1.58E-02 2.46E 02 1.95E 03 4.49E 05 4.63E 05 3.60E 02 2.90E 02 2.19E 02 9.12E 03 TE 132 7.17E 03 1.49E 06 2.75E 04 0.00E-01 130 6.24E 03 1.79E 04 0.00E-01 6.49E 03 I
4.91E 04 2.64E 04 1.46E 07 8.40E 04 I 131 3.54E 04 1.51E 05 6.92E 03 0.00E-01 1.27E 03 132 1.59E 03 4.38E 03 1.58E 03 1.03E 04 I 6.22E 03 2.92E C6 3.59E 04 0.00E-01 133 1.22E 04 2.05E 04 0.00E-01 2.04E 01 I 2.32E 03 8.40E 02 3.95E 04 3.66E 03 I 134 8.88E 02 6.21E 05 1.49E 04 0.00E-01 6.95E 03 135 3.70E 03 9.44E 03 3.49E 03 I 5.49E 05 0.00E-01 3.75E 05 1.46E 05 9.7tliE 03 CS 134 5.02E 05 1.13E 06 1.78E 04 1.09E 04 1.37E 05 0.00E-01 1.10E 05 CS 136 5.15E 04 1.94E 05 0.00E-01 3.04E 05 1.21E 05 8.48E 03 CS 137 6.70E 05 8.48E 05 3.11E 05 2.70E-01 4.46E 02 0.00E-01 6.62E 02 7.87E 01 CS 138 4.66E 02 8.56E 02 6.46E 03 6.45E 03 9.44E-04 3.90E-02 0.00E-01 8.88E-04 FW 139 1.34E 00 A-48 ADM 04-019 Rev. 5 Page 146 of 202 e '- 12WWh WVi?l$4S &Q& &{${eyff ' 'h~M*T"& ] _ 4 '!' i
. ~ . - . .
k TABLE A.5-3 (cont'd) INH.ALATION PATHWAY FACTOR MREM /YR PER pCI/M' TEEN (RI FACTORS) KIDNEY LIJfG GI-ILI LIVER T BJur 'IHYROID NUCLIDE DONE 0.00E-01 2.28E 01 2.03E 06 2.29E 05 BA 140 5.47E 04 6.70c 01 3.52E 03 3.29E 03 7.46E-04 4.74E-03 0.00E-01 9.84E-05 BA 141 1.42E-01 1.06E-04 3.14 E-05 1.91E 03 4.79E-10 ; 3 70E-05 2.27E-03 0.00E-01 BA 142 3.70E-02 0.00E-01 0.00E-01 2.14E 05 4.87E 05 > 4.79E 02 2.36E 02 6.26E 01 IA 140 1.06E-01 0.00E-01 0.00E-01 1.02E 04 1.20E 04 l IA 142 9.60E-01 4.25E-01 8.88E 03 6.14E 05 1.26E 05 1.90E 04 2.17E 03 0.00E-01 CE 141 2.84E 04 r 0.00E-01 8.64E 01 1.30E 05 2.55E 05 ! 2.66E 02 1.94E 02 2.16E 01 8.64E 05 CE 143 2.62E 05 0.00E-01 1.21E 06 1.34E 07 CE 144 4.89E 06 2.02E 06 3.09E 03 4.83E 05 2.14E 05 5.31E 03 6.62E 02 0.00E-01 , PR 143 1.34E 04 ! 1.01E-02 1.75E 03 2.35E-04 ; 1.76E-02 2.18E-03 0.00E-01 ~ PR 144 4.30E-02 0.00E-01 5.02E 03 3.72E 05 1.82E 05 7.86E 03 8.565 03 5.13E 02 1.77E 05 ND 147 3.43E 00 0.00E-01 0.00E-01 4.74E 04 W 187 1.20E 01 9.76E 00 ' 0.00E-01 1.00E 02 6.49E 04 1.32E 05 3.38E 02 3.19E 01 1.77E 01 NP 239 k t . 0 4 l I i A-49 , f ADM 04-019 l 1
.su e . 5 l Page 147 of 202 l
- i~
i s I ., ' ' Mj?,Y.i ~ . (( .k[.fi [-N , , . b 4 If .I y [ ,
TABLE A.5-4 INHALATION PATHWAY FACTOR MREM /YR PER pCI/M' CHILD (RI FACTORS) i KIDNEY IJRG GI-LLI , T BCDY '111YPOID IK2E LIVIE
.FRCLIDE 1.12E 03 1.12E 03 1.12E 03 l 1.12E 03 1.12E 03 1.12E 03 6.73E 03 H 3 0.00E-01 6.73E 03 6.73E 03 6.73E 03 3.59E 04 6.73E 03 6.73E 03 1.61E 04 1.61E 04 C 14 1.61E 04 1.61E 04 1.61E 04 NA 24 1.61E 04 1.61E 04 0.00E-01 0.00E-01 0.00E-01 4.22E 04 2.60E 06 1.14E 05 9.88E 04 1.70E 04 1.08E 03 ,
P 32 1.54E 02 8.55E 01 2.43E 01
- CR 51 0.00E-01 0.00E-01 1.00E 04 1.58E 06 2.29E 04 4.29E 04 9.5]E 03 0.00E-01 NN 54 0.00E-01 1.67E 00 1.31E 04 1.23E 05 1.66E 00 3.12E-01 0.00E-01 NN 56 0.00E-01 0.00E-01 1.11E 05 2.87E 03 2.52E 04 7.77E 03 0.00E-01 7.07E 04 FE 55 4.74E 04 0.00E-01 0.00E-01 1.27E 06 2.07E 04 3.34E 04 1.67E 04 FE 59 0.00E-01 1.11E 06 3.44E 04 1.77E 03 3.16E 03 0.00E-01 CD 58 0.00E-01 0.00E-01 0.00E-01 7.07E 06 9.62E 04 0.00E-01 1.31E 04 2.26E 04 6.33E 03 CD 60 0.00E-01 0.00E-01 2.75E 05 8.21E 05 4.63E 04 2.80E 04 in 63 0.00E-01 0.00E-01 8.18E 03 8.40E 04 2.99E 00 2.96E-01 1.64E-01 3.67E 04 N1 65 0.00E-01 6.03E 00 9.58E 03 0.00E-01 1.99E 00 3.07E 00 9.95E 05 1.63E 04 CU 64 7.03E 04 0.00E-01 7.14E 04 ZN 65 4.26E 04 1.13E 05 5.85E-02 1.42E 03 1.02E 04 9.66E-02 8.92E-03 0.00E-01 ZN 69 6.70E-02 0.00E-01 0.00E-01 3.70E-15 0.00E-01 4.74E 02 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 3.70E-15 0.00E-01 0.00E-01 5.48E 02 k BR 84 0.00E-01 0.00E-01 0.00E-01 3.70E-15 0.00E-01 0.00E-01 2.53E 01 7.99E 03 BR 85 0.00E-01 0.00E-01 0.00E-01 86 0.00E-01 1.98E 05 1.14E 05 0.00E-01 1.72E 01 RB 3.65E 02 0.00E-01 0.00E-01 88 0.00E-01 5.62E 02 EB 0.00E-01 0.00E-01 1.89E 00 3.45E 02 2.90E 02 0.00E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 2.16E 06 1.67E 05 89 5.99E 05 0.00E-01 1.72E 04 1.48E 07 3.43E 05 SR 6.44E 06 0.00E-01 0.00E-01 SR 90 1.01E 08 0.00E-01 4.59E 00 0.00E-01 0.00E-01 5.33E 04 1.74E 05 lI SR 91 1.21E 02 0.00E-01 0.00E-01 2.40E 04 2.42E 05 I 0.00E-01 5.25E-01 0.00E-01 SR 92 1.31E 01 0.00E-01 2.62E 05 2.68E 05 l 0.00E-01 1.11E 02 0.00E-01 Y 90 4.11E 03 0.00E-01 2.81E 03 1.72E 03 0.00E-01 1.84E-02 0.00E-01 Y 91M 5.07E-01 0.00E-01 0.00E-01 2.63E 06 1.84E 05 9.14E 05 0.00E-01 2.44E 04 2.39E 05 Y 91 0.00E-01 0.00E-01 2.39E 04 92 2.04E 01 0.00E-01 5.81E-01 Y
A-50 9/93 ADM 04-019 Rev. 5 Pdge 140 of 202 e - r. PMf4#PMf%MW M M gpg g gyp;7g*g'.;.
TABLE A.5-4 (cont'd) . INHALATION PATHWAY FACTOR MREM /YR PER pCI/M' CHILD (RI FACTORS) LIVER T BODY THYROID KIDNEY LIRC GI-LLI . grLIDE BONE 5.11E 00 0.00E-01 0.00E-01 7.44E 04 3.89E 05 y 93 1.86E 02 0.00E-01 6.11E 04 4.18E 04 3.70E 04 0.00E-01 5.96E 04 2.23E 06 l ZR 95 1.90E 05 1.13E 05 3.51E 05 1.8BE 02 2.72E 01 1.60E 01 0.00E-01 3.88E 01 zn 97 6.55E 03 0.00E-01 8.62E 03 6.14E 05 3.70E 04 l l NB 95 2.35E 04 9.18E 03 1.35E 05 1.27E 05 0.00E-01 1.72E 02 4.25E 01 0.00E-01 3.92E 02 10 99 0.00E-01 5.07E-02 9.51E 02 4.81E 03 UC 99M 1.78E-03 3. 48E-03 5.77E-02 l 1.08E-03 0.00E-01 1.45E-03 5.85E 02 1.63E 01 YC 101 0.10E-05 8.51E-05 4.48E 04 l 0.00E-01 1.07E 03 0.00E-01 7.03E 03 6.62E 05 RU 103 2.79E 03 1.34E 00 1.59E 04 9.95E 04 -l l 3.53E 00 0.00E-01 5.55E-01 0.00E-01 RU 105 1 1.69E 04 0.00E-01 1.84E 05 1.43E 07 4.29E 05 RU 106 1.36E 05 0.00E-01 9.14E 03 0.00E-01 2.12E 04 5.4BE 06 1.00E 05 JC 110M 1.69E 04 1.14E 04 3.30E 04 2.33E 03 9.14E 02 1.92E 03 0.00E-01 4.77E 05 TE 125M 6.73E 03 3.02E 03 6.07E 03 6.36E 04 1.48E 06 7.14E 04 TE 127M 2.49E 04 8.55E 03 2.77E 00 9.51E-01 6.10E-01 1.96E 00 7.07E 00 1.00E 04 5.62E 04 l TE 127 6.33E 03 5.03E 04 1.76E 06 1.82E 05 TE 129M 1.92E 04 6.85E 03 3.04E 03 2.38E-02 7.14E-02 2.57E-01 2.93E 03 2.55E 04 TE 129 9.77E-02 3.50E-02 3.0BE 05 5.92E 01 5.07E 01 9.77E 01 4.00E 02 2.06E 05 TE 131M 1.34E 02 2.05E 03 1.33E 03 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02 g TE 131 2.63E 02 3.17E 02 1.77E 03 3.77E 05 1.38E 05 TE 132 4.81E 02 2.72E 02 5.11E 03 1.64E 04 8.44E 03 1.85E 06 2.45E 04 0.00E-01 I 130 8.18E 03 0.00E-01 2.84E 03 4.81E 04 4.81E 04 2.73E 04 1.62E 07 7.88E 04 I 131 1.88E 03 1.94E 05 6.25E 03 0.00E-01 3.20E 03 132 2.12E 03 4.07E 03 I 7.70E 03 3.85E 06 3.38E 04 0.00E-01 5.48E 03 I 133 1.66E 04 2.03E 04 9.55E 02 2.16E 03 9.95E 02 5.07E 04 3.30E 03 0.00E-01 I 134 1.17E 03 4.14E 03 7.92E.1)5 1.34E 04 0.00E-01 4.44E 03 I 135 4.92E 03 8.73E 03 3.85E 03 1.01E 06 2.25E 05 0.00E-01 3.30E 05 1.21E 05 CS 134 6.51E 05 1.45E 04 4.18E 03 6.51E 04 1.71E 05 1.16E 05 0.00E-01 9.55E 04 CS 136 1.28E 05 0.00E-01 2.82E 05 1.04E 05 3.62E 03 CS 137 9.07E 05 8.25E 05 2.70E 02 i 8.40E 02 5.55E 02 0.00E-01 6.22E 02 6.81E 01 CS 138 6.33E 02 5.77E 03 5.77E 04 1.84E 00 9.84E-04 5.36E-02 0.00E-01 8.62E-04 In 139 i A-51 9/93 ADM 04-019 Rev. 5 Page 14 9 of 202 e ;; W:V. a' '*%l27:i',AQ%5R QdQ M yy f g!Q Q,'tjQ^ f ^.- } ,. l .
. . ._m_ _ . . _ _ _ _ . _ .. . _ - . - _ _ . _ - .
1 TABLE A.5-4 (cont'd) I INHALATION PATHWAY FACTOR ' MREM /YR PER CI/M' 4 CHILD (RI FACTORS) T BODY 'DIYROID YJDNEY LtJfG GI-ILI NUCLIDE BONE LIVER l 4.33E 03 0.00E-01 2.11E 01 1.74E 06 1.02E 05 BA 140 7.40E 04 6.48E 01 2.75E 02 1.09E-04 6.36E-03 0.00E-01 9.47E-05 2.92E 03 BA 141 1.96E-01 2.91E-05 1.64E 03 7.74E 00i 4.99E-02 3.60E-05 2.79E-03 0.OOE-01 BA 142 ! i 7.55E 01 0.00E-01 0.00E-01 1.83E 05 2.26E05j IA 140 6.44E 02 2.2SE 02 7.59E 04 4.11E-01 1.29E-01 0.00E-01 0.00E-01 8.70E 03 l IA 142 1.29E 00 2.90E 03 0.00E-01 8.55E 03 5.44E 05 5.66E 04 i CE 141 3.92E 04 1.95E 04 ! 2.87E 01 0.00E-01 8.36E 01 1.15E 05 1.27E 05 CE 143 3.66E 02 1.99E 02 3.89E 05 ; 2.12E 06 3.61E 05 0.00E-01 1.17E 06 1.20E 07 ' CE 144 6.77E 06 3.00E 03 4.33E 05 9.73E 04 1.85E 04 5.55E 03 9.14E 02 0.00E-01 PR 143 > 3.00E-03 0.00E-01 9.77E-03 1.57E 03 1.97E 02 PR 144 5.96E-02 1.85E-02 8.21E 04 8.73E 03 6.81E 02 0.00E-01 4.81E 03 3.28E 05 i ND 147 1.08E 04 0.00E-01 4.11E 04 9.10E 04 l W 187 1.63E 01 9.66E 00 4.33E 00 0.00E-01 l 2.35E 01 0.00E-01 9.73E 01 5.81E 04 6.40E 04 NP 239 4.66E 02 3.34E 01 i l i l l A-52 ADM 04-019 Rev. 5 Page 150 of 202 i I
. QMj{gggEg.g y{Ag g ,g j
;i 't
' Esi*f;I @ % M ,
TABLE A.5-5 INHAI,ATION PATHWAY FACTOR MREM /YR PER pCI/M' INFANT (RI FACTORS)
'IHYROID KIDNEY LUfG GI-LLI EONE LIVER T BODY
_N_UCLIDE 6.47E 02 6.47E 02 6.47E 02 6.47E 02 3 0.00E-01 6.47E 02 6.47E 02 5.31E 03 H 5.31E 03 5.31E 03 5.31E 03 5.31E 03 C 14 2.65E 04 5.31E 03 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 la 24 1.06E 04 0.00E-01 0.00E-01 0.00E-01 1.61E 04 32 2.03E 06 1.12E 05 7.74E 04 3.57E 02 P 0.95E 01 5.75E 01 1.32E 01 1.28E 04 CR 51 0.00E-01 0.00E-01 1.00E 06 7.06E 03 2.53E 04 4.98E 03 0.00E-01 4.98E. 03 MN 54 0.00E-01 0.00E-01 1.10E 00 1.25E 04 7.17E 04 56 0.00E-01 1.54E 00 2.21E-01 1.09E 03 MN 3.33E 03 0.00E-01 0.00E-01 8.69E 04 FE 55 1.97E 04 1.17E 04 1.02E 06 2.48E 04 2.35E 04 9.48E 03 0.00E-01 0.00E-01 FE 59 1.36E 04 i 1.82E 03 0.00E-01 0.00E-01 7.77E 05 1.11E 04 ' C) 58 0.00E-01 1.22E 03 4.51E 06 3.19E 04 ' 8.02E 03 1.18E 04 0.00E-01 0.00E-01 00 60 0.00E-01 0.00E-01 2.09E 05 2.42E 03 2.04E 04 1.16E 04 0.00E-01 NT 63 3.39E 05 0.00E-01 0.00E-01 8.12E 03 S.01E 04 NI 65 2.39E 00 2.84E-01 1.23E-01 1.50E 04
- 7. 74 E-01 0.00E-01 3.98E 00 9.30E 03 CU 64 0.00E-01 1.88E 00 6.47E 05 5.14E 04 6.26E 04 3.11E 04 0.00E-01 3.25E 04 ZN 65 1.93E 04 0.00E-01 4.02E-02 1.47E 03 1.32E 04 69 5.39E-02 9.67E-02 7.18E-03 1.40E-15 '
ZN 3.81E 02 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 1.40E-15 0.00E-01 4.00E 02 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1.40E-15 BR 85 0.00E-01 0.00E-01 2.04E 01 3.04E 03 8.82E 04 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 1.90E 05 0.00E-01 3.39E 02 S.57E 02 2.87E 02 0.00E-01 0.00E-01 nB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 6.82E 01 RB 89 0.00E-01 3.21E 02 2.06E 02 6.40E 04 1.14E 04 0.00E-01 0.00E-01 2.03E 06 SR 89 3.98E 05 0.00E-01 1.12E 07 1.31E 05 - 0.00E-01 2.59E 06 0.00E-01 0.00E-01 SR 90 4.09E 07 0.00E-01 0.00E-01 5.26E 04 7.34E 04 9.56E 01 0.00E-01 3.46E 00 SR 91 0.00E-01 0.00E-01 2.38E 04 1.40E 05 ' SR 92 1.05E 01 0.00E-01 3.91E-01 1.04E 05 8.82E 01 0.00E-01 0.00E-01 2.69E 05 Y 90 3.29E 03 0.00E-01 f 1.39E-02 0.00E-01 0.00E-01 2.79E 03 2.35E 03 Y 91M 4.07E-01 0.00E-01 7.03E 04 0.00E-01 1.57E 04 0.00E-01 0.00E-01 2.45E 06 Y 91 5.88E 05 0.00E-01 2.45E 04 1.27E 05 1.64E 01 0.00E-01 4.61E-01 0.00E-01 Y 92 A-53 ADM 04-019 Rev. 5 Page 151 of 202 l %TC.? ' HBWNTXl.'-Ufe2L%W.M&Q. Ai$$d;',%&YSlaQhk.l.Q'& .,h&,f*' [l *
.{lf.l 't
I TABLE A.5-5 (corat ' d) INHALATION PATHWAY FACTOR 3 MREM /YR PER pCI/M ' INFANT (RI FACTORS) LIVER T BODY 'IEYROID KIDNEY LUtG GI-LLI NUCLIDE BONE 0.00E-01 4.07E 00 0.00E-01 0.00E-01 7.64E 04 1.67E 05 Y 93 1.50E 02 2.17E 04 1.15E 05 2.79E 04 2.03E 04 0.00E-01 3.11E 04 1.75E 06 ZR 95 1.10E 05 1.40E 05 ZR 97 1.50E 02 2.56E 01 1.17E 01 0.00E-01 2.59E 01 6.43E 03 3.78E 03 0.00E-01 4.72E 03 4.79E 05 1.27E 04 i NB 95 1.57E 04 4.87E 04 0.00E-01 1.65E 02 3.23E 01 0.00E-01 2.65E 02 1.35E 05
}O 99 3.11E-02 8.11E 02 2.03E 03 l K 99M 1.40E-04 2.88E-03 3.72E-02 0.00E-01 .
~
8.23E-05 8.12E-04 0.00E-01 9.79E-04 5.84E 02 8.44E 02 YC 101 6.51E-05 1.61E 04 2.02E 03 0.00E-01 6.79E 02 0.00E-01 4.24E 03 5.52E 05 RU 103 8.99E-01 1.57E 04 4.84E 04 RU 105 1.22E 00 0.00E-01 4.10E-01 0.00E-01 , 0.00E-01 1.09E 04 0.00E-01 1.07E 05 1.16E 07 1.64E 05 RU 106 8.68E 04 3.30E 04 9.98E 03 7.22E 03 5.00E 03 0.00E-01 1.09E 04 3.67E 06 N3 110M 0.00E-01 4.47E 05 1.29E 04 TE 12SM 4.76E 03 1.99E 03 6.58E 02 1.62E 03 6.90E 03 2.07E 03 4.87E 03 3.75E 04 1.31E 06 2.73E 04 TE 127M 1.67E 04 4.89E-01 1.85E 00 4.86E 00 1.03E 04 2.44E 04 TE 127 2.23E 00 9.53E-01 6.09E 03 2.23E 03 5.47E 03 3.18E 04 1.68E 06 6.90E 04 TE 129M 1.41E 04 3.47E-02 1.88E-02 6.75E-02 1.75E-01 3.00E 03 2.63E 04 TE 129 7.88E-02 5.50E 01 3.63E 01 8.93E 01 2.65E 02 1.99E 05 1.19E 05 TE 131M 1.07E 02 8.22E 03 0.22E-03 5.00E-03 1.58E-02 3.99E-02 2.06E 03 $ TE 131 1.74E-02 2.37E 02 1.76E 02 2.79E 02 1.03E 03 3.40E 05 4.41E 04 TE 132 3.72E 02 0.00E-01 1.99E 03 I 130 6.36E 03 1.39E 04 5.57E 03 1.60E 06 1.53E 04 4.44E 04 1.96E 04 1.48E 07 5.18E 04 0.00E-01 1.06E 03 1 131 3.79E 04 3.54E 03 1.26E 03 1.69E 05 3.95E 03 0.00E-01 1.90E 03 I 132 1.69E 03 2.16E 03 133 1.32E 04 1.92E 04 5.60E 03 3.56E 06 2.24E 04 0.00E-01 1 1.88E 03 6.65E 02 4.45E 04 2.09E 03 ,0. 00E-01 1.29E 03 I 134 9.21E 02 7.60E 03 2.77E 03 6.96E 05 8.47E 03 0.00E-01 1.83E 03 I 135 3.86E 03 1.33E 03 3.96E 05 7.03E 05 7.45E 04 0.005-01 1.90E 05 7.97E 04 CS 134 1.18E 04 CS 136 4.03E 04 1.35E 05 5.29E 04 0.00E-01 5.64E 04 1.43E OJ I 6.12E 05 4.55E 04 0.00E-01 1.72E 05 7.13E 04 1.33E 03 CS 137 5.49E 05 6.54E 01 8.76E 02 CS 138 5.05E 02 7.81E 02 3.98E 02 0.00E-01 4.10E 02 9.84E-04 4.30E-02 0.00E-01 5.92E-04 5.95E 03 5.10E 04 BA 139 1.48E 00 A-54 ADM 04-039 Rev. 5 Page 152 cf 202 i f I O .onaWWm9 tat 2mWmWE5MF4 6 Td;p350;p a g g g g g g .gg .g ;
;a
i i l TABLE A.5-5 (cont' d) INHALATION PATHWAY FACTOR MREM /YR PER pCI/M' INFANT (RI FACTORS) I LIVliR T BJDY 'mYROID KIDfEY LUtG GI-LLI
'NUCLIDE BONE 5.60E 01 2.90E 03 0.00E-01 1.34E 01 1.60E 06 3.84E 04 l BA 140 5.60E 04 4.75E 03 1.57E-01 1.08E-04 4.97E-03 0.00E-01 6.50E-05 2.97E 03 l BA 141 1.90E-05 1.5SE 03 6'93E 02 BA 142 3.98E-02 3.30E-05 1.96E-03 0.00E-01 .
.i 2.00E 02 5.15E 01 0.00E-01 0.00E-01 1.68E 05 8.48E 04 IA 140 5.05E 02 8.22E 03 5.95E 04 3.77E-01 9.04E-02 0.00E-01 0.00E-01 1A 142 1.03E 00 5.25E 03 5.17E 05 2.16E 04 CE 141 2.77E 04 1.67E 04 1.99E 03 0.00E-01 1.93E d2 2.21E 01 0.00E-01 5.64E 01 1.16E 05 4.97E 04 I CE 143 2.93E 02 1.48E 05 3.19E 06 1.21E 06 1.76E 05 0.00E-01 5.38E 05 9.84E 06 !
CE 144 1.97E 03 4.33E 05 3.72E 04 ! PR 143 _ 1.40E 04 5.24E 03 6.99E 02 0.00E-01 1.85E-02 2.41E-03 0.00E-01 6.72E-03 1.61E 03 4.28E 03 i PR 144 4.79E-02 3.12E 04 7.94E 03 8.13E 03 5.00E 02 0.00E-01 3.15E 03 3.22E 05 l 10 147 3.96E 05 3.56E 04 W 187 1.30E 01 9.02E 00 3.12E 00 0.00E-01 0.00E-01 l 3.32E 01 1.88E 01 0.00E-01 6.62E 01 5.95E 04 2.49E 04 te 239 3.71E 02 ; 4 l ) I t I f k i A-55 l ADM 04-019 r Rev. a ; Page 153 of 202 : i " - P. g ksag ge; .
- i. /, t 4 ( N 4 4 '. ,
- 4 TABLE A.5-6 ,
GRASS-COW-MILK PATHWAY FACTOR ,1 M' MREM /YR PER pCI/SEC ADULT (RI FACTORS) ', LIVER T BCDY 'IHYBOID KIDNEY IDC GI-1LI JM LIDE BONE 7.63E 02 7.63E O2 7.63E 02 7.63E 02 7.63E 02 4 H 3 0.00E-01 7.63E 02 j 5.27E 07 5.27E 07 5 27E 07 C 14 2.63E 08 5.27E 07 5.27E 07 2.44E 06 2.44E 06 5.27E 07 *! 2.44E 06 ; 24 2.44E 06 2.44E 06 2.44E 06 2.44E 06 NA ! 0.00E-01 0.00E-01 0.00E-01 1.92E 09 P 32 1.71E 10 1.06E 09 6.60E 08 2.86E 04 0.00E-01 6.30E 03 3.79E 04 7.19E 06 i CR 51 0.00E-01 0.00E-01 2.58E 07 1.61E 06 0.00E-01 0.00E-01 0.00E-01 l MN 54 0.00E-01 8.41E 06 1.33E-01 : 4.16E-03 7.38E-04 0.00E-01 5.28E-03 0.00E-01 MN 56 0.00E-01 9.67E 06 9.95E 06 1.73E 07 4.04E 06 0.00E-01 0.00E-01 FE 55 2.51E 07 1.95E 07 2.33E 08 : 6.98E 07 2.68E 07 0.00E-01 0.00E-01 FE 59 2.97E 07 : 1.06E 07 0.00E-01 0.00E-01 0.00E-01 9.56E 07 CO 58 0.00E-01 4.71E 06 3.08E 08 1.64E 07 3.62E 07 0.00E-01 0.00E-01 0.00E-01 00 60 0.00E-01 0.00E-01 9.73E 97 l 6.73E 09 4.71E 08 2.26E 08 0.00E-01 0.00E-01 NI 63 2.75E-02 0.00E-01 0.00E-01 0.00E-01 1.53E 00 NI 65 4.63E-01 6.02E-02 2.03E 06 2.39E 04 1.12E 04 0.00E-01 6.02E 04 0.00E-01 CU 64 0.00E-01 2.92E 09 0.00E-01 2.75E 09 65 1.37E 09 4.37E 09 1.97E 09 0.00E-01 ZN I 6.95E-13 0.00E-01 6.49E-12 0.00E-01 1.50E-12 ZN 69 5.22E-12 9.99E-12 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01
- . 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR ,
0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 0.00E-01 2.59E 09 1.21E 09 0.00E-01 0.00E-01 0.00E-01 5.12E 08 , RB 86 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 l RB 89 0.00E-01 0.00E-01 2.33E 08 l 0.00E-01 4.16E 07 0.00E-01 0.00E-01 0.00E-01 SR 89 1.45E 09 0.00E-01 1.35E 09 90 4.68E 10 0.00E-01 1.15E 10 0.00E-01 0.00E-01 SR 0.00E-01 0.00E-01 1.37E 05 I SR 91 2.07E 04 0.00E-01 1.16E 03 0.005-01 2.12E-02 0.00E-01 0.00E-01 0.00E-01 9.70E 00 l SR 92 4.90E-01 0.00E-01 7.50E 05 0.00E-01 1.90E 00 0.00E-01 0.00E-01 0.00E-01 Y 90 7.07E 01 2.34E-21 0.00E-01 0.00E-01 0.00E-01 1.77E-19 Y 91M 6.03E-20 0.00E-01 2.30E 02 0.00E-01 0.00E-01 0.00E-01 4.73E 06 Y 91 8.59E 03 0.00E-01 1.63E-06 0.00E-01 0.00E-01 0.00E-01 9.79E Y 92 5.59E-05 0.00E-01 A-56 ADM 04-019 Rev. 5 Page 154 of 202 l 'e * - -
'
- M.*ff, W. M9M+T 6 @i>V,gi$ f[gQ.p*{'y@Qg {};~ ,- ;-- ,
TABLE A.5-6 (cont'd) GRASS-COW-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC ADULT (RI FACTORS)
'1HYROID KIDNEY LUtG GI-ILI FOJE LIVER T BODY JR'LIDE 0.00E-01 0.00E-01 0.00E-01 7.39E 03 ,
93 2.33E-01 0.00E-01 6.44E-03 9.59E 05 Y 2.05E 02 0.00E-01 4.75E 02 0.00E-01 l ZR 95 9.44E 02 3.03E 02 1.328-01 0.00E-01 2.71E 04 4.33E-01 8.75E-05 4.00E-02 0.00E-01 ZR 97 0.00E-01 4.54E 04 0.00E-01 2.79E 08 i 95 8.26E 04 4.59E 04 2.47E 04 5.74E 07 ! NB 4.71E 06 0.00E-01 5.61E 07 0.00E-01 ND 99 0.00E-01 2.48E 07 1.43E 02 4.60E 00 5.56E 03 0.00E-01 99M 3.33E 00
- 9.40E 00 1.20E 02
'JC 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ,
101 0.00E-01 0.00E-01 0.00E-01 1.19E 05
'It 4.38E 02 0.00E-01 3.88E 03 0.00E-01 .
RU 103 1.02E 03 0.00E-01 0.00E-01 5.25E-01 l 3.39E-04 0.00bO1 1.11E-02 RU 105 8.58E-04 0.00E-01 0.00E-01 3.94E 04 0.00E-01 1.32E 06 i RU 106 2.04E 04 0.00E-01 2.58E 03 2.20E 10 3.20E 07 0.00E-01 1.06E 08 0.00E-01 i AG 110M 5.82E 07 5.39E 07 0.00E-01 6.50E 07 i 5.90E 06 2.18E 06 4.90E 06 6.63E 07 TC 12SM 1.63E 07 1.17E 07 1.86E 08 0.00E-01 1.54E 08 i TE 127M 4.58E 07 1.64E 07 5.58E 06 4.84E 02 2.66E 03 0.00E-01 5.16E 04 l TE 127 6.54E 02 2.35E 02 1.41E 02 3.03E 08 9.53E 06 2.07E 07 2.51E 08 0.00E-01 j TE 129M 6.02E 07 2.25E 07 i i 2.18E-10 1.19E-09 0.00E-01 2.14E-10 : TE 129 2.84E-10 1.07E-10 6.29E-11 1.77E 05 1.47E 05 2.80E 05 1.79E 06 0.00E-01 1.73E07l l TE 131M 3.61E 05 1.61E-32 0.00E-01 0.00E-01 ' ; 7 3.67E-33 1.53E-33 1.16E-33 3.01E-33 TE 131 i 1.72E 06 1.50E 07 0.00E-01 7.35E 07 l TE 132 2.40E 06 1.55E 06 1.46E 06 1.05E 08 1.94E 06 0.00E-01 1.07E 06 130 4.20E 05 1.24E 06 4.89E 05 1.12E OB r I 2.43E 08 1.39E 11 7.26E 08 0.00E-01 I 131 2.96E 08 4.24E 08 1.54E 01 7.02E-01 0.00E-01 8.28E-02 1.65E-01 4.41E-01 1.54E-01 I 132 9.90E 08 1.18E 07 0.00E-01 6.05E 06 ; 133 3.87E 06 6.73E 06 2.05E 06 I 9.57E-11 8.78E-12 0.00E-01 4.81E-15 . I 134 2.03E-12 5.5?E-12 1.98E-12 i 2.22E 06 5.40E 04 0.00E-01 3.80E 04 135 1.29E 04 3.37E 04 1.24E 04 2.35E 08 I 1.10E 10 0.00E-01 4.35E 09 1.45E 09 CS 134 5.65E 09 1.35E 10 7.86E 07 1.17E 08 ! 1.03E 09 7.42E 08 0.00E-01 5.73E 08 CS 136 2.61E 08 6.61E 09 0.00E-01 3.43E 09 1.14E 09 1.95E 08 CS 137 7.38E 09 1.01E 10 7.72E-29 1.81E-23 8.97E-24 0.00E-01 1.33E-23 1.31E-24 CS 138 9.16E-24 3.04E-11 1.84E-11 8.09E-08 4.56E-08 3.25E-11 1.34E-09 0.00E-01 PA 139 A-57 ADM L4-019 ! 1 Rev. 5 Page 155 of 202 e - . . . ~~t* :ifM$1e.veW G;Egyg gy.lq % gg g.sg.g g.g ..
l TABLE A.5-6 (cont'd) GRASS-COW-MILK PATHWAY FACTOR , M' MREM /YR PER pCI/SEC l ADULT (RI FACTORS) l LIVER T BODY THYROID KIDtIEY LUtG GI-LLI IU 1IDE DOrlE J 2.69E 07 3.38E 04 1.76E 06 0.00E-01 1.15E 04 1.93E 04 5.54E 07 , 1 m 140 0.00E-01 0.00E-01 0.00E-01 : M 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I BA 142 4.52E 00 2.28E 00 6.02E-01 0.00E-01 0.00E-01 0.00E-01 1.67E 05 ; IA 140 0.00E-01 3.12E-08* IA 142 9.39E-12 4.27E-12 1.06E-12 0.00E-01 0.00E-01 4.84E 03 3.28E 03 3.72E 02 0.00E-01 1.52E 03 0.00E-01 1.25E07l CE 141 . 4.16E 01 3.07E 04 3.40E 00 0.00E-01 1.35E 01 0.00E-01 1.15E 06 CE 143 0.00E-01 1.21E 08 CE 144 3.58E 05 1.50E 05 1.92E 04 0.00E-01 8.87E 04 4 6.33E 01 7.83E 00 0.00E-01 3.66E 01 0.00E-01 6.92E 05 Mt 143 1.58E 02 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 HI 144 0.00E-01 0.00E-01 5.25E 05 to 147 9.46E 01 1.09E 02 6.55E 00 0.00E-01 6.40E 01 6.56E 03 5.49E 03 1.92E 03 0.00E-01 0.00E-01 0.00E-01 1.80E 06 W 107 3.61E-01 1.99E-01 0.00E-01 1.13E 00 0.00E-01 7.41E 04 NP 239 3.67E 00 I h 1 I A-58 ADM 04-019 Rev. 5 Page 156 cf 202 e -
. ; ggggg -- *r. :m ..9 % A g g,Aq,t g y ; . .
l TAGLE A.5-7 i i GRASS-COW-MILK PATHWAY FACTOR M' MREM /YR PER pCI/SEC f TEEN (RI FACTORS) T 10trr "DtYROID KIDNEY LUPC GI-LLI NtXIIDE BONE LIVER J 9.94E 02 9.94E 02 9.94E 02 9.94E 02 9.94E 02 H 3 0.00E-01 9.94E 02 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 * .l C 14 4.86E 08 4.26E 06 4.26E 06 ) 24 4.26E 06 4.26E 06 4.26E 06 4.26E 06 4.26E 06 NA 1.22E 09 0.00E-01 0.00E-01 0.00E-01 2.65E 09 P 32 3.15E 10 1.95E 09 l 0.00E-01 4.99E 04 2.77E 04 1.09E 04 7.13E 04 8.39E 06 l CR 51 0.00E-01 0.00E-01 2.87E 07 54 0.00E-01 1.40E 07 2.78E 06 0.00E-01 4.18E 06 MN 1.31E-03 0.00E-01 9.33E-03 0.00E-01 4.85E-01 NN 56 0.00E-01 7.37E 03 7.36E 06 0.00E-01 0.00E-01 2.00E 07 1.37E 07 FE 55 4.45E 07 3.16E 07 4.67E 07 0.005-01 0.00E-01 3.81E 07 2.86E 08 FE 59 5.18E 07 1.21E 08 l 7.94E 06 1.83E 07 0.00E-01 0.00E-01 0.00E-01 1.09E 08 00 58 0.00E-01 3.62E 08 2.78E 07 6.26E 07 0.00E-01 0.00E-01 0.00E-01 00 60 0.00E-01 1.33E 08 1.18E 10 8.35E 08 4.01E 08 0.00E-01 0.00E-01 0.00E-01 NI 63 1.08E-01 4.94E-02 0.00E-01 0.00E-01 0.00E-01 5.88E 00 NI 65 8.48E-01 3.30E 06 4.2SE 04 2.00E 04 0.00E-01 1.08E 05 0.00E-01 CU 64 0.00E-01 3.10E 09 2.11E 09 7.31E 09 3.41E 09 0.00E-01 4.68E 09 0.00E-01 ZN 65 1.83E-11 1.28E-12 0.00E-01 1.20E-11 0.00E-01 3.38E-11 ZN 69 9.62E-12 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I BR 83 0.00E-01 0.00E-01 0.00E-01' O.00E-01 0.00E-01 0.00E-01 0.00E-01 1 JR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 7.00E 08 86 0.00E-01 4.73E 09 2.22E 09 0.00E-01 0.00E-01 0.00E-01 RB 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 lb3 89 0 005-01 3.19E 08 89 2.67E 09 0.00E-01 7.66E 07 0.00E-01 0.005-01 0.00E-01 SR 6.61E 10 0.00E-01 1.63E 10 0.00E-01 0.00E-01 0.00E-01 1.86E 09 SR 90 5.27E 04 0.00E-01 2.10E 03 0.00E-01 0.00E-01 0.00E-01 2.39E 05 SR 91 0.00E-01 3.82E-02 0.00E-01 0.00E-01 0.00E-01 2.28E 01 SR 92 8.96E-01 1.07E 06 1.30E 02 0.00F.-01 3.50E 00 0.00E-01 0.00E-01 0.00E-01 Y 90 1.11E-19 0.00E-01 4.22E-21 0.00E-01 0.00E-01 0.00E-01 5.22E-18 Y 91M 0.00E-01 4.24E 02 0.00E-01 0.00E-01 0.00E-01 6.48E 06 Y 91 1.58E 04 0.00E-01 2.99E-06 0.00E-01 0.00E-01 0.00E-01 2.83E 00 Y 92 1.03E-04 A-59 ADM 04-019 Rev. 5 Page 157 of 202 e gg.ggg 'g g, ., e
- b E(Cf.GRW,M%
i TABLE A.5-7 (cont'd) GRASS-COW-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC ; TEEN (RI FACTORS) ; fU1IDE BCNE LIVER T BODY 'DmtOID KIDNEY LUfG GI-ILI Y 93 4.30E-01 0.00E-01 1.18E-02 0.00E-01 0.00E-01 0.00E-01 1.31E 04 ZR 95 1.65E 03 5.21E 02 3.58E 02 0.005-01 7.65E 02 0.00E-01 1.20E 06 ZR 97 7.895-01 1.56E-01 7.19E-02 0.00E-01 2.37E-01 0.00E-01 4.23E 04 j NB 95 1.41E 05 7.81E 04 4.30E 04 0.00E-01 7.57E 04 0.00E-01 3.34E 08 l PE) 99 0.00E-01 4.47E 07 8.53E 06 0.00E-01 1.02E 08 0.00E-01 8.01E 07 7C 99M 5.77E 00 1.61E 01 2.08E 02 0.00E-01 2.40E 02 8.93E 00 1.06E 04 i
'IC 101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RU 103 1.81E 03 0.00E-01 7.74E 02 0.00E-01 6.38E 03 0.00E-01 1.51E 05 !
RU 105 1.57E-03 0.00E-01 6.0BE-04 0.00E-01 1.98E-02 0.00E-01 1.27E 00 ! ; RU 106 3.75E 04 0.00E-01 4.73E 03 0.00E-01 7.23E 04 0.00E-01 1.80E 06 > AG limi 9.63E 07 9.11E 07 5.54E 07 0.00E-01 1.74E 08 0.00E-01 2.56E 10 TE 125M 3.00E 07 1.08E 07 4.02E 06 8.39E 06 0.00E-01 0.00E-01 8.86E 07 l TE 127M 8.44E 07 2.99E 07 1.00E 07 2.01E 07 3.42E 08 0.00E-01 2.10E 08 TE 127 1.21E 03 4.29E 02 2.61E 02 8.36E 02 4.91E 03 0.00E-01 9.35E 04 ; TE '129M 1.10E 08 4.098 07 1.74E 07 3.55E 07 4.61E 08 0.00E-01 4.13E 08 1E 129 5.23E-10 1.958-10 1.27E-10 3.74F-10 2.20E-09 0.00E-01 2.86E-09 i TE 131M 6.57E 05 3.15E 05 2.63E 05 4.74E 05 '3.29E 06 0.00E-01 2.53E 07 TE 131 6.70E-33 2.76E-33 2.09E-33 5.16E-33 2.93E-32 0.00E-01 5.50E-34 ; TE 132 4.29E 06 2.72E 06 2.56E 06 2.87E 06 2.61E 07 0.00E-01 8.61E 07 ; I 130 7.39E 05 2.14E 06 8.54E 05 1.74E 08 3.26E 06 0.00E-01 1.64E 06 l I 131 5.37E 08 7.52E 08 4.04E 08 2.20E 11 1.30E 09 0 00E-01 ,1.49E 08 l I 132 2.92E-01 7.65E-01 2.74E-01 2.58E 01 1.20E 00 0.00E-01 3.33E-01 i I 133 7.07E 06 1.20E 07 3.66E 06 1.67E 09 2.10E 07 0.00E-01 9.08E 06 I 134 3.61E-12 9.58E-12 1.44E-12 1.60E-10 1.51E-11 0.00E-01 1.26E-13 i 1 135 2.28E 04 5.00C 04 2.18E 04 3.78E 06 9.28E 04 0.00E-01 6.51E 04 CS 134 9.82E 09 2.31E 10 1.07E 10 0.00E-01 7.34E 09 2.80E 09 2.87E 08 CS 136 4.44E 08 1.75E 09 1.17E 09 0.00E-01 9.52E 08 1.50E 08 1.41E 08 i CS 137 1.34E 10 1.78E 10 6.20E 09 0.00E-01 6.06E 09 2.35E 09 2.53E 08l CS 138 1.66E-23 3.19E-23 1.60E-23 0.00E-01 2.36E-23 2.74E-24 1.45E-26 BA 139 8.44E-08 5.94E-11 2. 46 D-09 _0.005-01 5.60E-11 4.09E-11 7.53E-07 i l l A-60 ADM 04-019 Rev. 5 Page 158 of 202 l
~
e ,gy "n - %,-w4' Mt>U.gggglOff 6';MQ'JJingli'"s!,1gggp.!,Q.jTyirggt' g'fp - 1 a
~
{ TABLE A.5-7 (cont'd) GPM S-COW-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC TEEN (RI FACTORS) T BODY THYROID KIDtIEY TlJtG GI-LLI ; NUCLIDE dot 4 LIVD1 i i 0.00E-01 2.02E 04 4.00E 04 7.48E 07 l EA 140 4.85E 07 5.95E 04 3.13E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 l BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1 0,00E-01 0.00E-01 0.00E-01 0.00E-01 BA 142 1.06E 00 0.00E-01 0.00E-01 0.00E-01 2.29E 05 LA 140 8.12E 00 3.99E 00 2.29E-07 7.52E-12 1.87E-12 0.00E-01 0.00E-01 0.00E-01 IA 142* 1.69E-11 2.79E 03 0. 00E-01 1.70E 07 8.88E 03 5.5'3r 03 6.81E 02 0.00E-01 , CE 141 0.00E-01 2.49E 01 0.00E-01 1.67E 06 CE 143 7.64E 01 5.56E 04 6.21E 00 3.54E 04 0.00E-01 1.63E 05 0.00E-01 1.66E 08 CE 144 6.58E 05 2.72E 05 9.55E 05 1.44E 01 0.00E-01 6.73E 01 0.00E-01 PR 143 2.90E 02 1.16E 02 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 PR 144 0.00E-01 0.00E-01 7.15E 05 1.98E 02 1.19E 01 0.00E-01 1.16E 02 0.00E-01 to 147 1.82E 02 0.00E-01 0.00E-01 2.65E 06 W 187 1.20E 04 9.78E 03 3.43E 03 0.00E-01 3.67E-01 0.00E-01 2.07E 00 0.00E-01 1.06E 05 te 239 7.01E 00 6.61E-01 1 A-61 ADM 04 -(" 9 R.? v . S Page 159 of 202 T~T WU$!!Y": " l W ' '.'
~
':.T ~ W%f
- O !-s ';3 Y.' ! '?5 ? ? ? j ? U ' .
TABLE A.5-8 GRASS-COW-MILK PATHWAY FACTOR M' MREM /YR PER pCI/SEC CIIILD (RI FACTORS) EmE LIVER T BJDY 'IHYROID KIMEY IHG GI-LLI ntXIIDE 1.57E 03 1.57E 03 1.57E 03 1.57E 03 1.57E 03 H 3 0.00E-01 1.57E 03 2.39E 08 2.39E 08 2.39E 08 2.39E 08 2.39E 08 2.39E 08 C 14 1.19E 09 8.86E 06 8.86E 06 8.86E 06 24 8.86E 06 8.86E 06 8.86E 06 8.86E 06 trA i 3.00E 09 0.00E-01 0.00E-01 0.00E-01 2.15E 09 P 32 7.77E 10 3.64E 09 5.40E 06 0.00E-01 1.02E 05 5.65E 04 1.54E 04 1.03E 05 CR 51 0.00E-01 5.88E 06 0.00E-01 1.76E 07 ! 54 0.00E-01 2.10E 07 5.59E 06 0.00&O1 MN 2.90E-03 0.00E-01 1.56 W02 0.00E-01 1.86E 00 HN 56 0.00E-01 1.29E-02 1.10E 07 1.84E 07 0.00E-01 0.00E-01 3.35E 07 FE 55 1.12E 08 5.93E 07 5.64E 07 2.02E 08 1.94E 08 9.69E 07 0.00E-01 0.00E-01 FE 59 1.20E 08 3.71E 07 0.00E-01 0.00E-01 0.00E-01 7.07E 07 CD 58 0.00E-01 1.21E 07 2.39E 08 4.32E 07 1.27E 08 0.00E-01 0.00E-01 0.00E-01 CD 60 0.00E-01 0.00E-01 0.00E-01 1.07E 08 63 2.96E 10 1.59E 09 1.01E 09 0.00E-01 HI 1.14E-01 0.00E-01 0.00E-01 0.00E-01 2.39E 01 NI 65 2.07C 00 1.95E-01 3.51E 06 7.47E 04 4.51E 04 0.00E-01 1.81E 05 0.00E-01 CU 64 0.00E-01 0.00E-01 1.93E 09 4.13E 09 1.10E 10 6.85E 09 0.00E-01 6.94E 09 2N 65 0.00E-01 2.07E-11 0.00E-01 2.15E-09 ZN 69 2.36E-11 3.42E-11 3.16E-12 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 a 171 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 85 0.00E-01 0.00E-01 5.64E 08 III 5.39E 09 0.00E-01 0.00E- 01 0.00E-01 RB 86 0.00E-01 8.77E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 PR 88 0.00E-01 0.00E- 01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 1.89E 08 0.00E--01 0.00E-01 0.00E-01 2.56E 08 SR 89 6.62E 09 0.00E-01 1.50E 09 0.00E-01 2.83E 10 0.00E-01 0.00E-01 0.00E-01 SR 90 1.12E 11 4.88E 03 0.00E-01 0.005-01 0.00E-01 2.85E 05 SR 91 1.29E 05 0.00E-01 4.15E 01 0.00E-01 8.78E-02 0.00E-01 0.00E-01 0.00E-01 SR 92 2.19E 00 0.00E-01 9.15E 05 0.00E-01 8.61E 00 0.00E-01 0.00E-01 Y 90 3.22E 02 0.00E-01 0.00E-01 0.00E-01 5.29E-16 Y 91M 91 2.70E-19 3.90E 04 0.00E-01 0.90E-01 9.82E-21 1.04E 03 0.00E-01 0.00E-01 0.00E-01 5.20E 06 l! Y 0.00E-01 7.33E 00 2.54E-04 0.09E-01 7.26E-06 0.00E-01 0.00E-01 Y 92 A-62 9/93 ADM 04-019 Rev. 5 Page 160 of 202
. y '/
TABLE A.5-8 (cont'd) GRASS-COW-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC CHILD (RI FACTORS)
'IHYROID KIDNET LUtG GI-ILI BOtE LIVER T DODY ggLJDE 0.00E-01 0.00E-01 0.00E-01 1.57E 04 93 1.06E 00 0.00E-01 2.90E-02 8.79E 05 Y
7.50E 02 0.00E-01 1.21E 03 0.00E-01 ZR 95 3.83E 03 8.43E 02 0.00E-01 4.20E 04 2.77E-01 1. 64 E-01 0.00E-01 3.98E-01 ZR 97 1.92E 00 0.00E-01 1.16E 05 0.00E-01 2.29E 08 15 3.18E 05 1.24E 05 8.85E 04 6.73E 07 NB 2.01E 07 0.00E-01 1.74E 08 0.00E-01 10 99 0.00E-01 8.14E 07 1.32E 01 1.48E 04 2.59E 01 4.30E 02 0.00E-01 3.77E 02 E 99M 1.32E 01 0.00E-01 0.00E-01 0.00E-01 0.0'JE-01 TC 101 0.00E-01 0.00E-D1 0.00E-01 1.11E 05 1.65E 03 0.00E-01 1.08E 04 0.00E-01 RU 103 4.28E 03 0.00E-01 0.00E 01 2.50E 00 0.00E-01 1.3SE-03 0.00E-01 3.36E-02 RU 105 3.83E-03 0.00E-01 1.25E 05 0.00E-01 1.44E 06 RU 106 9.24E 04 0.00E-01 1.15E 04 1.68E 10 1.13E 08 0.00E-01 2.63E 08 C.00E-01 AG 110M 2.09E 08 1.41E 08 2.00E-01 7.12E 07 2.00E 07 9.84E 06 2.07E 07 0.00E-01 TE 125M 7.38E 07 4.97E 07 5.93E 08 (> . 00E-01 1.68E 08 TE 127M 2.08E 08 5.60E 07 2.47E 07 1.16E 05 6.39E 02 2.06E 03 0.47E 03 0.00E-01 TE 127 2.98E 03 8.03E 02 0.0tcE-01 3.31E 08 l 7.58E 07 4.21E 07 8.75E 07 7.97E 08 TE 129M 2.71E 08 3.78E-09 0.00E-01 8.03E-08 1.29E-09 3.60E-10 3.06E-10 9.21E-10 T2 129 1.14E 06 5.36E 06 0.00E-Ot 2.24E 07 TE 131M 1.60E 06 5.53E 05 5.89E 05 4.89E-33 1.26E-32 4.97E-32 0.00E-01_ 8.64E-32 ; d TE 131 1.64E-32 5.01E-33 6.61E 06 4.21E 07 0.00E-01 4.57E 07 TE 132 1.02E 07 4.54E 06 5.48E 06 1.63E 06 3.85E 08 5.22E 06 0.00E-01 130 1.73E 06 3.49E 06 1.80E 06 1.17E 08 I 7.45E 08 4.33E 11 2.15E 09 0.00E-01 I 131 1.30E 09 1.31E 09 5.89E 01 1.94E 00 0.00E-01 1.49E 00 132 6.91E-01 1.27E 00 5.84E-01 8.56E 06 I 8.04E 06 3.95E 09 3.54E 07 0.00E-01 133 1.72E 07 2.12E 07 0.00E-01 1.05E-11 I 1.595-11 7.31E-12 3.65E-10 2.43E-11 I 134 3.55E-12 8.62E 06 1.49E 05 0.00E-01 7.41E 04 ) 135 5.41E 04 9.73E 04 4.60E 04 2.00E 08 ' I 7.84E 09 0.00E-01 1.15E 10 4.13E 09 ; CS 134 2.27E 10 3.72E 10 2.19E 08 9.69E 07 2.76E 09 1.78E 09 ^ 0.00E-01 1.47E 09 CS 136_ 1.00E 09 0.00E-01 1.01E 10 3.62E 09 1.93E 08 . CS 137 3.22E 10 3.09E 10 4.55E 09 2.58E-23 3.55E-23 0.00E-01 3.94E-23 4.24E-24 CS 138 4.03E-23 5.60E-23 6.51E-11 1.20E-05 6.01E-09 0.00E-01 9. 67E-11 Lw 139 _2.07E-07 1.11E-10 A-63 9/93 i ADM 04-019 Rev. 5 Page 161 of 202 e ~ p., . L' % % ?.ML S E5 M Ya Q R *).Q y ;
,.y ( } ,,.
TABLE A.5-8 (cont'd) GRASS-COW-MILK PATHWAY FACTOR M' MREM /YR PER pCI/SEC CHILD (RI FACTORS) LIVER T DODY 'IHi'BOID KIDrEY IRG GI-ILI _tRJ3,IDE DONE 6.84E 06 0.00E-01 3.34E 04 6.12E 04 5.94E 07 BA 140 1.17E 08 1.03E 05 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 DA 142 2.29E 00 0.00E-01 0.00E-01 0.00E-01 1.89E 05 IA 140 1.94E 01 6.80E 00 0.00E-01 2.58E-06 1.30E-11 4.08E-12 0.00E-01 0.00E-01 IA 142 4.09E-11 1.62E 03 0.00E-01 4.78E 03 0.00E-01 1.36E 07 CE 141 2.19E 04 1.09E 04 i 1.47E 01 0.00E-01 4.27E 01 0.00E-01 1.49E 06 CE 143 1.88E 02 1.02E 05 1.33E 08 8.66E 04 0.00E-01 2.82E 05 0.00E-01 CE 144 1.62E 06 5.09E 05 0.00E-01 7.75E 05 2.16E 02 3.56E 01 0.00E-01 1.17E 02 PR 143 7.18E 02 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 PR 144 0.00E-01 0.00E-01 2.80E 01 0.00E-01 1.99E 02 0.00E-01 5.73E 05 to 147 4.47E 02 3.62E 02 2.42E 06 1.72E 04 7.73E 03 0.00E-01 0.00E-01 0.00E-01 W 187 2.91E 04 8.70E-01 0.00E-01 3.58E 00 0.00r-01 9.16E 04 NP 239 1.72E 01 1.24E 00 [ 1 I 1
'. A-64 4
ADM 04-019 s Rev. E Page ;62 of 202 w -
- Se *: n . a g tn pg y g,j;t . p ;y ; p , g 4 g g 3 g 3 3 3 g. g3 . ,
TABLE A.5-9 GRASS-COW-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC I INFANT (RI FACTORS) KIIEEY LUtG GI-ILI LIVER _ T uuvi 'DIYROID rarLIDE BONE 2.38E 03 2.38E 03 2.38E 03 0.00E-01 2.38E 03 2.38E 03 2.38E 03 5.00E 08 H 3 5.00E 08 5.00E 08 5.00E 08 14 2.34E 09 5.00E 08 5.00E 08 1.54E 07 1.54E 07 C 1.54E 07 1.54E 07 1.54E 07 NA 24 1.54E 07 1.54E 07 0.00E-01 0.00E-01 0.00E-01 2.17E 09 32 1.60E 11 9.42E 09 6.21E 09 2.05E 05 4.70E 06 P 1.61E 05 1.05E 05 2.30E 04 CR 51 0.00E-01 0.00E-01 8.64E 06 0.00E-01 1.43E 07 3.90E 07 8.64E 06 0.00E-01 NN 54 0.00E-01 . 2.71E-02 0.00E-01 2.86E 00 3.15E-02 5.43E-03 0.00E-01 1.11E 07 MN 56 0.00E-01 0.00E-01 0.bOE-01 4.26E 07 55 1.35E 08 8.72E 07 2.33E 07 1.16E 08 1.87E 08 FE 1.54E 08 0.00E-01 0.00E-01 FE 59 2.24E 08 3.92E 08 0.00E-01 0.00E-01 6.04E 07 2.43E 07 6.05E 07 0.00E-01 CO 58 0.00E-01 0.00E-01 0.00E-01 0.00E-01 2.10E 08 60 0.00E-01 8.82E 07 2.08E 08 0.00E-01 1.07E 08 CO 2.16E 09 1.21E 09 0.00E-01 0.00E-01 NI 63 3.49E 10 0.00E-01 0.00E-01 0.00E-01 3.78E 01 65 4.39E 00 4.97E-01 2.26E-01 3.81E 06 NI 0.00E-01 3.14E 05 0.00E-01 64 0.00E-01 1.86E 05 8.60E 04 0.00E-01 1.61E 10 CU 0.00E-01 9.23E 09 65 5.55E 09 1.90E 10 8.78E 09 ZN 3.77E-11 0.00E-01 7.40E-09 9.07E-11 6.75D-12 0.00E-01 ZN 69 5.04E-13 0.00E-01 0.00E-01 0.00E-01
*0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 g BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 85 0.00E-01 0.00E-01 0.00E-01 5.70E 08 BR 1.10E 10 0.00E-01 0.00E-01 0.00E-01 86 0.00E-01 2.23E 10 0.00E-01 0.00E-01 RB 0.00E-01 0.00E-01 0.00E-01 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rn 89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 2.59E 08 0.00E-01 3.61E 08 0.00E-01 0.00E-01 GR 89 1.26E 10 0.00E-01 0.00E-01 1.52E.Q9 0.00E-01 3.10E 10 0.00E-01 jh't 90 1.22E 11 0.00E-01 0.00E-01 0.00E-01 3.19E 05 SR 91 2.69E 05 0.00E-01 9.75E 02 9.00E-01 5.02E 01 1.73E-01 0.00E-01 0.00E-01 SR 92 4.66E 00 0.00E-01 0.00E-01 0.00E-01 9.39E 05 0.00E-01 1.82E 01 0.00E-01 y__, _ 90 6.80E 02 0.00E-01 0.00E-01 0.00E-01 1.91E-15 5.72E-19 0,00E-01 1.95E-20 5.25E 06 Y 91M 0.00E-01 0.00E-01 0.00E-01 7.33E 04 0.00E-01 1.95E 03 1.03E 01 Y 91 1.51E-05 0.00E-01 0.00E-01 0.00E-01 Y 92 5.39E-04 0.00E-01 A-65 i
ADM 04-019 Rev. 5 Page 1G3 of 202 f w > ywsum agia - yggg gg _
l TABLE A.5-9 (cont'd) GRASS-COW-MILK PATHWAY FACTOR M# MREM /YR PER pCI/SEC l INFANT (RI FACTORS) i LIVER T tuTI 'I1rIROID FJDNE"I IRG GI-LLI NLY'LIDE EOJE 6.13E-02 0.00E-01 0.00E-01 0.00E-01 1.78E 04 Y 93 2.25E 00 0.00E-01 8.26E 05 1.66E 03 1.18E 03 0.00E-01 1.79E 03 0.00E-01 ZR 95 6.81C 03 0.00E-01 4.45E 04 6.980-01 3.19E-01 0.00E-01 7.03E-01 ZR 97 4.06E 00 1.41E 05 0.00E-01 1.75E 05 0.00E-01 2.06E 08 NB 95 5.94E 05 2.45E 05 6.85E 07 2.08E 08 4.06E 07 0.00E--01 3.11E 08 0.00E-01 m 99 0.00E-01 7.31E 02 0.00E-01 _6.11E 02 2.97E 01 1.65E 04
'It 99M 2.75E 01 5.68E 01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 TC 101 0.00E-01 0.00E-01 1.05E 05 0.00E-01 2.90E 03 0.00E-01 1.80E 04 0.00E-01 RU 103 8.67E 03 0.00E-01 3.21E 00 0.00E-01 2.72E-03 0.00E-01 5.93E-02 RU 105 8.07E-03 2.38E 04 0.00E-01 2.25E 05 0.00E-01 1.44E 06 RU 106 1.90E 05 0.00E-01 1.86E 08 0.00E-01 4.03E 08 0.00E-01 1.46E 10 1G 110M 3.86E 08 2.82E 08 7.18E 07 5.04E 07 2.04E 07 5.07E 07 0.00E-01 0.00E-01 TE 125M 1.51E 08 5.10E 07 1.22E 08 1.04E 09 0.00E-01 1.70E 08 TE 127M 4.21E 00 1.40E 08 1.36E 03 5.15E 03 1.54E 04 0.00E-01 1.33E 05 TE 127 6.32E 03 2.12E 03 8.58E 07 2.14E 08 1.39E 09 0.00E-01 3.33E 08 TE 129M 5.57E 08 1.91E 08 6.39E-10 2.29E-09 6.81E-09 0.00E-01 2.19E-07 TE 129 2.74E-09 9.43E-10 2.29E 07 1.36E 06 1.12E 06 2.76E 06 9.36E 06 0.00E-01 AA TE 131M 3.38E 06 0.00E-01 1.41E-30 1.29E-32 9.78E-33 3.11E-32 8.91E-32 TE 131 3.49E-32 9.75E 06 1.54E 07 6.53E 07 0.00E-01 3.87E 07 TE 132 2.11E 07 1.05E 07 7.81E 06 3.14E 06 8.76E 08 8.58E 06 0.00E-01 1.68E 06 I 130 3.55E 06 3.74E 09 0.00E-01 1.14E 08 131 2.72E 09 3.21E 09 1.41E 09 1.05E 12 I
1.04E 00 1.37E 02 3.25E 00 0.00E-01 2.36E 00 I 132 1.430 00 2.91E 00 8.94E 06 5.28E 07 1.55E 07 9.61E 09 6.21E 07 0.00E-01 1 133 3.63E 07 0,00E-01 3.76E-11 1.77E-11 3.63E-11 1.29E-11 8.47E-10 4.06E-11 I 134 8.15E 04 2.00E 07 2.49E 05 0, -01 8.09E 04 135 1.12E 05 2.24E 05 I 6.87E 09 0.00E-01 1.75E 10 6.21E 09 1.85E 08 CS 134 3.65E 10 6.80E 10 5.76E 09 2.15E 09 0.00E-01 2.30E 09 4.70E 08 8.75E 07 , CS 136 1.96E 09 4.27E 09 0.00E-01 1.62E 10 6.55E 09 1.88E 08 CS 137 5.15E 10 6.02E 10 2.21E-22 6.70E-23 0.00E-01 6.89E-23 1.0BE-23 CS 138 8.50E-23 1.38E-22 2.SOE-05
- 2. 93E-10 1.28E-08 0.00E-01 1.76E-10 1.77E-10 m 139 4.41E-07 A-66 ADM 04-019 Rev 5 Page 164 of 202 e
]}
2*' - '
"Ot" - @ M M M , M M !7 f;T 3 ', , -c {-
TABLE A.5-9 (cont' d) GRASS-COW-MILK PATHWAY FACTOR M' MREM /YR PER pCI/SEC IfiFANT (RI FACTORS) LUIG GI-LLI j T UODY '1UYROID KIDNEY
!ECLIDE FONE LIVER 0.00E-01 5.72E 04 1.48E 05 5.92E 07 l 2.41E 08 2.41E 05 1.24E 07 0.00E-01 1 M 140 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 M 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1.88E 05 4.06E 01 1.60E 01 4.12E 00 5.36E-06 1A 140 7.55E-12 0.00E-01 0.00E-01 0.00E-01 4 1A 142 8.59E-11 3.15E-11 8.16E 03 0.00E-01 1.37E 07 2.64E 04 3.11E 03 0.00E-01 CE 141 4.34E 04 0.00E-01 7.67E 01 0.00E-01 1.54E 06 CE 143 3.97E 02 2.63E 05 3.00E 01 0.00E-01 1.33E 08 1.30E 05 0.00E-01 3.85E 05 CE 144 2.33E 06 9.52E 05 2.07E 02 0.00E-01 7.84E 05 1.49E 03 5.56E 02 7.36E 01 0.00E-01 PR 143 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 5.77E 05 PR 144 0.00E-01 3.51E 02 0.00E-01 ND 147 8.86E 02 9.10E 02 5.57E 01 2.50E 06 1.47E 04 0.00E-01 0.00E-01 0.00E-01 W 187 6.12E 04 4.26E 04 0.00E-01 1.50E 00 0.00E-01 9.43E 04 NP 239 3.65E 01 3.26E 00 1.84E 00 dc A-67 ADM 04-019 Rev. 5 f 1
Page 165 of 202
~2' ivi% ;a n JLi m s.;4gm m m g %=5g;4 p y y p . g s.3.3
TABLE A.5-10 GRASS-COW-MEAT PATHWAY FACTOR M' MREM /YR PER pCI/SEC ADUT.T (RI FACTORS)
'IIIYROID KIDNEY LURG GI-LLI NtII,IDE EDfE LIVER T BJOY 3.25E 02 3.25E 02 3.25E 02 3.25E 02 3 0.00E-01 3.25E 02 3.25E 02 4.83E 07 H
4.83E 07 4.83E 07 4.83E 07 4.83E 07 C 14 2.41E 08 4.83E 07 1.36E-03 1.36E-03 i 1.36E-03 1.36E-03 1.36E-03 1.36E-03 im 24 1.36E-03 0.00E-01 0.00E-01 0.00E-01 5.23E 08 32 4.65E 09 2.89E 08 1.80F 08 P 0.00E-01 0.00E-01 7.05E 03- 4.21E 03 1.55E 03 9.35E 03 1.77E06l CR 51 0.00E-01 2.73E 06 0.00E-01 2.81E 07 ! l MN 54 0.00E-01 9.18E 06 1.75E 06
- 0.00E-01 0.00E-01 0.00E-01 0.00E-01 MN 56 0.00E-01 0.00E-01 0.00E-01 1.16E 08 4.72E 07 0.00E-01 0.00E-01 1.13E 08 FE 55 2.93E 08 2.02E 08 1.74E 08 2.08E 09 6.24E 08 2.39E 08 0.00E-01 0.00E-01 FE 59 2.65E 08 '
0.00E-01 0.00E-01 0.00E-01 3.70E 08 CO 58 0.00E-01 1.82E 07 4.09E 07 1.41E 09 1.66E 08 0.00E-01 0.00E-01 0.00E-01 CD 60 0.00E-01 7.52E 07 0.00E-01 2.73E 08 1.32E 09 6.33E 08 0.00E-01 0.00E-01 NI 63 1.89E 10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 NI 65 0.00E-01 0.00E-01 0.00E-01 2.33E-05 2.73E-07 1.28E-07 0.00E-01 6.89E-07 CU 64 0.00E-01 7.57E 08 0.00E-01 7.13E 08 3.56E 08 1.13E 09 5.12E 08 0.00E-01 ZN 65 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 69 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 $d BR 83 0.00E-01 0.00E-01 0 00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 . 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ; 85 0.00E-01 0.00E-01 0.00E-01 BR 2.27E 08 0.00E-01 0.00E-01 0.00E-01 9.61E 07 ! RB 86 0.00E-01 4.87E 08 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BB. 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 4.84E 07 8.66E 06 0.00E-01 0.00E-01 0.00E-01 SR 89 3.02E 08 0.00E-01 3.59E 08 0.00E-01 3.05E 09 0.00E-01 0.00E-01 0.00E-01 SR 90 1.24E 10 5.73E-12 0.00E-01 0.00E-01 0.00E-01 6.76E-10 SR 91 1.43E-10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 92 0.00E-01 0.00E-01 1.13E 06 0.00E-01 2.86E 00 0.00E-01 0.00E-01 Y 90 1.07E 02 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y 91M 0.00E-01 0.00E-01 6.23E 08 3.03E 04 0.00E-01 0.00E-01 0.00E-01 4 Y 91 1.13E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i Y 92 0.00E-01 A-68 ADM 04-019 Rev. 5 Page 166 of 202 e# -
--r , . -.. . .
i,hM7'SMggbgglgggg}gg.g > g
- 0%'4*j g
l' TABLE A.5-10 (cont'd) GRASS-COW-MEAT PATHWAY FACTOR M* MREM /YR PER pCI/SEC ADULT (RI FACTORC) T BODY 'IHYROID KIDNEY URG GI-LLI ,, BONE LIVER HTLIDE 1 0.00E-01 0.00E-01 0.00E-01 2.09E-07 Y 93 6.59E-12 0.00E-01 1.82E-13 4.07E 05 0.00E-01 9 43E 05 0.00E-01 1.90E 0? l ZR 95 1.87E 06 6.01E 05 0.00E-01 1.30E_f ( 4.19E-06 1.92E-06 0.00E-01 6.33E-06 l ZR 97 2.08E-05 0.00E-01 1.2GE 06 0.00E-01 7.76E 09 i Im 95 2.30E 06 1.28E 06 6.88E 05 2.32E 05 1.90E 04 0.00E-01 2.26E 05 0.00E-01 l m 99 0.00E-01 9.99E 04 1.62E-19 0.00E.01 1.93E-19 6.23E-21 7.53E-18 ) T 99M 4.50E-21 1.27E-20 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 4
'It 101 0.00E-01 0.00E-01 0.00E-01 1.23E 10 !
0.00E-01 4.53E 07 0.00E-01 4.01E 08 RU 103 1.05E 08 7.58E-27 0.00E-01 3.59E-25 5.87E-28 0.00E-01 2.32E-28 0.00E-01 Ep 105 0.00E-01 5.40E 09 0.00E-01 1.81E 11 RU 106 2.80E 09 0.00E-01 3.54E 08 2.52E 09 3.67E 06 0.00E-01 1.22E 07 0.00E-01 AG 110M 6.68E 06 6.18E 06 1.43E 09 1.30E 08 4.81E 07 1.08E 08 1.46E 09 0.00E-01 E 125M 3.59E 08 1.36E 08 2.85E 08 4.53E 09 0.00E-01 3.74E 09 TE 127M 1.12E 09 3.99E 08 1.69E-08 7.68E-11 4.63E-11 1.58E-10 8.71E-10 0.00E-01 TE 127 2.14E-10 4.73E 09 0.00E-01 5.71E 09 1.13E 09 4.23E 08 1.80E 08 3.90E 08 TE 129M 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 TE 129 0.00E-01 0.00E-01 2.20E 04 2.21E 02 1.84E 02 3.50E 02 2.24E 03 0.00E-01 p TE 131M 4.52E 02 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 TE 131 8.63E 05 1.01E 06 8.85E 06 0.00E-01 4.35E 07 TE 132 1.42E 06 9.19E 05 5.39E-06 6.26E-06 2.47E-06 5.30E-04 9.76E-06 0.00E-01 I 130 2.12E-06 0.00E-01 4.06E 06 1.54E 07 8.81E 06 5.04E 09 2.64E 07 I 131 1.07E 07 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I 132 0.00E-01 0.00E-01 5.73E-01 6.38E-01 1.94E-01 9.37E 01 1.11E 00 0.00E-01 I 133 3.67E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I 134 4.32E-17 7.73E-15 1.88E-16 0.00E-01 1.32E-16 135 4.47E-17 1.17E-16 I 1.28E 09 0.00E-01 5.06E 08 1.68E 08 2.74E 07 : CS 134 6.58E 08 1.56E 09 5.24E 06 4.66E 07 3.35E 07 0.00E-01 2.59E 07 3.55E 06 CS 136 1.18E 07 7.81E 08 0.00E-01 4.05E 08 1.35E 08 2.31E 07 CS 137 8.72E 08 1.19E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 CS 138 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 139 0.00E-01 A-69 ADM 04-019 Rev. 5 Page 167 of 202 O ~ 't ' W t'J R T- M T i f. M T [~~? 2 f y , 3 1 t y ; 9 , ; . ., -
,;;, y r , ,g;
TABLE A.5-10 (cont'd) GRASS-COW-MEAT PATHWAY FACTOR M* MREM /YR PER pCI/SEC ADULT (RI FACTORS)
'niYROID KIDNEY IJJFG GI-LLI BJtTE LIVER T BODY IFJCLIDE 1.88E 06 0.00E-01 1.23E 04 2.07E 04 5.92E 07 BA 140 2.87E 07 3.61E 04 0.00E-01 0.00E-01 0.00E-01 0.005-01 0.00E-01 0.00E-01 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 142 5.00E-03 0.00E-01 0.00E-01 0.00E-01 1.39E 03 LA 140 3.76E-02 1.89E-02 0.00E-01 0.00E-01 '
0.00E-01 0.00E-01 0.00E-01 0.00E-01 LA 142 0.00E-01 4.41E 03 0.00E-01 3.63E 07 1.40E 04 9.50E 03 1.08E 03 0.00E-01 CE 141 1.65E-03 0.00E-01 6.55E-03 0.00E-01 5.56E 02 CE 143 2.01E-02 1.49E 01 0.00E-01 4.93E 08 6.09E 05 9.83E 04 0.00E-01 3.61E 05 CE 144 1.46E 06 4.86E 03 0.00E-01 9.19E 07 2.10E 04 8.41E 03 1.04E 03 0.00E-01 PR 143 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 PR 144 0.00E-01 0.00E-01 3.98E 07 8.29E 03 4.96E 02 0.00E-01 4.84E 03 0.00E-01 to 147 7.17E 03 0.00E-01 0.00E-01 5.93E 00 2.17 E-02 1.81E-02 6.33E-03 0.00E-01 W 187 1.40E-02 0.00E-01 7.94E-02 0.00E-01 5.22E M NP 239 2.59E-01 2.55E-02 A-70 ADM 04-019
'ie v 5 Page 168 of 202 0~ 't r .*: 7 ir; n;T : , y 3 p q g gj p g ,.5 . gg g. , ,, ,,
TABLE A.5-11 GRASS-COW-MEAT PATHWAY FACTOR M' MREM /YR PER pCI/SEC TEEN (RI FACTORS)
'IHYROID KIDNEY LUTC GI-ILI MJCLIDE DONE LIVER .
T HJDY 1.94E 02 1.94E 02 1.94E 02 1.94E 02 1.94E 02 1.94E 02 H 3 0.00E-01 4.08E 07 4.08E 07 2.04E 08 4.08E 07 4.08E 07 4.08E 07 4.08E 07 C 14 1.09E-03 1.09E-03 1.09E-03 1.09E-03 NA 24 1.09E-03 1.09E-03 1.09E-03l 2.44E 08 1.52E 08 0.00E-01 0.00E-01 0.00E-01 3.30E 08 P 32 3.93E 09 8.05E 03 9.47E 05 51 0.00E-01 0.00E-01 5.64E 03 3.13E 03 1.24E 03 CR 0.00E-01 1.44E 07 0.00E-01 7.00E 06 1.39E 06 0.00E-01 2.09E 06 MN 54 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 MN 56 0.00E-01 1.07E 08 7.30E 07 2.38E 08 1.69E 08 3.93E 07 0.00E-01 0.00E-01 FE 55 1.56E 08 1.17E 09 59 2.1?E 09 4.95E 08 1.01E 08 0.00E-01 0.00E-01 FE 0.00E-01 1.41E 07 3.24E 07 0.00E-01 0.00E-01 0.00E-01 1.94E 08 00 58 0.00E-01 7.60E 08 60 0.00E-01 5.83E 07 1.31E 08 0.00E-01 0.00E-01 CO 0.00E-01 1.71E 08 1.52E 10 1.07E 09 5.15E 08 0.00E-01 0.00E-01 NI 63 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 NI 65 0.00E-01 1.73E-05 0.00E-01 2.23E-07 1.05E-07 0.00E-01 5.64E-07 0.00E-01 CU 64- 3.68E 08 2.50E 08 8.69E 08 4.05E 08 0.00E-01 5.56E 08 0.00E-01 ZN 65 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 69 0.00E-01 0.00E-01 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-03 / BR 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 6.02E 07 0.00E-01 4.07E 08 1.91E 08 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 7.29E 06 0.00E-01 0.00E-01 0.00E-01 3.03E 07 SR 89 2.55E 08 2.26E 08 SR 90 8.05E 09 0.00E-01 1.99E 09 0.00E-01 0.00E-01 0.00E-01 1.19E-10 0.00E-01 4.75E-12 0.00E-01 0.00E-01 0.00E-01 5.41E-10 SR 91 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 92 0.00E-01 7.41E 05 8.98E 01 0.00E-01 2.42E 00 0.00E-01 0.00E-01 0.00E-01 Y 90 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y 91M 0.00E-01 9.54E 05 0.00E-01 2.56E D4 0.00E-01 0.00E-01 0.00E-01 3.91E 08 Y 91 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y 92 A-71 ADM 0 4 - 019 Rev. 5 Page 169 of 202 e *- ; . . 3xtxtyg.: .. - :.-.,-.
- Y'y14 W f.. W,ty?ry:9.qy::ppq p p;;p.pq ., .,
I l l TABLE A.5-11 (cont' d) l l GRASS-COW-MEAT PATHWAY FACTOR M* MREM /YR PER pCI/SEC e TEEN (RI FACTORS) T BODY 'IWYROID KIDNEY U.NC GI-LLI NUCLIDE EOJE LIVER 0.00E-01 0.00E-01 1.70E-07 , 93 5.56E 0.00E-01 1.53E-13 0.00E-01 , Y 3.26E 05 0.00E-01 6.96E 05 0.00E-01 1.09E 09 ' ZR 95 1.50E 06 4.73E 05 3.42E-06 1.58E-06 0.00E-01 5.19E-06 0.00E-01 9.27E-01 l' ZR 97 1.73E-05 ! 5.48E 05 0.00E-01 9.66E 05 0.00E-01 4.26E09f I NB 95 1.80E 06 9.96E 05 0.00E-01 1.48E 05 l l 0.00E-01 8.26E 04 1.58E 04 0.00E-01 1.89E 05 to 99 1.29E-19 0.00E-01 1.49E-19 5.54E-21 6.55E-18j
'IC 99M 3.58E-21 9.97E-21 i 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 'IC 101 0.00E-01 0.00F.-01 7.15E 09 0.00E-01 3.66E 07 0.00E-01 3.02E 08~ 0.00E-01 -
RU 103 8.56E 07 6.91E-27 0.00E-01 3.96E-25 4.91E-28 0.00E-01 1.91E-28 0.00E-01 , RU 105 2.97E 08 0.00E-01 4.55E 09 0.00E-01 1.13E 11 RU 106 2.36E 09 0.00E-01 1.35E 09 l 4.79E 06 2.91E 06 0.00E-01 9.13E 06 0.00E-01 AG 110M 5.06E 06 0.00E-01 0.00E-01 8.94E 08 3.03E 08 1.09E 08 4.05E 07 8.47E 07 TE 12SM 1.12E 08 2.24E 08 3.82E 09 0.00E-01 2.35E 09 . TE 127M 9.42E 08 3.34E 08 1.40E-08 : 6.43E-11 3.91E-11 1.25E-10 7.35E-10 0.00E-01 TE 127 1.BlE-10 0.00E-01 3.57E 09 3.53E 08 1.50E 08 3.07E 08 3.97E 09 l TE 129M 9.50E 08 i 0.00E-01 0. 00E-01 0.00E-01 0.00E-01 0.00E-01 i TE 129 0.00E-01 0.00E-01 1.45E 04 ; 0.00E-01 j TE 131M TE 131 3.77E 02 0.00E-01 1.81E 02 0.00E-01 1.51E 02 0.00E-01 2.72E 02 0.00E-01 1.88E 03 0.00E-01 0.00E-01 0.00E-01 l 6.93E 05 7.76E 05 7.06E 06 0.00E-01 2.33E Os j TE 132 1.16E 06 7.36E 05 3.80E-06 j 4.94E-06 1.97E-06 4.03E-04 7.61E-06 0.00E-01 I 130 1.71E-05 0.00E-01 2.47E 06 ! 8.93E 06 1.25E 07 6.72E 06 3.65E 09 2.15E 07 I 131 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I 132 0.00E-01 0.00E-01 3.93E-01 5.20E-01 1.59E-01 7.26E 01 9.12E-01 0.00E-01 l I 133 3.07E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I 134 3.47E-17 6.03E-15 1.48E-16 0.00E-01 1.04E-16 135 3.64E-17 9.37E-17 1.53E 07 I 1.23E 09 5.71E 08 0.00E-01 3.91E 08 1.49E 08 i CS 134 5.23E 08 1.97E 07 3.11E 06 2.91E 06 CS 136 9.20E 06 3.62E 07 2.43E 07 0.00E-01 , 3.36E 08 0. 00 E-01 3.28E 08 1.27E 08 1.37E 07 CS 137 7.24E 08 9.63E 08 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i CS 138 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 139 0.00E-01 , l l A 72 ADM 04-019 , Rev. 5 Page 170 of 202 e L 76~" ^ TUM7.fGUMJEM Tf3RdM,W M.pS qi, ][,Q G .
,.y ,
i
( TABLE A.5-11 (cont'd) GRASS-COW. MEAT PATHWAY FACTOR M* MREM /YR PER pCI/SEC TEEN (RI FACTORS)
'1HYRDID KIONEY LUtG GI-ILJ BONE LIVER T BODY tU"LIDE .
9.88E 03 1.96E 04 3.67E 07 2.91E 04 1.53E 06 0.00E-01 0.00E-01 BA 140 2.38E 07 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00F-01 0.00E-01 BA 141 0.00E-01 0.00E-01 0.00E-01 BA 142 0.00E-01 0.00E-01 l 0.00E-01 0.00E-01 8.72E 02 1.526-02 4.04E-03 0.00E-01 0.00E-01 IA 140 3.09E-02 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 2.25E 07
- LA 142 7.88E 03 9.05E 02 _ 0.00E-01 3.71E 03 t CE 141 1.18E 04 5.53E-03 0.00E-01 3.70E 02 1.23E05 1.38E-03 0.00E-01 3.09E 08 CE 143 1.69E-02 0.00E-01 3.04E 05 0.00E-01 1.23E 06 5.08E 05 6.60E 04 0.00E-01 5.81E 07 CE 144 8,78E 02 0.00E-01 4.10E 03 PR 143 1.77E 04 7.05E 03 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 2.48E 07 PR 144 0.00E-01 0.00E-01 4.03E 03 0.00E-01 6.32E 03 6.87E 03 4.11E 02 0.00E-01 4.00E 00 ND 147 5.18E-03 0.00E-01 0.00E-01 1.48E-02 W 187 1.81E-02 6.70E-07 0.00E-01 3.43E 03 2.13E-02 1.19E-02 0.00E-01 NP 239 2.26E-01 A-73 ADM 04-019 Rev. 5 Page 171 of 202 i
~ ~ve.'mv .n,co;gg.ggynmypqz. 3.y .. ,.._,,_ . ..
l TABLE A.5-12 GRASS-COW-MEAT PATHWAY FACTOR M* MREM /YR PER pCI/SEC CHILD (RI FACTORS) 1 LIVER T IKXTI 'DmOID KIDNEY IRG GI-LL1 NTLTDE BONE 0.00E-01 2.34E 02 2.34E 02 2.34E 02 '2.34E 02 2.34E O2 2.34E 02 l H 3 7.67E 07 7.67E 07 3.83E 00 7.67E 07 7.67E 07 7.67E 07 7.67E 07 C 14 1.73E-03 1.73E-03 1.73E-03 1.73E-03 1.73E-03 1.73E-03 ; NA 24 1.73E-03 2.86E 08 0.00E-01 0.00E-01 0.00E-01 2.05E 08 P 32 7.41E 09 3.47E 08 4.66E 05 0.00E-01 8.79E 03 4.88E 03 1.33E 03 8.91E 03 CR 51 0.00E-01 0.00E-01 6.72E 06 0.00E-01 8.01E 06 2.13E 06 0.00E-01 2.25E 06 MN 54 _ 1.63E-53 3.67E-54 0.00F-01 1.97E-53 0.00E-01 2.36E-51l MN 56 0.00E-01 0.00E-01 1.37E 08 4.49E 07 55 4.57E 08 2.42E 08 7.50E 07 0.00E-01 FE 1.76E 08 6.34E 08 3.76E 08 6.09E 08 3.03E 08 0.00E-01 0.00E-01 FE 59 5.03E 07 0.00E-01 0.00E-01 0.00E-01 9.58E 07 00 58 0.00E-01 1.64E 07 6.93E 07 2.04E 08 0.00E-01 0.00E-01 0.00E-01 3.84E 08 CD 60 0.00E-01 0.00E-01 1.05E 08 2.91E 10 1.56E 09 9.91E 08 0.00E-01 0.00E-01 NI 63 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 NI 65 0.00E-01 0.00E-01 1.41E-05 3.00E 07 1.81E-07 0.00E-01 7.24E-07 0.00E-01 CU 64 0.00E-01 0.00E-01 1.76E 08 6.22E 08 0.00E-01 6.30E 08 ZN 65 3.75E 08 1.00(09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 69 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 g 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ! BR 85 0.00E-01 0.00E-01 ! 3.55E 08 0.00E-01 0.00E-01 0.00E-01 3.71E 07 RB 86 0.00E-01 5.77E 08 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i RB 89 0.00E-01 0.00E-01 1.87E 07 0.00E-01 1.3BE 07 0.00E-01 0.00E-01 0.00E-01 SR 89 4.82E 08 0.00E-01 1.40E 08 1.04E 10 0.00E-01 2.64E 09 0.00E-01 0.00E-01 l SR 90 ! 0.00E-01 8.45E-12 0.00E-01 0.00E-01 0.00E-01 4.94E-10 ; SR 91 2.24E-10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 92 0.00E-01 0.00E-01 4.84E 05 1.70E 02 0.00E-01 4.55E 00 0.00E-01 0.00E-01 Y 90 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 - Y 91M 0.00E-01 0.00E-01 2.40E 08 I 0.00E-01 4.82E 04 0.00E-01 0.00E-01 0.00E-01 Y 91 1.80E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Y 92 A-74 9/93 ADM 04-019 Rev. 5 Page 172 of 202 e y psy gd g g g Ctf g g .p g [ g .?" g' Tav NW2t7h T EM 3p;;,,,,
TABLE A.5-12 (cont'd) GRASS-COW-MEAT PATHWAY FACTOR M' MREM /YR PER CI/SEC CHILD (RI FACTORS) Tm mmID WE Ws GI G EDE LIVER mTDE 0.00E-01 0.00E-01 1.56E-07 0.00E-01 2.87E-13 0.00E-01 Y 93 1.04E-11 8.38E 05 0.00E-01 6.11E 08 5.86E 05 5.21E 05 0.00E-01 7.055-01 ZR 95 2.66E 06 0.00E-01 6.68E-06 0.00E-01 3.22E-05 4.65E-06 2.74E-06 ZR 97 ' 1.13E 06 0.00E-01 2.23E 09 1.21E 06 8.63E 05 0.00E-01 NB 95 3.10E 06 2.45E 05 0.00E-01 9.51E 04 1.15E 05 2.84E 04 0.00E-01 7.00E-18 10 99 0.00E-01 0.00E-01 1.79E-19 6.24E-21 6.27E-21 1.23E-20 2.04E-19
'1C 99M 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 '1C 101 0. 00E.-01 3.90E 08 0.00E-01 4.00E 09 0.00E-01 5.955 07 0.00E-01 5.98E-25 RU 103 1.55E 08 0.00E-01 8.05E-27 0.00E-01 9.16E-28 0.00E-01 3.32E-28 RU 105 5.99E 09 0.00E-01 6.90E 10 0.00E-01 5.54E 08 0.00E-01 RU 106 4.44E 09 1.06E 07 0.003-01 6.74E 08 5.67E 06 4.53E 06 0.00E-01 JG 110M 8.34E 06 1.60E 08 0.00E-01 0.00E-01 5.49E 08 5.69E 08 1.54E 08 7.59E 07 TE 125M 4.24E 08 5.06E 09 0.00E-01 1.44E 09 1.77E 09 4.78E 08 2.11E 08 0.00E-01 1.33E-08 TE 127M 7.32E-11 2.36E-10 9.71E-10 TE 127 3.41E-10 9.20E-11 5.77E 08 5.26E 09 0.00E-01 2.18E 09 l 1.79E 09 5.00E 08 2.78E 08 TE 129M 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 TE 129 0.00E-01 2.35E 03 0.00E-01 9.84E 03 2.43E 02 2.58E 02 4.99E 02 0.00E-01 TE 131M 7.01E 02 0.00E-01 0.00E-01 0.00E-01
} TE 131 0.00E-01 0.00E-01 0.00E-01 8.72E 06 0.00E-01 9.46E 06 9.39E 05 1.13E 06 1.37E 06 2.89E-06 TE 132 2.12E 06 6.80E-04 9.22E-06 0.00E-01 3.05E-06 6.17E-06 3.18E-06 0.00E-01 1.48E 06 I 130 5.51E 09 2.74E 07 1.66E 07 1.67E 07 9.47E 06 I 131 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 2.84E-01 I 132 0.00E-01 1.31E 02 1.17E 00 0.00E-01 5.70E-01 7.04E-01 2.66E-01 0.00E-01 0.00E-01 1 133 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I 134 1.82E-16 0.00E-01 9.04E-17 1.19E 16 5.61E-17 1.05E-14 135 6.59E-17 4.69E 08 1.68E 08 8.16E 06 1 1.51E 09 3.19E 08 0.00E-01 1.53E 06 CS 134 9.22E 08 0.00E-01 2.32E 07 3.46E 06 1.59E 07 4.36E 07 2.82E 07 CS 136 4.16E 08 1.50E 08 7.99E 06 + 1.28E 09 1.88E 08 0.00E-01 0.00E-01 C5 137 1.33E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 CS 138 0.00E-01 0.00E-01 0.00E-01 UA 139 0. 0Pr.-01 0.00E-01 9/93 ADM 04-019 Rev. 5 Page ;13 of 202 e *4.' Mff. '%n :3,mz w y g Wsyr g Q R Q }{QTf g y g y Q* p ,
. .. _ . - . = _ .- - .-. - . . - ._ .-..
TABLE A.5-12 (con t' d) GRASS-COW-MEAT PATHWAY FACTOR M* MREM /YR PER pCI/SEC CHILD (RI FACTORS)
'mYROID KIDNEY IDG GI-LLI DONE T.Ivm T BODY m Ipc 0.00E-01 1.25E 04 2.29E 04 2.22E 07 '
4.39E 07 3.84E 04 2.56E 06 0.00E-01 BA 140 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 . 0.00E-01 0.00E-01 0.00E-01 _BA 142 0.00E-01 I 6.66E-03 0.00E-01 0.00E-01 0.00E-01 5.51E 02 l ' IA 140 5.66E-02 1.98E-02 0.00E-01 0.00E-01 ! 0.00E-01 0.00E-01 0.00E-01 IA 142 0.00E-01 0.00E-01 4.86E 03 0.00E-01 1.38E 07 1.11E 04 1.64E 03 0.00E-01 CE 141 2.22E 04 ' 0.00E-01 7.23E-03 0.00E-01 2.52E 02 3.18E-02 1.72E 01- 2.50E-03 1.89E 08 CE 143 1.24E 05 0.00E-01 4.02E 05 0.00E-01 CE 144 2.32E 06 7.26E 05 5.43E 03 0.00E-01 3.60E 07 ! 1.00E 04 1.66E 03 0.00E-01 PR 143 3.34E 04 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1.52E 07 PR 144 7.43E 02 0.00E-01 5.27E 03 0.00E-01 ND 147 1.19E 04 9.60E 03 0.00E-01 2.80E 00 8.94E-03 0.00E-01 0.00E-01 , W 187 3.36E-02 1.99E-02 1 0.00E-01 8.84E-02 0.00E-01 2.26E 03 l f NP 239 4.26E-01 3.06E-02 2.15E-02 I I h t l
^ 9/93 ADM 04-019 Rev. 5 Page 174 of 202
-e ~
.:* l t':T'." &M'diMNXMFVd.Q% M.'Q:E}?yl; , 2 ; }"!b , ^: '
#T' ); .Q. . },
TABLE A.5-13 VEGETATION PATHWAY FACTOR M# MREM /YR PER pCI/SEC ADULT (RI FACTORS)
'IHYROID KIDNEY Ill!G GI-ILI ;
NUCLIDE BONE LIVER T DODY 2.26E 03 2.26E 03 2.26E 03 2.26E 03 2.26E 03 H 3 0.00E 2.26E 03 4.55E 07 4.55E 07 2.38E 08 4.55E 07 4.55E 07 4.55E 07 4.55E 07 C 14 2.69E 05 2.69E 05 2.69E 05 2.69E 05 2.69E 05 NA 24 2.69E 05 2.69E 05 5.42E 07 0.00E-01 0.00E-01 0.00E-01 1.58E 08 P 32 1.40E 09 8.73E 07 6.16E 04 1.17E 07 0.00E-01 0.00E-01 4.64E 04 2.78E 04 1.02E 04 CR 51 0.00E-01 9.58E 08 3.13E 08 5.97E 07 0.00E-01 9.31E 07 Fc1 54 0.00E-01 2.82E 00 0.00E-01 2.02E 01 0.00E-01 5.08E 02 tel 56 0.00E-01 1.59E 01 8.06E 07 8.29E 07 1.45E 08 3.37E 07 0.00E-01 0.00E-01 FE 55 2.09E 08 0.00E-01 8.28E 07 9.83E 08 59 1.26E 08 2 96E 08 1.14E 08 0.00E-01 FE 6.89E 07 0.00E-01 0.00E-01 0.00E-01 6.23E 08 00 58 0.00E-01 3.07E 07 0.00E-01 3.14E 09 1.67E 08 3.69E 08 0.00E-01 0.00E-01 CO 60 0.00E-01 0.00E-01 0.00E-01 1.50E 08 1.04E 10 7.28E 08 3.49E 08 0.00E-01 NI 63 4.11E 00 0.00E-01 0.00E-01 0.00E-01 2.28E 02 NI 65 6.93E 01 9.01E 00 0.00E-01 7.85E 05 0.00E-01 9.21E 03 4.32E 03 0.00E-01 2.32E 04 CU 64 0.00E-01 6.36E 08 1.01E 09 4.56E 08 0.00E-01 6.75E 08 ZN 65 3.17E 08 1.17E-06 0.00E-01 1.09 E-05 0.00E-01 2.52E-06 ZN 69 8.77E-06 1.68E-05 4.48E 00 3.11E 00 0.00E-01 0.00E-01 0.00E-01 0.00E-01 f? BR 83 0.00E-01 0.00E-01 1.96E-16 0.00E-01 2.49E-11 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 0. 00E- 01 4.33E 07 2.19E 08 1.02E 08 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 0.00E-01 0.00E-01 0.00E-01 3.47E-27 1.84E-22 _0.00E-01 0.00E-01 RB 88 9.88E-27 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 1.41E-26 1.60E 09 0.00E-01 2.86E 08 0.00E-01 0.00E-01 0.00E-01 SR 89 9.97E 09 0.00E-01 0.00E-01 1.75E 10 90 6.05E 11 0.00E-01 1.48E 11 0.00E-01 SR 1.22E 04 0.00E-01 0.00E-01 0.00E-01 1.44E 06 SR 91 3.03E 05 0.00E-01 8.46E 03 0.00E-01 1.85E 01 0.00E-01 0.005-01 0.00E-01 SR 92 4.27E 02 0.00E-01 1.41E 08 1.33E 04 0.00E-01 3.56E 02 0.00E-01 0.00E-01 Y 90 2.03E-10 0.00E-01 0.00E-01 0.00E-01 1.54E-08 Y 91M 5.24E-09 0.00E-01 2.81E 09 0.00E-01 1.37E 05 0.00E-01 0.00E-01 0.00E-01 l Y 91 5.11E 06 0.00E-01 1.60E 04 0.00E-01 2.68E-02 0.00E-01 0.00E-01 Y 92 9.16E-01 A-77 ADM 04-019 Rev. 5 Page 175 of 202 I e ' '*XM' 2 137%7v 7fpnygg gpygr.vgg,ygygi,*.yqjpyg g ,
3 l TABLE A.5-13 (cont'd) VEGETATION PATHWAY FACTOR l M* MREM /YR PER pCI/SEC ADULT (RI FACTORS) ,
'IHYROID KIDNEY 11RG GI-LLI :
BONE LIVER T BODY t NLCLIDE 4.81E 00 0.00E-01 0.00E-01 0.00E-01 5.52E 06 Y 93 1.74E 02 0.00E-01 0.00E-01 1.20E 09 ! 3.77E 05 2.55E 05 0.00E-01 5.92E 05 ZR 95 1.18E 06 1.03E 02 0.00E-01 2.11E 07 3.37E 02 6.81E 01 3.11E 01 0.00E-01 ZR 97 4.26E 04 0.00E-01 7.84E 04 0.00E-01 4.81E 08 NB 95 1.43E 05 7.93E 04 0.00E-01 1.43E 07 6.15E 06 1.17E 06 0.00E-01 1.39E 07 MD 99 0.00E-01 1.33E 02 4.30E 00 5.19E 03 i 3.10E 00 8.77E 00 1.12E 02 0.00E-01
'IC 99M 0.00E-01 2.16E-29 6.14E -31 0.00E-01 i 101 8.34E-31 1.20E-30 1.18E-29
'IC 2.05E 06 0.00E-01 1.82E 07 0.00E-01 5.56E 08 RU 103 4.76E 06 0.00E-01 0.00E-01 3.30E 04 0.00E-01 2.13E 01 0.00E-01 6.97E 02 RU 105 5.39E 01 f 0.00E-01 3.72E 08 0.00E-01 1.25E 10 RU 106 1.93E 08 0.00E-01 2.44E 07 5.79E 06 0.00E-01 1.92E 07 0.00E-01 3.98E 09 ;
r, 110M 1.05E 07 9.75E 06 0.00E-01 3.50E 07 1.29E 07 2.90E 07 3.93E 08 3.86E 08 , l TE 125M 9.66E 07 4.26E 07 8.93E 07 1.42E 09 0.00E-01 1.17E 09 - TE 127M 3.49E 08 1.2SE 08 4.47E 05 1.23E 03 4.20E 03 2.31E 04 0.00E-01 TE 127 5.66E 03 2.03E 03 0.00E-01 1.27E 09 : 9.38E 07 3.98E 07 8.63E 07 1.05E 09 TE 129M 2.51E 08 5.87E-04 3.22E-03 0.00E-01 5.77E-04 , TE 129 7.65E-04 2.87E-04 1.86E-04 ' 7.07E 05 4.52E 06 0.00E-01 4.43E 07 ' TE 131M 9.12E 05 4.46E 05 3.72E 05 2.14E-16 6.32E-16 4.78E-16 1.24E-15 6.63E-15 0.00E-01 f I TE 131 1.51E-15 , 3.07E 06 2.68E 07 0.00E-01 1.32E 08 i TE 132 4.30E 06 2.78E 06 2.61E 06 4.57E 05 9.81E 07 1.81E 06 0.00E-01 9.97E 05 i 1 130 3.95E 05 1.16E 06 3.05E 07 I 6.62E 07 3.79E 10 1.98E 08 0.00E-01 I 131 8.08E 07 1.16E 08 5.40E 03 2.46E 02 0.00E-01 2.90E 01 ! 132 5.77E 01 1.54E 02 5.40E 01 3.26E 06 I 1.11E 06 5.33E 08 6.33E 06 0.00E-01 133 2.09E 06 3.63E 06 0.00E-01 2.30E-07
- I 2.63E-04 9.42E-05 4.56E-03 4.19E-04 I 134 9.69E-05 3.77E 04 6.74E 06 1.64E 05 0.00E-01 1.15E05[
I 135 3.90E 04 1.02E 05 1.19E 09 1.94E 08 i 1.11E 10 9.0BE 09 0.00E-01 3.59E 09 CS 134 4.67E 09 9.22E 07 1.26E 07 1.88E 07 4.20E 07 1.66E 08 1.19E 08 0.00E-01 CS 136 5.70E 09 0.00E-01 2.95E 09 9.81E 08 1.68E 08 f CS 137 6.36E 09 8.70E 09 3.32E-16 3.86E-11 0.00E-01 5.72E-11 5.65E-12 CS 138 3.94E-11 7.78E-11 1.17E-05 5.15E-02 l 2.07E-05 8.50E-04 0.00E-01 1.93E-05 BA 139 2.90E-02 ; 4 A-78 4 ADM 0'-019 Rev. 5 Page 176 of 202 i i a y; - . . .. .p
, , qg y,g_ .g. ,p ,g ,-
v . u.ywa e 37. , , v- .4
,n---.r - - - - - , -- - ,p ,
TABLE A.5-13 (cont'd) VEGETATION PATHWAY FACTOR M' MREM /YR PER CI/SEC ADULT (RI FACTORS) THYROID KIDffEY LUtG GI-ILI BOtIE LIVER T DODY NUCLIDE 0.00E 01 5.49E 04 9.25E 04 2.65E 08 BA 140 1.29E 08 1.61E 05 8.42E 06 6.01E-31 4.31E-23 0.00E-01 8.96E-25 5.47E-25 BA 141 1.28E-21 9.64E-25 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 14 2 0.00E-01 0.00E-01 0.00E-01 0.00E-01 7.33E 07 1A 140 1.98E 03 9.99E 02 2.64E 02 4.70E-01 1.61E-05 0.00E-01 0.00E-01 0.00E-01 1A 142 1.42E-04 6.44E-05 0.00E-01 5.10E 08 1.33E 05 1.51E 04 0.00E-01 6.19E 04 CE 141 1.97E 05 , 0.00E-01 3.25E 02 0.00E-01 2.76E 07 CE 143 9.98E 02 7.38E 05 8.17E 01 1.11E 10 1.77E 06 0.005-01 8.1GE 06 0.00E-01 CE 144 3.29E 07 1.38E 07 0.00E-01 2.74E 08 2.51E 04 3.11E 03 0.00E-01 1.45E 04 PR 143 6.26E 04 0.00E-01 7.32E-27 0.00E-01 0.00E-01 PR 144 3.13E-26 1.30s-26 1.59E-27 1.87E 08 2.32E 03 0.00E-01 2.27E 04 0.00E-01 to 147 3.36E 04 3.89E 04 0.00E-01 1.05E 07 3.20E 04 1.12E 04 0.00E-01 0.00E-01 W 187 3.82E 04 0.00E-01 4.38E 02 0.00E-01 2.88E 07 1.43E 03 1.40E 02 7.74E 01 NP 239 o A-79 ADM 04-019 Rev. 5 Page 177 of 202 e - E' MMM'NIWP'ETWVZ1TM.fFRFJ'LT!?gg 'g,{.a'l .rg.p,,. , ,.{* , .g ,
, , . .- - . - . .-- . . .- . ~ .- - - -
TABLE A.5-14 VEGRTATION PATHWAY FACTOR M# MREM /YR PER pCI/SEC TEEN (RI FACTORS) l 1 T BODY '1HYRO1D KIDNEY LUN3 GI-ILI NUCLIDE BONE LIVER 2.59E 03 2.59E 03 2.59E 03 2.59E 03 2.59E 03 l H 3 0.00E-01 2.59E 03 7.38E 07 7.38E 07 7.38E 07 7.38E 07 7.38E 07 7.38E 07 C 14 3.69E 08 2.39E 05 2.39E 05 2.39E 05 ; NA 24 2.39E 05 2.39E 05 2.39E 05 2.39E 05 6.23E 07 0.00E-01 0.00E-01 0.00E-01 1.35E 08 f P 32 1.61E 09 9.96E 07 1.04E 07 0.00E-01 6.17E 04 3.43E 04 1.35E 04 8.81E 04 -l CR 51 0.00E-01 1.36E 08 0.00E-01 9.32E 08 54 0.00E-01 .4.54E 08 9.01E 07 0.00E-01 191 2.55E 00 0.00E-01 1.82E 01 0.00E 9.45E 02: MN 56 0.00E-01 1.44E 01 9.98E 07 L31E 08 5.38E 07 0.00E-01 0.00E-01 1.46E 08 FE 55 3.25E 08 1.32E 08 9.90E 08 59 1.79E 08 4.18E 08 1.62E 08 0.00E-01 0.00E-01 FE 1.01E 08 0.00E-01 0.00E-01 0.00E-01 6.01E 08 ! CD 58 0.00E-01 4.36E 07 3.24E 09 2.49E 08 5.60E 08 0.00E-01 0.00E-01 0.00E-01 CD 60 0.00E-01 0.00E-01 1.81E 08 1.61E 10 1.13E 09 5.44E 08 0.00E-01 0.00E-01 , NI 63 0.00E-01 0.00E-01 0.00E-01 4.47E 02 ! NI 65 6.45E 01 8.24E 00 3.76E 00 3.92E 03 0.00E-01 2.11E 04 0.00E-01 6.47E 05 CU 64 0.00E-01 8.34E 03 6.23E 08 1.47E 09 6.86E 08 0.00E-01 9.42E 08 0.00E-01 ZN 65 4.24E 08 1.10E-06 0.00E-01 1.02E-05 0.00E-01 2.88E-05 ZN 69 8.21E-06 1.56E 05 2.92E 00 0.00E-01 0.00E-01 0.00E-01 5.08E-17 i gl BR 83 0.00E-01 0.00E-01 3.14 E-29 0.00E-01 2.27E-11 0.00E-01 0.00E-01 0.00E-01 l BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 0.00E-01 4.05E 07 2.74E 08 1.29E 08 0.00E-01 0.00E-01 0.00E-01 RB 86 0.00E-01 0.00E-01 2.75E-29 - 88 0.00E-01 3.21E-22 1.71F-22 0.00E-01 0.00E-01 RB 1.26E-26 8.94E-27 0.00E-01 0.00E-01 0.00E-01 1.94E-35 RB 89 0.00E-01 0.00E-01 1.80E 09 1.51E 10 0.00E-01 4.34E 08 0.00E-01 0.00E-01 . SR 89 0.00E-01 2.11E 10 7.51E 11 0.00E-01 1.85E 11 0.00E-01 0.00E-01 SR 90 0.00E-01 1.13E 04 0.00E-01 0.00E-01 0.00E-01 1.28E 06 - i SR 91 2.83E 05 0.00E-01 1.01E 04 92 3.98E 02 0.00E-01 1.70E 01 0.00E-01 0.00E-01 SR 0.00E-01 .02E 08 1.24E 04 0.00E-01 3.34E 02 0.00E-01 0.00E-01 Y 90 , 1.87E-10 0.00E-01 0.00E-01 0.00E-01 2.30E-07 Y 91M 4.88E-09 0.00E-01 0.00E-01 2.10E 05 0.00E-01 0.00E-01 0.00E-01 3.21E 09 Y 91 7.84E 06 2.36E 04 0.00E-01 2.49E-02 0.005-01 0.00E-01 0.00E-01 Y 92 8.61E-01 A-80 f 3 4 ADM 04-019 Rev. 5 Page 178 of 202 l .~ O '~'v[ g . ~g 4 Wu 4;it?ca W PARA 15lTT*:!i M N fR*GQQ Q ~j ggg Vfq*. (*. \f Q ,
d i-TABLE A.5-14 (cont'd) VEGETATION PATHWAY FACTOR M* MREM /YR PER pCI/SEC TEEN (RI FACTORS) T BCDY 'UmOID KIDNEY IJUNG GI-ILI FN.CLIDE BONE LIVER 0.00E-01 4.47E 00 0.00E-01 0.00E-01 0.00E-01 4.99E 06 1 Y 93 1.63E 02 0.00E-01 1.25E 09 ) 1.72E 06 5.44E 05 3.74E 05 0.00E-01 7.99E 05 ZR 95 0.00E-01 1.67E 07. 97 3.12E 02 6.18E 01 2.85E 01 0.00E-01 9.37E 01 ZR 1.07E 05 5.88E 04 0.00E-01 1.04E 05 0.00E-01 4.57E 08 NB 95 1.93E 05 0.00E-01 1.01E 07 0.00E-01 5.65E 06 1.08E 06 0.00E-01 1.29E 07 20 99 1.14E 02 4.24E 00 5.02E 03
'IC 99M 2.74E 00 7.64E 00 9.90E 01 0.00E-01 1.08E-29 0.00E-01 2.00E-29 6.72E-31 0.00E-01 'IC 101 7.76E-31 1.10E-30 5.69E 08' 0.00E-01 2.91E 06 0.00E-01 2.40E 07 0.00E-01 ,
RU 103 6.81E 06 0.00E-01 4.04E 04 5.01E 01 0.00E-01 1.94E 01 0.00E-01 6.32E 02 RU 105 0.00E-01 3.90E 07 0.00E-01 5.97E 08 0.00E-01 1.48E 10 i RU 106 3.09E 08 0.00E-01 4.03E 09 N; 110M 1.52E 07 1.43E 07 8.72E 06 0.00E-01 2.74E 07 1.98E 07 4.14E 07 0.00E-01 0.00E-01 4.39E 08 TE 125M 1.48E 08 5.34E 07 6.56E 07 1.31E 08 2.24E 09 0.00E-01 1.37E 09 TE 127M 5.52E 08 1.96E 08 4.12E 05 ' 1.89E 03 1.15E 03 3.68E 03 2.16E 04 0.00E-01 TE 127 5.34E 03 0.00E-01 1.36E 09 3.62E 08 1.34E 08 5.73E 07 1.17E 08 1.51E 09 TE 129M 1.74E-04 5.12E-04 3.01E-03 0.00E-01 3.92E-03 TE 129 7.16E-04 2.67E-04 6.09E 05 4.22E 06 0.00E-01 3.25E 07 f
~
TE 131M TE 131 8.44E 05 1.41E-15 4.05E 05 5.80E-16 3.38E 05 4.40E-16 1.08E-15 6.15E-15 0.00E-01 1.15E-16 2.33E 06 2.61E 06 2.37E 07 0.00E-01 7.84E 07 TC 132 3.91E 06 2.48E 06 7.80E 05 1.02E 06 4.05E 05 8.28E 07 1.56E 06 0.00E-01 I 130 3.51E 05 0.00E-01 2.13E 07 7.69E 07 1.08E 08 5.78E 07 3.14E 10 1.85E 08 ' I 131 ; 1.36E 02 4.99E 01 4.59E 03 2.14E 02 0.00E-01 5.93E 01 - 1 132 5.20E 01 0.00E-01 2.49E 06 133 1.94E 06 3.29E 06 1.00E 06 4.59E 08 5.77E 06 I 8.34E-05 3.87E-03 3.66E-04 0.00E-01 3.06E-06
~
I 134 8.76E-05 2.32E-04 , i 3.36E 04 5.84E 06 1.43E 05 0.00E-01 1.01E 05 I 135 3.52E 04 9.07E 04 ' 1.67E 10 7.75E 09 0.00E-01 5.31E 09 2.03E 09 2.08E 08 CS 134 7.10E 09 1.35E 07 - 1.68E 08 1.13E 08 0.00E-01 9.16E 07 1.44E 07 CS 136 4.28E 07 . 4.69E 09 0.00E-01 4.59E 09 1.78E 09 1.92E 08 CS 137 1.01E 10 1.35E 10 6.98E-11 3.49E-11 0.00E-01 5.15E-11 6.00E-12 3.17E-14 CS 138 3.64E-11 1.32E-05 2.44E-01 2.73E-02 1.92E-05 7.96E-04 0.00E-01 1.81E-05 _BA 139 A-81 ADM 04-019 Rev. S Page 179 of 202
# a* I Ab ' N W YN3i ,5 ($
)[ (, [ ) #
. [* I
TABLE A.5-14 (cont'd) VEGETATION PATHWA- FACTOR M* MREM /YR PER FL'1/SEC TEEN (RI FACTORS) NUCLIDE DONE LIVER T BJDY 'mYROID KIDfEY IUG GI-LLI 1.69E 05 8.91E 06 0.00E-01 5.74E 04 1.14E 05 2.13E 08 BA 140 1.38E 08 1.19E-21 0.90E-25 3.98E-23 0.00E-01 8.27E-25 6.10E-25 2.54 E-27 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 142 1.81E 03 8.89E 02 2.37E 02 0.00E-01 0.00E-01 0.00E-01 5.11E 07 LA 140 1.76E 00 LA 142 1.30E-04 5.78E-05 1.44E-05 0.00E-01 0.00E-01 0.00E-01 2.83E 05 1.89E 05 2.17E 04 .0.00E-01 8.90E 04 0.00E-01 5.41E 08 CE 141 6.79E 05 7.58E 01 0.00E-01 3.04E 02 0.00E-01 2.04E 07 CE 143 9.33E 02 1.33E 10 5.27E 07 2.18E 07 2.83E 06 0.00E-01 1.30E 07 0.00E-01 CE 144 0.00E-01 2.31E 08 PR 143 7.01E 04 2.802 04 3.49E 03 0.00E-01 1.63E 04 2.93E-26 1.20E-26 1.49E-27 0.00E-01 6.88E-27 0.00E-01 3.23E-29 PR 144 1.44E 08 3.66E 04 3.98E 04 2.38E 03 0.00E-01 2.34E 04 0.00E-01 ND 147 0.00E-01 7.84E 06 W 187 3.56E 04 2.90E 04 1.02E 04 0.00E-01 0.00E-01 1.31E 02 7.26E 01 0.00E-01 4.10E 02 0.00E-01 2.20E 07 NP 239 1.39E 02 s A-82 ADM 04-019 Rev. 5 Page 180 cf 202
- : ~
,; ;, ,9: .- ., . t - c ~g.3.# ,, g n~. ~ ;f, ,
TABLE A.5-15 VEGETATION PATHWAY FACTOR M* MREM /YR PER pCI/SEC CIIILD (RI FACTORS) ! i I
'nffROID KIENEY 11JfG GI-LLI J BCNE LIVER T B3)Y Mf1IDE 4.01E 03 4.01E 03 4.01E 03 4.01E 03 0.00E-01 4.01E 03 4.01E 03 1.78E 08
!! 3 1.78E 08 1.78E 08 1.78E 08 1.78E 08 C 14 8.89E 08 1.78E 08 3.73E 05 3.73E 05 3.73E 05 3.73E 05 3.73E 05 in 24 3.73E 05 3.73E 05 1.30E 08 0.00E-01 0.00E-01 0.00E-01 9.30E 07 i P 32 3.37E 09 1.58E 08 1.19E 05 6.21E 06 0.00E-01 1.17E 05 6.50E 04 1.78E 04 CR 51 0.00E-01 0.00E-01 1.86E 08 0.00E-01 5.58E 08 MN 54 0.00E-01 6.65E 08 1.77E 08 0.00E-01 2.27E 01 0.00E-01 2.72E 03 0.00E-01 1.88E 01 4.24E 00 7.86E 07 let 56 1.31E 08 0.00E-01 0.00E-01 2.40E 08 FE 55 8.00E 08 4.24E 08 1.86E 08 6.69E 08 6.43E 08 3.20E 08 0.00E-01 0.00E-01 l ,
FE 59 3.97E 08 0.00E-01 0.00E-01 0.00E-01 3.76E 08 58 0.00E-01 6.44E 07 1.97E 08 2.10E 09 CD 1.12E 09 0.00E-01 0.00E-01 0.00E-01 00 60 0.00E-01 3.78E 08 0.00E-01 1.42E 08 2.11E 09 1.34E 09 0.00E-01 0.00E-01 171 63 3.95E 10 6.51E 00 0.00E-01 0.00E-01 0.00E-01 1.37E 03 HI 65 1.18E 02 1.11E 01 0.00E-01 5.16E 05 1.10E 04 6.65E 03 0.00E-01 2.66E 04 CU 64 0.00E-01 1.36E 09 0.00E-01 3.80E 08 2.16E 09 1.35E 09 0.00E-01 ZN 65 8.12E 08 0.00E-01 1.33E-05 0.00E-01 1.38E-03 1.51E-05 2.19E-05 2.02E-06
. ZN 69 0.00E-01 0.00E-01 0.00E-01 3.14E-17 83 0.00E-01 0.00E-01 5.38E 00 1.94E-28
/ BR 3.85E-11 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 2.78E 08 0.00E-01 0.00E-01 0.00E-01 2.91E 07 RB 86 0.00E-01 4.52E 08 0.00E-01 2.17E-23 4.43E-22 3.08E-22 0.00E-01 0.00E-01 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1.45E-28 RB 89 0.00E-01 1.67E-26 1.48E-26 1.39E 09 1.03E 09 0.00E-01 0.00E-01 0.00E-01 SR 89 3.60E 10 0.00E-01 0.00E-01 1.67E 10 0.00E-01 3.15E 11 0.00E-01 0.00E-01 SR 90 1.24E 12 0.00E-01 0.00E-01 0.00E-01 1.15E 06 91 5.21E 05 0.00E-01 1.97E 04 1.38E 04 - SR 2.92E 01 0.00E-01 0.00E-01 0.00E-01 SR 92 7.29E 02 0.00E-01 0.00E-01 6.56E 07 0.00E-01 6.17E 02 0.00E-01 0.00E-01 Y 90 2.30E 04 0.00E-01 0.00E-01 0.00E-01 1.75E-05 Y 91M 8.95E-09 0.00E-01 3.26E-10 2.48E 09 4.99E 03 0.00E-01 0.00E-01 0.00E-01 Y 91 1.86E 07 0.00E-01 0.00E-01 4.58E 04 0.00E-01 4. 54 E-02 0.00E-01 0.00E-01 Y 92 1.59E 00 i A-83
? :D ADM 04-019 )
Rev. S Page 181 of 202 l I e - 9-7 , TM.WHMPP!)M.URSEM;g m.yjgggggggtg ,
TABLE A.5-15 (cont'd) VEGETATION PATHWAY FACTOR M* MREM /YR PER pCI/SEC CHILD (RI FACTORS)
'DIYROID KIDNEY IJJtG GI-ILI +
f DONE LIVER T BODY 1 NUCLIDE 0.00E-01 0.00E-01 0.00E-01 4.48E 06 i 3.01E 02 0.00E-01 8.26E 00 0.00E-01 8.85E 08 ! Y 93 0.00E-01 1.22E 06 3.86E 06 8.49E 05 7.56E 05 1.25E 07 l ZR 95 4.06E 01 0.00E-01 1.18E 02 0.00E-01 ZR 97 5.70E 02 8.24E 01 l 0.00E-01 2.96E 08 l 1.60E 05 1.14E 05 0.00E-01 1.50E 05
- NB 95 4.11E 05 0.00E-01 1.65E 07 0.00E-01 6.38E 06 0.00E-01 7.71E 06 1.91E 06 4.69E 00 5.26E 03 l 10 99 1.51E 02 0.00E-01 1.34E 02 .!
r 99M 4.71E 00 9.24E 00 i 0.00E-01 2.55E-29 7.90E-31 4.75E-30 1.43E-30 1.49E-30 1.89E-29 3.96E 08 T 101 5.88E 06 0.00E-01 3.85E 07 0.00E-01 , RU 103 1.53E 07 0.00E-01 8.06E 02 0.00E-01 5.99E 04 ; 0.00E-01 3.33E 01 0.00E-01 RU 105 9.17E 01 , 0.00E-01 1.01E 09 0.00E-01 1.16E 10 ; 7.45E 08 0.00E-01 9.30E 07 2.58E 09 RU 106 1.73E 07 0.00E-01 4.04E 07 0.00E-01 i AG 110M 3.21E 07 2.17E 07 0.00E-01 3.38E 08 j 4.67E 07 9.84E 07 0.00E-01 TE 125M 3.51E 08 9.50E 07 > 3.16E 08 3.77E 09 0.00E-01 1.07E 09 , 1.32E 09 3.56E 08 1.57E 08 3.85E 05 TE 127M 2.11E 03 6.82E 03 2.80E 04 0.00E-01 ! TE 127 9.85E 03 2.66E 03 0.00E-01 1.03E 09 l l 2.35E 08 1.30E 08 2.71E 08- 2.47E 09 TE 129M 8.41E 08 : 9.46E-04 3.88E-03 0.00E-01 8.25E-02 1.33E-03 3.70E-04 3.15E-04 2.16E 07 TE 129 5.68E 05 1.10E OG 5.16E 06 0.00E-01 ! TE 131M 1.54E 06 5.33E 05 7.84E-15 0.00E-0J. 1.36E-14 i ; 7.90E-16 7.71E-16 1.98E-15 E TE 131 2. 59 E-15 4.51E 06 2.88E 07 0.00E-01 3.12E 07 ! 7.00E 06 3.10E 06 3.74E 06 5.82E 05 TE 132 6.41E 05 1.37E 08 1.86E 06 0.00E-01 ; 130 6.16E 05 1.24E 06 0.00E-01 1.28E 07 I 1.44E 08 8.17E 07 4.76E 10 2.36E 08 I 131 1.43E 08 i 7.87E 03 2.60E 02 0.00E-01 2.00E 02 f 132 9.23E 01 1.70E 02 7.80E 01 1.76E 06 1 1.65E 06 8.12E 08 7.28E 06 0.00E-01 l 133 3.53E 06 4.37E 06 0.00E-01 1.92E 04 ; I 1.33E-04 6.65E-03 4.42E-04 I 134 1.56E-04 2.89E-04 E 9.98E 06 1.73E 05 0.00E-01 8.59E 04 135 6.26E 04 1.13E 05 5.33E 04 1.42E 08 1 5.55E 09 0.00E-01 8.15E 09 2.93E 09 , 2.63E 10 CS 134 1.60E 10 1.18E 08 1.76E 07 7.77E 06 8.04E 07 2.21E 08 1.43E 08 0.00E-01 : p 136 0.00E-01 7.46E 09 2.68E 09 1.43E 08 l 2.29E 10 3.38E 09 CS 137 2.39E 10 ~ 6.47E-11 6.96E-12 4.24E-11 9.20E-11 5.83E-11 0.00E-01 Ci 138 6.61E-11 1.46E-03 0.00E-01 2.35E-05 1.58E-05 2.91E 00 , 5.04E-02 2.69E-05 JA 139 l j A-84 9/93 ' ADM 04-019 Rev. 5 Page 182 of 202 i O - - TM ""*C1*Q Pj',%'Mf_ W M M M Q Q K {.Q g-}Z1 g ag .
1 l TABLE A.5-15 (cont'd) f y VEGETATION PATHWAY FACTOR M' MREM /YR PER pCI/SEC CHILD (RI FACTORS)
}
'1HYROID KIDNEY IIRC GI-LLI BJNE LIVD1 T BODY 8 ,!
NtK1IDE 0.00E-01 7.90E 04 1.45E 05 1.40E 08 . 2.77E 08 2.43E 05 1.62E 07 7.24E-24 1.25E-21 I BA 140 7.16E-23 0.00E-01 1.07E-24 BA 141 2.20E-21 1.23E-24 0.00E-01 0.00E-01 0.00E-01 , 0.00E-01 0.00E-01 0.00E-01 ! BA 142 0.00E-01 ' 0.00E-01 0.00E-01 0.00E-01 3.17E 07 3.25E 03 1.14E 03 3.83E 02 0.00E-01 1.49E 01 IA 140 2.35E-05 0.00E-01 0.00E-01 IA 142 2.36E-04 7.51E-05 1.43E 05 0.00E-01 4.08E 08 ! 3.27E 05 4.86E 04 0.00E-01 : CE 141 6.56E 05 i 0.00E-01 3.91E 02 0.00E-01 1.36E 07 1.72E 03 9.31E'05 1.35E 02 0.00E-01 1.04E 10 CE 143 6.78E 06 0.00E-01 2.21E 07 CE 144 1.27E 08 3.98E 07 2.37E 04 0.00E-01 1.57E 08 i 4.38E 04 7.23E 03 0.00E-01 ! PR 143 1.46E 05 8.90E-27 0.00E-01 3.62E-23+ 1.68E-26 2.74E-27 0.00E-01 ' PR 144 5.44E-26 0.00E-01 3.22E 04 0.00E-01 9.29E 07 7.24E 04 5.86E 04 4.54E 03 5.38E 07' ND 147 0.00E-01 0.00E-01 0.00E-01 ; 6.47E 04. 3.83E 04 1.72E 04 W 187 5.31E 02 0.00E-01 1.36E 07 l 1.84E 02 1.29E 02 0.00E-01 NP 239 2.56E 03 l L l
, i l l
[ I i 1 I ! l l I A-85 l I I ADM 04-019 Rev. 5 Page 183 of 202 i O . . , q. _ . . . , . mp4p, =p,7,3gpr,sg2 , ,y.+ 1*t e s .,,yt( p ,
1 l l TABLE A.5-16 GROUND PLANE PATHWAY FACTOR M* MREM /YR PER pCI/SEC ' (RI FACTOR) 1.00E 05 CS-134 6.86E 09 H-3 0.00E 00 Y-91M 1.07E 06 CS-136 1.49E 08 l C-14 0.00E 00 Y-91 1.03E 10 1.80E 05 CS-137 NA-24 1.19E 07 Y-92 3.59E 05 Y-93 1.85E 05 CS-138 P-32 0.00E 00 1.06E 05 ZR-95 2.45E 08 BA-139 CR-51 4.66E 06 2.05E 07 ZR-97 2.96E 06 BA-140 MN-54 1.39E 09 BA-141 4.18E 04 9.03E 05 NB-95 1.37E 08 MN-56 BA-142 4.49E 04 FE-55 0.00E 00 .MO-99 3.99E 06 1.84E 05 LA-140 1.92E 07 FE-59 2.73E 08 TC-99M TC-101 2.04E 04 1.08E 08 LA-142 7.37E 05 CO-58 3.79E 08 RU-103 6.36E 05 CE-141 1.37E 07 CO-60 2.15E 10 RU-105 RU-106 4.21E OB CE-143 2.31E 06 NI-63 0.00E 00 CE-144 6.96E 07 3.02E 05 AG-110M 3.44E 09 NI-65 PR-143 0.00E 00 6.07E 05 TE-125M 1.55E 06 CU-64 PR-144 1.83E 03 7.46E 08 TE-127M 9.17E 04 ZN-65 ND-147 8.46E 06 0.00E 00 TE-127 2.98E 03 ZN-69 1.98E 07 W-187 2.36E 06 BR-83 4.87E 03 TE-129M 2.62E 04 NP-239 1.71E 06 BR-84 2.03E 05 TE-129 0.00E 00 TE-131M 8.03E 06 BR-85 8.99E 06 TE-131 2.92E 04 M RB-86 3.31E 04 TE-132 4.23E 06 RB-88 1.21E 05 I-130 5.51E 06 RB-89 2.16E 04 I-131 1.72E 07 SR-89 SR-90 0.00E 00 I-132 1.25E 06 2.14E 06 I-133 2.45E 06 SR-91 7.77E 05 I-134 4.47E 05 SR-92 4.49E 03 I-135 2.53E 06 Y-90 A-86 9/93 ADM 04-019 Rev. 5 Page 184 of 202
' t8 ? t.. ' .w,v3 q w g g y,;;.,; g h.,; g ,, g g fg Q , j. y 'T-T;
TABLE A.5-17 GRASS-GOAT-MILK PATHWAY FACTOR M' MREM /YR PER FCI/SEC ADULT
'1HYROID KIDNEY LUfC GI-ILI BONE LIVER T BODY NtX'LIDE 1.56E 03 1.56E 03 1.56E 03 1.56E 03 0.00'E-01 1.56E 03 1.56E 03 5.27E 07 5.27E 07 H 3 5.27E 07 5.27E 07 2.63E 08 5.27E 07 5.27E 07 2.93E 05 2.93E 05 C 14 2.93E 05 2.93E 05 2.93E 05 Nn 24 2.93E 05 2.93E 05 0.00E-01 0.00E-01 0.00E-01 2.31E 09 2.05E 10 1.27E 09 7.93E 08 4.55E 03 8.62E 05 P 32 2.05E 03 7.55E 02 0.00E-01 0.00E-01 3.43E 03 0.00E-01 3.09E 06 ,
CR 51 1.93E 05 0.00E-01 3.00E 05 MN 54 0.00E-01 1.01E 06 0.00E-01 6.34E-04 0.00E-01 1.59E-02 0.00E-01 4.99E-O'4 8.85E-05 1.26E 05 1.29E 05 NN 56 0.00E-01 0.00E-01 55 3.26E 05 2.2SE 05 5.26E 04 2.54E 05 3.02E 06 > FE 3.48E 05 0.00E-01 0.00E-01 PE 59 3.86E 05 9.07E 05 0.00E-01 0.00E-01 1.15E 07 5.66E 05 1.27E 06 0.00E-01 00 58 0.00E-01 0.00E-01 0.00E-01 0.00E-01 3.70E 07 0.00E-01 1.97E 06 4.34E 06 1.17E 07 00 60 0.00E-01 0.00E-01 0.00E-01 63 8.07E 08 5.6SE 07 2.71E 07 NI 0.00E-01 0.00E-01 1.83E-01 7.22E-03 3.30E-03 0.00E-01 2.27E 05 NI 65 5.56E-02 0.00E-01 6.70E 03 0.00E-01 0.00E-01 2.66E 03 1.25E 03 3.30E 08 CU 64 0.00E-01 3.50E 08 0.00E-01 1.65E 08 5.24E 08 2.37E 08 ZN 65 7.79E-13 0.00E-01 1.80E-13 1.20E-12 8.34E-14 0.00E-01 0.00E-01 EN 69 6.27E-13 0.00E-01 0.00E-01 0.00E-01 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 0.00E-01 h 0.00E-01 0.00E-01 0.00E-01 0.00E-01 85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 6.14E 07 BR 1.45E 08 0.00E-01 0.00E-01 RB 86 0.00E-01 3.11E 08 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 88 0.00E_01 0.00E-01 0.00E-01 0.00E-01 : 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 4.89E 08 , 0.00E-01 8.75E 07 0.00E-01 2.84E 09 SR 89 3.05E 09 0.00E-01 0.00E-01 0.00E-01 90 9.83E 10 0.00E-01 2.41E 10 SR 0.00E-01 0.00E-01 2.87E 05 0.00E-01 2.43E 03 0.00E-01 2.' b; 01 SR 91 6.02E 04 0.00E-01 0.00E-01 0.00E-01 i 1.03E 00 0.00E-01 4. 45E-02 9.Upi: 04 ; SR 92 0.00E-01 0.00E-01 0.00E-01 l 90 8.49E 00 0.00E-01 2.28E-01 Y 0.00E-01 0.00E-01 0.00E-01 2.13E-20i 7.24E-21 0.00E-01 2.80E-22 5.67E 05 Y 91M 2.76E 01 0.00E-01 0.00E-01 0.00E-01 Y 91 1.03E 03 0.00E-01 0.00E-01 1.18E-01 i 0.00E-01 1.96E-07 0.00E-01 0.00E-01 Y 92 6.71E-06 A-87 ADM 04-019 Rev.' 5 Page 185 of 202 l
>; r-- .
e . % 22 OM.3)S f M y[ Q QJ}yj,q Q Q'g g 7 Q f y p _p F
l TABLE A.5-17 (contod) GRASS-GOAT-MILK FATHWAY FACTOR M' MREM /YR PER pCI/SEC ADULT K1DNEY LUTC GT-LLI T avi '1HYROID BONE LIVER NLCLIDE 0.00E-01 0.00E-01 8.87E 02 1 0.00E-01 7.73E-04 0.00E-01 1.15E 05 Y 93 2.80E-02 0.00E-01 5.70E 01 0.00E-01 1.13E 02 3.63E 01 2.46E 01 0.00E-01 3.25E 03 ZR 95 4.80E-03 0.00E-01 1.58E-02 l ZR 97 5.20E-02 1.05E-02 5.45E 03 0.00E-01 3.35E 07 5.51E 03 2.96E 03 0.00E-01 6.89E 06 NB 95 9 91E 03 0.00E-01 6.73E 06 0.00E-01 0.00E-01 2.97E 06 5.65E 05 5.53E-01 6.67E 02 10 99 1.44E 01 0.00E-01 1.71E 01 T 99M 3.99E-01 1.13E 00 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1.43E 04 K 101 0.00E-01 0.00E-01 4.66E 02 0.00E-01 1.22E 02 0.00E-01 5.26E 01 0.00E-01 6.30E-02 RU 103 4.07E-05 0.00E-01 1.33E-03 RU 105 1.03E-04 0.00E-01 4.73E 03 0.00E-01 1.58E 05 0.00E-01 3.10E 02 0.00E-01 2.64E 09 RU 106 2.45E 03 0.00E-01 1.27E 07 0.00E-01 6.99E 06 6.46E 06 3.84E 06 0.00E-01 7.81E 06 N1 110M 2.62E 05 5.88E 05 7.95E 06 TE 125M 1.95E 06 7.08E 05 2.23E 07 0.00E-01 1.84E 07 1.96E 06 6.702 05 1.40E 06 6.19E 03 TE 127H 5.49E 06 5.81E 01 3.19E 02 0.00E-01 7.84E 01 2.82E 01 1.70E 01 0.00E-01 3.64E 07 TE 127 1.14E 06 2.48E 06 3.02E 07 TE 129M 7.22E 06 2.69E 06 1.43E-10 0.00E-01 2.57E-11 1.28E-11 8.31E-12 2.62E-11 2.10E 06 i TE 129 3.41E-11 3.36E 04 2.15E 05 0.00E-01 4.33E 04 2:12E 04 1.77E 04 0.00E-01 6.23E-35 g TE 131M 1.39E-34 3.62E-34 1.93E-33 TE 131 4.40E-34 1.84E-34 1.80E 06 0.00E-01 8.82E 06 4 1.86E 05 1.75E 05 2.06E 05 1.28E 06 TE 132 2.88E 05 1.26E 08 2.32E 06 0.00E-01 130 5.04E 05 1.49E 06 5.87E 05 0.00E-01 1.34E 08 I 2.91E 08 1.67E 11 8.71E 08 I 131 3.55E 08 5.08E 08 ' 8.43E-01 0.00E-01 9.94E-02' 5.29E-01 1.85E-01 1.85E 01 7.26E 06 I 132 1.98E-01 1.19E 09 1.41E 07 0.00E-01 4.65E 06 8.08E 06 2.46E 06 5.78E-15 I .133 1.15E-10 1.05E-11 0.00E-01 2.44E-12 6.63E-12 2.37E-12 I 134 ' 6.48E 04 0.00E-01 4.56E 04 4.04E 04 1.49E 04 2.66E 06 7.06E 08 I 135 1.54E 04 0.00E-01 1.31E 10 4.34E 09 1.70E 10 4.04E 10 3.30E 10 2.36E 08 3.51E 08 CS 134 2.23E 09 0.00E-01 1.72E 09 CS 136 7.83E 08 3.09E 09 . 1.03E 10 3.42E 09 5.86E 08 2.21E 10 3.03E 10 1.98E 10 0.00E-01 2.32E-28 t CS 137 0.00E-01 3.99E-23 3.94E-24 2.75E-23 5.43E-23 2.69E-23 2.21E-12 9.71E-09 CS 138 1.60E-10 0.00E-01 3.65E-12 BA 139 5.48E-09 3.90E-12 i A-88 ADM 04-019 Rev. 5 Page 106 of 202 l O Ty * '- '; M .t, W Gi@l'i~t"Q M M E Q { Q ] Q g 'y Q g Y
TABLE A.5-17 (cont'd) GRASS-GOAT-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC ADULT
'IHYROID KIDtEY IRC GI-U 1 POtE LIVER T DODY NIXIIDE 0.00E-01 1.38E 03 2.32E 03 6.64E 06 3.23E 06 4.05E 03 2.11E 05 0.00E-01 BA 140 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01g 0.00E-01 0.00E-01 0.00E-01 BA 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 2.01E 04 5.43E-01 2.73E-01 7.23E-02 3.74E-09 IA 140 1.28E-13 0.00E-01 0.00E-01 0.00E-01 IA 142 1.13E-12 5.12E-13 1.83E 02 0.00E-01 1.50E 06 3.93E 02 4.46E 01 0.00E-01 CE 141 5.81E 02 0.00E-01 1.62E 00 0.00E-01 1.38E 05 4.99E 00 3.69E'03 4.08E-01 1.45E 07 CE 143 2.30E 03 0.00E-01 1.06E 04 0.00E-01 CE 144 4.29E 04 1.79E 04 4.39E 00 0.00E-01 8.30E 04 7.60E 00 9.39E-01 0.00E-01 PR 143 1.90E 01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 6.30E 04 PR 144 7.85E-01 0.00E-01 7.67E 00 0.00E-01 ND 147 1.14E 01 1.31E 01 0.00E-01 0.00E-01 2.16E 05 6.58E 02 2.30E 02 0.00E-01 W 187 7.87E 02 0.00E-01 1.35E-01 0.00E-01 8.89E 03 te 239 4.418-01 4.33E-02 2.39E-02 Y
A-89 ADM 04-019 Rev. 5 l Page 167 of 202 l l l ~ ' ~ ~ ' T'i[5E.'P ' ~~'f.M 9%LW;'Q%*WRMH?QfQ}Q*fW'[:ff-} fe,}' v,*
. *'q 7'~~Tf,L. .y -- r -' - * -r ** ,
l TABLE A.5-18 GRASS-GOAT-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC TEEN KIDNEY 1/UtG GI-LLI LTVFR T BCOY 'DIYROID ECLipE DONE 2.03E 03 2.03E 03 2.03E 03 2.03E 03 2.03E 03 2.03E 03 9.72E 07 H 3 0.00E-01 9.72E 07 9.72E 07 9.72E 07 4.86E 08 9.72E 07 9.72E 07 5.11E 05 5.11E 05 ' C 14 5 11E 05 5.11E 05 5.11E 05 NA 24 5.11E 05 5.11E 05 l 0.00E-01 0.00E-01 3.18E 09 2.34E 09 1.47E 09 0.00E-01 1.01E 06 P 32 3.78E 10 3.33E 03 1.31E 03 8.55E 03 0.00E-01 0.00E-01 5.99E 03 0.00E-01 3.45E 06 CR 51 3.34E 05 0.00E-01 5.02E 05 MN 54 0.00E-01 1.68E 06 1.12E-03 0.00E-01 5.82E-02 8.85E-04 1.57E-04 0.00E-01 1.78E 05 NN 56 0.00E-01 0.00E-01 0.00E-01 2.60E 05 5.79E 05 4.10E 05 9.57E 04 4.96E 05 3.72E 06 FE 55 6.07E 05 0.00E-01 0.00E-01 FE 59 6.74E 05 1.57E 06 0.00E-01 0.00E-01 1.31E 07 9.52E 05 2.19E 06 0.00E-01 4.35E 07 Q 58 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 3.34E 06 7.52E 06 0.00E-01 1.59E 07 00 60 4.81E 07 0.00E-01 0.00E-01 NI 63 1.42E 09 1.00E 08 0.00E-01 0.00E-01 7.05E-01 1.30E-02 5.92E-03 0.00E-01 3.67E 05 NI 65 1.02E-01 0.00E-01 1.20E 04 0.00E-01 0.00E-01 4.74E 03 2.23E 03 0.00E-01 3.72E 08 CU 64 4.09E 08 0.00E-01 5.62E 08 ZM 65 2.53E 08 8.78E 08 1.44E-12 0.00E-01 4.05E-12 2.20E-12 1.54E-13 0.00E-01 0.00E-01 ZN 69 1.15E-12 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR - 83 0.00E-01 0.00E-01 0.00E-01 'g BR 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 8.40E 07 BR 85 0.00E-01 0.00E-01 86 0.00E-01 5.67E 08 2.67E 08 0.00E-01 0.00E-01 RB 0.00E-01 0.00E-01 0.00E-01 RB 88 0.00E- 01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 6.69E 08 RB 89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 89 5.62E 09 0.00E-01 1.61E 08 0.00E-01 3.90E 09 SR 3.43E 10 0.00E-01 0.00E-01 90 1.39E 11 0.00E-01 SR 0.00E-01 0.00E-01 0.00E-01 5.02E 05 1.11E 05 0.00E-01 4.40E 03 4.80E 01 SR 91 0.00E-01 0.00E-01 0.00E-01 1.88E 00 0.00E-01 8.02E-02 0.00E-01 1.29E 05 SR 92 0.00E-01 0.00E-01 1.56E 01 0.00E-01 4.20E-01 Y 90 0.00E-01 0.00E-01 6.26E-19 0.00E-01 5.07E-22 0.00E-01 7.77E 05 Y 91M 1.33E-20 0.00E-01 0.00E-01 0.00E-01 1.90E 03 0.00E-01 5.08E 01 3. 40E-01 Y 91 0.00E-01 0.00E-01 ~0.00E-01 92 1.24E-05 0.00E-01 3.59E-07 Y A-90 ADM 04-019 Rev. 5 0 age 168 of 202 s
'i D NM YM, W [ '
ag ' g $ . ,((. , Y
TABLE A.5-18 (cont'd) GRAGS-GOAT-MILK PATHWAY FACTOR M' MREM /YR PER pCI/SEC TEEN LIVER T BODY 'IUYTOID KIDNEY URG GI-LLI NUCLIDE HONE. __ 0.00E-01 0.00E-01 0.00E-01 1.58E 03 93 5.16E-02 0.00E-01 1.41E-03 Y 4.30E 01 0.00E-01 9.18E 01 0.00E-01 1.44E 05 ZR 95 1.98E 02 6.25E 01 0.00E-01 5.07E 03 1.87E-02 8.63E-03 0.00E -01 2.84E-02 ZR 97 9.47E-02 5.16E 03 0.00E-01 9.09E 03 0.00E-01 4.01E 07 i is 95 1.69E 04 9.37E 03 9.61E 06 1.02E 06 0.00E-01 1.23E 07 0.00E-01 No 99 0. 00E-.01 S.37E 06 1.07E 00 1.27E 03 1.93E 00 2.50E 01 0.00E-01 2.88E 01 1C 99M 6.92E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-.01 0.00E-01
'IC 101 0.005-01 0.00E-01 1.81E 04 0.00E-01 9.28E 01 0.00E-01 7.66E 02- 0.00E-01 RU 103 2.17E 02 2.37E-03 0.00E-01 1.52E-01 1.88E-04 0.00E-01 7.30E-05 0.00E-01 1 RU 105 0.00E-01 8.68E 03 0.00E-01 2.16E 05 RU 106 4.50E 03 0.00E-01 5.67E 02 3.07E 09 1.098 07 6.65E 06 0.00E-01 2.08E 07 0.00E-01 Y, 110M 1.16E 07 0.00E-01 0.00E-01 1.06E 07 I
3.60E 06 1.30E 06 4.82E 05 1.01E 06 l l'E _125M 1.20E 06 2.41E 06 4.10E 07 0.00E-01 2.52E 07 TE 127M 1.01E 07 3.59E 06 1.12E 04 3.13E 01 1.00E 02 5.89E 02 0.00E-01 TE 127 1.45E 02 5.15E 01 4.96E 07 2.09E 06 4.26E 06 5.53E 07 0.00E-01 p? 129M 1.32E 07 4.90E 06 1.53E-11 4.48E-11 2.63E-10 0.00E-01 3.43E-10 / TE 129 6.28E-11 2.34E-11 3.04E 06 3.16E 04 5.69E 04 3.94E 05 0.00E-01 TE 131M 7.89E 04 3.78E 04 0.00E-01 6.60E-35 3.31E-34 2.51E-34 6.19E-34 3.51E-33 TE 131 3.04E-34 f 0.00E-01 1.03E 07 5.15E 05 3.26E 05 3.07E 05 3.44E 05 3.13E 06 TE 132 3.95E 06 0.00E-01 1.97E 06 130 9.87E 05 2.57E 06 1.02E 06 2~.09E 08 I 4.85E 08 2.63E 11 1.55E 09 0.00E-01 1.79E 08 I 131 6.45E 08 9.03E 08 3.09E 01 1.45E 00 0.00E-01 4.00E-01 132 3.51E-01 9.18E-01 3.29E-01 I 4.39E 06 2.01E 09 2.52E 07 0.00E-01 1.09E 07 133 8.49E 06 1.44E 07 1.51E-13 I 1.15E-11 4.13E-12 1.92E-10 1.81E-11 0.00E-01 I 134 4 . 34 E-.12 2.61E 04 4.54E 06 1.11E 05 0.00E-01 7.82E 04 135 2.74E 04 7.0SE 04 8.62E,08 I 6.93E 10 3.22E 10 0.00E-01 2.20E 10 8.41E 09 CS 134 2.94E 10 2.86E 09 4.50E 08 4.22E 08 CS 136 1.33E 09 5.25E 09 3.52E 09 0.00E-01 1.86E 10 0.00E-01 1.82E 10 7.06E 09 7.60E 08 4.02E 10 5.34E 10 CS 137 7.07E-23 8.23E-24 4.305-26 l CS 138 4.99E-23 9.58E-23 4.79E-23 0.00E-01 7.13E-12 2.95E-10 0.00E-01 6.72E-12 4.91E-12 9.0fE-08 BA 139 1.01E-08 I l i A-91 l ADM 04-019 Rev. 5 Page 189 of 202 f
- s. .
a
. cm.gm amm maym.m.3,g,,,. n.,,., - ..
- . _ - . -_ - .- ._ - ._ = . . _ - _ _ - . . .- - . - . . .
TABLE A.5-18 (cont'd) j GRASS-GOAT-MILK PATHWAY FACTOR f M* MREM /YR PER pCI/SEC l TEEN t I Nic.IDE ErJNE LIVER T BJDY 'IWYROID KIDNEY InG GI-1/LI i BA 140 S.82E 06 7.14E 03 3.75E 05 0.00E-01 2.42E 03 4.08E 03 8.98E 06 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 , t IA 140 1.75E-01 4.79E-01 1.27E-01 0.00E-01 0.00E-01 0.00E-01 2.75E 04 IA 142 2.03E-12 9.03E 13 2.25E-13 0.00E-01 0.00E-01 0.00E-01 2.75E-08 CE 141 1.07E 03 7.12E 02 8.18E 01 0.00E-01 3.35E 02 0.00E-01 2.04E 06 CE 143 9.17E 00 6.67E 03 7.45E-01 0.00E-01 2.99E 00 0.00E-01 2.01E 05 ? CE 144 7.90E 04 3.27E 04 4.24E 03 0.00E-01 1.95E 04 0.00E-01 1.99E 07 PR 143 3.4hE 01 1.39E 00 1.73E 00 0.00E-01 8.08E 00 0.00E-01 1.15E 05 , PR 144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ND 147 2.19E 01 2.38E 01 1.42E 00 0.0GE-01 1.40E 01 0.00E-01 8.57E 04 ; w 1.44E 03 1.17E f}3 4.11E 02 0.00E-01 0.00E-01 0.00E-01 3.18E 05 11 IF 239 8.41E-01 7.93E-02 4.41E-02 0.00E-01 2.49E-01 0.00E-01 1.28E 04 , 1 i i I , i t t l i A-92 ; ADM 04-019 i Rev. 5 ! Page 190 of 202 l l i h 7 . 5.k'5WW3%WW:? 3}5?TF,TW%WFly3: %%fSh'l.'+?,Mt.{(pg.%;!(QC SG1-.
~*
I
TABLE A.5-19 GRASS-COAT-MILK PATHWAY FACTOR M' MREM /YR PER pCI/SEC f CHILD I (
- l l KTINEY LUlG GI-ILI l LIVD1 T BJDY 'nDTOID 1AX'LTDE DONE l 3 20E 03 3.20E 03 3.20E 03 3.20E 03 3.20E 03 l
3 0.00E-01 3.20E 03 2.39E 08 2.39E 08 2.39E 08 ! H 2.39E 08 2.39E 08 2.39E 08 1.06E 06 C 14 1.19E 09 1.06E 06 1.06E 06 1.06E 06 1.06E 06 1.06E 06 1.06E 06 PM 24 0.00E-01 0.00E-01 2.58E 09 4.37E 09 3.60E 09 0.00E-01 6.48E 05 P 32 9.33E 10 6.78E 03 1 85E 03 1.24E 04 0.00E-01 0.00E-01 1.22E 04 0.00E-01 2.11E 06 CR 51 6.70E 05 0.00E-01 7.06E 05 MN 54 0.00E-01 2.52E 06 1.87E-03 0.00E-01 2.24E-01 1.54E-03' 3.48E-04 0.00E-01 1.43E 05 MN 56 0.00E-01 0.00E-01 0.00E-01 4.36E 05 1.45E 06 7.70E 05 2.39E 05 7.33E 05 2.63E 06 i FE 55 0.00E-01 0.00E-01 1.56E 06 2.53E 06 1.26E 06 i FE 59 0.00E-01 0.00E-01 8.49E 06 ' 1.46E 06 4.45E 06 0.00E-01 2.87E 07 00 58 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 5 18E 06 1.53E 07 0.00E-01 1.28E 07 CO 60 0.00E-01 0.00E-01 3a 56E 09 1.90E 08 1.21E 08 NI 63 0.00E-01 0.00E-01 2.87E 00 2.34E-02 1.37E-02 0.00E-01 3.91E 05 NI 65 2.49E-01 0.00E-01 2.01E 04 0.00E-01 0.00E-01 8.23E 03 5.03E 03 0.00E-01 2.32E 08 CU 64 0.00E-01 8.33E 08 4.96E 08 1.32E 09 8.22E 08 ZN _55 2.58E-10 0.00E-01 2.49E-12 0.0')E-01 69 2.84E-12 4.10E-12 3.79E-13 0.00E-01 0.00E-01 I ZN 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 f 0.00E-01 0.00E-01 0.00E-01 N .Mt__, 84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 85 0.00E-01 0.00E-01 0.00E-01 6.77E 07 1.05E 09 6.47E 08 0.00E-01 RB 86 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.60E-01 RB 89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 5.38E 08 89 1.39E 10 0.00E-01 3.97E 08 0.00E-01 3.16E 09 SR 5.95E 10 0.00E-01 0.00E-01 90 2.35E 11 0.00E-01
.51 0.00E-01 0.00E-01 0.00E-01 5.99E 05 91 2.71E 05 0.00E-01 1.02E 04 0.00E-01 8.71E 01 SR 1.84E-01 0.00E-01 0.00E-01 SR 92 4.60E 00 0.00E-01 0.00E.01 0.00E-01 1.10E 05 .
0.00E-01 1.03E-00 0.00E-01 Y 90 3.86E 01 0.00E-01 0.00E-01 6.34E-17 I 0.00E-01 1.18E-21 0.00E-01 Y 91M 3.24E-20 0.00E-01 0.00E-01 0.00E-01 6.24E 05 91 4.68E 03 0.00E-01 1.25E 00 0.00E-01 8.79E-01 Y 0.00E-01 0.00E-01 92 3.04E-05 0.00E-01 8.71E-07 Y A-93 ADM 04-019 Rev. 5 Pag: 191 of 202 O r M " -%F.i.%W2DgG1 6 6 L g gygg g g':g.{,g g
TABLE A.5-19 (cont'd) GRASS-GOAT-MILK PATHWAY FACTOR Mf MREM /YR PER pCI/SEC CHILD KIDNEY IDG GI-LLI T UQUI *ntrT<0TD IGE LIVER NU~LIDE 0.00E-01 1.89E 03 0.00E-01 0.00E-01 0.00E-01 3 48E-03 0.00E-01 1.05E 05 Y 93 1.27E-01 0.00E-01 1.45E 02 5.04E 03 4.60E 02 1.01E 02 9.00E 01 4.78E-02 0.00E-01 ZR 95 1.96E-02 0.00E-01 97 2.30E-01 3.33E-02 zR 0.00E-01 2.75E 07 0.00E-01 1.40E 04 1.49E 04 1.06E 04 2.08E 07 0.00E-01 8 07E 06 NB 95 3.82E 04 2.42E 06 0.00E-01 1.77E 03 ! 0.00E-01 9.76E 06 0.00&O1 4.52E 01 1.58E 00 to 99 5.16E 01 99M 1.59E 00 3.11E 00 7C 0 00001 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1.33E 04 7C 101 0.00E-01 1.97E 0'; 0.00E-01 1.29E 03 3.00E-01 5.14E 02 0.00E-01 4.04E-03 0.00E-01 RU 103 1.67E-44 0.00E-01 4.59E-04 0.00E-01 nu 105 0.00E-01 1.72E 05 0.00E-01 1.50E 04 0.00E-01 1.3BE 03 0.00E-01 2.01E 09 RU 106 1.11E 04 1.35E 07 0.00E-01 3.15E 07 1.69E 07 0.00E-01 0.00E-01 8.54E 06 AG 110M 2.51E 07 1.18E 06 2.4BE 06 8.85E 06 2.40E 06 TE 125M 0.00E-01 2.02E 07 2.96E 06 5.97E 06 7.12E 07 1.40E 04 2.50E 07 6.72E 06 1.02E 03 0.00E-01 TE 127M 7.67E 01 2.47E 02 0.00E-01 3.97E 07 l TE 127 3.57E 02 9.64E 01 1.05E 07 9.56E 07 9.09E 06 5.05E 06 TE 129M 3.26E 07 9.64E-09 4.53E-10 0.00E-01 3.68E-11 1.11E-10 0.00E-01 2.69E 06 1.55E-10 4.32E-11 6.43E 05 TE .' 29 7.07E 04 1.37E 05 0.00E-01 1.04E-32 1.92E 05 6.64E 04 1. 51E-33 5.97E-33 TE 131M 6.01E-34 5.87E-34
- g TE 131 1.97E-33 5.48E 06 7.93E 05 5.05E 06 0.00E-01 5.44E 05 6.58E 05 6.27E 06 0.00E-01 1.96E 06 TE 132 1.23E 06 2.16E 06 4.62E 08 1.40E 08 2.07E 06 4.19E 06 2.58E 09 0.00E 1 130 8.94E 08 5.20E 11 131 1.56E 09 1.57E 09 :
1 0.00E-01 1.79E 00 7.07E 01 2.33E 00 1.03E 07 1 1.52E 00 7.01E-01 0.00E-01 7 132 8.30E-01 4.74E 09 4.25E 07 1.26E-11 l 2.55E 07 9.65E 06 2.92E-11 0.00E-01 I 133 2.06E 07 8.77E-12 4.39E-10 134 1.03E-11 1.91E-11 1 8.90E 04 1.79E 05 0.00E-01 5.52E 04 1.03E 0'I 1.24E 10 6.01E 08 l 135 6.49E 04 1.17E 05 0.00E-01 3.45E 10 J 2.35E 10 6.57E 08 2.91E 08 6.79E 10 1.11E 11 4.40E 09 CS 134 8.27E 09 5.35E 09 0.00E-01 i CS 136 3.01E 09 5.80E 08 3.02E 10 1.09E 10 , 1.37E 10 0.00E-01 1.27E-23 7.74E-23 CS 137 9.67E 10 9.26E 10 0.00E-01 1.18E-22 1.68E-22 1.07E-22 7.82E-12 1.44E-06 1.21E-22 1.16E-11 CS 138 1.33E-11 7.21E-10 0.00E-01 Im 139 2.49E-08 A-94 9/93 ADM 04-019 Rev. 5 Page 192 of 202 1 6 gggf. eg Ir ::n M 's3...ns N E W 4 2 ."TfM2f M W j)$ y i & k Q Q Q g ge ., , ,
TABLE A.5-19 (cont'd) GRASS-GOAT-MILK PATHWAY FACTOR M' MREM /YR PER pCI/SEC CHILD
'DP/ROID YJDNEY LUtG C I_-ILI TOJE I,IVFR T 10DY IU'LIDE 0.00401 4.01E 03 7.34E 03 7.12E 06 FM 140 1.41E 07 1.23E 04 8.21E 05 0.005-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 in 142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 2.27E 04 1A 140 2.33E 00 8.16E-01 2.75E-01 3.10E-07 4.90E-13 0.00E-01 0.00E-01 0.00E-01 .'
1A 142 4.91E-12 1.56E-12 0.00E-01 1.63E 06 1.31E 03 1.94E 02 0.00 401 5.74E 02 CE 141 2. 6 R.O.L 0.00E-01 5.12E 00 0.00E-01 1.79E 05 CE 143 2.25I: 01 :.22E 04
- 1.77E 00 3.38E 04 0.00E-01 1.59E 07 1.95E 05 5.11E 04 1.04E 04 0.00E-01 CE 144 0.00E-01 1.40E 01 0.00E-01 9.30E 04 8.62E 01_ _ 2.59E 01 4.28E 00 PR 143 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 PR 144 0.00E-01 2.38E 01 0.00E-01 6.88E 04 5.36E 01 4.34E 01 3.36E 00 ND 147 9.28E 02 0.00E-01 0.00E-01 0.00E-01 2.90E05l W 187 3.49E 03 2.07E 03 0.00E-01 4.30E-01 0.00E-01 1.10E 04 LIP 239 2.07E 00 1.49E-01 1.04E-01 l
A-95 9/93 ADM 04-019 Rev. 5 Page 193 of 202 e ,; ^
.'t : ' 9-m' '.~ 3-
" * ' '?' Y' : NMQ..iM#ie%%M frQ[e'QQ~QQ,}
.- - __ ~. . _ . -. . . - - . .
i TABLE A.5-20 , t GRASS-GOAT-MILK PATHWAY FACTOR M' MREM /YR PER pCI/SEC ; INFANT T DODY _'NIYROID KIDNEY LUfG GI-LLI NUCLIDE DCNE LIV E 4.86E 03 4.86E 03 4.86E 03 4.86E 03 4.86E 03 H 3 0.00E-01 4.86E 03 5.00E 08 5.00E 08 5.00E 08 5.00E 08 5.00E 08 5.00E 08 C 14 2.34E 09 1.85E 06 1.85E 06 1.85E 06 l l 24 1.85E 06 1.85E 06 1.85E 06 1.85E 06 NA 7.45E 09 0.00E-01 0.00E-01 0.00E-01 2.60E 09 P 32 1.92E 11 1.13E 10 2.46E 04 5.64E 05 i 0.00E-01 1.94E 04 1.26E 04 2.76E 03 CR 51 0.00E-01 1.04E 06 0.00E-01 1.72E 06 I 0.00E-01 4.68E 06 1.06E 06 0.00E-01 HN 54 0.00E-01 3.25E-03 0.00E-01 3.43E-01 56 0.00E-01 3.78E-03' 6.51E-04 MN 0.00E-01 0.00E-01 5.54E 05 1.44E 05 FE 55 1.76E 06 1.13E 06 3.03E 06 2.43E 06 2.01E 06 0.00E-01 0.00E-01 1.51E 06 FE 59 2.92E 06 5.09E 06 0.00E-01 0.00E-01 0.00E-01 7.25E 06 d) 58 0.00E-01 2.91E 06 7.26E 06 ' 0.00E-01 0.00E-01 0.00E-01 2.52E 07 CO 60 0.00E-01 1.06E 07 2.50E 07 0.00E-01 0.00E-01 0.00E-01 1.29E 07 NI 63 4.19E 09 2.59E 08 1.45E_08 2.71E-02 0.00E-01 0.00E-01 0.00E-01 4.54E 00 NI 65 5.27E-01 5.96E-02 0.00E-01 4.25E 05 2.07E 04 9.58E 03 0.00E-01 3.50E 04 CU 64 0.00E-01 1.11E 09 0.00E-01 1.93E 09 65 6.66E 08 2.28E 09 1.05E 09 0.00E-01 j;N 8.10E-13 0.00E-01 4.52E-12 0.00E-01 8.87E-10 ZN 69 6.04E-12 1.09E-11 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 83 0.00E-01 0.00E-01 0.00E-01 g 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BR 84 0.00E-01 1 0.00E-01 0.00E-01 0.00E-01 0.00E-01 85 0.00E-01 0.00E-01 0.00E-01 ! BR 0.00E-01 0.00E-01 0.00E-01 6.83E 07 Rn 86 0.00E-01 2.67E 09 1.32E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 , RB 88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 RB 89 0.00E-01 0.00E-01 7.58E 08 0.00E-01 0.00E-01 0.00E-01 5.43E 08 : SR 89 2.64E 10 0.00E-01 3.19E 09 ? 0.00E-01 6.50E 10 0.00E-01 0.00E-01 0.00E-01 SR 90 2.55EJ1 2.05E 03 0.00E-01 0.00E-01 0.00E-01 6.69E 05 SR 91 5.65E 05 0.00E-01 1.05E 02 f 0.00E-01 3.63E-01 0.00E-01 0.00E-01 0.00E-01 SR 92 9.78E 00 0.00E-01 1.13E 05 8.16E 01 0.00E-01 2.19E 00 0.00E-01 0.00E-01 Y 90 2.34E-21 0.00E-O' O.00E-01 0.00E-01 2.29E-16: Y 91M 6.87E-20 0.00E-01 6.30E 05 0.00E-01 2.34E 02 0.00E ' 1 0.00E-01 0.00E-01 Y 91 8.79E 03 0.00E-01 1.23E 00 6.47E-05 0.00E-01 1.82E-06 0.00E-01 0.00E-01 I_ 92 A-96 ADM 04-019 Rev. 5 Page 194 of 202 1 O .y, . wt c . : c* 'F?@W'/JpMg**!i saggfEggg >. .g 4.j e. ,
TABLE A.5-20 (cont'd) GRASS-GOAT-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC INFANT T BODY 'IEMOID KIMEY LUtG GI-LLI NUCLIDE BONE LIVDI 0.00E-01 0.00E-01 0.00E-01 2.13E 03 93 2.70E-01 0.00E-01 7.36E-03 Y 1.41E 02 0.00E-01 2.14E 02 0.00E-01 9.91E 04 51 95 8.17E 02 1.99E 02 0.00E-01 5.34E 03 8.37E-02 3.82E-02 0.00E-01 8.44E-02 ZR 97 4.88E-01 1.70E 04 0.00E-01 2.10E 04 0.00E-01 2.48E 07 NB 95 7.12E 04 2.93E 04 0.00E-01 8.22E 06 2.50E 07 4.87E 06 0.00E-01 3.73E 07 i 10 99 0.00E-01 7.33E 01 3.56E 00 1.98E 03 1 3.30E 00 6.81E 00 8.77E 01 0.00E-01
'It 99M 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i
'IC 101 0.00E-01 0.00E-01 0.00E-01 '
0.00E-01 2.16E 03 0.00E-01 1.26E 04 RU 103 1.04E 03 0.00E-01 3.48E 02 3.85E-01' 3.26E-04 0.00E-01 7.12E-03 0.00E-01 RD 105 9.68E-04 0.00E-01 2.85E 03 0.00E-01 2.70E 04 0.00E-01 1.73E 05 RU 106 2.28E 04 0.00E-01 0.00E-01 1.75E 09 3.38E 07 2.24E 07 0.00E-01 4.83E 07
/G 110M 4.63E 07 0.00E-01 0.00E-01 8.62E 06 1.81E 07 6.05E 06 2.45E 06 6.09E 06
.3 125M 1.46E 07 1.24E 08 0.00E-01 2.04E 07 TE 127M 5.0SE 07 1.68E 07 6.12E 06 1.59E 04 1.63E 02 6.18E 02 1.85E 03 0.00E-01 TE 127 7.59E 02 2.54E 02 0.00E-01 3.99E 07 2.29E 07 1.03E 07 2.57E 07 1.67E 08 TE 129M 6.69E 07 7.668-11 2.75E-10 8.17E-10 0.00E-01 2.62E-08 TE 129 3.28E-10 1.13E-10 2.75E 06 1.35E 05 3.31E 05 1.12E 06 0.00E-01 TE 131M 4.05E 05 1.63E 05 0.00E-01 1.69E-31 g- 1.54E-33 1.17E-33 3.73E-33 1.07E-32 TE 131 4.18E-33 1.85E 06 7.84E 06 0.00E-01 4.64E 06 TE 132 2.53E 06 1.25E 06 1.17E 06 3.76E 06 1.05E 09 1.03E 07 0.00E-01 2.01E 06 130 4.26E 06 9.38E 06 0.00E-01 1.37E 08 I
3.85E 09 1.69E 09 1.26E 12 4.49E 09 I 131 3.26E 09 1.24E 00 1.64E 02 3.90E 00 0.00E-01 2.83E 00 132 1.72E 00 3.49E 00 0.00E-01 1.07E 07 l I 6.34E 07 1.86E 07 1.15E 10 7.45E 07 I 133 4.35E 07 0.00E-01 4.51E-11 l 4. 36E- 11 1.55E-11 1.02E-09 4.88E-11 I I 134 ].13E-11 9.79E 04 2.41E 07 2.99E 05 0.00E-01 9.71E 04 135 1.35E 05 2.68E 05 5.54E 08 I 2.06E 10 0.00E-01 5.25E 10 1.86E 10 CS 134 1.09E 11 2.04E 11 1.41E 09 2.63E 08 1.73E 10 6.45E 09 0.00E-01 6.89E 09 CS 136 5.88E 09 1,28E 10 0.00E-01 4.85E 10 1.96E 10 5.65E 08 CS 137 1.54E 11 1.81E 11 6.63E-22 4.15E-22 2.01E-22 0.00E-01 2.07E-22 3.23E-23 CS 138 2.55E-22 2.11E-11 2.13E-11 3.35E-06 5.30E-08 3.51E-11 1.53E-09 0.00E-01 BA 139 A-97 ADM 04-019 Rev. S Page 295 of 202 e
. . ,y + :,
~. - .~ ~ -_,
TABLE A.5-20 (cont'd) GRASS-GOAT-MILK PATHWAY FACTOR M* MREM /YR PER pCI/SEC INFANT
'IWYROID _ KIDNEY 1UtG GI-LLI l FOIE LIVER T BODY NUCLIDE 7.11E 06 !
1.49E 06 0.00E-01 6.87E 03 1.78E 04 DA 140 2.09E 07 2.89E 04 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 BA 141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 j 0.005-01 0.00E-01 0.00E-01 BA 142 ' 0.00E-01 0.00E-01 2.26E 04 , 4.88E 00 1.92E 00 4.94E-01 0.00E-01 LA 140 0.00E-01 0.00E-01 0.00E-01 6.43E-07 ; 1.03E-11 3.78E-12 9.06E-13 1.64E 06 1A 142 3.74E 02 0.00E-01 9.79E 02 0.00E-01 : j CE 141 5.20E 03 3.17E 03 0.00E-01 9.21E 00 0.00E-01 1.84E 05 CE 143 4.76E 01 3.16E 04
- 3.61E 00 0.00E-01 1.60E 07 ;
1.56E 04 0.00E-01 4.62E 04 CE 144 2.79E 05 1.14E 05 2.40E 01 0.00E-01 9.41E 04 ! 6.67E 01 8.84E 00 0.00E-01 PR 143 1.78E 02 0.00E-01 0.00E-01 0.00E-01 0.00E-01 , 0.00E-01 0.00E-01 0.00E-01 6.92E 04 : PR 144 6.69E 00 0.00Fe01 4.21E 01 0.00E-01 ND 147 1.06E 02 1.09E 02 0.00E-01 0.00E-01 3.00E 05 I 5.11E 03 1.77E 03 0.00E-01 t W 187 7.35E 03 0.00E-01 7.80E-01 0.00E-01 1.13E 04 ; 4.38E 00 3.91E-01 2.21E-01 NP 239 l I h t A-98 ! l ADM 04-019 i iMV 5 , Page 196 of 202 ; f a d ' , , , ,* j , 4 ' i * , k =h ,
?
e m
APPENDIX B Neteorological Model 3 B-1 ADM 04-019 Rev. 5 Page 197 of 202
*.a.c e w.werexs'emnt;g MrTrW:7<31 9747li 4,:pil. .i,du o, ,, g',JjJ ff{f:_l?]{ft~g-l;'
3 ,,* . g',y,* { - 2.]
i APP N IX B , h' PROPRIETARY TNFORMATION StfPPLIED BY SAI f l l The X/Q's and D/Q's are calculated using the guidance of Reg. Guide ! 1.111. The constant mean wind direction model, as defined in equation 3 of [ Reg. Guide 1.111, is used to calculated X/O values. t 2 2 2,032 Eng exp (h , /2 o ,;(x)} (x / Q )" - _ NxUiZ(x) l 4 l
- l Where:
h, - ef f ective release height (m). (All releases from Wolf Creek Generating Station are considered as ground l' releases therefore he = 0.) : ny = hours of valid data for weather conditions in given r l direction, windspeed class I, and atmospheric stability class j. N = total house of valid data
$ Di = midpoint of windspeed class (m/s) i x = distance downwind (m) og (x) = vertical plume spread without volumetric correction See Figure at distance x and stability class j. !
- B.1.
E,j(x) = vertical plume spread with columetric correction for release within buildings wake cavity, at distance x and stability class j. , For ground level releases L3 (x) is the lesser of l 2 or ]3 o ,) (x) h24 (x) + 0.5 D : / n : Where: . D, - maximum adjacent building height either up- or ' down-wind from the release }oint B '2 ADM 04-019 Rev. 5 , Page 198 of 202
- i e -
L U"'i . ^_ta .4. l_- 6..@r21QMZMMWW{ggg,fj',*ff{@jfy,g.ggigg _ _ _ _ _
2.032 = (2/x) u2 divided by width, in radians, of a 22.5 sector Average effluent concentration, X, normalized to (X/Q)p - source strength, 0, at distance x in sector D. For WCGS the above Meteorological Model will simplify to the following equation for X/Q: 2.032 Eng U
=
(X / Q)D N Ui x [(x) U The calculation of the relative dispostion per unit area, D/Q, is performed using the deposition rate graphs found in Reg. Guide 1.111. For a 22.5 sector, since the effluent concentration is assumed uniform across the sector, the relative deposition per unit area is assumed uniform across the sector. I 1 The calculation of D/O is determined from relative deposition by the following relationships D3 (x) . DEPLo (x) D/Q = l 0 (2 n /16)x Where: Do (x) = Relative deposition rate for windspeed class i and stability class j at downwind distance x (1/m). See Figure B.3. (2n/16)x = length of arc across sector at downwind distance x (m). D/O = relative deposition per unit area (m) DEPLy (x) = Reduction factor due to plume depletion at distance x for windspeed i and stability class j- i l l i B-3 ADM 04-019 Rev. 5 Page 199 of 202 O m>McJ s;gg;.gg,c -' me: > ., r,4 ,.s q 4) ,.
'~ wm _ _ _ _ _ _ _ _ _ _ _ _ . . _ _ _
E
- i r
Figure B.1'
,, . i i m r1.--- .
1000 1 si . ,
/ / 41 / .
i y -- j I / / l / / / i < -
) / / ./
/ /
/ / / /
/ ./ ,/ ' /
/
' i A
f' .
- .- y
' / / /
,no 1 r 1 ,
/
/ / / /
a C j
/ / s' _
/ .' .' / s' .s " j j / ,. / t ,/ ,
s i ,- . s' ' /
~
/ / / y , . , 3 --
' ' W
$ -/ / / o f2 / _f t j /// /i!/' f y1
~ / / , // v/ / l
' O i 10 1 / .- 1 i s,. ! is .
s
/ , . . . . .
/ / / e sr s ,
et i st l p- / / I /' i
/ / yl A s 81 s s I eiet
/ I/ l _V l ' li i! I I I ll 1 I i i ili
/ / ll Ll !
{ l lll l
/ - / ;
/ -
I 0.1 1.0 10 100 f PLUME TRAVEL DIST ANCE (KILOMETERS)
- i verticat Standard Deviation of Materialin a Plurrie (Letters denote Pasquitt Stability Class) i tJO T E : THESE ARE $ T ANOAnD (tE t A T80N$4tif'$ AND t.1AY M AVE TO DE f MOOtFt(O FOR CEnTAIN TYPE $ Or TEnR AIN AND/ Ort Cttr.tA Tsc CONOtTsor45 IE.C.. V ALLE V. OE SE sit. OVE ft WA T E ft t.
B-4 ADM 04-019 Rev. 5 i Page 200 of 202 O 4m.fes W)Mtist ?Ti@fspig';W 7,5;mpgjg.154Wy.g{.;gggiffgg5g 'qgy ,, ; p- , c-o
Figure B.2 o q o Od 9
} o pi o e
/
/
/
/
/
/
A us C w H w I - o, 2 o
/ 6 SJ f
/ Q
~
f w o 1 / : 1 l <
/ 8 F vi f i a
5 i
/ ! w c2 c
F m ) / 2 O
/ ,,.
c-I
/ . i i t
te I f (i ' I
/
I
/
I
/
I
- o c3 % 9 m n e. c? -
o: o o o o o c' o o d o
.:t13d til 'J:.:.:s vv:ial taos 1Jy: .
ADM 04-019 Rev. 5 Page 201 of 202 3
"^
act.n ri r,r.. ?:.:gt:1, tygggypg;34..g.; g g; -
Figure G.3 l 1 f 3 i' l io-3 ,
, ;':' i
. i , ,
4 l l io 4 N w N m c N, w s
- r. -
\
W
' X ~
a w s m N r
< ss cr <
N -s
.m ~
a 3.s o , i s x . , . . . .
, I I I I
_ . .I g % l M 4 ai ~x i I tii i 2 s. 4 I i 1_i III' l g Il I
'% l l l N
if p l I l\_
,~,
ll c
.. i w
e
' l . x y
10-6 ., .
.. 1 j l .I i 4
j 4 e f l1 i
, 'i 1 1' I
10-7 100.0, 200.0 1.o 10.0 0.1 PLUt.1F TRAVEL DIST ANCE (KILOMETERS) B-6 ADM 04-019 Rev. 5 Page 202 of 202 r.. . e '"F.',Q 1:gp,3 , i .-i- .,.
-_ . 3}.
MMT 7.2T3" M r.?,; py ig ;4.g q q 3;ty.ggeypj'f( Jg;igip; '
- f. " . - -
[a s' BATCH PRINTING REQUEST HEADER' l i SUBMITTED BY: wense : WOLF ' CREEK: FileN2t DATE: Apr 26, 1995 (Wed) l DOCUMENTS REQUESTED: , ADM 04-019 1 5~ j DOCUMENTS NOT FOUND ON IMAGING SYSTEM:
..................--......... _______ i i N/Al r F
f I t 4 f , t i e I f I 7 P h r f I f 1-l t 4 - r+ I-a--' w -}}